
<html lang="en"     class="pb-page"  data-request-id="d99d521b-0262-4344-b417-6579a2bbedbb"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2014.57.issue-6;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm400658e"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?" /></meta><meta name="dc.Creator" content="Lucienne  Juillerat-Jeanneret" /></meta><meta name="dc.Description" content="The proline-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26), widely expressed in mammalians, releases X-Pro/Ala dipeptides from the N-terminus of peptides. DPP IV is responsible of the ..." /></meta><meta name="Description" content="The proline-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26), widely expressed in mammalians, releases X-Pro/Ala dipeptides from the N-terminus of peptides. DPP IV is responsible of the ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 24, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400658e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400658e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400658e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400658e" /></link>
        
    
    

<title>Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400658e" /></meta><meta property="og:title" content="Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0008.jpeg" /></meta><meta property="og:description" content="The proline-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26), widely expressed in mammalians, releases X-Pro/Ala dipeptides from the N-terminus of peptides. DPP IV is responsible of the degradation of the incretin peptide hormones regulating blood glucose levels. Several families of DPP IV inhibitors have been synthesized and evaluated. Their positive effects on the degradation of the incretins and the control of blood glucose levels have been demonstrated in biological models and in clinical trials. Presently, several DPP IV inhibitors, the “gliptins”, are approved for type 2 diabetes or are under clinical evaluation. However, the gliptins may also be of therapeutic interest for other diseases beyond the inhibition of incretin degradation. In this Perspective, the biological functions and potential substrates of DPP IV enzymes are reviewed and the characteristics of the DPP IV inhibitors are discussed in view of type 2 diabetes and further therapeutic interest." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400658e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400658e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400658e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400658e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400658e&amp;href=/doi/10.1021/jm400658e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2197-2212</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4005847" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm401603e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucienne++Juillerat-Jeanneret">Lucienne Juillerat-Jeanneret</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">University Institute of Pathology, CHUV-UNIL, Bugnon 25, CH-1011 Lausanne, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Phone: +41 21 314 7173. Fax: +41 21 314 7115. E-mail: <a href="/cdn-cgi/l/email-protection#8de1f8eee4e8e3e3e8a3e7f8e4e1e1e8ffecf9cdeee5f8fba3eee5"><span class="__cf_email__" data-cfemail="224e57414b474c4c470c48574b4e4e4750435662414a57540c414a">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400658e&amp;href=/doi/10.1021%2Fjm400658e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2197–2212</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 7, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2013</li><li><span class="item_label"><b>Published</b> online</span>24 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 March 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400658e" title="DOI URL">https://doi.org/10.1021/jm400658e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2197%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLucienne%2BJuillerat-Jeanneret%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D6%26contentID%3Djm400658e%26title%3DDipeptidyl%2BPeptidase%2BIV%2Band%2BIts%2BInhibitors%253A%2BTherapeutics%2Bfor%2BType%2B2%2BDiabetes%2Band%2BWhat%2BElse%253F%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2212%26publicationDate%3DMarch%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400658e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3509</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">113</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400658e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Dipeptidyl Peptidase IV and Its Inhibitors: Therapeutics for Type 2 Diabetes and What Else?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Lucienne&quot;,&quot;last_name&quot;:&quot;Juillerat-Jeanneret&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;2197-2212&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400658e&quot;},&quot;abstract&quot;:&quot;The proline-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26), widely expressed in mammalians, releases X-Pro/Ala dipeptides from the N-terminus of peptides. DPP IV is responsible of the degradation of the incretin peptide hormones regulating blood glucose levels. Several families of DPP IV inhibitors have been synthesized and evaluated. Their positive effects on the degradation of the incretins and the control of blood glucose levels have been demonstrated in biological models and in clinical trials. Presently, several DPP IV inhibitors, the “gliptins”, are approved for type 2 diabetes or are under clinical evaluation. However, the gliptins may also be of therapeutic interest for other diseases beyond the inhibition of incretin degradation. In this Perspective, the biological functions and potential substrates of DPP IV enzymes are reviewed and the characteristics of the DPP IV inhibitors are discussed in view of type 2 diabetes and further therapeutic interest.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400658e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400658e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400658e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400658e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400658e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400658e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400658e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400658e&amp;href=/doi/10.1021/jm400658e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400658e" /></input><a href="/doi/pdf/10.1021/jm400658e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400658e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400658e%26sid%3Dliteratum%253Aachs%26pmid%3D24099035%26genre%3Darticle%26aulast%3DJuillerat-Jeanneret%26date%3D2014%26atitle%3DDipeptidyl%2BPeptidase%2BIV%2Band%2BIts%2BInhibitors%253A%2BTherapeutics%2Bfor%2BType%2B2%2BDiabetes%2Band%2BWhat%2BElse%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D6%26spage%3D2197%26epage%3D2212%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=291497" title="Differential pulse voltammetry">Differential pulse voltammetry</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jmcmar.2014.57.issue-6/production/jmcmar.2014.57.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0008.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The proline-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26), widely expressed in mammalians, releases X-Pro/Ala dipeptides from the N-terminus of peptides. DPP IV is responsible of the degradation of the incretin peptide hormones regulating blood glucose levels. Several families of DPP IV inhibitors have been synthesized and evaluated. Their positive effects on the degradation of the incretins and the control of blood glucose levels have been demonstrated in biological models and in clinical trials. Presently, several DPP IV inhibitors, the “gliptins”, are approved for type 2 diabetes or are under clinical evaluation. However, the gliptins may also be of therapeutic interest for other diseases beyond the inhibition of incretin degradation. In this Perspective, the biological functions and potential substrates of DPP IV enzymes are reviewed and the characteristics of the DPP IV inhibitors are discussed in view of type 2 diabetes and further therapeutic interest.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proteolytic post-translational modification of peptides by peptidases, either secreted, cell surface, or intracellular enzymes, is a major regulatory event for biologically active peptides. Peptidases may activate or inactivate or modulate the activities of biological peptides. Therefore, peptidase activities are major targets for the development of drugs aimed at treating human disorders, such as cancer, degenerative, immune/inflammatory, and metabolic disorders, and selective inhibitors for peptidases are in clinical use or are under development. This includes the development of inhibitors for a peptidase that has been involved in the pathogenesis of the metabolic disease type 2 diabetes (T2D), the prolyl-specific dipeptidyl aminopeptidase IV (DPP IV, DPP-4, CD26). Many biologically active peptides are protected from general proteolytic degradation by evolutionary conserved prolyl (Pro) residues that induce conformational constraints in peptide hormones.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Only a few Pro-specific proteases have been described.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8 ref9 ref10">(2-10)</a> However, presently, inhibitors for only one prolyl-specific peptidase, the DPP IV peptidase, are in clinical use and under further clinical development for the control of T2D.</div><div class="NLM_p">T2D is a metabolic disease linked to aging, hypertension, and obesity. T2D complications involve dysfunction of the ocular, the nervous, the renal, and the cardiovascular systems. T2D arises as a consequence of resistance to insulin action. In response to food intake and an increase in blood glucose, the incretin hormones glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are released by the gut. These hormones bind to their respective receptors, potentiating insulin synthesis and secretion, inhibiting glucagon release, and reducing glucose production by the liver. Altogether in a normal situation these effects result in a decrease in blood glucose. In T2D, following secretion these incretin hormones are rapidly degraded into inactive peptides by the enzyme DPP IV, present in the blood and ubiquitously expressed at the surface of endothelial and epithelial cells. The hydrolysis of incretins by DPP IV inhibits the normal functions of these hormones. Evidence in vivo in experimental animal models and in initial clinical trials has demonstrated that DPP IV inhibitors have therapeutic potential in the long term chronic treatment of T2D, delaying disease progression and decreasing the circulating levels of glycated hemoglobin (HbA1c), which is used as a reporter for long-term hyperglycemia.</div><div class="NLM_p last">As stated above, DPP IV catalyzes the cleavage of GLP-1(7–36) to GLP-1(9–36) and of GIP(1–42) to GIP(3–42), respectively. The unhydrolyzed hormones mediate glucose-stimulated insulin secretion, while the truncated versions are antagonists of the binding of the hormones to their receptors. DPP IV is hence a relevant target for the therapeutic control of T2D. The main player of this pathway, GLP-1 (GIP being of lower relevance than GLP-1 in the context of T2D), is a gastrointestinal hormone released by the intestine but that targets the pancreas where it enhances glucose-induced insulin secretion and also induces satiety. As GLP-1 is rapidly inactivated by DPP IV, inhibitors of DPP IV increase the circulating levels of the endogenous bioactive GLP-1.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Orally active small molecule agonists of GLP-1-receptors, GLP-1 infusion, or DPP IV-resistant GLP-1 analogues represent other possibilities than DPP IV inhibitors to treat T2D. However, parenteral administration of these peptides is necessary for such therapeutic approaches. Presently, standard pharmacological antidiabetic treatments include sulfonylureas (tolbutamide, glyburide, etc.), glinides (repaglinide, nateglinide), biguanides (metformin), glitazones (rosigliztazone, pioglitazone), and α-glucosidase inhibitors (miglitol, acarbose). These agents have important side effects, like weight gain, edema, digestive problems, and importantly, hypoglycemic episodes. Such side effects are not shared by the DPP IV inhibitors, collectively called the “gliptins”, and by metformin. In this Perspective, I will concentrate on the development of inhibitors of DPP IV initially developed for T2D, which are now in clinical use, and on the evaluation of some of the new inhibitors presently under experimental and clinical development. I will also review some of the other potential biological pathways, other than the incretin system, that may be modified by the inhibitors of DPP IV.</div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Proteic and Enzymatic Characteristics of the DPP IV Aminodipeptidase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Dipeptidyl aminopeptidase IV (DPP IV/DPP-4/CD26, EC 3.4.14.5) is a dimeric type II integral membrane glycoprotein of 766 amino acids able to release X-Pro or X-Ala dipeptides from the free N-terminal sequence of peptides. The protein consists of a small cytoplasmic domain, a transmembrane domain, and a large extracellular domain containing the active site. The <i>DPP IV</i> gene is constituted of 26 exons. The promoter contains no TATA or CAAT box but NFkB, AP2, and Sp1 binding sites and is GC-rich, suggesting potential regulation of its expression by promoter methylation. In support of this hypothesis, we have previously shown that detection of DPP IV mRNA does not always correlate with protein expression and enzymatic activity.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The 3D-structure of DPP IV (X-ray crystal structure) and the crystal structure of DPP IV bound to its inhibitors have been determined.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16 ref17">(13-17)</a> The enzyme is a homodimer (the crystallized porcine enzyme may be a symmetric tetramer, depending on the gylcosylation of the β-propeller<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a>). Each subunit comprises a C-terminal α/β-hydrolase domain encompassing the enzymatic active site, and a N-terminal eight-bladed β-propeller domain.<a onclick="showRef(event, 'ref13 ref15 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref15 ref18">(13, 15, 18)</a> A large cavity located between the domains contains the inhibitor binding pocket (Glu205, Glu206, and Arg125) provided by both subunits. The free N-terminal amine of the substrate binds to Glu205, and Arg125 stabilizes the amide carbonyl. The binding pocket for the Pro residue of the substrate is formed by hydrophobic aromatic amino acids from the α/β hydrolase domain, with no space for large substituents at that position. The information obtained for the DPP IV family of peptidases suggests that the substrate accesses the buried active site through the β-propeller and that the products leave through a different exit site. The Gly-Trp-Ser-Tyr-Gly sequence around the active Ser, and the organization of the catalytic triad is conserved in the DPP IV family members.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6">(2-6)</a> The active site Ser (Ser630) can form an imidate with nitrile-bearing inhibitors (cf. below). From these observations, several families of inhibitors have been designed and synthesized and their inhibitory potential evaluated on purified enzymes.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23 ref24">(19-24)</a> Surprisingly and interestingly, a wide variety of structures demonstrated inhibitory potential for DPP IV activity, suggesting low stringency but also a wide range of binding modes for inhibitors. As a consequence, a huge number of different chemical structures and analogues have been designed and developed as DPP IV inhibitors. Their effects have been determined using purified enzymes, biological models, and clinical trials, suggesting therapeutically interesting properties (cf. below).</div><div class="NLM_p">DPP IV belongs to a family of prolyl-specific proteases that contains several closely related members: DPP-2/QPP, DPP-8, DPP-9, FAP-α, and POP/PREP (for a more detailed review, see refs <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a> and <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>). Most prolyl-specific peptidases belong to the class of serine proteases and may be secreted, cell-membrane inserted, or intracellular proteins. However, the observation that these proteases are ubiquitously expressed in various cellular locations, and with comparable overlapping enzymatic activities, is challenging for the development of selective inhibitors and also for defining the biological target(s) of these inhibitors. The information previously obtained suggests that inhibitor selectivity is of utmost importance to avoid side effects and toxicity. DPP IV and FAP-α (fibroblast activation protein-α/seprase) share the highest sequence homology. Therefore, the biological effects of DPP IV inhibitors attributed to DPP IV may be related to other members of the family. The serine protease enzymes of the DPP IV family exhibit similarities in their catalytic behavior: preference for Pro in P1-position, similar rate constants, and catalytic mechanisms different from those of other serine proteases of the trypsin and subtilisin families. Nearly all peptides bearing an X-P or X-A sequence (X is variable) are potential substrates for DPP IV, including cytokines, chemokines, and growth factors. DPP IV-mediated limited proteolysis of these peptides results in their activation or modulation of activity or initiation of degradation.<a onclick="showRef(event, 'ref4 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref4 ref25 ref26">(4, 25, 26)</a> It has been postulated that DPP IV inhibitors may prolong the half-life of the nonhydrolyzed forms of these peptides, thus enhancing their bioactivity, or on the contrary may block their activation. However, as stated above, the therapeutic efficacy of DPP IV inhibitors has been mainly demonstrated for the peptides involved in the pathogenesis of T2D.<a onclick="showRef(event, 'ref4 ref25 ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref4 ref25 ref27 ref28 ref29 ref30">(4, 25, 27-30)</a></div><div class="NLM_p">DPP IV has several different functions: (i) as already stated, as a regulatory protease involved in the digestion of Pro/Ala-containing oligopeptides and nutrients and in the absorption of their fragments; (ii) as a binding protein, in particular for collagens I and III via the DPP IV Cys-rich domain, independent of its enzymatic activity; (iii) as a receptor associated with CD45 and adenosine deaminase (ADA); (iv) as a costimulatory molecule for lymphocytes, DPP IV being known as CD26 in the immune context. DPP IV is widely expressed in epithelial and nonepithelial tissues, the highest expression being observed in the kidney and the colon, and can be released from the cell membrane into the blood.</div><div class="NLM_p last">Several families of DPP IV inhibitors have been synthesized, with increased selectivity for DPP IV versus the other members of the family. However, only DPP IV inhibitors will be considered in this Perspective. They will be reviewed first as antidiabetic drugs able to protect the incretin peptide hormones from rapid degradation (cf below), and then other possible substrates and functions for this enzyme and its inhibitors will be assessed. It is also emphasized that other proteolytic enzymes, and their associated inhibitors, are involved in the degradation of GLP-1, in addition to DPP IV, which may have therapeutic importance<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and may have to be considered in the future for development of therapeutics.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Initial Development of DPP IV Inhibitors in Clinical Use for Type 2 Diabetes (T2D)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74123" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74123" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peptidomimetics were the first class of DPP IV inhibitors designed and evaluated. As they were associated with poor biological stability, nonpeptidomimetic inhibitors were then developed. Covalent and noncovalent inhibitors of DPP IV have been designed, developed, and evaluated in vitro, in vivo, and in clinical trials. Several synthetic routes were explored during these initial developments,<a onclick="showRef(event, 'ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36 ref37 ref38 ref39 ref40 ref41 ref42 ref43 ref44 ref45 ref46 ref47 ref48 ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref58 ref59">(34-59)</a> which will not be described in depth in this Perspective. We and many others have recently reviewed these initial developments.<a onclick="showRef(event, 'ref28 ref32 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref28 ref32 ref60 ref61">(28, 32, 60, 61)</a> Thus, only the most relevant information, and in particular the information concerning the molecules that were evaluated in humans, will be provided here. A detailed model of the binding of nonpeptidomimetic inhibitors to DPP IV is provided in an extensive, detailed, and excellent review<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> of the development of DPP IV inhibitors. The readers interested in obtaining extensive information on the SAR development of DPP IV inhibitors and their modeling into DPP IV are referred to this review. This model and all other models propose that a primary amine, an aromatic ring, and a variable substituent are necessary on the core scaffold. The C-terminus of the enzyme consists of the catalytic triad Ser630, Asp708 (Asn710), His740, and the hydrophobic S1 pocket (Tyr631, Val656, Trp659, Tyr662, Tyr666, Val711). The S2 pocket (Arg125, Glu205, Glu206, Phe357, Ser209, Arg358) is involved both in the key salt bridge interactions of cationic groups with Glu205 and Glu206 and in the main binding site involving the residues Ser209, Phe357, Arg358, allowing inhibitor selectivity for DPP IV over DPP-8 and DPP-9. In the schematic representation of the binding of DPP IV inhibitors to the enzyme shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, the example represents a covalent theoretical inhibitor and only the minimal amino acids that have been most frequently involved in the binding. Because of the large diversity of the chemical structures able to inhibit DPP IV, each inhibitor will display a slightly or largely different mode of binding than this theoretical covalent inhibitor, involving other amino acids in the S2 pocket binding site and S1 selectivity pocket of the enzyme.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Amino Acids Involved in the Binding of Inhibitors to DPP IV</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Different core scaffolds and analogues have been explored: xanthine analogues, quinazolinone and pyrimidone analogues, β-homophenylalanine analogues, (constrained) phenethylamine analogues, arylmethylamine analogues, aminobenzo[α]quinolizine analogues, and sulphostin analogues. Their modes of binding to DPP IV have been proposed (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> The impact of specific substituents of the different scaffolds on the inhibitory activity, selectivity, and side effects was also analyzed in detail in this extensive review. The most relevant information from SAR studies can be summarized as follows. For xanthine analogues, an aminopiperidine or piperazine group was necessary for inhibition. Substituents of the N-7 position occupying the S1 pocket allowed control of selectivity. Optimization of xanthine scaffolds afforded quinazolinone and pyrimidinone analogues. For this series, a 2-cyanobenzyl group occupying the S1 pocket interacted with Arg125, while the R-aminopiperidine group formed a salt bridge. A phenyl ring on the quinazolinone scaffold improved selectivity, while pyrimidinone analogues displayed better pharmacokinetic profiles. For β-homophenylalanine scaffolds, a trifluorophenyl group was optimal to occupy the S1 pocket. The chirality of the amino group was important for inhibition, and the physicochemical characteristics of the substituents of the amide carbonyl were important for occupancy of the S2 pocket. Starting from β-homophenylalanine scaffolds, constrained phenethylamine analogues were prepared. SAR studies demonstrated that a trifluorobenzyl group on the ring was optimal to fill the S1 pocket, while substituents on the 4-position of the central ring allowed occupying the S2 pocket. Arylmethylamine analogues need a central rigid aromatic core able to form a π–π interaction with Arg125 and another substituent able to form a salt bridge. The filling of the hydrophobic S1 pocket with a substituted phenyl ring is necessary, while the filling of the S2 pocket is less strictly defined. The optimization of aminobenzo[α]quinolizine mainly focused on the substituents occupying the S1 pocket. Finally, the analogues of sulphostin (3(<i>S</i>)-amino-1-((<i>R</i>)-amino(sulfoamino)phosphinyl)-2-piperidone, a DPP IV inhibitor isolated from culture broth of <i>Streptomyces</i> sp., structure not disclosed) displayed the best potency if the central lactam ring was five-membered with an <i>S</i> C-3 configuration. More recently new possibilities have also been explored. For example, a carboxyl-group-based DPP IV inhibitor demonstrated an ionic interaction with Arg125<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and good pharmacodynamic and pharmacokinetic properties.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Binding Modes of the Different Scaffold-Based Analogues in the DPP IV Enzyme [Adapted from Ref <a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">61</a>]</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first inhibitors of DPP IV available were the tripeptides diprotin A (Ile-Pro-Ile) and diprotin B (Val-Pro-Leu), which likely act as competitive substrates. The first classes of DPP IV inhibitors evaluated were substrate analogues bearing a pyrrolidine ring. The first biological validation of DPP IV as a therapeutic target was provided by <b>1</b> (Val-Pyr), which was also evaluated in an X-ray crystal structure of DPP IV.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> The results then allowed for the synthesis of new pyrrolidine analogues with optimized properties by several academic and industrial groups. α-Aminoacylpyrrolidine derivatives have been exploited to synthesize reversible DPP IV inhibitors. Considering the selectivity of DPP IV for Pro at the P1 position, DPP IV inhibitors having five-membered heterocyclic rings mimicking proline were designed. However, it is emphasized that GLP-1, the initial target of DPP IV inhibition, has an Ala at that position. A free N-terminal amino group is mandatory for substrate binding to DPP IV, whereas any amino acid is permitted at this position, with branched amino acids being preferred. The requirement of DPP IV for a free N-terminal amine allows selectivity over prolyl endopeptidases, and the accommodation of pyrrolidine at the cleavage site allows for selectivity over other <i>exo</i>-amino(di)peptidases. Potency depends on the presence of an electrophile at the 2-position of the pyrrolidine ring, able to form an adduct with the Ser (Ser630) of the enzyme active site. Thus, small molecules bearing electrophiles able to interact with the catalytic serine have been mostly designed. Product-like inhibitors lacking an electrophile are more stable in biological media but generally less potent. One example is <b>2</b> (P32/98) (<i>K</i><sub>i</sub> = 126 nM), which has been evaluated in early phase clinical trials only.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. DPP IV Inhibitors Evaluated in Initial Clinical Trials</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Irreversible inhibitors have also been identified. In light of the substrate specificity of DPP IV, aminoacylpyrrolidine derivatives bearing an electrophile at the 2-position of the ring have been initially explored to increase potency. Then compounds targeting the active site serine and containing diphenylphosphonate esters or <i>O</i>-acylhydroxamic acids were developed as irreversible inhibitors of DPP IV, while the presence of a boronic acid or nitrile moieties provides slowly reversible potent covalent inhibitors. The most explored covalent inhibitors are those containing a nitrile at that position. The nitrile, boronic acid, and diphenylphosphonate electrophilic groups can lead to biological stability issues and unfavorable pharmacokinetic and pharmacodynamic profiles. However, this is not always true, since, for example, <b>5</b> (vildagliptin/LAF237,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> structure shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, now approved for clinical use in Europe), which is a nitrile-based DPP IV inhibitor, does not have all of the biological issues cited above. Thus, the development of <b>3</b> (NVP-DPP728) has been discontinued in favor of <b>5</b>, which has a better pharmacokinetic profile. The replacement of the pyrrolidine with heterocycles, thiazolidine, piperidine, homopiperidine, and oxalidine has also been explored.<a onclick="showRef(event, 'ref28 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref28 ref34 ref35">(28, 34, 35)</a> Consistent with the substrate specificity at the P2, a wide range of side chains are tolerated, but at that position a free N-terminal is required. N-Substituted glycine derivatives, including the bulky adamantyl group, have also been explored as DPP IV inhibitors, resulting in compounds <b>3</b> (IC<sub>50</sub> = 22 nM) and <b>5</b> (IC<sub>50</sub> = 3.5 nM). Structures devoid of peptide-like character, like xanthine, isoquinoline, and isoquinolinone derivatives, are also potentially interesting scaffolds that were explored. Selectivity over other exopeptidases of the DPP IV family, with very similar activity, active site, and kinetics properties, was more difficult to achieve. The biological functions of most of the enzymes of the DPP IV family may recover the enzymatic functions of DPP IV. Therefore, selectivity is an important consideration in designing inhibitors; in particular selectivity toward FAP-α/seprase was the most difficult to achieve. Inhibitors without an electrophilic group were also developed but at the price of a loss of selectivity for DPP IV versus the other dipeptidyl peptidases of the family, DPP-2, DPP-8, and DPP-9.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">Early inhibitors of DPP IV (<b>3</b>, <b>5</b>, or <b>4</b> (MK-0431/sitagliptin))<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> were therefore evaluated in preclinical or clinical trials for the potentiation of the effects of GLP-1 for the treatment of T2D. They were safe and well-tolerated and dose-dependently inhibited DPP IV activity, decreasing the circulating levels of glucose and of glycated hemoglobin (HbAc1), a marker for chronic hyperglycemia in diabetic patients, with few side effects.<a onclick="showRef(event, 'ref29 ref64'); return false;" href="javascript:void(0);" class="ref ref29 ref64">(29, 64)</a> As inhibition of off-target enzymes has been associated with toxicity, selectivity was important, and the initial trials have demonstrated safety of these drugs. The clinical evaluation of these drugs has demonstrated a large tolerability, safety, and efficacy. Adverse effects of DPP IV inhibitors, including nasopharyngitis, headache, nausea, hypersensitivity, skin reactions, and pancreatitis have been observed, but with the exception of pancreatitis, they were minor problems. Importantly, compared to the earlier treatments for T2D, they displayed the advantage of not inducing weight gain, edema, and hypoglycemia.</div><div class="NLM_p">A nonsubstrate-like noncovalent inhibitor bearing an aromatic ring instead of a proline mimetic led to the discovery of compound <b>4</b>, the first DPP IV inhibitor that was approved by the FDA for the treatment of T2D.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Since these initial trials, numerous clinical trials for DPP IV inhibitors have been conducted (for reviews and reports of the results of the clinical trials for approved drugs, see refs <a onclick="showRef(event, 'ref65 ref66 ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67 ref68 ref69 ref70">65−70</a>), resulting in the approval and marketing of six DPP IV inhibitors, collectively called the “gliptins”: <b>4 (</b>sitagliptin/MK-0431),<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a><b>5</b> (vildagliptin/LAF237),<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a><b>6</b> (saxagliptin/BMS-477118),<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a><b>7</b> (alogliptin/SYR-322),<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a><b>8</b> (linagliptin/BI-1356),<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> and <b>9</b> (gemigliptin/LC15-0444)<a onclick="showRef(event, 'ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref74 ref75">(-74, 75)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. DPP IV Inhibitors, the “Gliptins” Presently Approved for Clinical Use<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0006.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">LGLS, LG Life Sciences; DCPC, Double Crane Pharmaceuticals Co.; BMS, Bristol-Myers Squibb.</p></div></div><div></div></div><div class="NLM_p">The biological characteristics of the gliptins differ. Compound <b>4</b><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> is a reversible inhibitor, which is not rapidly metabolized in human, allowing a once a day dosing. Compound <b>5</b> forms a reversible covalent bond between its cyano group and the active site serine (Ser630), which is readily hydrolyzed into an inactive metabolite. Compound <b>5</b> is rapidly cleared, requiring twice daily dosing. Incorporation of steric bulk was one of the techniques used to improve the chemical stability of cyanopyrrolidines, and this led to development of compounds <b>5</b><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and <b>6</b>.<a onclick="showRef(event, 'ref60 ref72'); return false;" href="javascript:void(0);" class="ref ref60 ref72">(60, 72)</a> In the search for biologically stable DPP IV inhibitors azetidine-based compounds like 2-cyanoazetidines, 3-fluoroazetidines, and 2-ketoazetidines with activity below 100 nM were also developed.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Compound <b>7</b> was discovered during attempts to increase the metabolic stability of quinazoline-based compounds by replacing the quinazoline moiety with pyrimidinedione.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Compound <b>8</b><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> is a methylxanthine-based drug, exhibiting good selectivity for DPP IV compared to the other members of the family. X-ray studies of compound <b>8</b> complexed with DPP IV have shown that its butynyl substituent occupies the S1 hydrophobic pocket, the aminopiperidine of the xanthine scaffold occupies the S2 subsite, and its primary amine interacts with the key aminoacids of the substrate site. Compound <b>9</b> was only very recently approved and is presently marketed only in Korea. Its pharmacodynamic and pharmacokinetic properties allow for once a day dosing as a monotherapy for T2D.</div><div class="NLM_p">Extensive reviews of the pharmacotherapeutic characteristics of the gliptins in clinical studies in 2011 and 2012 (with the exception of <b>9</b> which was approved later than the others), their safety and efficacy profiles, have been recently published.<a onclick="showRef(event, 'ref77 ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref79">(77-79)</a> The results of the clinical trials demonstrated excellent profiles for this class of therapeutics. However, long-term surveillance for the development of pancreatitis and/or pancreatic cancer and a better understanding of the mechanism of action of the gliptins other than the incretins protection and T2D will be required.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">How do these gliptins differ between them, and how do they compare with other antidiabetic therapies from a clinical point of view? Unfortunately, presently, direct comparisons of the gliptins in head-to-head clinical trials are very scarce. Most of the clinical trials of gliptins have compared the decrease in glycated hemoglobin or plasma glucose versus placebo or an antidiabetic drug of another class. But the trial designs and the medical characteristics of the patient cohorts differed between the trials, thus adding to the inherent heterogeneity of human clinical trials. However, all authors<a onclick="showRef(event, 'ref77 ref79 ref80 ref81 ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref77 ref79 ref80 ref81 ref82 ref83">(77, 79-83)</a> who have analyzed these comparisons agree that the clinical benefit and profile of the gliptins are generally very similar in terms of efficacy and safety profiles, all inducing a decrease of glycated hemoglobin of about 0.8% without episodes of hypoglycemia, without weight gain, and without adverse side effects including gastrointestinal adverse effects as seen with metformin. No significant drug–drug interactions with the other antidiabetics have been observed. Compound <b>6</b> may interfere with CYP3A4/5 for the metabolism of other drugs. Initially, an increased risk of pancreatitis and pancreas and thyroid cancers had been suggested for patients under gliptin therapy, but recent clinical analyses have not supported this possibility.</div><div class="NLM_p">There are some clinically relevant similarities and differences between these molecules. All gliptins are orally available, low nanomolar inhibitors of DPP IV activity (IC<sub>50</sub>: 19 nM for <b>4</b>, 62 nM for <b>5</b>, 50 nM for <b>6</b>, 24 nM for <b>7</b>, and 1 nM for <b>8</b>), long-lasting (over 70% plasma DPP IV activity inhibition 24 h postdose), do not interfere with food intake, and are selective at different levels versus DPP-8 and DPP-9, compounds <b>5</b> and <b>6</b> being the least selective. The inhibition of DPP-8 and DPP-9 was related to toxicity in preclinical evaluation, but it has to be remembered that species differences exist. The selectivity versus the other peptidases of the DPP IV family is less homogeneous; selectivity versus DPP-2 was always high, whereas <b>5</b> and <b>8</b> are less selective drugs versus FAP-α. Some DPP IV inhibitors are peptidomimetics (compounds <b>5</b> and <b>6</b>), and some are not (compounds <b>4</b> (β-amino acid based), <b>7</b> (pyrimidinedione-based), <b>8</b> (xanthine-based)). In general, the peptidomimetics are less selective for DPP IV versus DPP-8 and DPP-9. Inhibitors that form noncovalent interactions may result in potent immediate inhibition but of shorter duration. Covalent inhibitors forming a reversible, slowly dissociating complex can result in more persistent inhibition. But drug metabolism also has to be considered. For example, the cyano group of compound <b>5</b> is hydrolyzed by DPP IV; thus, <b>5</b> is both an inhibitor and a substrate of DPP IV. Covalent inhibitors are likely more prone to induce an antigenic reaction. Compounds <b>4</b> and <b>7</b> are not appreciably metabolized and are excreted unmodified by the kidney. Compound <b>5</b> is metabolized into inactive metabolites, whereas compound <b>6</b> is oxidatively metabolized into active metabolites, and both metabolites and drugs are excreted by the kidney. Renal elimination implies that the doses must be adjusted for patients with kidney disease. Interestingly, compound <b>8</b> is not extensively metabolized and is not excreted by the kidney but by biliary secretion; thus, the clinical use of this gliptin does not require dose adjustment for patients with kidney diseases.</div><div class="NLM_p last">Therapeutic dosages of the different gliptins are very different: <b>4</b> is used at 100 mg once a day, <b>5</b> at 50 mg twice a day, <b>7</b> at 25 mg once a day, and <b>6</b> and <b>8</b> at 5 mg once a day. Half-lives of the drugs in plasma are also very different: compounds <b>5</b> and <b>6</b> display the shortest plasma half-lives, about 2 h, in humans. However, <b>6</b> can be dosed once a day, even if displaying an apparent short half-life, since active metabolites are produced, while <b>5</b> needs to be dosed twice a day. It has also to be kept in mind that some of the drugs are covalent inhibitors, whose persistence of inhibition may last longer than suggested by plasma drug levels, which is particularly true for <b>5</b>. Also very importantly, it has to be considered that most of the DPP IV in the human body is cell-bound, for which persistence of inhibition cannot be determined, rendering a direct evaluation of DPP IV inhibition in the clinic and the direct comparison of these drugs over time even more difficult. Thus, evaluation of DPP IV inhibition in plasma may not always be representative of the effect of DPP IV inhibitors in the tissues. Gliptins are generally considered as second-line therapy, after metformin therapy, in combination with another antidiabetic agent. However, on the basis of all the above considerations, the choice of a particular gliptin by the clinician will likely depend on the clinical characteristics of the patient.</div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">More Recent DPP IV Inhibitors under Development</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The clinical success of the gliptins following the initial approval of compound <b>4</b> has also stimulated the field to develop and evaluate additional DPP IV inhibitors in order to obtain drugs with improved properties. Several excellent recent reviews have been published covering the development of potential new therapeutic DPP IV inhibitors;<a onclick="showRef(event, 'ref28 ref32 ref61'); return false;" href="javascript:void(0);" class="ref ref28 ref32 ref61">(28, 32, 61)</a> thus, only the most relevant findings will be discussed in this Perspective and only the very recent publications, covering 2011 to early 2013, will be discussed here in more detail. Several new molecules have reached different phases of clinical trials (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), including for example <b>14</b> (anagliptin/SK-0403),<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84, 85)</a><b>18</b> (DA-1229),<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a><b>19</b> (E3024),<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a><b>20 (</b>TAK-100),<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> or the long-lasting compounds <b>10</b> (omarigliptin/MK-3102<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and PKF-275-055 (structure not disclosed),<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> or are in preclinical evaluation (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Examples of DPP IV Inhibitors under Different Phases of Clinical Trials<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0007.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">disc: discontinued.</p></div></div><div></div></div><div class="NLM_p">Starting from a xanthine scaffold, deazaxanthine compounds were prepared as a novel class of DPP IV inhibitors.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Peptidomimetic DPP IV inhibitors of the α-series are mainly represented by pyrrolidines, the C2 substituent allowing the design of irreversible (diphenyl phosphonates and <i>O</i>-acylhydroxamic acid) or slowly reversible (boronic acid and nitrile) inhibitors. Some of the gliptins, even if displaying good oral bioavailability, also displayed a rapid clearance, requiring repeated dosing. Thus, attempts have been made to develop long-acting inhibitors. One approach involves the design of cyanopyrrolidines, with very slow binding and dissociation rates. This approach was explored from the scaffold of compound <b>3</b>, resulting in the phase 3 clinical trial of <b>10</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) and in compound <b>26</b><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The design of novel DPP IV inhibitors from the β-series peptidomimetics was also attempted, resulting in compound <b>28</b>.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Small modifications of already approved molecules were also explored; for example, from the β-aminoamide backbone of compound <b>4</b>, compound <b>25</b> was proposed.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Isoindoline-based<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> and pyrrolopyrimidine-based<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> compounds were also developed through lead optimization as nanomolar highly selective DPP IV inhibitors. Many additional compounds have been described based on various scaffolds and SAR modifications, which are not presented in this Perspective only because of space limitation. I apologize to the authors for not citing their work.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Examples of Recent Development of DPP IV Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>In this scheme, the compound codes in parentheses represent the designations attributed to the compounds by the authors in the original publications.</p></p></figure><div class="NLM_p">The most recent developments of improved small molecule DPP IV inhibitors relied on computing approaches. By use of such tools and chemical refinement of the lead structure <b>21</b>, compound <b>22</b> (TAK-100) was developed,<a onclick="showRef(event, 'ref62 ref90 ref96'); return false;" href="javascript:void(0);" class="ref ref62 ref90 ref96">(62, 90, 96)</a> the first in its class to bear a carboxyl group to reach clinical trial, presently in phase 1. By use of structure-based virtual screening of structural similarities of known inhibitors, and rigid or flexible docking programs of the cyanopyrrolidine moieties, the xanthines/pyrimidines parts, and amino-like linkages, novel potential DPP IV inhibitors were proposed.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Out of 99 virtual hits, 15 were evaluated and found to be DPP IV inhibitors but with high 5–50 μM IC<sub>50</sub> values. But novel structures were also found, allowing refining of the pharmacophore model. On the basis of the pyrazole-3-carbohydrazone scaffold, modeling approaches, chemical syntheses, and SAR studies, compounds with 2–70 μM IC<sub>50</sub> values for DPP IV inhibition were obtained.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> By use of triazol substituted prolylfluoropyrrolidines, a series of potent and selective inhibitors with IC<sub>50</sub> values of ∼1 μM were also obtained.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Xanthine-based compounds were also developed, resulting in compounds with 1–30 μM IC<sub>50</sub> values and acceptable selectivity versus the other peptidases of the DPP IV family.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Therefore, docking-based approaches resulted in DPP IV inhibitors that were very selective for this enzyme compared to DPP-8 and DPP-9 but with low inhibition potency. However, it can be postulated that pursuing these lead molecules may result in potentially interesting therapeutics for further clinical development.</div><div class="NLM_p last">Approaches other than the syntheses of small inhibitors have also been explored. For T2D patients, changes in the diet may improve the condition; therefore, it would be logical to look for DPP IV-active molecules in food, since the DPP IV-target incretin peptides are produced by the gut and DPP IV is expressed in the digestive tract. In support of this hypothesis, it has been previously shown in the case of hypertension that angiotensin converting enzyme (ACE) inhibitory peptides can be found in food. Food sources of peptides capable of DPP IV inhibition have thus been sought and found. These include peptides from hydrolyzed α<sub>S1</sub>-casein (-Pro-Phe-Pro-) and β-casein (-Pro-Leu-Pro-) of bovine milk<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> and peptides from hydrolyzed salmon skin (Gly-Pro-Ala-Glu and Gly-Pro-Gly-Ala)<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and from tuna extracts.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> The amino acid sequences of these peptides suggest that they will act as competitive substrates. However, the IC<sub>50</sub> values of these food-derived peptides for inhibiting DPP IV activity are generally much higher than the IC<sub>50</sub> values of synthetic molecules, which may be overcome by their large abundance in the digestive tract during food intake.</div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Off-Targets Effects and Potential Use of DPP IV Inhibitors in Human Diseases Other than Type 2 Diabetes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20350" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20350" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">DPP IV is constitutively expressed on capillary endothelial cells, epithelial cells, hematopoietic cells, and stem cells and on activated lymphocytes (as CD26) and is a soluble active enzyme in plasma, lacking the transmembrane region and the cytoplasmic tail. The highest expression of DPP IV is observed in the proximal tubules of the kidney and the luminal membrane of epithelial cells of the small intestine. As already stated in the <a class="ref internalNav" href="#sec1" aria-label="Introduction">Introduction</a>, many biologically active peptides are protected from general proteolytic degradation by evolutionary conserved prolines, either at the terminal or in the core of peptides, pointing to the biological importance and a high potential for drug discovery of prolyl-specific peptidases. Of the known human proteases, only a few prolyl-specific proteases have been described which include exopeptidases and endopeptidases. DPP IV cleaves a dipeptide from the N-terminal side of peptides with a proline or an alanine at the second position of the amino acid chains of peptides. In addition to GLP-1 and GIP, other biologically active peptides can be substrates of DPP IV, resulting in truncated forms of these peptides. However, no other peptide hormone has yet been proved to be potentiated by DPP IV inhibitors in humans, even if it is obvious that GLP-1 and GIP are not the only biological substrates of DPP IV. It is hypothesized that DPP IV has over 35 potential peptide hormone substrates. For most of these other potential peptide substrates, the physiological relevance of their truncation by DPP IV still has to be demonstrated. However, from the known sequence of many peptides, some hypotheses can be proposed. We have previously reviewed these possibilities;<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> therefore, here I will only summarize this previous information and comment in more detail the new information published and what is being undertaken toward extensive use of DPP IV inhibitors.</div><div class="NLM_p">Other potential substrates of DPP IV include PACAP, NPY, or PYY or β-MSH.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Thus, DPP IV inhibitors may have other applications in metabolic disorders, such as obesity. NPY is a substrate of DPP IV and is involved in the control of feeding, as is the analgesic peptide endomorphin 1; DPP IV inhibitors reduce appetite. DPP IV has an adipogenic effect through NPY cleavage, which may be released by DPP IV inhibitors.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> β-Casomorphin, an opioid peptide of β-casein of milk, is a good substrate of DPP IV. GLP-2, a gastrointestinal postprandial peptide, represents another potential substrate of DPP IV in disorders of the digestive tract. Therefore, DPP IV inhibitors may also prove to be useful as therapies for metabolic disorders other than T2D. Possible utility of DPP IV inhibitors in immune/inflammatory response, ischemia–reperfusion injury, heart failure, cancer, tissue remodeling, and neurodegenerative diseases have also been suggested. Many patients with T2D are overweight and also have hypertension and vascular and renal diseases. In the kidney, in animal model of hypertension, DPP IV inhibitors may potentiate the NPY-dependent cell proliferative effects of preglomerular microcirculation and glomeruli.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Therefore, DPP IV inhibitors are generally considered to be kidney protective in animal models of diabetic nephropathy.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> However, care must be taken in extrapolating these positive effects of DPP IV inhibitors, since a few reports suggest a link between DPP IV inhibitors and renal impairment. Some reports suggest that the DPP IV inhibitor <b>4</b> may have a direct effect on the activation of kinases of intestinal cells, independent of DPP IV inhibition.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Thus, possible off-target effects must be considered. Generally, the published information supports a positive role of DPP IV inhibition in diseases of the kidney and the cardiovascular system. DPP IV inhibition may promote angiogenesis, affording a positive effect in diabetic patients but also having a negative potential in cancer by enhancing tumor angiogenesis and progression.</div><div class="NLM_p">DPP IV was shown to be down-regulated during neoplastic transformation, and DPP IV expression was inversely correlated to the progression and the grading of cancer.<a onclick="showRef(event, 'ref108 ref109 ref110 ref111 ref112 ref113 ref114'); return false;" href="javascript:void(0);" class="ref ref108 ref109 ref110 ref111 ref112 ref113 ref114">(108-114)</a> Thus, loss of DPP IV (and possibly of its activity) could be considered oncogenic. The DPP IV protein, not its enzymatic activity, is a cell adhesion regulating factor. DPP IV expressed on endothelial cells is a receptor for tumor-associated fibronectin and has been shown to favor tumor cell adhesion and metastasis.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Therefore, no beneficial effects for inhibitors can be postulated in this context. However, not all published information agrees with this observation. We have shown a decreased vascular expression of DPP IV activity in human glioblastoma and in an experimental model of glioblastoma.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> In support of this finding, a small boronic inhibitor of DPP IV-like peptidases had antitumor effects, which were hypothesized to be mediated by the immune system and FAP-α inhibition.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> The pharmacological blockade of DPP IV activity by compound <b>4</b> reduced the growth of skin tumors, possibly mediated by the associated fibroblasts.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> However, these authors did not consider that this type of fibroblasts may also express the related peptidase FAP-α, whose induced expression has been clearly associated with cancer progression. It has been shown in several published papers that blockade of FAP-α activity by small molecules or by antibodies resulted in anticancer efficacy in experimental animal models of cancer, again underlining the importance of considering the enzyme selectivity of these inhibitors. Therefore, published information has mostly shown that DPP IV is a tumor suppressor and a proliferation inhibitor and that loss of DPP IV in cancer cells and/or cancer-associated stromal cells favors cancer progression, suggesting that inhibition of DPP IV has little interest in cancer and may possibly be detrimental. In further support of this, no formal demonstration of the efficacy of inhibiting DPP IV in cancer has been provided.</div><div class="NLM_p">Immune and inflammatory disorders involve the sequential activation and then tissue recruitment of activated immune cells, the lymphocytes, and the macrophages. Immune/inflammatory cell recruitment into organs is mediated by families of adhesion molecules and cytokines/chemokines locally produced by the inflamed tissue. CD26/DPP IV is a marker of immune/inflammatory cell activation in immune and inflammatory diseases,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> independent of its enzymatic activity, suggesting that inhibitors of this enzyme are not of interest in modulating leukocyte adhesion.<a onclick="showRef(event, 'ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref119 ref120">(119, 120)</a> However, the functions of immune/inflammatory cells are also fine-tuned by cytokines and chemokines peptides. Many biologically active cytokines and chemokines bear evolutionary conserved N-terminal X-Pro sequences that play a major role in regulating their biological functions and modulating their activity, since the N-terminus of chemokines and cytokines is required for interaction with their cognate receptors. Thus, DPP IV truncation has important effects on these peptide functions, involving for example (more detailed reviews in refs <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a> and <a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">32</a>) the proinflammatory cytokines (IL-2, IL-6, IL-1β, IL-10, IL-12, IFN-γ, MIP1α, IL-3, TNF-α), the chemokines (SDF-1α, MIP-1β/CCL4, RANTES/CCL5), or other inflammation-modulating peptides (substance P, neurotensin, bradykinin, leptin). Consequently, DPP IV inhibitors have received some interest in this context as relevant therapeutics for the treatment of diseases of the colon, joints, and lung or for neurodegeneration.<a onclick="showRef(event, 'ref12 ref121 ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref12 ref121 ref122 ref123">(12, 121-123)</a> However, it is not always clear which of these families of related prolyl-specific proteases are important in immune diseases. For example, DPP IV inhibitors were able to induce apoptosis even in DPP IV-negative lymphocytes,<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> suggesting the inhibition of other enzymes with similar activity. Very recently, it was shown that des-fluorositagliptin exhibited GLP-1-mediated antiatherogenic effects in macrophages and endothelial cells by controlling inflammatory response.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Also very recently, it was shown that the cytokine high mobility group box-1, important in tissue regeneration and angiogenesis, is a potential substrate of DPP IV, which inhibits its proangiogenic properties.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> In ischemia–reperfusion<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> it was also very recently shown that stabilization of SDF-1 through DPP IV inhibition increased the recruitment of regenerative stem cells to grafts and improved recovery from ischemia–reperfusion in experimental lung transplantation,<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> an observation that seems to be generally valid for all cell engraftment attempts. Therefore, inhibitors of DPP IV developed for T2D may be of use in the treatment of immune disorders involving both resident and recruited immune cells, but presently, in my opinion, it is not yet clear which inhibitor for which disease may be the most efficient as a combination with other therapeutics.</div><div class="NLM_p last">Insulin signaling is desensitized in the brains of patients with Alzheimer’s disease; therefore, it has been postulated that improving insulin signaling may have therapeutic interest for this devastating disease. In murine models of Alzheimer’s disease, GLP-1 analogues have shown some neuroprotective effects. Thus, it can be hypothesized that DPP IV inhibitors, by protecting GLP-1 from degradation, may also have a protective role.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> However, it was also shown that the phosphorylation of the Alzheimer’s disease-associated tau protein is increased in animal models of the disease exposed to compound <b>4</b>, which represents a negative effect.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Thus, apart from GLP-1, other biologically active peptides can be truncated by DPP IV. However, for these peptides the physiological relevance of their truncation still has to be demonstrated, in most situations.</div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">What Else and What Is Next?</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05742" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05742" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Several open questions are left concerning the use and effects of DPP IV inhibitors in medicinal chemistry. Among them, it will be important to do the following:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Understand new clinical applications of DPP IV and its inhibitors. For example, a phase 3 clinical trial is currently underway (<a href="http://clinicaltrials.gov" class="extLink">http://clinicaltrials.gov</a>; identifier NCTO1822548; sponsor, University Hospital of Parma, Italy) to evaluate the effect of compound <b>5</b> on the number of circulating endothelial progenitor cells in T2D patients.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Validate the effects of DPP IV inhibitors on the metabolism of peptide hormones other than the incretins, in particular peptides that may be relevant for understanding the postulated role of DPP IV also in cancer progression, which is a major concern for the long-term use of these drugs.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Evaluate the development of therapeutic small molecule inhibitors with a longer duration of action, as exemplified by the clinical trials initiated for compound <b>10</b>, with once a week dosing.</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Evaluate the combination of DPP IV inhibitors with other antidiabetic therapeutics, which has already started (for example, <b>7</b>–metformin (trade name, Kazano) or <b>7</b>–pioglitazone (trade name, Oseni) tablets), in order to improve glycemic control without enhancing side effects.</p></td></tr><tr class="li1"><td valign="top">(5)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Develop new dual drug scaffolds represented by compounds bearing two therapeutic functionalities on one scaffold, one of them being a DPP IV inhibitor.</p></td></tr></table></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The enzymatic action of DPP IV-related peptidases leads to both quantitative and qualitative changes in the signaling potential of bioactive peptides. CD26/DPP IV/DPP-4 is involved in the development and progression of metabolic and other disorders. DPP IV inhibitors may attenuate, or potentiate, the effects of peptides involved in these diseases, depending on the context of a particular disorder or its stage of evolution. DPP IV-related peptidases have multiple substrates and are located in different biological compartments. Therefore, the effects, development, and evaluation of inhibitors must be examined from the perspective of selectivity, cellular localization, and transport through biological barriers. The possibility that indirect effects on the processing of peptides involved in the regulation of pathways other than the pathways initially targeted also needs consideration. Functional consequences of inhibiting related enzymatic activities may be similar, but because of differences in the (sub)cellular localization of the enzymes, inhibitors may have different effects. Families of covalent and noncovalent DPP IV inhibitors have been shown in clinical trials to potentiate the effects of biological peptides involved in metabolic disorders, such as T2D. Therefore, inhibiting this enzyme was a favorable option. Well-tolerated, efficient, and selective inhibitors have reached the market with few side effects over several years, and new inhibitors are under development and evaluation. In the context of T2D therapy, the development of DPP IV inhibitors with a high selectivity for DPP IV over the other enzymes of the family has provided drugs with an excellent safety profile, tolerability, and efficacy.</div><div class="NLM_p last">For T2D, the goal was to protect GLP-1 and GIP from degradation, and the selective inhibition of DPP IV was probably necessary. As families of enzymes display DPP IV-like activities, the selectivity of the therapeutic inhibitors for the actual target peptidase, DPP IV, has to be considered. The expression of DPP IV has been reported to be inversely correlated with the development and progression of cancer. Thus, it may be detrimental over the long term to inhibit this enzyme in cancer, while the inhibition of the closely related FAP-α would be favorable for cancer patients. Therefore, for their application in other human diseases, which is presently under investigation, inhibitors with less selectivity may be more interesting. Thus, in the follow-up of possible development of cancer during DPP IV inhibition, less selective inhibitors may prove to be safer drugs than very selective inhibitors. The validity of this hypothesis can only be ascertained after long-term use of DPP IV-specific inhibitors. Therefore, although DPP IV inhibitors are beneficial and well-tolerated for T2D therapy, mainly in combination with other antidiabetic drugs, adverse effects of DPP IV inhibitors have also been suggested, and these can only be assessed by long-term follow-up.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm400658e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62570" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62570" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucienne Juillerat-Jeanneret</span> - <span class="hlFld-Affiliation affiliation">University Institute of
Pathology, CHUV-UNIL, Bugnon 25, CH-1011 Lausanne, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1c70697f7579727279327669757070796e7d685c7f74696a327f74"><span class="__cf_email__" data-cfemail="c6aab3a5afa3a8a8a3e8acb3afaaaaa3b4a7b286a5aeb3b0e8a5ae">[email protected]</span></a></span></div></li></ul></li><li><ul></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Biography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Lucienne Juillerat-Jeanneret</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=BIO-d3023e945-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lucienne Juillerat-Jeanneret</b> obtained her Ph.D. from the University of Geneva, Switzerland. After postdoctoral experiences at the University of Geneva and the University Hospital of Lausanne (CHUV), Switzerland, she joined the University Institute of Pathology of Lausanne as a tenured senior lecturer and a teacher at the University of Lausanne and the Swiss Federal Institute of Technology of Lausanne (EPFL). Her main research interests are focused at the interface between biomedicine, chemistry, and biomaterials to design and develop innovative devices to selectively deliver therapeutic drugs. She is also involved in the development of novel approaches for diagnosis, for therapy, and for tissue engineering. The strategies investigated include nanotechonology, nanotherapeutics, and the design and evaluation of targeted chemotherapeutics for the treatment of cancer and degenerative diseases.</p></figure></div><div class="ack" id="ACK-d3023e950-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">I thank W. Greenlee for his valuable suggetions and comments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i17" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i17"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i18" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i18"> Abbreviations Used</h2><tr><td class="NLM_term">ADA</td><td class="NLM_def"><p class="first last">adenosine deaminase</p></td></tr><tr><td class="NLM_term">CD26</td><td class="NLM_def"><p class="first last">cluster differentiation antigen 26</p></td></tr><tr><td class="NLM_term">DASH</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase IV activity and/or structure homologue</p></td></tr><tr><td class="NLM_term">DPP</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase</p></td></tr><tr><td class="NLM_term">FAP-α</td><td class="NLM_def"><p class="first last">fibroblast activation protein-α/seprase</p></td></tr><tr><td class="NLM_term">GLP-1</td><td class="NLM_def"><p class="first last">glucagon-like peptide 1</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">glucose-dependent insulinotropic polypeptide</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">inhibitor concentration inhibiting 50% of the enzyme activity</p></td></tr><tr><td class="NLM_term">HbAc1</td><td class="NLM_def"><p class="first last">glycated hemoglobin</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">POP/PREP</td><td class="NLM_def"><p class="first last">prolyl oligopeptidase</p></td></tr><tr><td class="NLM_term">QPP</td><td class="NLM_def"><p class="first last">quiescent cell proline dipeptidase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">T2D</td><td class="NLM_def"><p class="first last">type 2 diabetes</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 130 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Yaron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naider, F.</span><span> </span><span class="NLM_article-title">Proline-dependent structural and biological properties of peptides and proteins</span> <span class="citation_source-journal">Crit. Rev. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.3109%2F10409239309082572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=8444042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADyaK3sXit1ylu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1993&pages=31-81&author=A.+Yaronauthor=F.+Naider&title=Proline-dependent+structural+and+biological+properties+of+peptides+and+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Proline-dependent structural and biological properties of peptides and proteins</span></div><div class="casAuthors">Yaron, Arieh; Naider, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-81</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    </div><div class="casAbstract">A review, with 383 refs.  Proline residues confer unique structural constraints on peptide chains and markedly influence the susceptibility of proximal peptide bonds to protease activity.  A crit. anal. of peptidases involved in the cleavage of proline-contg. peptide bonds is presented, with particular attention to the role of proline peptidases in the regulation of the lifetime of biol. active peptides.  Peptidases discussed include aminopeptidase P, prolidase, dipeptidyl peptidase IV, prolyl endopeptidase, and prolyl iminopeptidase.  Attention is also given to HIV-1 protease, because this key enzyme processes an Xaa-Pro peptide bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr89TQn-XtgJrVg90H21EOLACvtfcHk0lgKfC8yxg76tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1ylu70%253D&md5=67f47aa3fbe158ca0e236c7ba8665cde</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3109%2F10409239309082572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409239309082572%26sid%3Dliteratum%253Aachs%26aulast%3DYaron%26aufirst%3DA.%26aulast%3DNaider%26aufirst%3DF.%26atitle%3DProline-dependent%2520structural%2520and%2520biological%2520properties%2520of%2520peptides%2520and%2520proteins%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D28%26spage%3D31%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS1357-2725%2803%2900262-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=14687920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=408-421&author=P.+Busekauthor=R.+Malikauthor=A.+Sedo&title=Dipeptidyl+peptidase+IV+activity+and%2For+structure+homologues+%28DASH%29+and+their+substrates+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer</span></div><div class="casAuthors">Busek, Petr; Malik, Radek; Sedo, Aleksi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">408-421</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Post-translational modification of proteins is an important regulatory event.  Numerous biol. active peptides that play an essential role in cancerogenesis contain an evolutionary conserved proline residue as a proteolytic-processing regulatory element.  Proline-specific proteases could therefore be viewed as important "check-points".  Limited proteolysis of such peptides may lead to quant. but, importantly, due to the change of receptor preference, also qual. changes of their signaling potential.  Dipeptidyl peptidase-IV (DPP-IV, EC 3.4.14.5, identical with CD26) was for many years believed to be a unique cell membrane protease cleaving X-Pro dipeptides from the N-terminal end of peptides and proteins.  Subsequently, a no. of other mols. were discovered, exhibiting various degree of structural homol. and DPP-IV-like enzyme activity, capable of cleaving similar set of substrates.  These comprise for example, seprase, fibroblast activation protein α, DPP6, DPP8, DPP9, attractin, N-acetylated-α-linked-acidic dipeptidases I, II and L, quiescent cell proline dipeptidase, thymus-specific serine protease and DPP IV-β.  It is tempting to speculate their potential participation on DPP-IV biol. function(s).  Disrupted expression and enzymic activity of "DPP-IV activity and/or structure homologs" (DASH) might corrupt the message carried by their substrates, promoting abnormal cell behavior.  Consequently, modulation of particular enzyme activity using e.g.  DASH inhibitors, specific antibodies or DASH expression modification may be an attractive therapeutic concept in cancer treatment.  This review summarizes recent information on the interactions between DASH members and their substrates with respect to their possible role in cancer biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqoAqZiP-Z1rVg90H21EOLACvtfcHk0lgKfC8yxg76tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWgu7o%253D&md5=0472b5bc6e382a602719dc44159b03c7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2803%2900262-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252803%252900262-0%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DMalik%26aufirst%3DR.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520activity%2520and%252For%2520structure%2520homologues%2520%2528DASH%2529%2520and%2520their%2520substrates%2520in%2520cancer%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2004%26volume%3D36%26spage%3D408%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Chen, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghersi, G.</span><span> </span><span class="NLM_article-title">DPPIV, seprase and related serine peptidases in multiple cellular functions</span> <span class="citation_source-journal">Curr. Top. Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2003&pages=207-232&author=W.+T.+Chenauthor=T.+Kellyauthor=G.+Ghersi&title=DPPIV%2C+seprase+and+related+serine+peptidases+in+multiple+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DGhersi%26aufirst%3DG.%26atitle%3DDPPIV%252C%2520seprase%2520and%2520related%2520serine%2520peptidases%2520in%2520multiple%2520cellular%2520functions%26jtitle%3DCurr.%2520Top.%2520Dev.%2520Biol.%26date%3D2003%26volume%3D54%26spage%3D207%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mentlein, R.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS0167-0115%2899%2900089-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=10588446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADyaK1MXntVCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=9-24&author=R.+Mentlein&title=Dipeptidyl-peptidase+IV+%28CD26%29%E2%80%94role+in+the+inactivation+of+regulatory+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides</span></div><div class="casAuthors">Mentlein, R.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-24</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 112 refs.  Dipeptidyl-peptidase IV (DPP IV/CD26) has a dual function as a regulatory protease and as a binding protein.  Its role in the inactivation of bioactive peptides was recognized 20 yr ago due to its unique ability to liberate Xaa-Pro or Xaa-Ala dipeptides from the N-terminus of regulatory peptides, but further examples are now emerging from in vitro and vivo expts.  Despite the minimal N-terminal truncation by DPP IV, many mammalian regulatory peptides are inactivated - either totally or only differentially - for certain receptor subtypes.  Important DPP IV substrates include neuropeptides like neuropeptide Y or endomorphin, circulating peptide hormones like peptide YY, growth hormone-releasing hormone, glucagon-like peptides(GLP)-1 and -2, gastric inhibitory polypeptide as well as paracrine chemokines like RANTES (regulated on activation normal T cell expressed and secreted), stromal cell-derived factor, eotaxin and macrophage-derived chemokine.  Based on these findings the potential clin. uses of selective DPP IV inhibitors or DPP IV-resistant analogs, esp. for the insulinotropic hormone GLP-1, have been tested to enhance insulin secretion and to improve glucose tolerance in diabetic animals.  Thus, DPP IV appears to be a major physiol. regulator for some regulatory peptides, neuropeptides, circulating hormones and chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsOF6uG5OnTrVg90H21EOLACvtfcHk0lgHd8WAHPY9mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVCitLs%253D&md5=5e2ec3c86e1b2d77f5259bbd33b26c37</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0167-0115%2899%2900089-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-0115%252899%252900089-0%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26atitle%3DDipeptidyl-peptidase%2520IV%2520%2528CD26%2529%25E2%2580%2594role%2520in%2520the%2520inactivation%2520of%2520regulatory%2520peptides%26jtitle%3DRegul.%2520Pept.%26date%3D1999%26volume%3D85%26spage%3D9%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Polgar, L.</span><span> </span><span class="NLM_article-title">The prolyl oligopeptidase family</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=349-362&author=L.+Polgar&title=The+prolyl+oligopeptidase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DL.%26atitle%3DThe%2520prolyl%2520oligopeptidase%2520family%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2002%26volume%3D59%26spage%3D349%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rosenblum, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosarich, J. W.</span><span> </span><span class="NLM_article-title">Prolyl peptidases: a serine protease subfamily with high potential in drug discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS1367-5931%2803%2900084-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=12941425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmslemsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=496-504&author=J.+S.+Rosenblumauthor=J.+W.+Kosarich&title=Prolyl+peptidases%3A+a+serine+protease+subfamily+with+high+potential+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl peptidases: a serine protease subfamily with high potential for drug discovery</span></div><div class="casAuthors">Rosenblum, Jonathan S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">496-504</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review and discussion.  Much attention has recently been given to a class of proteases that cleave proteins and peptides after Pro residues.  This class includes esp. dipeptidyl peptidase IV (DPP IV; also termed CD26) and fibroblast activation protein α (FAP; seprase), but also includes DPP7 (DPP II; quiescent cell proline dipeptidase), DPP8, DPP9, and prolyl carboxypeptidase (PCP; angiotensinase C).  More distant members include prolyl oligopeptidase (POP; post-proline cleaving enzyme) and acylaminoacylpeptidase (AAP; acylpeptide hydrolase).  The DPPs and related proteins contain both membrane-bound and sol. members and span a broad range of expression patterns, tissue distributions and compartmentalization.  These proteins have important roles in regulation of signaling by peptide hormones, and are emerging targets for diabetes, oncol., and other indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMVbHHOPDw7Vg90H21EOLACvtfcHk0lgHd8WAHPY9mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmslemsrk%253D&md5=5c7d9bb0b121fd8d29c675270898b89f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2803%2900084-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252803%252900084-X%26sid%3Dliteratum%253Aachs%26aulast%3DRosenblum%26aufirst%3DJ.%2BS.%26aulast%3DKosarich%26aufirst%3DJ.%2BW.%26atitle%3DProlyl%2520peptidases%253A%2520a%2520serine%2520protease%2520subfamily%2520with%2520high%2520potential%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2003%26volume%3D7%26spage%3D496%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Cunningham, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B.</span><span> </span><span class="NLM_article-title">Proline specific peptidases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1343</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1343&publication_year=1997&pages=160-186&author=D.+F.+Cunninghamauthor=B.+O%E2%80%99Connor&title=Proline+specific+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DD.%2BF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%26atitle%3DProline%2520specific%2520peptidases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1997%26volume%3D1343%26spage%3D160%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Sedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities</span> <span class="citation_source-journal">Biochem. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1550</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS0167-4838%2801%2900278-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=11755200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1550&publication_year=2001&pages=107-116&author=A.+Sedoauthor=R.+Malik&title=Dipeptidyl+peptidase+IV-like+molecules%3A+homologous+proteins+or+homologous+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?</span></div><div class="casAuthors">Sedo, Aleksi; Malik, Radek</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1550</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-116</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Membrane-bound proteases are widely distributed among various cell systems.  Their expression in a particular cell type is finely regulated, reflecting the specific functional cell implications and engagement in defined physiol. pathways.  Protein turnover, ontogeny, inflammation, tissue remodeling, cell migration and tumor invasion are among the many physiol. and pathol. events in which membrane proteases play a crucial role, both as effector as well as regulatory mols.  The presence of proline residues gives unique structural features to peptide chains, substantially influencing the susceptibility of proximal peptide bond to protease cleavage.  Among the rare group of proline-specific proteases, dipeptidyl peptidase IV (DPP-IV, EC 3.4.14.5) was originally believed to be the only membrane-bound enzyme specific for proline as the penultimate residue at the amino-terminus of the polypeptide chain.  However, other mols., even structurally non-homologous with the DPP-IV but bearing corresponding enzyme activity, have been identified recently.  This review summarizes the present knowledge of 'DPP-IV activity- and/or structure-homologs' (DASH) and provides some insight into their multifunctional roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ov8OGHsknrVg90H21EOLACvtfcHk0lgHd8WAHPY9mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWi&md5=8a7c5761fa97851f207f3a38effd42c2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2801%2900278-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252801%252900278-3%26sid%3Dliteratum%253Aachs%26aulast%3DSedo%26aufirst%3DA.%26aulast%3DMalik%26aufirst%3DR.%26atitle%3DDipeptidyl%2520peptidase%2520IV-like%2520molecules%253A%2520homologous%2520proteins%2520or%2520homologous%2520activities%26jtitle%3DBiochem.%2520Biophys.%2520Acta%26date%3D2001%26volume%3D1550%26spage%3D107%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fleischer, B.</span><span> </span><span class="NLM_article-title">CD26: a surface protease involved in T-cell activation</span> <span class="citation_source-journal">Immunol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2F0167-5699%2894%2990316-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=7911022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADyaK2cXis1Omu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=180-184&author=B.+Fleischer&title=CD26%3A+a+surface+protease+involved+in+T-cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">CD26: a surface protease involved in T-cell activation</span></div><div class="casAuthors">Fleischer, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">180-4</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    </div><div class="casAbstract">A review, with 45 refs.  CD26 is a proteolytic enzyme (dipeptidylpeptidase IV) with a wide tissue distribution and a unique specificity.  Recent developments indicate that CD26 is a multifunctional mol. that may have important functions in the immune system.  Here, the current knowledge of CD26 and the possible functions of this mol. in T lymphocytes are discussed..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRnmqKAop_frVg90H21EOLACvtfcHk0lizM0NyGnQj0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1Omu7w%253D&md5=d2ce3a14fa4a85c06e638dcf18cfa7bc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0167-5699%2894%2990316-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-5699%252894%252990316-6%26sid%3Dliteratum%253Aachs%26aulast%3DFleischer%26aufirst%3DB.%26atitle%3DCD26%253A%2520a%2520surface%2520protease%2520involved%2520in%2520T-cell%2520activation%26jtitle%3DImmunol.%2520Today%26date%3D1994%26volume%3D15%26spage%3D180%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1042%2FCS20040302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15584901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2005&pages=277-292&author=M.+D.+Gorrell&title=Dipeptidyl+peptidase+IV+and+related+enzymes+in+cell+biology+and+liver+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span></div><div class="casAuthors">Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-292</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  DP (dipeptidyl peptidase) IV is the archetypal member of its six-member gene family.  Four members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare substrate specificity, hydrolysis of a prolyl bond two residues from the N-terminus.  The ubiquitous DPIV glycoprotein has proved interesting in the fields of immunol., endocrinol., haematol. and endothelial cell and cancer biol. and DPIV has become a novel target for Type II diabetes therapy.  The crystal structure shows that the sol. form of DPIV comprises two domains, an α/β-hydrolase domain and an eight-blade β-propeller domain.  The propeller domain contains the ADA (adenosine deaminase) binding site, a dimerization site, antibody epitopes and two openings for substrate access to the internal active site.  FAP is structurally very similar to DPIV, but FAP protein expression is largely confined to diseased and damaged tissue, notably the tissue remodelling interface in chronically injured liver.  DPIV has a variety of peptide substrates, the best studied being GLP-1 (glucagon-like peptide-1), NPY (neuropeptide Y) and CXCL12.  The DPIV family has roles in bone marrow mobilization.  The functional interactions of DPIV and FAP with extracellular matrix confer roles for these proteins in cancer biol.  DP8 and DP9 are widely distributed and indirectly implicated in immune function.  The DPL (DP-like) glycoproteins that lack peptidase activity, DPL1 and DPL2, are brain-expressed potassium channel modulators.  Thus the six members of the DPIV gene family exhibit diverse biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJupx2RWQPHbVg90H21EOLACvtfcHk0lizM0NyGnQj0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D&md5=64bbb7dbec2fa9c0c49a2e54c0be908e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2FCS20040302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20040302%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520and%2520related%2520enzymes%2520in%2520cell%2520biology%2520and%2520liver%2520disorders%26jtitle%3DClin.%2520Sci.%26date%3D2005%26volume%3D108%26spage%3D277%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">Glucagon-like peptides 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Curr. in. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.coph.2004.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptl2ksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=589-596&author=J.+J.+Holstauthor=C.+F.+Deacon&title=Glucagon-like+peptides+1+and+inhibitors+of+dipeptidyl+peptidase+IV+in+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Holst, Jens Juul; Deacon, Carolyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">589-596</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Proof-of-concept for the efficacy of a glucagon-like peptide 1 (GLP-1)-based therapy of patients with type 2 diabetes was provided in 2002 by prolonged continuous s.c. infusion of native GLP-1.  Since then, several long-acting analogs of GLP-1, as well as inhibitors of dipeptidyl peptidase IV, the enzyme that rapidly inactivates endogenous GLP-1, have demonstrated efficacy in long term clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXKDwEWvb257Vg90H21EOLACvtfcHk0lizM0NyGnQj0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptl2ksbo%253D&md5=35a828501cde38c10e44f91677441cb2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DGlucagon-like%2520peptides%25201%2520and%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DCurr.%2520in.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Berger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis Bernasconi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Determination of intracellular prolyl/glycyl-specific proteases in intact living human cells using protoporphyrin IX production as a reporter system</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.chembiol.2005.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=16125098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVeksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=867-872&author=Y.+Bergerauthor=C.+Chapuis+Bernasconiauthor=R.+Neierauthor=L.+Juillerat-Jeanneret&title=Determination+of+intracellular+prolyl%2Fglycyl-specific+proteases+in+intact+living+human+cells+using+protoporphyrin+IX+production+as+a+reporter+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Intracellular Prolyl/Glycyl Proteases in Intact Living Human Cells and Protoporphyrin IX Production as a Reporter System</span></div><div class="casAuthors">Berger, Yann; Chapuis Bernasconi, Catherine; Schmitt, Frederic; Neier, Reinhard; Juillerat-Jeanneret, Lucienne</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">867-872</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The detn. of enzyme activity or inhibition in intact living cells is a problem in the development of inhibitors for intracellular proteases.  The prodn. of fluorescent protoporphyrin IX (PpIX) from the nonfluorescent (N)-Gly/Pro-5-aminolevulinic acid (ALA) substrates was used to evaluate the prolyl/glycyl-specific dipeptidylpeptidase IV (DPPIV)-like and prolyloligopeptidase (POP)-like activities of human cells.  The results demonstrated that whereas POP-like activity could be attributed to the actual POP, the DPPIV-like activity could be related to actual DPPIV only in one colon cell line.  In the other breast and colon cell lines, DPPIV-like activity was intracellular and displayed by other prolyl-specific aminopeptidases.  Our expts. also demonstrated the involvement of glycyl-specific proteases in the processing of ALA precursors.  These observations have important consequences for the development and evaluation of selective inhibitors for these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqREpFhOCyW3bVg90H21EOLACvtfcHk0lizM0NyGnQj0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVeksbc%253D&md5=9a4b532fac2976eed6b2c6b0c618f591</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DY.%26aulast%3DChapuis%2BBernasconi%26aufirst%3DC.%26aulast%3DNeier%26aufirst%3DR.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DDetermination%2520of%2520intracellular%2520prolyl%252Fglycyl-specific%2520proteases%2520in%2520intact%2520living%2520human%2520cells%2520using%2520protoporphyrin%2520IX%2520production%2520as%2520a%2520reporter%2520system%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D867%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Engel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefersauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span> </span><span class="NLM_article-title">The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanisms</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">5063</span><span class="NLM_x">–</span> <span class="NLM_lpage">5068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=5063-5068&author=M.+Engelauthor=T.+Hoffmannauthor=L.+Wagnerauthor=M.+Wermannauthor=U.+Heiserauthor=R.+Kiefersauerauthor=R.+Huberauthor=W.+Bodeauthor=H.+U.+Demuthauthor=H.+Brandstetter&title=The+crystal+structure+of+dipeptidyl+peptidase+IV+%28CD26%29+reveals+its+functional+regulation+and+enzymatic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DKiefersauer%26aufirst%3DR.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBode%26aufirst%3DW.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DThe%2520crystal%2520structure%2520of%2520dipeptidyl%2520peptidase%2520IV%2520%2528CD26%2529%2520reveals%2520its%2520functional%2520regulation%2520and%2520enzymatic%2520mechanisms%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D5063%26epage%3D5068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hiramatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, R.</span><span> </span><span class="NLM_article-title">The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2004&pages=561-564&author=H.+Hiramatsuauthor=A.+Yamamotoauthor=K.+Kyonoauthor=Y.+Higashiyamaauthor=C.+Fukushimaauthor=H.+Shimaauthor=S.+Sugiyamaauthor=K.+Inakaauthor=R.+Shimizu&title=The+crystal+structure+of+human+dipeptidyl+peptidase+IV+%28DPPIV%29+complex+with+diprotin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DA.%26aulast%3DKyono%26aufirst%3DK.%26aulast%3DHigashiyama%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DC.%26aulast%3DShima%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DS.%26aulast%3DInaka%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DR.%26atitle%3DThe%2520crystal%2520structure%2520of%2520human%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPPIV%2529%2520complex%2520with%2520diprotin%2520A%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D385%26spage%3D561%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rasmussen, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiberg, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagtmann, N.</span><span> </span><span class="NLM_article-title">Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=19-25&author=H.+B.+Rasmussenauthor=S.+Brannerauthor=F.+C.+Wibergauthor=N.+Wagtmann&title=Crystal+structure+of+human+dipeptidyl+peptidase+IV%2FCD26+in+complex+with+a+substrate+analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DH.%2BB.%26aulast%3DBranner%26aufirst%3DS.%26aulast%3DWiberg%26aufirst%3DF.%2BC.%26aulast%3DWagtmann%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520human%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520in%2520complex%2520with%2520a%2520substrate%2520analog%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Sweeney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, G. E.</span><span> </span><span class="NLM_article-title">High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[({2-[85-iodopyridin-2-yl)aminoethyl}amino)acetyl]-2-cyano-(<i>S</i>)-pyrrolodine</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">D59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D59&publication_year=2003&pages=1206-1212&author=C.+Oefnerauthor=A.+D%E2%80%99Arcyauthor=A.+Mac+Sweeneyauthor=S.+Pierauauthor=R.+Gardinerauthor=G.+E.+Dale&title=High-resolution+structure+of+human+apo+dipeptidyl+peptidase+IV%2FCD26+and+its+complex+with+1-%5B%28%7B2-%5B85-iodopyridin-2-yl%29aminoethyl%7Damino%29acetyl%5D-2-cyano-%28S%29-pyrrolodine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DPierau%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DR.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DHigh-resolution%2520structure%2520of%2520human%2520apo%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520and%2520its%2520complex%2520with%25201-%255B%2528%257B2-%255B85-iodopyridin-2-yl%2529aminoethyl%257Damino%2529acetyl%255D-2-cyano-%2528S%2529-pyrrolodine%26jtitle%3DActa%2520Crystallogr.%26date%3D2003%26volume%3DD59%26spage%3D1206%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Thoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löffler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henning, M.</span><span> </span><span class="NLM_article-title">Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase IV</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=947-959&author=R.+Thomaauthor=B.+L%C3%B6fflerauthor=M.+Stihleauthor=W.+Huberauthor=A.+Rufauthor=M.+Henning&title=Structural+basis+of+proline-specific+exopeptidase+activity+as+observed+in+human+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DL%25C3%25B6ffler%26aufirst%3DB.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DHenning%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520of%2520proline-specific%2520exopeptidase%2520activity%2520as%2520observed%2520in%2520human%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DStructure%26date%3D2003%26volume%3D11%26spage%3D947%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böcskei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, L.</span><span> </span><span class="NLM_article-title">Prolyl oligopeptidase: an unusual β-propeller domain regulates proteolysis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=161-170&author=V.+F%C3%BCl%C3%B6pauthor=Z.+B%C3%B6cskeiauthor=L.+Polgar&title=Prolyl+oligopeptidase%3A+an+unusual+%CE%B2-propeller+domain+regulates+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DB%25C3%25B6cskei%26aufirst%3DZ.%26aulast%3DPolgar%26aufirst%3DL.%26atitle%3DProlyl%2520oligopeptidase%253A%2520an%2520unusual%2520%25CE%25B2-propeller%2520domain%2520regulates%2520proteolysis%26jtitle%3DCell%26date%3D1998%26volume%3D94%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Edmondson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastracchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E. R.</span><span> </span><span class="NLM_article-title">Potent and selective proline derived dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5151-5155&author=S.+D.+Edmondsonauthor=A.+Mastracchioauthor=M.+Beconiauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=S.+Kumarauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=A.+Maoauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Potent+and+selective+proline+derived+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26aulast%3DMastracchio%26aufirst%3DA.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DPotent%2520and%2520selective%2520proline%2520derived%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5151%26epage%3D5155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ok, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E. R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective beta-homophenylalanine based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4759</span><span class="NLM_x">–</span> <span class="NLM_lpage">4762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4759-4762&author=J.+Xuauthor=H.+O.+Okauthor=E.+J.+Gonzalezauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Discovery+of+potent+and+selective+beta-homophenylalanine+based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DOk%26aufirst%3DH.%2BO.%26aulast%3DGonzalez%26aufirst%3DE.%2BJ.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520beta-homophenylalanine%2520based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4759%26epage%3D4762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A .E.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2533</span><span class="NLM_x">–</span> <span class="NLM_lpage">2536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.bmcl.2005.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15863311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2533-2536&author=J.+Xuauthor=L.+Weiauthor=R.+Mathvinkauthor=J.+Heauthor=Y.+J.+Parkauthor=H.+Heauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A+.E.+Weber&title=Discovery+of+potent+and+selective+phenylalanine+based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Xu, Jinyou; Wei, Lan; Mathvink, Robert; He, Jiafang; Park, You-Jung; He, Huaibing; Leiting, Barbara; Lyons, Kathryn A.; Marsilio, Frank; Patel, Reshma A.; Wu, Joseph K.; Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2533-2536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anti-Substituted β-methylphenylalanine derived amides have been shown to be potent DPP-IV inhibitors exhibiting excellent selectivity over both DPP8 and DPP9.  These are among the most potent compds. reported to date lacking an electrophilic trap.  The most potent compd. among these is 5-oxo-1,2,4-oxadiazole I, which is a 3 nM DPP-IV inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRQ1sHQJH4ebVg90H21EOLACvtfcHk0lhhddhH4_yoQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D&md5=14bb621ee7b95eb2e00ac0bd5c8c99eb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA%2B.E.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520phenylalanine%2520based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2533%26epage%3D2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmonson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Discovery of potent,selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5373</span><span class="NLM_x">–</span> <span class="NLM_lpage">5377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5373-5377&author=J.+Xuauthor=L.+Weiauthor=R.+Mathvinkauthor=S.+D.+Edmonsonauthor=G.+J.+Eiermannauthor=H.+Heauthor=J.+F.+Leoneauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=S.+B.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Discovery+of+potent%2Cselective%2C+and+orally+bioavailable+oxadiazole-based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DEdmonson%26aufirst%3DS.%2BD.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520potent%252Cselective%252C%2520and%2520orally%2520bioavailable%2520oxadiazole-based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5373%26epage%3D5377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, J. T.</span><span> </span><span class="NLM_article-title">Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptido-mimetic</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=207-215&author=K.+Zhaoauthor=D.+S.+Limauthor=T.+Funakiauthor=J.+T.+Welch&title=Inhibition+of+dipeptidyl+peptidase+IV+%28DPP+IV%29+by+2-%282-amino-1-fluoro-propylidene%29-cyclopentanecarbonitrile%2C+a+fluoroolefin+containing+peptido-mimetic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DD.%2BS.%26aulast%3DFunaki%26aufirst%3DT.%26aulast%3DWelch%26aufirst%3DJ.%2BT.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP%2520IV%2529%2520by%25202-%25282-amino-1-fluoro-propylidene%2529-cyclopentanecarbonitrile%252C%2520a%2520fluoroolefin%2520containing%2520peptido-mimetic%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D207%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitkof, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Diprolyl nitriles as potent dipeptidylpeptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3992</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3992-3995&author=G.+Zhaoauthor=P.+C.+Taunkauthor=D.+R.+Magninauthor=L.+M.+Simpkinsauthor=J.+A.+Roblauthor=A.+Wangauthor=J.+G.+Robertsonauthor=J.+Marcinkevicieneauthor=D.+F.+Sitkofauthor=R.+A.+Parkerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Diprolyl+nitriles+as+potent+dipeptidylpeptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DTaunk%26aufirst%3DP.%2BC.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DSitkof%26aufirst%3DD.%2BF.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiprolyl%2520nitriles%2520as%2520potent%2520dipeptidylpeptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3992%26epage%3D3995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Mentlein, R.</span><span> </span><span class="NLM_article-title">Therapeutic assessement of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=57-64&author=R.+Mentlein&title=Therapeutic+assessement+of+glucagon-like+peptide-1+agonists+compared+with+dipeptidyl+peptidase+IV+inhibitors+as+potential+antidiabetic+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26atitle%3DTherapeutic%2520assessement%2520of%2520glucagon-like%2520peptide-1%2520agonists%2520compared%2520with%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520as%2520potential%2520antidiabetic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D57%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=525-532&author=B.+Leitingauthor=K.+A.+Pryorauthor=J.+K.+Wuauthor=F.+Marsilioauthor=R.+A.+Patelauthor=C.+S.+Craikauthor=J.+A.+Ellmanauthor=R.+T.+Cummingsauthor=N.+A.+Thornberry&title=Catalytic+properties+and+inhibition+of+proline-specific+dipeptidyl+peptidases+II%2C+IV+and+VII"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DCatalytic%2520properties%2520and%2520inhibition%2520of%2520proline-specific%2520dipeptidyl%2520peptidases%2520II%252C%2520IV%2520and%2520VII%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D525%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Evans, D. M.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=12802706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFyitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=577-585&author=D.+M.+Evans&title=Dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Evans, D. Michael</div><div class="citationInfo"><span class="NLM_cas:title">IDrugs</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">577-585</span>CODEN:
                <span class="NLM_cas:coden">IDRUFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-7056</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review.  The patent literature for dipeptidyl peptidase IV (DPP-IV) inhibitors for the period of Jan. 2001 to May 2002 is reviewed.  There has been increased interest in DPP-IV inhibitors since their potential for the treatment of diabetes was identified.  This review will focus on reversible inhibitors of the enzyme, for which the primary interest has been for use in the treatment of Type II diabetes.  The majority of the new chem. entities reported are dipeptide-like inhibitors that mimic the preferred substrates and the best of these display nanomolar activity.  There have been fewer reports of non-peptide inhibitors suggesting that it is much more difficult to identify new classes of inhibitors.  In addn. to new chem. entities this review will cover new indications for DPP-IV inhibitors that have been identified using previously reported inhibitors as research tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp09hVqU-_miLVg90H21EOLACvtfcHk0ljRo1DmPcpOqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFyitrs%253D&md5=80066694d62995b845b223bf404fe51e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DIDrugs%26date%3D2002%26volume%3D5%26spage%3D577%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibitors for the treatment of diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030628v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4135-4141&author=A.+E.+Weber&title=Dipeptidyl+peptidase+IV+inhibitors+for+the+treatment+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm030628v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030628v%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibitors%2520for%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4135%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">MK-431 Merck</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=419-426&author=C.+F.+Deacon&title=MK-431+Merck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DMK-431%2520Merck%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D6%26spage%3D419%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=1663-1670&author=J.+J.+Holstauthor=C.+F.+Deacon&title=Inhibition+of+the+activity+of+dipeptidyl+peptidase+IV+as+a+treatment+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DInhibition%2520of%2520the%2520activity%2520of%2520dipeptidyl%2520peptidase%2520IV%2520as%2520a%2520treatment%2520for%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D1998%26volume%3D47%26spage%3D1663%26epage%3D1670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Prolyl-specific peptidases and their inhibitors in biological processes</span> <span class="citation_source-journal">Curr. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1998&pages=97-109&author=L.+Juillerat-Jeanneret&title=Prolyl-specific+peptidases+and+their+inhibitors+in+biological+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DProlyl-specific%2520peptidases%2520and%2520their%2520inhibitors%2520in%2520biological%2520processes%26jtitle%3DCurr.%2520Chem.%2520Biol.%26date%3D1998%26volume%3D2%26spage%3D97%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber-Lemaire, S.</span><span> </span><span class="NLM_article-title">The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=215-226&author=L.+Juillerat-Jeanneretauthor=S.+Gerber-Lemaire&title=The+prolyl-aminodipeptidases+and+their+inhibitors+as+therapeutic+targets+for+fibrogenic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DGerber-Lemaire%26aufirst%3DS.%26atitle%3DThe%2520prolyl-aminodipeptidases%2520and%2520their%2520inhibitors%2520as%2520therapeutic%2520targets%2520for%2520fibrogenic%2520disorders%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Plamboeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">Neutral endopeptodase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaestised pig</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1882</span><span class="NLM_x">–</span> <span class="NLM_lpage">1890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1882-1890&author=A.+Plamboeckauthor=J.+J.+Holstauthor=R.+D.+Carrauthor=C.+F.+Deacon&title=Neutral+endopeptodase+24.11+and+dipeptidyl+peptidase+IV+are+both+mediators+of+the+degradation+of+glucagon-like+peptide+1+in+the+anaestised+pig"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlamboeck%26aufirst%3DA.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DCarr%26aufirst%3DR.%2BD.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DNeutral%2520endopeptodase%252024.11%2520and%2520dipeptidyl%2520peptidase%2520IV%2520are%2520both%2520mediators%2520of%2520the%2520degradation%2520of%2520glucagon-like%2520peptide%25201%2520in%2520the%2520anaestised%2520pig%26jtitle%3DDiabetologia%26date%3D2005%26volume%3D48%26spage%3D1882%26epage%3D1890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and structural determination of β-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2622</span><span class="NLM_x">–</span> <span class="NLM_lpage">2628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2622-2628&author=J.+H.+Ahnauthor=M.+S.+Shinauthor=M.+A.+Junauthor=S.+H.+Jungauthor=S.+K.+Kangauthor=K.+R.+Kimauthor=S.+D.+Rheeauthor=N.+S.+Kangauthor=S.+Y.+Kimauthor=S.+K.+Sohnauthor=S.+G.+Kimauthor=M.+S.+Jinauthor=J.+O.+Leeauthor=H.+G.+Cheonauthor=S.+S.+Kim&title=Synthesis%2C+biological+evaluation+and+structural+determination+of+%CE%B2-aminoacyl-containing+cyclic+hydrazine+derivatives+as+dipeptidyl+peptidase+IV+%28DPP-IV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DShin%26aufirst%3DM.%2BS.%26aulast%3DJun%26aufirst%3DM.%2BA.%26aulast%3DJung%26aufirst%3DS.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BR.%26aulast%3DRhee%26aufirst%3DS.%2BD.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DSohn%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BO.%26aulast%3DCheon%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BS.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520structural%2520determination%2520of%2520%25CE%25B2-aminoacyl-containing%2520cyclic%2520hydrazine%2520derivatives%2520as%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2622%26epage%3D2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6525</span><span class="NLM_x">–</span> <span class="NLM_lpage">6529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=6525-6529&author=J.+H.+Ahnauthor=W.+S.+Parkauthor=M.+A.+Junauthor=M.+S.+Shinauthor=S.+K.+Kangauthor=K.+Y.+Kimauthor=S.+D.+Rheeauthor=M.+A.+Baeauthor=K.+R.+Kimauthor=S.+G.+Kimauthor=S.+Y.+Kimauthor=S.+K.+Sohnauthor=N.+S.+Kangauthor=J.+O.+Leeauthor=D.+H.+Leeauthor=H.+G.+Cheonauthor=S.+S.+Kim&title=Synthesis+and+biological+evaluation+of+homopiperazine+derivatives+with+beta-aminoacyl+group+as+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DW.%2BS.%26aulast%3DJun%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DM.%2BS.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BY.%26aulast%3DRhee%26aufirst%3DS.%2BD.%26aulast%3DBae%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DK.%2BR.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DSohn%26aufirst%3DS.%2BK.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BO.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DCheon%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520homopiperazine%2520derivatives%2520with%2520beta-aminoacyl%2520group%2520as%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D18%26spage%3D6525%26epage%3D6529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, P.</span><span> </span><span class="NLM_article-title">Molecular recognition of ligands in dipeptidyl peptidase IV</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=609-619&author=B.+Kuhnauthor=M.+Hennigauthor=P.+Mattei&title=Molecular+recognition+of+ligands+in+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of ligands in dipeptidyl peptidase IV</span></div><div class="casAuthors">Kuhn, Bernd; Hennig, Michael; Mattei, Patrizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-619</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serine protease dipeptidyl peptidase IV (DPP-IV) is a clin. validated target for the treatment of type II diabetes and has received considerable interest from the pharmaceutical industry over the last years.  Concomitant with a large variety of published small mol. DPP-IV inhibitors almost twenty co-crystal structures have been released to the public as of May 2006.  In this review, we discuss the structural characteristics of the DPP-IV binding site and use the available x-ray information together with published structure-activity relationship data to identify the mol. interactions that are most important for tight enzyme-inhibitor binding.  Optimized interactions with the two key recognition motifs, i.e. the lipophilic S1 pocket and the neg. charged Glu 205/206 pair, result in large gains in binding free energy, which can be further improved by addnl. favorable contacts to side chains that flank the active site.  First examples show that the lessons learned from the x-ray structures can be successfully incorporated into the design of novel DPP-IV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQohM2c75l7Vg90H21EOLACvtfcHk0ljc47OL5DIzog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers7s%253D&md5=f7e9b1cdff1f900a3fc83a6a758f1eea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156802607780091064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091064%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DMattei%26aufirst%3DP.%26atitle%3DMolecular%2520recognition%2520of%2520ligands%2520in%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D609%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Discovery of JANUVIA (sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type-2 diabetes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFersrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=557-568&author=N.+A.+Thornberryauthor=A.+E.+Weber&title=Discovery+of+JANUVIA+%28sitagliptin%29%2C+a+selective+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type-2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of JANUVIA (sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">557-568</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The emergence of glucagon-like peptide 1 (GLP-1) as a well validated approach to the treatment of type 2 diabetes and preclin. validation of dipeptidyl peptidase IV (DPP-4) inhibition as an alternate, oral approach to GLP-1 therapy prompted the initiation of a DPP-4 inhibitor program at Merck in 1999.  DPP-4 inhibitors threo- and allo-isoleucyl thiazolidide were in-licensed to jump start the program; however, development was discontinued due to profound toxicity in rat and dog safety studies.  The observation that both compds. inhibit the related proline peptidases DPP8 and DPP9 led to the hypothesis that inhibition of DPP8 and/or DPP9 could evoke severe toxicities in preclin. species.  Indeed, the obsd. toxicities were recapitulated with a selective dual DPP8/9 inhibitor but not with an inhibitor selective for DPP-4.  Thus, medicinal chem. efforts focused on identifying a highly selective DPP-4 inhibitor for clin. development.  Initial work in an α-amino acid series related to isoleucyl thiazolidide was discontinued due to lack of selectivity; however, SAR studies on two screening leads led to the identification of a highly selective β-amino acid piperazine series.  In an effort to stabilize the piperazine moiety, which was extensively metabolized in vivo, a series of bicyclic derivs. were prepd., culminating in the identification of a potent and selective triazolopiperazine series.  Unlike their monocyclic counterparts, these analogs typically showed excellent pharmacokinetic properties in preclin. species.  Optimization of this series led to the discovery of JANUVIA (sitagliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY2DdNBCPea7Vg90H21EOLACvtfcHk0ljc47OL5DIzog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFersrY%253D&md5=8221de915c797c517f6116acb9c03cd1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F156802607780091028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091028%26sid%3Dliteratum%253Aachs%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520JANUVIA%2520%2528sitagliptin%2529%252C%2520a%2520selective%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type-2%2520diabetes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D557%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">White, J.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-IV inhibitors: pharmacological profile and clinical use</span> <span class="citation_source-journal">Clin. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2337%2Fdiaclin.26.2.53" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=53-57&author=J.+White&title=Dipeptidyl+peptidase-IV+inhibitors%3A+pharmacological+profile+and+clinical+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2337%2Fdiaclin.26.2.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiaclin.26.2.53%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%26atitle%3DDipeptidyl%2520peptidase-IV%2520inhibitors%253A%2520pharmacological%2520profile%2520and%2520clinical%2520use%26jtitle%3DClin.%2520Diabetes%26date%3D2008%26volume%3D26%26spage%3D53%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070104l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2297-2300&author=J.+Fengauthor=Z.+Zhangauthor=M.+Wallaceauthor=J.+Staffordauthor=S.+Kaldorauthor=D.+Kasselauthor=M.+Navreauthor=L.+Shi&title=Discovery+of+alogliptin%3A+a+potent%2C+selective%2C+bioavailable%2C+and+efficacious+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm070104l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070104l%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%26aulast%3DStafford%26aufirst%3DJ.%26aulast%3DKaldor%26aufirst%3DS.%26aulast%3DKassel%26aufirst%3DD.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520alogliptin%253A%2520a%2520potent%252C%2520selective%252C%2520bioavailable%252C%2520and%2520efficacious%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2297%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Belyae, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedemikova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1052</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1041-1052&author=A.+Belyaeauthor=X.+Zhangauthor=K.+Augustynsauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=I.+Vedemikovaauthor=S.+Scharpeauthor=A.+Haemers&title=Structure%E2%80%93activity+relationship+of+diaryl+phosphonate+esters+as+potent+irreversible+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelyae%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DVedemikova%26aufirst%3DI.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DHaemers%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520diaryl%2520phosphonate%2520esters%2520as%2520potent%2520irreversible%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1041%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Villhauer, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naderi, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russel, M .E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, T. E.</span><span> </span><span class="NLM_article-title">1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino] acetyl-2-(<i>S</i>)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2362</span><span class="NLM_x">–</span> <span class="NLM_lpage">2365</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025522z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2362-2365&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+E.+Dunningauthor=B.+L.+Mangoldauthor=M.+D.+Moneauthor=M+.E.+Russelauthor=S.+C.+Weldonauthor=T.+E.+Hughes&title=1-%5B2-%5B%285-Cyanopyridin-2-yl%29amino%5Dethylamino%5D+acetyl-2-%28S%29-pyrrolidinecarbonitrile%3A+a+potent%2C+selective%2C+and+orally+bioavailable+dipeptidyl+peptidase+IV+inhibitor+with+antihyperglycemic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm025522z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025522z%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DMone%26aufirst%3DM.%2BD.%26aulast%3DRussel%26aufirst%3DM%2B.E.%26aulast%3DWeldon%26aufirst%3DS.%2BC.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-%255B2-%255B%25285-Cyanopyridin-2-yl%2529amino%255Dethylamino%255D%2520acetyl-2-%2528S%2529-pyrrolidinecarbonitrile%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520with%2520antihyperglycemic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2362%26epage%3D2365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Villhauer, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naderi, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkey, B. N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, T. E.</span><span> </span><span class="NLM_article-title">1-3[(3-Hydroxy-1-adamantyl)amino] acetyl-2-cyano-(<i>S</i>)-pyrrolidine, a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030091l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2774-2789&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+N.+F.+Burkeyauthor=B.+E.+Dunningauthor=K.+Prasadauthor=B.+L.+Mangoldauthor=M.+E.+Russellauthor=T.+E.+Hughes&title=1-3%5B%283-Hydroxy-1-adamantyl%29amino%5D+acetyl-2-cyano-%28S%29-pyrrolidine%2C+a+potent%2C+selective%2C+and+orally+bioavailable+dipeptidyl+peptidase+IV+inhibitor+with+antihyperglycemic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm030091l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030091l%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DBurkey%26aufirst%3DB.%2BN.%2BF.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-3%255B%25283-Hydroxy-1-adamantyl%2529amino%255D%2520acetyl-2-cyano-%2528S%2529-pyrrolidine%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520with%2520antihyperglycemic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2774%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lautar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalish, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyakoy, S.</span><span> </span><span class="NLM_article-title">Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5579</span><span class="NLM_x">–</span> <span class="NLM_lpage">5583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5579-5583&author=D.+Ferrarisauthor=Y.+S.+Koauthor=D.+Calvinauthor=T.+Chiouauthor=S.+Lautarauthor=B.+Thomasauthor=K.+Wozniakauthor=C.+Rojasauthor=V.+Kalishauthor=S.+Belyakoy&title=Ketopyrrolidines+and+ketoazetidines+as+potent+dipeptidyl+peptidase+IV+%28DPP+IV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DKo%26aufirst%3DY.%2BS.%26aulast%3DCalvin%26aufirst%3DD.%26aulast%3DChiou%26aufirst%3DT.%26aulast%3DLautar%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DKalish%26aufirst%3DV.%26aulast%3DBelyakoy%26aufirst%3DS.%26atitle%3DKetopyrrolidines%2520and%2520ketoazetidines%2520as%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP%2520IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5579%26epage%3D5583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulsky, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanks, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitkoff, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5- methanoprolinenitrile-based inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049924d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2587-2598&author=D.+R.+Magninauthor=J.+A.+Roblauthor=R.+B.+Sulskyauthor=D.+J.+Augeriauthor=Y.+Huangauthor=L.+M.+Simpkinsauthor=P.+C.+Tanksauthor=D.+A.+Betebennerauthor=J.+G.+Robertsonauthor=B.+E.+Abboa-Offeiauthor=A.+Wangauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=D.+F.+Sitkoffauthor=M.+F.+Malleyauthor=J.+Z.+Gougoutasauthor=A.+Khannaauthor=Q.+Huangauthor=S.+P.+Hanauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Synthesis+of+novel+potent+dipeptidyl+peptidase+IV+inhibitors+with+enhanced+chemical+stability%3A+interplay+between+the+N-terminal+amino+acid+alkyl+side+chain+and+the+cyclopropyl+group+of+alpha-aminoacyl-l-cis-4%2C5-+methanoprolinenitrile-based+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm049924d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049924d%26sid%3Dliteratum%253Aachs%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DSulsky%26aufirst%3DR.%2BB.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTanks%26aufirst%3DP.%2BC.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DAbboa-Offei%26aufirst%3DB.%2BE.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DSitkoff%26aufirst%3DD.%2BF.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DSynthesis%2520of%2520novel%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520with%2520enhanced%2520chemical%2520stability%253A%2520interplay%2520between%2520the%2520N-terminal%2520amino%2520acid%2520alkyl%2520side%2520chain%2520and%2520the%2520cyclopropyl%2520group%2520of%2520alpha-aminoacyl-l-cis-4%252C5-%2520methanoprolinenitrile-based%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2587%26epage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Peters, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, B. M.</span><span> </span><span class="NLM_article-title">Aminomethylpyrimidines as novel DPP-IV inhibitors: a 105-fold activity increase by optimization of aromatic substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1491-1493&author=J.+U.+Petersauthor=S.+Weberauthor=S.+Kritterauthor=P.+Weissauthor=A.+Wallierauthor=M.+Boehringerauthor=M.+Hennigauthor=B.+Kuhnauthor=B.+M.+Loeffler&title=Aminomethylpyrimidines+as+novel+DPP-IV+inhibitors%3A+a+105-fold+activity+increase+by+optimization+of+aromatic+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DKritter%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DP.%26aulast%3DWallier%26aufirst%3DA.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DLoeffler%26aufirst%3DB.%2BM.%26atitle%3DAminomethylpyrimidines%2520as%2520novel%2520DPP-IV%2520inhibitors%253A%2520a%2520105-fold%2520activity%2520increase%2520by%2520optimization%2520of%2520aromatic%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1491%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">1-((S)-γ-Substituted prolyl)-(<i>S</i>)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2441-2445&author=H.+Sakashitaauthor=H.+Kitajimaauthor=M.+Nakamuraauthor=F.+Akahoshiauthor=Y.+Hayashi&title=1-%28%28S%29-%CE%B3-Substituted+prolyl%29-%28S%29-2-cyanopyrrolidine+as+a+novel+series+of+highly+potent+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DKitajima%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3D1-%2528%2528S%2529-%25CE%25B3-Substituted%2520prolyl%2529-%2528S%2529-2-cyanopyrrolidine%2520as%2520a%2520novel%2520series%2520of%2520highly%2520potent%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2441%26epage%3D2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumiuchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">[(<i>S</i>)-γ-(Arylamino)prolyl]thiazolidine compounds as a novel series of potent and stable DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3662</span><span class="NLM_x">–</span> <span class="NLM_lpage">3671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3662-3671&author=H.+Sakashitaauthor=F.+Akahoshiauthor=H.+Kitajimaauthor=R.+Tsutsumiuchiauthor=Y.+Hayashi&title=%5B%28S%29-%CE%B3-%28Arylamino%29prolyl%5Dthiazolidine+compounds+as+a+novel+series+of+potent+and+stable+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DKitajima%26aufirst%3DH.%26aulast%3DTsutsumiuchi%26aufirst%3DR.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3D%255B%2528S%2529-%25CE%25B3-%2528Arylamino%2529prolyl%255Dthiazolidine%2520compounds%2520as%2520a%2520novel%2520series%2520of%2520potent%2520and%2520stable%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3662%26epage%3D3671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashina, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumiuchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span> </span><span class="NLM_article-title">Lead optimization of [(<i>S</i>)-γ-(arylamino)prolyl]thiazolidine focused on γ-substituent: indoline compounds as potent DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=641-655&author=H.+Sakashitaauthor=F.+Akahoshiauthor=T.+Yoshidaauthor=H.+Kitajimaauthor=Y.+Hayashiauthor=S.+Ishiiauthor=Y.+Takashinaauthor=R.+Tsutsumiuchiauthor=S.+Ono&title=Lead+optimization+of+%5B%28S%29-%CE%B3-%28arylamino%29prolyl%5Dthiazolidine+focused+on+%CE%B3-substituent%3A+indoline+compounds+as+potent+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKitajima%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DTakashina%26aufirst%3DY.%26aulast%3DTsutsumiuchi%26aufirst%3DR.%26aulast%3DOno%26aufirst%3DS.%26atitle%3DLead%2520optimization%2520of%2520%255B%2528S%2529-%25CE%25B3-%2528arylamino%2529prolyl%255Dthiazolidine%2520focused%2520on%2520%25CE%25B3-substituent%253A%2520indoline%2520compounds%2520as%2520potent%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D641%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Haffner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDougald, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reister, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conlee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenhard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secosky-Chang, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. R.</span><span> </span><span class="NLM_article-title">2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5257</span><span class="NLM_x">–</span> <span class="NLM_lpage">5261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5257-5261&author=C.+D.+Haffnerauthor=D.+L.+McDougaldauthor=S.+M.+Reisterauthor=B.+D.+Thompsonauthor=C.+Conleeauthor=J.+Fangauthor=J.+Bassauthor=J.+M.+Lenhardauthor=D.+Croomauthor=M.+B.+Secosky-Changauthor=T.+Tomaszekauthor=D.+McConnauthor=K.+Wells-Knechtauthor=P.+R.+Johnson&title=2-Cyano-4-fluoro-1-thiovalylpyrrolidine+analogues+as+potent+inhibitors+of+DPP-IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaffner%26aufirst%3DC.%2BD.%26aulast%3DMcDougald%26aufirst%3DD.%2BL.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DThompson%26aufirst%3DB.%2BD.%26aulast%3DConlee%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DBass%26aufirst%3DJ.%26aulast%3DLenhard%26aufirst%3DJ.%2BM.%26aulast%3DCroom%26aufirst%3DD.%26aulast%3DSecosky-Chang%26aufirst%3DM.%2BB.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DMcConn%26aufirst%3DD.%26aulast%3DWells-Knecht%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DP.%2BR.%26atitle%3D2-Cyano-4-fluoro-1-thiovalylpyrrolidine%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520DPP-IV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5257%26epage%3D5261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Fukushima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munetomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of potent 3- or 4-substituted-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6053</span><span class="NLM_x">–</span> <span class="NLM_lpage">6061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=6053-6061&author=H.+Fukushimaauthor=A.+Hiratateauthor=M.+Takahashiauthor=M.+Satioauthor=E.+Munetomoauthor=K.+Kitanoauthor=H.+Saitoauthor=Y.+Takaokaauthor=K.+Yamamoto&title=Synthesis+and+structure%E2%80%93activity+relationships+of+potent+3-+or+4-substituted-2-cyanopyrrolidine+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DH.%26aulast%3DHiratate%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DSatio%26aufirst%3DM.%26aulast%3DMunetomo%26aufirst%3DE.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DTakaoka%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520potent%25203-%2520or%25204-substituted-2-cyanopyrrolidine%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D6053%26epage%3D6061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraoka, Y.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=785-797&author=M.+Abeauthor=T.+Akiyamaauthor=Y.+Umezawaauthor=K.+Yamamotoauthor=M.+Nagaiauthor=H.+Yamazakiauthor=Y.+I.+Ichikawaauthor=Y.+Muraoka&title=Synthesis+and+biological+activity+of+sulphostin+analogues%2C+novel+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DUmezawa%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DNagai%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DH.%26aulast%3DIchikawa%26aufirst%3DY.%2BI.%26aulast%3DMuraoka%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520sulphostin%2520analogues%252C%2520novel%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D785%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Gilmore, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McShane, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B.</span><span> </span><span class="NLM_article-title">Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2006&pages=373-379&author=B.+F.+Gilmoreauthor=L.+Carsonauthor=L.+L.+McShaneauthor=D.+Quinnauthor=W.+A.+Coulterauthor=B.+Walker&title=Synthesis%2C+kinetic+evaluation%2C+and+utilization+of+a+biotinylated+dipeptide+proline+diphenyl+phosphonate+for+the+disclosure+of+dipeptidyl+peptidase+IV-like+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilmore%26aufirst%3DB.%2BF.%26aulast%3DCarson%26aufirst%3DL.%26aulast%3DMcShane%26aufirst%3DL.%2BL.%26aulast%3DQuinn%26aufirst%3DD.%26aulast%3DCoulter%26aufirst%3DW.%2BA.%26aulast%3DWalker%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520kinetic%2520evaluation%252C%2520and%2520utilization%2520of%2520a%2520biotinylated%2520dipeptide%2520proline%2520diphenyl%2520phosphonate%2520for%2520the%2520disclosure%2520of%2520dipeptidyl%2520peptidase%2520IV-like%2520serine%2520proteases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D347%26spage%3D373%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">[(<i>S</i>)-γ-(4-Aryl-1-piperazinyl)-l-prolyl] thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2618</span><span class="NLM_x">–</span> <span class="NLM_lpage">2621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2618-2621&author=T.+Yoshidaauthor=H.+Sakashitaauthor=F.+Akahoshiauthor=Y.+Hayashi&title=%5B%28S%29-%CE%B3-%284-Aryl-1-piperazinyl%29-l-prolyl%5D+thiazolidines+as+a+novel+series+of+highly+potent+and+long-lasting+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3D%255B%2528S%2529-%25CE%25B3-%25284-Aryl-1-piperazinyl%2529-l-prolyl%255D%2520thiazolidines%2520as%2520a%2520novel%2520series%2520of%2520highly%2520potent%2520and%2520long-lasting%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2618%26epage%3D2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-IV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5934</span><span class="NLM_x">–</span> <span class="NLM_lpage">5939</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5934-5939&author=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+D.+Pryorauthor=F.+Marsilioauthor=J.+K.+Wuauthor=H.+Heauthor=K.+A.+Lyonsauthor=G.+J.+Eiermannauthor=A.+Petrovauthor=G.+Scapinauthor=R.+A.+Patelauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=D.+Kim&title=Design%2C+synthesis%2C+and+biological+evaluation+of+triazolopiperazine-based+%CE%B2-amino+amides+as+potent%2C+orally+active+dipeptidyl+peptidase+IV+%28DPP-IV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BD.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DKim%26aufirst%3DD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520triazolopiperazine-based%2520%25CE%25B2-amino%2520amides%2520as%2520potent%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5934%26epage%3D5939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Corbett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirico, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscoe, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanVolkenburg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, R .K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, E. D.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide) pyrrolidinyl DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6707</span><span class="NLM_x">–</span> <span class="NLM_lpage">6713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6707-6713&author=J.+W.+Corbettauthor=K.+Diricoauthor=W.+Songauthor=B.+P.+Boscoeauthor=S.+D.+Doranauthor=D.+Boyerauthor=X.+Qiuauthor=M.+Ammiratiauthor=M.+A.+VanVolkenburgauthor=R+.K.+McPhersonauthor=J.+C.+Parkerauthor=E.+D.+Cox&title=Design+and+synthesis+of+potent+amido-+and+benzyl-substituted+cis-3-amino-4-%282-cyanopyrrolidide%29+pyrrolidinyl+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DDirico%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBoyer%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DVanVolkenburg%26aufirst%3DM.%2BA.%26aulast%3DMcPherson%26aufirst%3DR%2B.K.%26aulast%3DParker%26aufirst%3DJ.%2BC.%26aulast%3DCox%26aufirst%3DE.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520amido-%2520and%2520benzyl-substituted%2520cis-3-amino-4-%25282-cyanopyrrolidide%2529%2520pyrrolidinyl%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6707%26epage%3D6713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Coumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W. T.</span><span> </span><span class="NLM_article-title">3-[2-((2<i>S</i>)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methylbutyramide analogues as selective DPP-IV inhibitors for the treatement of type-II diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2077</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2077&pages=1274-1279&author=M.+S.+Coumarauthor=C.+N.+Changauthor=C.+T.+Chenauthor=X.+Chenauthor=C.+H.+Chienauthor=T.+Y.+Tsaiauthor=J.+H.+Chengauthor=H.+Y.+Wuauthor=C.+H.+Hanauthor=S.+H.+Wuauthor=Y.+W.+Huangauthor=T.+Hsuauthor=L.+J.+Hsuauthor=Y.+S.+Chaoauthor=H.+P.+Hsiehauthor=W.+T.+Jiaang&title=3-%5B2-%28%282S%29-2-Cyano-pyrrolidin-1-yl%29-2-oxo-ethylamino%5D-3-methylbutyramide+analogues+as+selective+DPP-IV+inhibitors+for+the+treatement+of+type-II+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DCheng%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DHan%26aufirst%3DC.%2BH.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DHuang%26aufirst%3DY.%2BW.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DHsu%26aufirst%3DL.%2BJ.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26atitle%3D3-%255B2-%2528%25282S%2529-2-Cyano-pyrrolidin-1-yl%2529-2-oxo-ethylamino%255D-3-methylbutyramide%2520analogues%2520as%2520selective%2520DPP-IV%2520inhibitors%2520for%2520the%2520treatement%2520of%2520type-II%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2077%26volume%3D17%26spage%3D1274%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Biftu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doss, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-IV inhibitors by application of molecular modeling and X-ray crystallography of sitaliptin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3384</span><span class="NLM_x">–</span> <span class="NLM_lpage">3387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3384-3387&author=T.+Biftuauthor=G.+Scapinauthor=S.+Singhauthor=D.+Fengauthor=J.+W.+Beckerauthor=G.+Eiermannauthor=H.+Heauthor=K.+Lyonsauthor=S.+Patelauthor=A.+Petrovauthor=R.+S.+Royauthor=B.+Zhangauthor=J.+Wuauthor=X.+Zhangauthor=G.+A.+Dossauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Rational+design+of+a+novel%2C+potent%2C+and+orally+bioavailable+cyclohexylamine+DPP-IV+inhibitors+by+application+of+molecular+modeling+and+X-ray+crystallography+of+sitaliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DRational%2520design%2520of%2520a%2520novel%252C%2520potent%252C%2520and%2520orally%2520bioavailable%2520cyclohexylamine%2520DPP-IV%2520inhibitors%2520by%2520application%2520of%2520molecular%2520modeling%2520and%2520X-ray%2520crystallography%2520of%2520sitaliptin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3384%26epage%3D3387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biftu, T.</span><span> </span><span class="NLM_article-title">Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3877</span><span class="NLM_x">–</span> <span class="NLM_lpage">3879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3877-3879&author=Y.+D.+Gaoauthor=D.+Fengauthor=R.+P.+Sheridanauthor=G.+Scapinauthor=S.+B.+Patelauthor=J.+K.+Wuauthor=X.+Zhangauthor=R.+S.+Royauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=T.+Biftu&title=Modeling+assisted+rational+design+of+novel%2C+potent%2C+and+selective+pyrrolopyrimidine+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DSheridan%26aufirst%3DR.%2BP.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DBiftu%26aufirst%3DT.%26atitle%3DModeling%2520assisted%2520rational%2520design%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520pyrrolopyrimidine%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3877%26epage%3D3879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kondo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nekado, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1613</span><span class="NLM_x">–</span> <span class="NLM_lpage">1631</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1613-1631&author=T.+Kondoauthor=T.+Nekadoauthor=I.+Sugimotoauthor=K.+Ochiauthor=S.+Takaiauthor=A.+Kinoshitaauthor=A.+Hatayamaauthor=S.+Yamamotoauthor=K.+Kishikawaauthor=H.+Nakaiauthor=M.+Toda&title=Design+and+synthesis+of+DPP-IV+inhibitors+lacking+the+electrophilic+nitrile+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DNekado%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DI.%26aulast%3DOchi%26aufirst%3DK.%26aulast%3DTakai%26aufirst%3DS.%26aulast%3DKinoshita%26aufirst%3DA.%26aulast%3DHatayama%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DKishikawa%26aufirst%3DK.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520DPP-IV%2520inhibitors%2520lacking%2520the%2520electrophilic%2520nitrile%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D16%26spage%3D1613%26epage%3D1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Peters, J. U.</span><span> </span><span class="NLM_article-title">11 years of cyanopyrrolidines as DPP-IV inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=579-595&author=J.+U.+Peters&title=11+years+of+cyanopyrrolidines+as+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">11 years of cyanopyrrolidines as DPP-IV inhibitors</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyanopyrrolidines (cyanopyrrolidides, pyrrolidine-2-nitriles, prolinenitriles) as inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV, DP IV, CD26, EC 3.4.14.5) were first reported in 1995.  The interest in this compd. class grew immensely when DPP-IV was discovered as a target for the treatment of type 2 diabetes.  The research on cyanopyrrolidines cumulated in the discoveries of vildagliptin (LAF237, NVP-LAF237) and saxagliptin (BMS-477118).  These compds. entered Phase III clin. trials in 2004 and 2005, resp., and an application for market approval has been filed for vildagliptin in 2006.  Today cyanopyrrolidines are, as judged by the nos. of patent applications, the most prominent of several series of DPP-IV inhibitors, and have the potential to become valuable medicines for type 2 diabetes in the near future.  This review summarizes some historical aspects of the discovery of cyanopyrrolidine DPP-IV inhibitors, and then focuses mainly on structure-activity-relationships, the evolution of different subseries, the possibilities to improve on the chem. instability that is assocd. with this compd. class, and on the discoveries of vildagliptin and saxagliptin.  Within this context, the properties of individual compds. and results from biol. studies are discussed.  The rationale of DPP-IV inhibition, clin. data, and the relevance of selectivity over related proteases are extensively reviewed in other contributions to this issue of Curr.  Top. Med. Chem., and are therefore only very briefly touched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMheLlajHi0LVg90H21EOLACvtfcHk0lib8ItUJh-RwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D&md5=1aed687f83d3d35a2a581956ce4b82e0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F156802607780091000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091000%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26atitle%3D11%2520years%2520of%2520cyanopyrrolidines%2520as%2520DPP-IV%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span> </span><span class="NLM_article-title">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F092986712802002491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22709010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3982-3999&author=Y.+Liuauthor=Y.+Huauthor=T.+Liu&title=Recent+advances+in+non-peptidomimetic+dipeptidyl+peptidase+4+inhibitors%3A+medicinal+chemistry+and+preclinical+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span></div><div class="casAuthors">Liu, Y.; Hu, Y.; Liu, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3982-3999</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase 4 (DPP-4), a substrate-specific serine protease, has been validated as a promising drug target for the treatment of type 2 diabetes.  DPP-4 inhibitors significantly lowered blood glucose levels in patients with type 2 diabetes without common body wt. gain, hypoglycemia and gastrointestinal disturbance side effects.  Therefore, DPP-4 inhibitors attracted more and more attention.  In particular, non-peptidomimetic DPP-4 inhibitors have been a focus of research and development and made great progress in recent years, which resulted in the discovery of a wide variety of potent non-peptidomimetic DPP-4 inhibitors.  Some of them, such as sitagliptin, alogliptin and linagliptin have already been used as marketed drugs, while others have been into clin. trials.  Based on the core structural features of non-peptidomimetic DPP-4 inhibitors, seven types were classified in the article.  For each type, we focused on the description of strategies for design and optimization, together with a discussion on concluded structure-activity relationships (SAR).  In addn., the contribution of specific substituents to the inhibition of DPP-4 was summarized.  Selectivity towards the inhibition of DPP-4 over dipeptidyl peptidase 8 (DPP-8) and dipeptidyl peptidase 9 (DPP-9) was also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLqQuB1LrfarVg90H21EOLACvtfcHk0lib8ItUJh-RwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI&md5=3ad3980483dcdcb29868b34a8bf77e6b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F092986712802002491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712802002491%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26atitle%3DRecent%2520advances%2520in%2520non-peptidomimetic%2520dipeptidyl%2520peptidase%25204%2520inhibitors%253A%2520medicinal%2520chemistry%2520and%2520preclinical%2520aspects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3982%26epage%3D3999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikedo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maezaki, H.</span><span> </span><span class="NLM_article-title">Discovery of a 3-pyridylacetamide derivative (TAK-100) as a potent, selective and orally active dipeptidyl peptidase IV (DPP-IV) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101236h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=831-850&author=Y.+Miyamotoauthor=Y.+Bannoauthor=T.+Yamashitaauthor=T.+Fujimotoauthor=S.+Oiauthor=Y.+Moritohauthor=T.+Asakawaauthor=O.+Kataokaauthor=K.+Takeuchiauthor=N.+Suzukiauthor=K.+Ikedoauthor=T.+Kosakaauthor=S.+Tsubotaniauthor=A.+Taniauthor=M.+Sasakiauthor=M.+Funamiauthor=M.+Amanoauthor=Y.+Yamamotoauthor=K.+Aertgeertsauthor=J.+Yanoauthor=H.+Maezaki&title=Discovery+of+a+3-pyridylacetamide+derivative+%28TAK-100%29+as+a+potent%2C+selective+and+orally+active+dipeptidyl+peptidase+IV+%28DPP-IV%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm101236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101236h%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DOi%26aufirst%3DS.%26aulast%3DMoritoh%26aufirst%3DY.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DKataoka%26aufirst%3DO.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIkedo%26aufirst%3DK.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DTsubotani%26aufirst%3DS.%26aulast%3DTani%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DMaezaki%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%25203-pyridylacetamide%2520derivative%2520%2528TAK-100%2529%2520as%2520a%2520potent%252C%2520selective%2520and%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-IV%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D831%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">Prolyl peptidase related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=621-635&author=P.+van+der+Vekenauthor=A.+Haemersauthor=K.+Augustyns&title=Prolyl+peptidase+related+to+dipeptidyl+peptidase+IV%3A+potential+of+specific+inhibitors+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery</span></div><div class="casAuthors">Van der Veken, Pieter; Haemers, Achiel; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-635</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase IV (DPP IV) is a validated target for the treatment of type 2 diabetes, with several inhibitors currently in phase 3 clin. trials.  This review will mainly focus on proline-specific dipeptidyl peptidases related to DPP IV: fibroblast activation protein (FAP), dipeptidyl peptidase 8 (DPP8), dipeptidyl peptidase 9 (DPP9) and dipeptidyl peptidase II (DPP II).  The biochem. and biol. properties of these enzymes will be discussed, as well as the therapeutic potential of their inhibition.  The development of potent and selective inhibitors for each of these peptidases will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJIONvS_JxQ7Vg90H21EOLACvtfcHk0lib8ItUJh-RwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers7k%253D&md5=7ee3184cc0d1fd12b34cf268ae27aaec</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F156802607780091046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091046%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DProlyl%2520peptidase%2520related%2520to%2520dipeptidyl%2520peptidase%2520IV%253A%2520potential%2520of%2520specific%2520inhibitors%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D621%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Ristic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byiers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D.</span><span> </span><span class="NLM_article-title">Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response</span> <span class="citation_source-journal">Diabetes, Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1463-1326.2005.00539.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=16219012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1amt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=692-698&author=S.+Risticauthor=S.+Byiersauthor=J.+Foleyauthor=D.+Holmes&title=Improved+glycaemic+control+with+dipeptidyl+peptidase-4+inhibition+in+patients+with+type+2+diabetes%3A+vildagliptin+%28LAF237%29+dose+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: Vildagliptin (LAF237) dose response</span></div><div class="casAuthors">Ristic, S.; Byiers, S.; Foley, J.; Holmes, D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">692-698</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Objective: A novel treatment option for diabetic patients is the enhancement of incretin hormone activity by inhibition of the enzyme dipeptidyl peptidase-4 (DPP-4).  This study was designed to establish a dose of the DPP-4-inhibitor vildagliptin (LAF237) that was effective in reducing HbA1c levels and was safe and well tolerated in patients with type 2 diabetes.  Patients and Methods: The study of 279 patients with type 2 diabetes consisted of a 4-wk run-in phase where patients received placebo and a 12-wk active treatment phase where they received one of the following dosages of vildagliptin: 25 mg twice daily, 25, 50 or 100 mg once daily (qd), or placebo.  Results: There was a statistically significant redn. in HbA1c levels in the vildagliptin 50 mg qd (p = 0.003) and 100 mg qd groups (p = 0.004) compared with the placebo group.  The mean 4-h postprandial glucose level was significantly reduced from placebo in the vildagliptin 50 mg qd group (p = 0.012) and mean 4-h postprandial insulin was significantly increased from baseline vs. placebo in the vildagliptin 100 mg qd group (p = 0.022).  The assessment of β-cell function (HOMA-B) was significantly increased in the vildagliptin 100 mg qd treatment group (p = 0.007).  The incidence of adverse events was similar in all treatment groups including placebo.  Conclusions: Vildagliptin, at 50 and 100 mg qd, was effective in reducing HbA1c levels compared with placebo in patients with type 2 diabetes.  Vildagliptin at dosages up to 100 mg qd appeared safe and well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoacW0uyENfOLVg90H21EOLACvtfcHk0lisD6b5HP0dcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1amt73M&md5=0bb376c79066c25a3b4cc8466ef8f80b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1463-1326.2005.00539.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1463-1326.2005.00539.x%26sid%3Dliteratum%253Aachs%26aulast%3DRistic%26aufirst%3DS.%26aulast%3DByiers%26aufirst%3DS.%26aulast%3DFoley%26aufirst%3DJ.%26aulast%3DHolmes%26aufirst%3DD.%26atitle%3DImproved%2520glycaemic%2520control%2520with%2520dipeptidyl%2520peptidase-4%2520inhibition%2520in%2520patients%2520with%2520type%25202%2520diabetes%253A%2520vildagliptin%2520%2528LAF237%2529%2520dose%2520response%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2005%26volume%3D7%26spage%3D692%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Russell-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, S.</span><span> </span><span class="NLM_article-title">Recent advances in incretin-based therapy</span> <span class="citation_source-journal">Clin. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1365-2265.2012.04483.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22804841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlait77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=489-499&author=D.+Russell-Jonesauthor=S.+Gough&title=Recent+advances+in+incretin-based+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in incretin-based therapies</span></div><div class="casAuthors">Russell-Jones, David; Gough, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Endocrinology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">489-499</span>CODEN:
                <span class="NLM_cas:coden">CLECAP</span>;
        ISSN:<span class="NLM_cas:issn">0300-0664</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Summary: The global burden of type 2 diabetes is growing.  Traditional therapies are suboptimal and there is a clear unmet need for treatments that offer effective glucose control while addressing the comorbid factors assocd. with diabetes, such as obesity and risk of cardiovascular disease, without the fear of hypoglycemia.  Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors offer a novel way of reducing hyperglycemia by targeting the incretin system.  This review provides an overview of the development of incretin-based therapies and explains their differing modes of action compared with traditional interventions.  A comparison of the clin. profiles of current glucagon-like peptide-1 receptor agonists [liraglutide and exenatide (twice-daily and once-weekly)] and dipeptidyl peptidase-4 inhibitors (sitagliptin, saxagliptin, vildagliptin and linagliptin) is performed alongside a discussion of the placement of incretin-based therapies in treatment guidelines.  Further improvements in this class are expected, and we will examine some of the novel glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsNSR5LO-DNrVg90H21EOLACvtfcHk0lisD6b5HP0dcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlait77L&md5=974697d2411b2f5d5df73dbe9515ae38</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2265.2012.04483.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2265.2012.04483.x%26sid%3Dliteratum%253Aachs%26aulast%3DRussell-Jones%26aufirst%3DD.%26aulast%3DGough%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520incretin-based%2520therapy%26jtitle%3DClin.%2520Endocrinol.%26date%3D2012%26volume%3D77%26spage%3D489%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Cox, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J. B.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy</span> <span class="citation_source-journal">Drug Healthcare Patient Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFyjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=7-19&author=M.+E.+Coxauthor=J.+Rowellauthor=L.+Corsinoauthor=J.+B.+Green&title=Dipeptidyl+peptidase-4+inhibitors+in+the+management+of+type+2+diabetes%3A+safety%2C+tolerability%2C+and+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy</span></div><div class="casAuthors">Cox, Mary Elizabeth; Rowell, Jennifer; Corsino, Leonor; Green, Jennifer B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug, Healthcare and Patient Safety</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">DHPSBA</span>;
        ISSN:<span class="NLM_cas:issn">1179-1365</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Although glycemic control is an important and effective way to prevent and minimize the worsening of diabetes-related complications, type 2 diabetes is a progressive disease which often proves difficult to manage.  Most affected patients will eventually require therapy with multiple medications in order to reach appropriate glycemic targets.  The dipeptidyl peptidase-4 (DPP-4) inhibitors constitute a relatively new class of oral medications for the treatment of type 2 diabetes, which has become widely incorporated into clin. practice.  This review summarizes the available data on the efficacy, safety, and tolerability of these medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3zlOnURaMwLVg90H21EOLACvtfcHk0lhK8NKWCB7NMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFyjtb8%253D&md5=22788015259562ead81bfa404aa19008</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DM.%2BE.%26aulast%3DRowell%26aufirst%3DJ.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DGreen%26aufirst%3DJ.%2BB.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520in%2520the%2520management%2520of%2520type%25202%2520diabetes%253A%2520safety%252C%2520tolerability%252C%2520and%2520efficacy%26jtitle%3DDrug%2520Healthcare%2520Patient%2520Saf.%26date%3D2010%26volume%3D2%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Keeks, E. D.</span><span> </span><span class="NLM_article-title">Linagliptin: a review of its use in the management of type 2 diabetes mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1793-1824&author=E.+D.+Keeks&title=Linagliptin%3A+a+review+of+its+use+in+the+management+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeeks%26aufirst%3DE.%2BD.%26atitle%3DLinagliptin%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520the%2520management%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DDrugs%26date%3D2012%26volume%3D72%26spage%3D1793%26epage%3D1824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Bohanson, N.</span><span> </span><span class="NLM_article-title">Overview of the gliptin class (dipeptidyl peptidase-4 inhibitors) in clinical practice</span> <span class="citation_source-journal">Postgrad. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=19940423" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=121&author=N.+Bohanson&title=Overview+of+the+gliptin+class+%28dipeptidyl+peptidase-4+inhibitors%29+in+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohanson%26aufirst%3DN.%26atitle%3DOverview%2520of%2520the%2520gliptin%2520class%2520%2528dipeptidyl%2520peptidase-4%2520inhibitors%2529%2520in%2520clinical%2520practice%26jtitle%3DPostgrad.%2520Med.%26date%3D2009%26spage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Karagiannis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paletas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsapas, A.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis</span> <span class="citation_source-journal">BMJ</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2012&pages=e1369&author=T.+Karagiannisauthor=P.+Paschosauthor=K.+Paletasauthor=D.+R.+Matthewsauthor=A.+Tsapas&title=Dipeptidyl+peptidase-4+inhibitors+for+treatment+of+type+2+diabetes+mellitus+in+the+clinical+setting%3A+systematic+review+and+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaragiannis%26aufirst%3DT.%26aulast%3DPaschos%26aufirst%3DP.%26aulast%3DPaletas%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DD.%2BR.%26aulast%3DTsapas%26aufirst%3DA.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520for%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%2520in%2520the%2520clinical%2520setting%253A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DBMJ%26date%3D2012%26volume%3D344%26spage%3De1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Derosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffioli, P.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors: 3 years of experience</span> <span class="citation_source-journal">Diabetes Technol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1089%2Fdia.2011.0204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22324384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=350-364&author=G.+Derosaauthor=P.+Maffioli&title=Dipeptidyl+peptidase-4+inhibitors%3A+3+years+of+experience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience</span></div><div class="casAuthors">Derosa, Giuseppe; Maffioli, Pamela</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Technology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-364</span>CODEN:
                <span class="NLM_cas:coden">DTTHFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-9156</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">According to the latest American Diabetes Assocn. guidelines, lowering glycated Hb (HbA1c) to below or around 7% has been shown to reduce microvascular and neuropathic complications of diabetes and, if implemented soon after the diagnosis of diabetes, is assocd. with long-term redn. in macrovascular disease.  Recently a new class of antidiabetes drugs has been developed, dipeptidyl peptidase-4 (DPP-4) inhibitors, which act by inhibiting DPP-4, the enzyme that inactivates glucagon-like peptide-1 (GLP-1).  Through the inhibition of DPP-4, DPP-4 inhibitors enhance the effects of GLP-1 and glucose-dependent insulinotropic peptide, increasing glucose-mediated insulin secretion and suppressing glucagon secretion.  We conducted a review analyzing clin. efficacy and safety of DPP-4 inhibitors, both alone and in combination with other antidiabetes drugs, including randomized controlled trials about sitagliptin, vildagliptin, saxagliptin, and linagliptin conducted in the latest 15 years.  We concluded that, once metformin fails to maintain glycemic control, addn. of DPP-4 inhibitors should be the logical choice: they seems to lower HbA1c levels by 0.6-0.9 percentage points and to have a comparable effect on HbA1c vs. the addn. of a sulfonylurea or glitazone.  They also have pos. effects on β-cell function, and they have neutral effects on body wt.  Furthermore, DPP-4 inhibitors prevent the risk of hypoglycemia posed by sulfonylureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWF2HG6yjq3bVg90H21EOLACvtfcHk0lhK8NKWCB7NMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D&md5=c17b5978ffa303d88b1ad76dca040199</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1089%2Fdia.2011.0204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdia.2011.0204%26sid%3Dliteratum%253Aachs%26aulast%3DDerosa%26aufirst%3DG.%26aulast%3DMaffioli%26aufirst%3DP.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%253A%25203%2520years%2520of%2520experience%26jtitle%3DDiabetes%2520Technol.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3D350%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifuloromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluoro-phenyl)butan-2-amine: a potent orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+Sinhaauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifuloromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluoro-phenyl%29butan-2-amine%3A+a+potent+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifuloromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluoro-phenyl%2529butan-2-amine%253A%2520a%2520potent%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L G.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5025</span><span class="NLM_x">–</span> <span class="NLM_lpage">5037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.+P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L+G.+Hamann&title=Discovery+and+preclinical+profile+of+saxagliptin+%28BMS-477118%29%3A+a+highly+potent%2C+long-acting%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of β-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0lhHdUcMVWz_VQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL%2BG.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520saxagliptin%2520%2528BMS-477118%2529%253A%2520a%2520highly%2520potent%252C%2520long-acting%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5025%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Eckhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langkop, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfengle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelsbach, E.</span><span> </span><span class="NLM_article-title">8-[(3<i>R</i>)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1<i>H</i>-purine-2,6-dione (BI-1356) a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type-2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6450</span><span class="NLM_x">–</span> <span class="NLM_lpage">6453</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701280z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6450-6453&author=M.+Eckhardtauthor=E.+Langkopauthor=M.+Markauthor=M.+Tadayyonauthor=L.+Thomasauthor=H.+Narauthor=W.+Pfengleauthor=B.+Guthauthor=R.+Lotzauthor=P.+Siegelauthor=H.+Fuchsauthor=E.+Himmelsbach&title=8-%5B%283R%29-3-aminopiperidin-1-yl%5D-7-%28but-2-yn-1-yl%29-3-methyl-1-%5B%284-methylquinazolin-2-yl%29methyl%5D-3%2C7-dihydro-1H-purine-2%2C6-dione+%28BI-1356%29+a+highly+potent%2C+selective%2C+long-acting%2C+and+orally+bioavailable+DPP-4+inhibitor+for+the+treatment+of+type-2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm701280z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701280z%26sid%3Dliteratum%253Aachs%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DLangkop%26aufirst%3DE.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DL.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DPfengle%26aufirst%3DW.%26aulast%3DGuth%26aufirst%3DB.%26aulast%3DLotz%26aufirst%3DR.%26aulast%3DSiegel%26aufirst%3DP.%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DHimmelsbach%26aufirst%3DE.%26atitle%3D8-%255B%25283R%2529-3-aminopiperidin-1-yl%255D-7-%2528but-2-yn-1-yl%2529-3-methyl-1-%255B%25284-methylquinazolin-2-yl%2529methyl%255D-3%252C7-dihydro-1H-purine-2%252C6-dione%2520%2528BI-1356%2529%2520a%2520highly%2520potent%252C%2520selective%252C%2520long-acting%252C%2520and%2520orally%2520bioavailable%2520DPP-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type-2%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6450%26epage%3D6453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Lim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. S.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitors, after multiple dosing in healthy volunteers</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1365-2125.2009.03376.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=20002082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=883-890&author=K.+S.+Limauthor=J.+Y.+Choauthor=B.+H.+Kimauthor=J.+R.+Kimauthor=H.+S.+Kimauthor=D.+K.+Kimauthor=S.+H.+Kimauthor=H.+J.+Yimauthor=S.+H.+Leeauthor=S.+G.+Shinauthor=I.+J.+Jangauthor=K.+S.+Yu&title=Pharmacokinetics+and+pharmacodynamics+of+LC15-0444%2C+a+novel+dipeptidyl+peptidase+IV+inhibitors%2C+after+multiple+dosing+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers</span></div><div class="casAuthors">Lim, Kyoung Soo; Cho, Joo-Youn; Kim, Bo-Hyung; Kim, Jung-Ryul; Kim, Hwa-Sook; Kim, Dong-Kyu; Kim, Sung-Ho; Yim, Hyeon Joo; Lee, Sung-Hack; Shin, Sang-Goo; Jang, In-Jin; Yu, Kyung-Sang</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-890</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">LC15-0444 is a selective and competitive inhibitor of dipeptidyl peptidase (DPP) IV with potential for the treatment of Type 2 diabetes.  The aim was to investigate the pharmacokinetic (PK) and pharmacodynamic (PD) profiles after multiple oral ascending doses of LC15-0444 in healthy male subjects.  A dose block-randomized, double-blind, placebo-controlled, parallel group study was performed in three groups with 10 subjects (eight for active drug; two for placebo) per group; each group received 200, 400, or 600 mg of LC15-0444 once daily for 10 days.  Blood and urine samples were collected up to 24 h after the first dosing and up to 72 h after the last dosing.  The LC15-0444 concn.-time profiles exhibited characteristics of multicompartment disposition.  No dose- or time-dependent change in PK parameters was obsd.  Mean elimination half-life was in a range 16.6-20.1 h in the dose groups.  Mean renal clearance and fraction of unchanged drug excreted in urine was 18.6-21.9 and 0.40-0.48 l/h-1, resp.  In the steady state, mean accumulation ratios by dose groups were between 1.22 and 1.31.  More than 80% inhibition of DPP IV activity from baseline was sustained for >24 h in all dose groups.  This study provides evidence of the pharmacol. activity of LC15-0444 in humans.  LC15-0444 possesses PK and PD characteristics that support a once-daily dosing regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8t1ofBW7qarVg90H21EOLACvtfcHk0lj233r-paIZsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFOruw%253D%253D&md5=9f6e162ae8274a38ce5feeb415c6badd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2009.03376.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2009.03376.x%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BS.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DYim%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DShin%26aufirst%3DS.%2BG.%26aulast%3DJang%26aufirst%3DI.%2BJ.%26aulast%3DYu%26aufirst%3DK.%2BS.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520LC15-0444%252C%2520a%2520novel%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%252C%2520after%2520multiple%2520dosing%2520in%2520healthy%2520volunteers%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D68%26spage%3D883%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Yang, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivane, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitale, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharmalingam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makesh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, S. H.</span><span> </span><span class="NLM_article-title">A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes</span> <span class="citation_source-journal">Diabetes, Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fdom.12042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=23170990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVems7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=410-416&author=S.+J.+Yangauthor=K.+W.+Minauthor=S.+K.+Guptaauthor=J.+Y.+Parkauthor=V.+K.+Shivaneauthor=S.+U.+Pitaleauthor=P.+K.+Agarwalauthor=A.+Sosaleauthor=P.+Gandhiauthor=M.+Dharmalingamauthor=V.+Mohanauthor=U.+Makeshauthor=D.+M.+Kimauthor=J.+A.+Kimauthor=P.+K.+Kimauthor=S.+H.+Baik&title=A+multicentre%2C+multinational%2C+randomized%2C+placebo-controlled%2C+double-blind%2C+phase+3+trial+to+evaluate+the+efficacy+and+safety+of+gemigliptin+%28LC15-0444%29+in+patients+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes</span></div><div class="casAuthors">Yang, S. J.; Min, K. W.; Gupta, S. K.; Park, J. Y.; Shivane, V. K.; Pitale, S. U.; Agarwal, P. K.; Sosale, A.; Gandhi, P.; Dharmalingam, M.; Mohan, V.; Mahesh, U.; Kim, D. M.; Kim, Y. S.; Kim, J. A.; Kim, P. K.; Baik, S. H.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-416</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim : This study was designed to assess the efficacy and safety of the dipeptidyl peptidase IV inhibitor gemigliptin (LC15-0444) 50 mg vs. placebo in patients with type 2 diabetes.  Methods : We conducted a 24-wk, randomized, double-blind, placebo-controlled phase III trial in 182 patients (74 from Korea and 108 from India) with type 2 diabetes.  After an initial 2 wk of a diet and exercise program followed by 2 wk of a single-blind placebo run-in period, eligible patients were randomized to gemigliptin 50 mg or placebo, receiving the assigned treatment for 24 wk.  HbA1c and fasting plasma glucose (FPG) were measured periodically, and oral glucose tolerance test was performed at baseline and weeks 12 and 24.  Results : At week 24, gemigliptin treatment led to significant redns. in HbA1c measurements compared to placebo (adjust mean after subtracting the placebo effect size: -0.71%, 95% confidence interval: -1.04 to -0.37%).  A significantly greater proportion of patients achieved an HbA1c <7% with gemigliptin than with placebo.  The placebo-subtracted FPG change from baseline at week 24 was -19.80 mg/dL.  The overall incidence rates for adverse events were similar in the gemigliptin and placebo groups.  Conclusions : This study showed the efficacy and safety of gemigliptin 50 mg administered once daily as a monotherapy for type 2 diabetes patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEY87Pr0t-7Vg90H21EOLACvtfcHk0lj233r-paIZsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVems7Y%253D&md5=2902a431fbc6fb1375ae686679aee126</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Fdom.12042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.12042%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BJ.%26aulast%3DMin%26aufirst%3DK.%2BW.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DShivane%26aufirst%3DV.%2BK.%26aulast%3DPitale%26aufirst%3DS.%2BU.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26aulast%3DSosale%26aufirst%3DA.%26aulast%3DGandhi%26aufirst%3DP.%26aulast%3DDharmalingam%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DV.%26aulast%3DMakesh%26aufirst%3DU.%26aulast%3DKim%26aufirst%3DD.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DP.%2BK.%26aulast%3DBaik%26aufirst%3DS.%2BH.%26atitle%3DA%2520multicentre%252C%2520multinational%252C%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%252C%2520phase%25203%2520trial%2520to%2520evaluate%2520the%2520efficacy%2520and%2520safety%2520of%2520gemigliptin%2520%2528LC15-0444%2529%2520in%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2013%26volume%3D15%26spage%3D410%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Agrawal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, S. N.</span><span> </span><span class="NLM_article-title">Linagliptin, a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F138945012800675731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22420306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFeku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=970-983&author=R.+Agrawalauthor=J.+Pratimaauthor=S.+N.+Dikshit&title=Linagliptin%2C+a+novel+methylxanthin+based+approved+dipeptidyl+peptidase-4+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor</span></div><div class="casAuthors">Agrawal, Ritesh; Jain, Pratima; Dikshit, S. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">970-983</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chem., methylxanthine nucleus based Linagliptin (BI-1356, BI-1356-BS) is a dipeptidyl peptidase-IV inhibitor, which has been developed by Boehringer Ingelheim in assocn. with Lilly for the treatment of Type-II Diabetes.  Linagliptin was marketed by Lilly under the trade name Tradjenta and Trajenta.  Linagliptin was approved as the once-daily dose by USFDA on 2 May 2011, for the treatment of Type-II Diabetes.  Linagliptin 5mg once daily dose was approved based on a clin. trial program, which was conducted on approx. 4,000 adults with Type-II Diabetes.  Linagliptin demonstrated statistically significant mean difference in HbA1c from placebo of up to 0.72 percent, when it was used monotherapically.  In patients, who were not adequately controlled on metformin or metformin plus sulfonylurea, the addn. of Linagliptin resulted in a statistically significant mean difference in HbA1c from placebo of -0.6 percent.  Linagliptin was obsd. to produce significant redn. in fasting plasma glucose (FPG) compared to placebo, when used as a monotherapy in combination with metformin, sulfonylurea and/or pioglitazone.  Linagliptin demonstrated significant redn. post-prandial glucose (PPG) levels in two hours as compared with placebo in monotherapy as well as in combination with metformin.  In vitro assays also anticipated that Linagliptin is a potent DPP-IV inhibitor as well as it exhibits good selectivity for DPP-IV as compared with other DPPs.  The in-vivo studies also demonstrated same anticipation with respect to Linagliptin.  Consequently, increasing the GLP-1 levels so far improved glucose tolerance in both healthy animals.  X-ray crystallog. anticipates that Linagliptin complexes with human DPP-IV enzyme, e.g. butynyl substituent occupies the S1 hydrophobic pocket of the enzyme; the aminopiperidine substituent in the xanthine scaffold occupies the S2 subsite and its primary amine interacts with the key amino acid residues, which involves in the recognition of peptide substrates.  In the present review, we have tried to cover comparative study of DPP-IV inhibitors, chem., phys. properties, com. synthesis, patent portfolio, cryst. polymorphic forms of Linagliptin and its receptor interaction, Pharmacophore rational, mechanism, clin. studies, preclin., adverse effect, available formulations, dose regimen, co-therapy of Linagliptin, giving emphasis on the medicinal chem. aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1laoHnRsVb7Vg90H21EOLACvtfcHk0lhCglsFuXB2kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFeku7Y%253D&md5=457dcf4f094ac456cc7691285750c01a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.2174%2F138945012800675731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945012800675731%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DR.%26aulast%3DPratima%26aufirst%3DJ.%26aulast%3DDikshit%26aufirst%3DS.%2BN.%26atitle%3DLinagliptin%252C%2520a%2520novel%2520methylxanthin%2520based%2520approved%2520dipeptidyl%2520peptidase-4%2520inhibitor%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2012%26volume%3D13%26spage%3D970%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Scheen, A. J.</span><span> </span><span class="NLM_article-title">A review of gliptins in 2011</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1517%2F14656566.2012.642866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22149369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SktLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=81-99&author=A.+J.+Scheen&title=A+review+of+gliptins+in+2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A review of gliptins in 2011</span></div><div class="casAuthors">Scheen, Andre J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-99</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Dipeptidylpeptidase-4 (DPP-4) inhibitors offer new options for the management of type 2 diabetes (T2DM).Areas covered: This paper is an updated review, providing an anal. of both the similarities and the differences between the various compds. known as gliptins, currently used in the clinic (sitagliptin, vildagliptin, saxagliptin, alogliptin and linagliptin).  This paper discusses the pharmacokinetic and pharmacodynamic characteristics of gliptins; both the efficacy and safety profiles of gliptins in clin. trials (compared with classical glucose-lowering agents), given as monotherapy or in combination, including in special populations; the positioning of DPP-4 inhibitors in the management of T2DM in recent guidelines; and various unanswered questions and perspectives.Expert opinion: The role of DPP-4 inhibitors in the therapeutic armamentarium of T2DM is evolving, as their potential strengths and weaknesses become better defined.  Future crit. issues may include the durability of glucose control, resulting from better β-cell protection, pos. effects on cardiovascular outcomes and long-term safety issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3V0SJS_tTbrVg90H21EOLACvtfcHk0lhCglsFuXB2kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SktLfF&md5=8d90eb509fb8649ac1f0fc068f874e0a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1517%2F14656566.2012.642866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2012.642866%26sid%3Dliteratum%253Aachs%26aulast%3DScheen%26aufirst%3DA.%2BJ.%26atitle%3DA%2520review%2520of%2520gliptins%2520in%25202011%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2012%26volume%3D13%26spage%3D81%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Gueler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmschrott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeing, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erbel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankenstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleissner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhpaewar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dengler, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katus, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doesch, A. O.</span><span> </span><span class="NLM_article-title">Effects of vildagliptin (galvus) therapy in patients with type 2 diabetes</span> <span class="citation_source-journal">Drug Des. Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVSntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=297-303&author=I.+Guelerauthor=S.+Muellerauthor=M.+Helmschrottauthor=C.+U.+Oeingauthor=C.+Erbelauthor=L.+Frankensteinauthor=C.+Gleissnerauthor=A.+Ruhpaewarauthor=P.+Ehlermanauthor=T.+J.+Denglerauthor=H.+A.+Katusauthor=A.+O.+Doesch&title=Effects+of+vildagliptin+%28galvus%29+therapy+in+patients+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of vildagliptin (Galvus) therapy in patients with type 2 diabetes mellitus after heart transplantation</span></div><div class="casAuthors">Gueler, Ibrahim; Mueller, Susanne; Helmschrott, Matthias; Oeing, Christian U.; Erbel, Christian; Frankenstein, Lutz; Gleissner, Christian; Ruhparwar, Arjang; Ehlermann, Philipp; Dengler, Thomas J.; Katus, Hugo A.; Doesch, Andreas O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">297-303</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Type 2 Diabetes mellitus (T2DM) is a common comorbidity in patients after heart transplantation (HTx) and is assocd. with adverse long-term outcomes.  Methods: The retrospective study reported here analyzed the effects of vildagliptin therapy in stable patients post-HTx with T2DM and compared these with control patients for matched-pairs anal.  A total of 30 stable patients post-HTx with T2DM were included in the study.  Fifteen patients (mean age 58.6 ± 6.0 years, mean time post-HTx 4.9 ± 5.3 years, twelve male and three female) were included in the vildagliptin group (VG) and 15 patients were included in the control group (CG) (mean age 61.2 ± 8.3 years, mean time post-HTx 7.2 ± 6.6 years, all male).  Results: Mean glycated Hb (HbA1c) in the VG was 7.4% ± 0.7% before vs. 6.8% ± 0.8% after 8 mo of vildagliptin therapy (P = 0.002 vs. baseline).  In the CG, HbA1c was 7.0% ± 0.7% vs. 7.3% ± 1.2% at follow-up (P = 0.21).  Addnl., there was a significant redn. in mean blood glucose in the VG, from 165.0 ± 18.8 mg/dL to 147.9 ± 22.7 mg/dL (P = 0.002 vs. baseline), whereas mean blood glucose increased slightly in the CG from 154.7 ± 19.7 mg/dL to 162.6 ± 35.0 mg/dL (P = 0.21).  No statistically significant changes in body wt. (from 83.3 ± 10.8 kg to 82.0 ± 10.9 kg, P = 0.20), total cholesterol (1.5%, P = 0.68), or triglyceride levels (8.0%, P = 0.65) were seen in the VG.  No significant changes in immunosuppressive drug levels or dosages were obsd. in either group.  Conclusion: Vildagliptin therapy significantly reduced HbA1c and mean blood glucose levels in post-HTx patients in this study with T2DM and did not have any neg. effects on lipid profile or body wt.  Thus, vildagliptin therapy presented an interesting therapeutic approach for this selected patient cohort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAIk48pts7FLVg90H21EOLACvtfcHk0liuQymiqGgBFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVSntLo%253D&md5=b0a4aa610c5d9cad1aaa897a5f4d7e4e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGueler%26aufirst%3DI.%26aulast%3DMueller%26aufirst%3DS.%26aulast%3DHelmschrott%26aufirst%3DM.%26aulast%3DOeing%26aufirst%3DC.%2BU.%26aulast%3DErbel%26aufirst%3DC.%26aulast%3DFrankenstein%26aufirst%3DL.%26aulast%3DGleissner%26aufirst%3DC.%26aulast%3DRuhpaewar%26aufirst%3DA.%26aulast%3DEhlerman%26aufirst%3DP.%26aulast%3DDengler%26aufirst%3DT.%2BJ.%26aulast%3DKatus%26aufirst%3DH.%2BA.%26aulast%3DDoesch%26aufirst%3DA.%2BO.%26atitle%3DEffects%2520of%2520vildagliptin%2520%2528galvus%2529%2520therapy%2520in%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDrug%2520Des.%2520Dev.%2520Ther.%26date%3D2013%26volume%3D7%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Matteuchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianpietro, O.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibition: linking chemical properties to clinical safety</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4753</span><span class="NLM_x">–</span> <span class="NLM_lpage">4760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F092986711797535290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=21919850" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4753-4760&author=E.+Matteuchiauthor=O.+Gianpietro&title=Dipeptidyl+peptidase-4+inhibition%3A+linking+chemical+properties+to+clinical+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.2174%2F092986711797535290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535290%26sid%3Dliteratum%253Aachs%26aulast%3DMatteuchi%26aufirst%3DE.%26aulast%3DGianpietro%26aufirst%3DO.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibition%253A%2520linking%2520chemical%2520properties%2520to%2520clinical%2520safety%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4753%26epage%3D4760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltra, S.</span><span> </span><span class="NLM_article-title">Choosing a gliptin</span> <span class="citation_source-journal">Int. J. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=298-308&author=V.+Guptaauthor=S.+Kaltra&title=Choosing+a+gliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DKaltra%26aufirst%3DS.%26atitle%3DChoosing%2520a%2520gliptin%26jtitle%3DInt.%2520J.%2520Endocrinol.%2520Metab.%26date%3D2011%26volume%3D15%26spage%3D298%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Aleskow Stein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamos, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. N.</span><span> </span><span class="NLM_article-title">A review of the efficacy and safety of oral antidiabetic drugs</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1517%2F14740338.2013.752813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=23241069" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=153-175&author=S.+Aleskow+Steinauthor=E.+M.+Lamosauthor=S.+N.+Davis&title=A+review+of+the+efficacy+and+safety+of+oral+antidiabetic+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1517%2F14740338.2013.752813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.2013.752813%26sid%3Dliteratum%253Aachs%26aulast%3DAleskow%2BStein%26aufirst%3DS.%26aulast%3DLamos%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DS.%2BN.%26atitle%3DA%2520review%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520oral%2520antidiabetic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2013%26volume%3D12%26spage%3D153%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Landesdorfer, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jusko, W. J.</span><span> </span><span class="NLM_article-title">Mechanism-based population pharmacokinetic modeling in diabetes: vildagliptin as a tight binding inhibitor and substrate of dipeptidyl peptidase IV</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1365-2125.2011.04108.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=391-401&author=C.+B.+Landesdorferauthor=Y.+L.+Heauthor=W.+J.+Jusko&title=Mechanism-based+population+pharmacokinetic+modeling+in+diabetes%3A+vildagliptin+as+a+tight+binding+inhibitor+and+substrate+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.04108.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.04108.x%26sid%3Dliteratum%253Aachs%26aulast%3DLandesdorfer%26aufirst%3DC.%2BB.%26aulast%3DHe%26aufirst%3DY.%2BL.%26aulast%3DJusko%26aufirst%3DW.%2BJ.%26atitle%3DMechanism-based%2520population%2520pharmacokinetic%2520modeling%2520in%2520diabetes%253A%2520vildagliptin%2520as%2520a%2520tight%2520binding%2520inhibitor%2520and%2520substrate%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D73%26spage%3D391%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Gross, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polhamus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monz, B. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staabm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Retlich, S.</span><span> </span><span class="NLM_article-title">A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, intreatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">BMJ Open</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e001844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e001844&author=J.+L.+Grossauthor=J.+Rogersauthor=D.+Polhamusauthor=W.+Gillespieauthor=C.+Friedrichauthor=Y.+Gongauthor=B.+U.+Monzauthor=S.+Patelauthor=A.+Staabmauthor=S.+Retlich&title=A+novel+model-based+meta-analysis+to+indirectly+estimate+the+comparative+efficacy+of+two+medications%3A+an+example+using+DPP-4+inhibitors%2C+sitagliptin+and+linagliptin%2C+intreatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DJ.%2BL.%26aulast%3DRogers%26aufirst%3DJ.%26aulast%3DPolhamus%26aufirst%3DD.%26aulast%3DGillespie%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DC.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMonz%26aufirst%3DB.%2BU.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DStaabm%26aufirst%3DA.%26aulast%3DRetlich%26aufirst%3DS.%26atitle%3DA%2520novel%2520model-based%2520meta-analysis%2520to%2520indirectly%2520estimate%2520the%2520comparative%2520efficacy%2520of%2520two%2520medications%253A%2520an%2520example%2520using%2520DPP-4%2520inhibitors%252C%2520sitagliptin%2520and%2520linagliptin%252C%2520intreatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBMJ%2520Open%26date%3D2013%26volume%3D3%26spage%3De001844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Ervinna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukmawati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watada, H.</span><span> </span><span class="NLM_article-title">Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=1260-1270&author=N.+Ervinnaauthor=T.+Mitaauthor=E.+Yasunariauthor=K.+Azumaauthor=R.+Tanakaauthor=S.+Fujimuraauthor=D.+Sukmawatiauthor=T.+Nomiyamaauthor=A.+Kanazawaauthor=R.+Kawamoriauthor=Y.+Fujitaniauthor=H.+Watada&title=Anagliptin%2C+a+DPP-4+inhibitor%2C+suppresses+proliferation+of+vascular+smooth+muscles+and+monocyte+inflammatory+reaction+and+attenuates+atherosclerosis+in+male+apo+E-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErvinna%26aufirst%3DN.%26aulast%3DMita%26aufirst%3DT.%26aulast%3DYasunari%26aufirst%3DE.%26aulast%3DAzuma%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DFujimura%26aufirst%3DS.%26aulast%3DSukmawati%26aufirst%3DD.%26aulast%3DNomiyama%26aufirst%3DT.%26aulast%3DKanazawa%26aufirst%3DA.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DWatada%26aufirst%3DH.%26atitle%3DAnagliptin%252C%2520a%2520DPP-4%2520inhibitor%252C%2520suppresses%2520proliferation%2520of%2520vascular%2520smooth%2520muscles%2520and%2520monocyte%2520inflammatory%2520reaction%2520and%2520attenuates%2520atherosclerosis%2520in%2520male%2520apo%2520E-deficient%2520mice%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26spage%3D1260%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakairi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakufu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakigami, T.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Org. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1186%2F2191-2858-1-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22373386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlersLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=7&author=N.+Katoauthor=M.+Okaauthor=T.+Muraseauthor=M.+Yoshidaauthor=M.+Sakairiauthor=M.+Yakufuauthor=S.+Yamashitaauthor=Y.+Yasudaauthor=A.+Yoshikawaauthor=Y.+Hayashiauthor=M.+Shiraiauthor=Y.+Mizunoauthor=M.+Takeuchiauthor=M.+Makinoauthor=M.+Takedaauthor=T.+Kakigami&title=Synthesis+and+pharmacological+characterization+of+potent%2C+selective%2C+and+orally+bioavailable+isoindoline+class+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Kato, Noriyasu; Oka, Mitsuru; Murase, Takayo; Yoshida, Masahiro; Sakairi, Masao; Yakufu, Mirensha; Yamashita, Satoko; Yasuda, Yoshika; Yoshikawa, Aya; Hayashi, Yuji; Shirai, Masahiro; Mizuno, Yukie; Takeuchi, Mitsuaki; Makino, Mitsuhiro; Takeda, Motohiro; Kakigami, Takuji</div><div class="citationInfo"><span class="NLM_cas:title">Organic and Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7/1-7/7</span>CODEN:
                <span class="NLM_cas:coden">OMCLBC</span>;
        ISSN:<span class="NLM_cas:issn">2191-2858</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Focused structure-activity relationships of isoindoline class DPP-IV inhibitors have led to the discovery of dihydroisoindoline I (R = Me) as a highly selective, potent inhibitor of DPP-IV.  In vivo studies in Wistar/ST rats showed that the above compd. was converted into the strongly active metabolite I (R = CH2OH) in high yield, resulting in good in-vivo efficacy for antihyperglycemic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqABXoMC9RVS7Vg90H21EOLACvtfcHk0li5oGgk6_LGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlersLfE&md5=4d9ac4d59d5113c3297fc52db9ddc9fd</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1186%2F2191-2858-1-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-2858-1-7%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DN.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DMurase%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSakairi%26aufirst%3DM.%26aulast%3DYakufu%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DYasuda%26aufirst%3DY.%26aulast%3DYoshikawa%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DShirai%26aufirst%3DM.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DMakino%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DKakigami%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520isoindoline%2520class%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DOrg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D1%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, C. Y.</span><span> </span><span class="NLM_article-title">DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=21-29&author=M.+K.+Kimauthor=Y.+N.+Chaeauthor=H.+D.+Kimauthor=E.+K.+Yangauthor=E.+J.+Choauthor=S.+H.+Choiauthor=Y.+H.+Cheongauthor=H.+S.+Kimauthor=H.+J.+Kimauthor=Y.+W.+Joauthor=M.+H.+Sonauthor=S.+H.+Kimauthor=C.+Y.+Shin&title=DA-1229%2C+a+novel+and+potent+DPP4+inhibitor%2C+improves+insulin+resistance+and+delays+the+onset+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DChae%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DH.%2BD.%26aulast%3DYang%26aufirst%3DE.%2BK.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DCheong%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DJo%26aufirst%3DY.%2BW.%26aulast%3DSon%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DShin%26aufirst%3DC.%2BY.%26atitle%3DDA-1229%252C%2520a%2520novel%2520and%2520potent%2520DPP4%2520inhibitor%252C%2520improves%2520insulin%2520resistance%2520and%2520delays%2520the%2520onset%2520of%2520diabetes%26jtitle%3DLife%2520Sci.%26date%3D2012%26volume%3D90%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Yasuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagakura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsutani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, I.</span><span> </span><span class="NLM_article-title">E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-<i>4H</i>-imidazo[4,5-<i>d</i>]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase IV inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">548</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.ejphar.2006.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=16973152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFekt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2006&pages=181-187&author=N.+Yasudaauthor=T.+Nagakuraauthor=T.+Inoueauthor=K.+Yamazakiauthor=N.+Katsutaniauthor=O.+Takenakaauthor=R.+Clarkauthor=F.+Matsuuraauthor=E.+Emoriauthor=S.+Yoshikawaauthor=K.+Kiraauthor=H.+Ikutaauthor=T.+Okadaauthor=T.+Saekiauthor=O.+Asanoauthor=I.+Tanaka&title=E3024%2C+3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3%2C5-dihydro-4H-imidazo%5B4%2C5-d%5Dpyridazin-4-one+tosylate%2C+is+a+novel%2C+selective+and+competitive+dipeptidyl+peptidase+IV+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor</span></div><div class="casAuthors">Yasuda, Nobuyuki; Nagakura, Tadashi; Inoue, Takashi; Yamazaki, Kazuto; Katsutani, Naruo; Takenaka, Osamu; Clark, Richard; Matsuura, Fumiyoshi; Emori, Eita; Yoshikawa, Seiji; Kira, Kazunobu; Ikuta, Hironori; Okada, Toshimi; Saeki, Takao; Asano, Osamu; Tanaka, Isao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">548</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a useful new class of anti-diabetic agent.  The aim of the present study is to characterize the in vitro and in vivo profile of E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, which is a novel imidazopyridazinone-derived DPP-IV inhibitor.  E3024 inhibited recombinant human and mouse DPP-IV with IC50 values of approx. 100 nM.  E3024 inhibited DPP-IV in human, mouse, rat and canine plasma with IC50 values of 140 to 400 nM.  In contrast, E3024 did not inhibit DPP-8 or DPP-9 activity.  Kinetic anal. indicated that E3024 is a competitive DPP-IV inhibitor.  In Zucker fa/fa rats, E3024 (1 mg/kg) reduced glucose excursion after glucose load, with increases in plasma insulin and active glucagon-like peptide-1 levels.  In fasted rats, this compd. did not cause hypoglycemia.  In a rat 4-wk toxicol. study, no notable changes were found at doses up to 750 mg/kg.  The present preclin. studies indicate that E3024 is a novel selective DPP-IV inhibitor with anti-diabetic effects and a good safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSLh02Uv1y0rVg90H21EOLACvtfcHk0livF8XJSACS3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFekt7g%253D&md5=a419a83adc00184d53fef21b3b112835</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DN.%26aulast%3DNagakura%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKatsutani%26aufirst%3DN.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DMatsuura%26aufirst%3DF.%26aulast%3DEmori%26aufirst%3DE.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DKira%26aufirst%3DK.%26aulast%3DIkuta%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DSaeki%26aufirst%3DT.%26aulast%3DAsano%26aufirst%3DO.%26aulast%3DTanaka%26aufirst%3DI.%26atitle%3DE3024%252C%25203-but-2-ynyl-5-methyl-2-piperazin-1-yl-3%252C5-dihydro-4H-imidazo%255B4%252C5-d%255Dpyridazin-4-one%2520tosylate%252C%2520is%2520a%2520novel%252C%2520selective%2520and%2520competitive%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D548%26spage%3D181%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Biftu, T.</span><span> </span><span class="NLM_article-title">MK-3102: A Novel Once-Weekly DPP IV Inhibitor for Type 2 Diabetes</span>. Presented at the Society for Medicines Research Research Symposium, December 5,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>London, U.K.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Biftu&title=MK-3102%3A+A+Novel+Once-Weekly+DPP+IV+Inhibitor+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBiftu%26aufirst%3DT.%26atitle%3DMK-3102%253A%2520A%2520Novel%2520Once-Weekly%2520DPP%2520IV%2520Inhibitor%2520for%2520Type%25202%2520Diabetes%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Brunavs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span> </span><span class="NLM_article-title">Recent disclosures of clinical candidates</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=127-133&author=M.+Brunavsauthor=P.+Cowleyauthor=S.+E.+Wardauthor=P.+Weber&title=Recent+disclosures+of+clinical+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunavs%26aufirst%3DM.%26aulast%3DCowley%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DWeber%26aufirst%3DP.%26atitle%3DRecent%2520disclosures%2520of%2520clinical%2520candidates%26jtitle%3DDrugs%2520Future%26date%3D2013%26volume%3D38%26spage%3D127%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Akarte, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinvasan, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, S.</span><span> </span><span class="NLM_article-title">A novel long-acting DPP-IV inhibitor PKF-275-055 stimulated cell proliferation resulting in improved glucose homeostasis in diabetics rats</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=241-252&author=A.+S.+Akarteauthor=B.+P.+Srinvasanauthor=S.+Gandhi&title=A+novel+long-acting+DPP-IV+inhibitor+PKF-275-055+stimulated+cell+proliferation+resulting+in+improved+glucose+homeostasis+in+diabetics+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkarte%26aufirst%3DA.%2BS.%26aulast%3DSrinvasan%26aufirst%3DB.%2BP.%26aulast%3DGandhi%26aufirst%3DS.%26atitle%3DA%2520novel%2520long-acting%2520DPP-IV%2520inhibitor%2520PKF-275-055%2520stimulated%2520cell%2520proliferation%2520resulting%2520in%2520improved%2520glucose%2520homeostasis%2520in%2520diabetics%2520rats%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D241%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Sutton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, S, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillmore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krintel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duttaroy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirockin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeschlin, D. K.</span><span> </span><span class="NLM_article-title">Novel heterocyclic DPP-IV inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1464-1468&author=J.+M.+Suttonauthor=D.+E.+Clarkauthor=S%2C+J.+Dunsdonauthor=G.+Fentonauthor=A.+Fillmoreauthor=N.+V.+Harrisauthor=C.+Higgsauthor=C.+A.+Hurleyauthor=S.+L.+Krintelauthor=R.+E.+MacKenzieauthor=A.+Duttaroyauthor=E.+Ganglauthor=W.+Maniaraauthor=R.+Sedraniauthor=K.+Namotoauthor=N.+Ostermannauthor=B.+Gerhartzauthor=F.+Sirockinauthor=J.+Trappeauthor=U.+Hassiepenauthor=D.+K.+Baeschlin&title=Novel+heterocyclic+DPP-IV+inhibitors+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DDunsdon%26aufirst%3DS%252C%2BJ.%26aulast%3DFenton%26aufirst%3DG.%26aulast%3DFillmore%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DN.%2BV.%26aulast%3DHiggs%26aufirst%3DC.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DKrintel%26aufirst%3DS.%2BL.%26aulast%3DMacKenzie%26aufirst%3DR.%2BE.%26aulast%3DDuttaroy%26aufirst%3DA.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DNamoto%26aufirst%3DK.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DSirockin%26aufirst%3DF.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DBaeschlin%26aufirst%3DD.%2BK.%26atitle%3DNovel%2520heterocyclic%2520DPP-IV%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1464%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Jadav, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahekar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joharapurkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kshirsagar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sairam, K. V.</span><span> </span><span class="NLM_article-title">Long-acting peptidomimetics based DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3516</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3516-3521&author=P.+Jadavauthor=R.+Bahekarauthor=S.+R.+Shahauthor=D.+Patelauthor=A.+Joharapurkarauthor=S.+Kshirsagarauthor=M.+Jainauthor=M.+Shaikhauthor=K.+V.+Sairam&title=Long-acting+peptidomimetics+based+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJadav%26aufirst%3DP.%26aulast%3DBahekar%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DS.%2BR.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DJoharapurkar%26aufirst%3DA.%26aulast%3DKshirsagar%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DShaikh%26aufirst%3DM.%26aulast%3DSairam%26aufirst%3DK.%2BV.%26atitle%3DLong-acting%2520peptidomimetics%2520based%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3516%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. J.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors with β-amino amide scaffold; synthesis, SAR and biological evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5545</span><span class="NLM_x">–</span> <span class="NLM_lpage">5549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5545-5549&author=H.+J.+Kimauthor=W.+Y.+Kwakauthor=J.+P.+Minauthor=S.+Y.+Sungauthor=H.+D.+Kimauthor=M.+K.+Kimauthor=H.+S.+Kimauthor=K.+J.+Parkauthor=M.+H.+Sonauthor=S.+H.+Kimauthor=B.+J.+Lee&title=Dipeptidyl+peptidase-4+inhibitors+with+%CE%B2-amino+amide+scaffold%3B+synthesis%2C+SAR+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DKwak%26aufirst%3DW.%2BY.%26aulast%3DMin%26aufirst%3DJ.%2BP.%26aulast%3DSung%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BD.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DK.%2BJ.%26aulast%3DSon%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DB.%2BJ.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520with%2520%25CE%25B2-amino%2520amide%2520scaffold%253B%2520synthesis%252C%2520SAR%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5545%26epage%3D5549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Shan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Discovery of potent dipeptidyl peptidase IN inhibitors derived from β-aminoamides bearing substituted [1,2,3]-triazolopiperidines for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1731-1735&author=Z.+Shanauthor=M.+Pengauthor=H.+Fanauthor=Q.+Luauthor=P.+Luauthor=C.+Zhaoauthor=Y.+Chen&title=Discovery+of+potent+dipeptidyl+peptidase+IN+inhibitors+derived+from+%CE%B2-aminoamides+bearing+substituted+%5B1%2C2%2C3%5D-triazolopiperidines+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520potent%2520dipeptidyl%2520peptidase%2520IN%2520inhibitors%2520derived%2520from%2520%25CE%25B2-aminoamides%2520bearing%2520substituted%2520%255B1%252C2%252C3%255D-triazolopiperidines%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1731%26epage%3D1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span> </span><span class="NLM_article-title">Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=205-212&author=H.+Xieauthor=L.+Zengauthor=S.+Zengauthor=X.+Luauthor=G.+Zhangauthor=X.+Zhaoauthor=N.+Chengauthor=Z.+Tuauthor=Z.+Liauthor=H.+Xuauthor=Y.+Yang&title=Novel+pyrrolopyrimidine+analogues+as+potent+dipeptidyl+peptidase+IV+inhibitors+based+on+pharmacokinetic+property-driven+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DNovel%2520pyrrolopyrimidine%2520analogues%2520as%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520based%2520on%2520pharmacokinetic%2520property-driven%2520optimization%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span> </span><span class="NLM_article-title">Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4033</span><span class="NLM_x">–</span> <span class="NLM_lpage">4042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1007%2Fs00894-012-1394-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22460522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4033-4042&author=C.+Liauthor=W.+Luauthor=C.+Luauthor=W.+Xiaauthor=X.+Shenauthor=J.+Huangauthor=G.+Liuauthor=Y.+Tang&title=Identification+of+diverse+dipeptidyl+peptidase+IV+inhibitors+via+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening</span></div><div class="casAuthors">Li, Cui; Lu, Weiqiang; Lu, Chunhua; Xiao, Wen; Shen, Xu; Huang, Jin; Liu, Guixia; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4033-4042</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP4) is an important target for the treatment of type II diabetes mellitus.  Inhibition of DPP4 will improve glycemic control in such patients by preventing the rapid breakdown and thereby prolonging the physiol. actions of incretin hormones.  Known DPP4 inhibitors (including marketed drugs and those drug candidates) appear to share similar structural features: the cyanopyrrolidine moieties, the xanthenes/pyrimidine parts and amino-like linkages.  In this study, a multi-step virtual screening strategy including both rigid and flexible docking was employed to search for novel structures with DPP4 inhibition.  From SPECS database, consisting of over 190,000 com. available compds., 99 virtual hits were picked up and 15 of them were eventually identified to have DPP4 inhibitory activities at 5 ∼ 50 μM.  Diverse structures of our compds. were out of usual structural categories.  Hence a pharmacophore model was built to further explore their common binding features on the enzyme.  The results provided a new pathway for the discovery of DPP4 inhibitors and would be helpful for further optimization of DPP4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0SD-Ww74h5rVg90H21EOLACvtfcHk0lg1eMXzEuLy-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrtbbL&md5=7a34282901e72ea605ad4a18d11f0e1b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2Fs00894-012-1394-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-012-1394-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520diverse%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520via%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2012%26volume%3D18%26spage%3D4033%26epage%3D4042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Synthesis, structure–activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1747-0285.2012.01365.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22381062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=897-906&author=D.+Wuauthor=F.+Jinauthor=W.+Luauthor=J.+Zhuauthor=C.+Liauthor=W.+Wangauthor=Y.+Tangauthor=H.+Jiangauthor=J.+Huangauthor=G.+Liuauthor=J.+Li&title=Synthesis%2C+structure%E2%80%93activity+relationship%2C+and+pharmacophore+modeling+studies+of+pyrazole-3-carbohydrazone+derivatives+as+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Wu, Deyan; Jin, Fangfang; Lu, Weiqiang; Zhu, Jin; Li, Cui; Wang, Wei; Tang, Yun; Jiang, Hualiang; Huang, Jin; Liu, Guixia; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">897-906</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Type 2 diabetes mellitus (T2DM) is a metabolic disease and a major challenge to health care systems around the world.  Dipeptidyl peptidase IV (DPP-4), a serine protease, has been rapidly emerging as an effective therapeutic target for the treatment for T2DM.  In this study, a series of novel DPP-4 inhibitors, featuring the pyrazole-3-carbohydrazone scaffold, have been discovered using an integrated approach of structure-based virtual screening, chem. synthesis, and bioassay.  Virtual screening of SPECS Database, followed by enzymic activity assay, resulted in five micromolar or low-to-mid-micromolar inhibitory level compds. with different scaffold.  N'-[(2-hydroxy-1-naphthalenyl)methylene]-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid hydrazide was selected for the further structure modifications in considering inhibitory activity, structural variability, and synthetic accessibility.  Seventeen new compds. were synthesized and tested with biol. assays.  Nine compds. were found to show inhibitory effects against DPP-4.  Mol. docking models give rational explanation about structure-activity relationships.  Based on eight DPP-4 inhibitors the best pharmacophore model hypo1 was obtained, consisting of one hydrogen bond donor (HBD), one hydrogen bond acceptor (HBA), and two hydrophobic (HY) features.  Both docking models and pharmacophore mapping results are in agreement with pharmacol. results.  The present studies give some guiding information for further structural optimization and are helpful for future DPP-4 inhibitors design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK2DxGN3EOGLVg90H21EOLACvtfcHk0lg1eMXzEuLy-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyhurs%253D&md5=1343d6f864fbfedc8834d5c6db009cad</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2012.01365.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2012.01365.x%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520pharmacophore%2520modeling%2520studies%2520of%2520pyrazole-3-carbohydrazone%2520derivatives%2520as%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D897%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span> </span><span class="NLM_article-title">Design, synthesis, structure–activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(<i>S</i>)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fcbdd.12058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22994702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=198-207&author=L.+Zhangauthor=M.+Suauthor=J.+Liauthor=X.+Jiauthor=J.+Wangauthor=Z.+Liauthor=J.+Liauthor=H.+Liu&title=Design%2C+synthesis%2C+structure%E2%80%93activity+relationships%2C+and+docking+studies+of+1-%28%CE%B3-1%2C2%2C3-triazol+substituted+prolyl%29-%28S%29-3%2C3-difluoropyrrolidines+as+a+novel+series+of+potent+and+selective+dipeptidyl+peptidase-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors</span></div><div class="casAuthors">Zhang, Lei; Su, Mingbo; Li, Jingya; Ji, Xun; Wang, Jiang; Li, Zeng; Li, Jia; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-207</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase-4 inhibitors hold great potential for the treatment of type 2 diabetes.  A series of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines were designed, synthesized, and evaluated as novel dipeptidyl peptidase-4 inhibitors.  Most of the compds. exhibited good in vitro potency against dipeptidyl peptidase-4.  Among these, 3 compds. displayed good dipeptidyl peptidase-4 activity and excellent selectivity vs. other proteases including dipeptidyl peptidase-8, dipeptidyl peptidase-9, and FAP.  The possible binding modes of these compds. with dipeptidyl peptidase-4 were also explored by mol. docking simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA0xpXgNAdI7Vg90H21EOLACvtfcHk0lg1eMXzEuLy-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKhtrk%253D&md5=8ae3ed9955bbd0e29b986f97dbf867d0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12058%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520docking%2520studies%2520of%25201-%2528%25CE%25B3-1%252C2%252C3-triazol%2520substituted%2520prolyl%2529-%2528S%2529-3%252C3-difluoropyrrolidines%2520as%2520a%2520novel%2520series%2520of%2520potent%2520and%2520selective%2520dipeptidyl%2520peptidase-4%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D198%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=477-482&author=K.+Linauthor=Z.+Caiauthor=F.+Wangauthor=W.+Zhangauthor=W.+Zhou&title=Synthesis+and+biological+evaluation+of+xanthine+derivatives+on+dipeptidyl+peptidase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520xanthine%2520derivatives%2520on%2520dipeptidyl%2520peptidase%25204%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2013%26volume%3D61%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat, M. A.</span><span> </span><span class="NLM_article-title">Peptides from <i>Lactobacillus</i> hydrolysates of bovine milk caseins inhibit prolyl-peptidases of human colon cells</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf102803a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=370-377&author=L.+Juillerat-Jeanneretauthor=M.+C.+Robertauthor=M.+A.+Juillerat&title=Peptides+from+Lactobacillus+hydrolysates+of+bovine+milk+caseins+inhibit+prolyl-peptidases+of+human+colon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjf102803a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf102803a%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DRobert%26aufirst%3DM.%2BC.%26aulast%3DJuillerat%26aufirst%3DM.%2BA.%26atitle%3DPeptides%2520from%2520Lactobacillus%2520hydrolysates%2520of%2520bovine%2520milk%2520caseins%2520inhibit%2520prolyl-peptidases%2520of%2520human%2520colon%2520cells%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2011%26volume%3D59%26spage%3D370%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Li-Chan, E. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K. C.</span><span> </span><span class="NLM_article-title">Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf204720q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=973-978&author=E.+C.+Y.+Li-Chanauthor=S.+L.+Huangauthor=C.+L.+Jaoauthor=K.+P.+Hoauthor=K.+C.+Hsu&title=Peptides+derived+from+atlantic+salmon+skin+gelatin+as+dipeptidyl-peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjf204720q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf204720q%26sid%3Dliteratum%253Aachs%26aulast%3DLi-Chan%26aufirst%3DE.%2BC.%2BY.%26aulast%3DHuang%26aufirst%3DS.%2BL.%26aulast%3DJao%26aufirst%3DC.%2BL.%26aulast%3DHo%26aufirst%3DK.%2BP.%26aulast%3DHsu%26aufirst%3DK.%2BC.%26atitle%3DPeptides%2520derived%2520from%2520atlantic%2520salmon%2520skin%2520gelatin%2520as%2520dipeptidyl-peptidase%2520IV%2520inhibitors%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2012%26volume%3D60%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Huang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K. C.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=114-121&author=S.+L.+Huangauthor=C.+L.+Jaoauthor=K.+P.+Hoauthor=K.+C.+Hsu&title=Dipeptidyl-peptidase+IV+inhibitory+activity+of+peptides+derived+from+tuna+cooking+juice+hydrolysates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BL.%26aulast%3DJao%26aufirst%3DC.%2BL.%26aulast%3DHo%26aufirst%3DK.%2BP.%26aulast%3DHsu%26aufirst%3DK.%2BC.%26atitle%3DDipeptidyl-peptidase%2520IV%2520inhibitory%2520activity%2520of%2520peptides%2520derived%2520from%2520tuna%2520cooking%2520juice%2520hydrolysates%26jtitle%3DPeptides%26date%3D2012%26volume%3D35%26spage%3D114%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Hsiung, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. P.</span><span> </span><span class="NLM_article-title">Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavage of human β-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1988-1996&author=H.+M.+Hsiungauthor=D.+L.+Smileyauthor=X.+Y.+Zhangauthor=L.+Zhangauthor=L.+Z.+Yanauthor=L.+Craftauthor=M.+L.+Heimanauthor=D.+P.+Smith&title=Potent+peptide+agonists+for+human+melanocortin+3+and+4+receptors+derived+from+enzymatic+cleavage+of+human+%CE%B2-MSH%285-22%29+by+dipeptidyl+peptidase+I+and+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiung%26aufirst%3DH.%2BM.%26aulast%3DSmiley%26aufirst%3DD.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DL.%2BZ.%26aulast%3DCraft%26aufirst%3DL.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BP.%26atitle%3DPotent%2520peptide%2520agonists%2520for%2520human%2520melanocortin%25203%2520and%25204%2520receptors%2520derived%2520from%2520enzymatic%2520cleavage%2520of%2520human%2520%25CE%25B2-MSH%25285-22%2529%2520by%2520dipeptidyl%2520peptidase%2520I%2520and%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DPeptides%26date%3D2005%26volume%3D26%26spage%3D1988%26epage%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Rosmanho-Salgado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marques, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grouzman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavadas, C.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-expression</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=49-54&author=J.+Rosmanho-Salgadoauthor=J.+P.+Marquesauthor=M.+Estradaauthor=M.+Santanaauthor=Y.+Cortezauthor=E.+Grouzmanauthor=C.+Cavadas&title=Dipeptidyl-peptidase+IV+by+cleaving+neuropeptide+Y+induces+lipid+accumulation+and+PPAR-expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosmanho-Salgado%26aufirst%3DJ.%26aulast%3DMarques%26aufirst%3DJ.%2BP.%26aulast%3DEstrada%26aufirst%3DM.%26aulast%3DSantana%26aufirst%3DM.%26aulast%3DCortez%26aufirst%3DY.%26aulast%3DGrouzman%26aufirst%3DE.%26aulast%3DCavadas%26aufirst%3DC.%26atitle%3DDipeptidyl-peptidase%2520IV%2520by%2520cleaving%2520neuropeptide%2520Y%2520induces%2520lipid%2520accumulation%2520and%2520PPAR-expression%26jtitle%3DPeptides%26date%3D2012%26volume%3D37%26spage%3D49%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Jackson, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochanek, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, D. G.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=757-764&author=E.+K.+Jacksonauthor=S.+J.+Kochanekauthor=D.+G.+Gillespie&title=Dipeptidyl+peptidase+IV+regulates+proliferation+of+preglomerular+vascular+smooth+muscle+and+mesangial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DKochanek%26aufirst%3DS.%2BJ.%26aulast%3DGillespie%26aufirst%3DD.%2BG.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520regulates%2520proliferation%2520of%2520preglomerular%2520vascular%2520smooth%2520muscle%2520and%2520mesangial%2520cells%26jtitle%3DHypertension%26date%3D2012%26volume%3D60%26spage%3D757%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Liu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibitor attenuate kidney injury in streptozotocin-induced diabetic rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1124%2Fjpet.111.186866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22025647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2012&pages=248-255&author=W.+J.+Liuauthor=S.+H.+Xieauthor=Y.+N.+Liuauthor=W.+Kimauthor=H.+Y.+Jinauthor=S.+K.+Parkauthor=Y.+M.+Shaoauthor=T.+S.+Park&title=Dipeptidyl+peptidase+IV+inhibitor+attenuate+kidney+injury+in+streptozotocin-induced+diabetic+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats</span></div><div class="casAuthors">Liu, Wei Jing; Xie, Shu Hua; Liu, Yu Ning; Kim, Won; Jin, Heung Yong; Park, Sung Kwang; Shao, Yi Ming; Park, Tae Sun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">248-255</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase (DPP) IV inhibitors are probably beneficial for preventing diabetic complication and modulating glucagon-like peptide-1 receptor (GLP-1R) expression.  The aim of this study was to det. whether the DPP IV inhibitor LAF237 (vildagliptin) has renoprotective qualities in streptozotocin-induced diabetic rats.  Diabetic and nondiabetic rats were treated with an oral dose of 4 or 8 mg/kg/day LAF237 or placebo for 24 wk, and renal injury was obsd. by light and electron microscopy.  We also assessed DPP IV activity, active GLP-1 level, cAMP and 8-hydroxy-deoxyguanosine excretion, and GLP-1R, cleaved caspase 3, and transforming growth factor-β1 (TGF-β1) expression.  LAF237 significantly decreased proteinuria, albuminuria, and urinary albumin/creatinine ratio, improved creatinine clearance, and dose-dependently inhibited interstitial expansion, glomerulosclerosis, and the thickening of the glomerular basement membrane in diabetic rats.  It is noteworthy that LAF237 markedly down-regulated DPP IV activity and increased active GLP-1 levels, which probably prevented oxidative DNA damage and renal cell apoptosis by activating the GLP-1R and modulating cAMP.  Renoprotection was also assocd. with a redn. in TGF-β1 overexpression.  Our study suggests that DPP IV inhibitors may ameliorate diabetic nephropathy as well as reduce the overprodn. of TGF-β1.  The obsd. renoprotection is probably attributable to inhibition of DPP IV activity, mimicking of incretin action, and activation of the GLP-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprz731SAvmSbVg90H21EOLACvtfcHk0ljKfiKrPebLpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSltL0%253D&md5=8488a9a54d1ad6a6b4c54165507e4977</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.186866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.186866%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%2BJ.%26aulast%3DXie%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DShao%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DT.%2BS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibitor%2520attenuate%2520kidney%2520injury%2520in%2520streptozotocin-induced%2520diabetic%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D340%26spage%3D248%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Sangle, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Läuffer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iaboukov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brubaker, P. L.</span><span> </span><span class="NLM_article-title">Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=564-573&author=G.+V.+Sangleauthor=L.+M.+L%C3%A4ufferauthor=A.+Griecoauthor=S.+Trivediauthor=R.+Iaboukovauthor=P.+L.+Brubaker&title=Novel+biological+action+of+the+dipeptidylpeptidase-IV+inhibitor%2C+sitagliptin%2C+as+a+glucagon-like+peptide-1+secretagogue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSangle%26aufirst%3DG.%2BV.%26aulast%3DL%25C3%25A4uffer%26aufirst%3DL.%2BM.%26aulast%3DGrieco%26aufirst%3DA.%26aulast%3DTrivedi%26aufirst%3DS.%26aulast%3DIaboukov%26aufirst%3DR.%26aulast%3DBrubaker%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520biological%2520action%2520of%2520the%2520dipeptidylpeptidase-IV%2520inhibitor%252C%2520sitagliptin%252C%2520as%2520a%2520glucagon-like%2520peptide-1%2520secretagogue%26jtitle%3DEndocrinology%26date%3D2012%26volume%3D153%26spage%3D564%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Pethiyagoda, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T. P.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells</span> <span class="citation_source-journal">Clin. Exp. Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1023%2FA%3A1010930918055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvVKit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=391-400&author=C.+L.+Pethiyagodaauthor=D.+R.+Welchauthor=T.+P.+Fleming&title=Dipeptidyl+peptidase+IV+%28DPPIV%29+inhibits+cellular+invasion+of+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells</span></div><div class="casAuthors">Pethiyagoda, C. L.; Welch, D. R.; Fleming, T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV) is a 110-kD, trans-membrane, ectoenzyme, with ubiquitous expression.  We have identified DPPIV as a gene that can alter the invasive potential of a no. of melanoma cell lines.  By transfecting the full-length cDNA of DPPIV, we have established stable melanoma cell lines that express comparable levels of the DPPIV protein as normal epidermal melanocytes.  Matrigel invasion assays were utilized to study the effects of DPPIV expression on the invasive potential of these cells.  The parental and vector transfectants readily migrated across the Matrigel while the invasiveness of DPPIV transfected cells was reduced by > 75%.  The effects on cellular invasion are not attributed to overall growth characteristics, as both DPPIV expressing and non-expressing cells behave comparably in culture.  We have also constructed mutants of DPPIV that lack either the extra-cellular serine protease activity or the six amino acid cytoplasmic domain.  Both mutants were stably expressed in melanoma cells.  Matrigel invasion assays performed with cells expressing the two mutant forms of the protein revealed phenotypic effects similar to wild type function.  Thus, expression of a proteolytically active form of the DPPIV protein inhibits the invasiveness of malignant melanoma cell lines lacking endogenous DPPIV expression.  Furthermore, neither the protease activity nor the cytoplasmic domain of DPPIV is required for its anti-invasive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodpER4q6uwiLVg90H21EOLACvtfcHk0ljKfiKrPebLpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvVKit7w%253D&md5=2e5d69a22938d34f381616bfe397f369</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010930918055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010930918055%26sid%3Dliteratum%253Aachs%26aulast%3DPethiyagoda%26aufirst%3DC.%2BL.%26aulast%3DWelch%26aufirst%3DD.%2BR.%26aulast%3DFleming%26aufirst%3DT.%2BP.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520%2528DPPIV%2529%2520inhibits%2520cellular%2520invasion%2520of%2520melanoma%2520cells%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2001%26volume%3D18%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Wesley, U. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1999&pages=311-322&author=U.+V.+Wesleyauthor=A.+P.+Albinoauthor=S.+Tiwariauthor=A.+N.+Houghton&title=A+role+for+dipeptidyl+peptidase+IV+in+suppressing+the+malignant+phenotype+of+melanocytic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWesley%26aufirst%3DU.%2BV.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26aulast%3DTiwari%26aufirst%3DS.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DA%2520role%2520for%2520dipeptidyl%2520peptidase%2520IV%2520in%2520suppressing%2520the%2520malignant%2520phenotype%2520of%2520melanocytic%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D190%26spage%3D311%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Wesley, U. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1002%2Fijc.20091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15027119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1ens74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=855-866&author=U.+V.+Wesleyauthor=S.+Tiwariauthor=A.+N.+Houghton&title=Role+for+dipeptidyl+peptidase+IV+in+tumor+suppression+of+human+non+small+cell+lung+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells</span></div><div class="casAuthors">Wesley, Umadevi V.; Tiwari, Shakuntala; Houghton, Alan N.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">855-866</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Lung cancer is the leading cause of cancer death.  Lung cancers produce a variety of mitogenic growth factors that stimulate tumor cell proliferation and migration.  The cell surface protease, dipeptidyl peptidase IV (DPPIV), is involved in diverse biol. functions, including peptide-mediated cellular growth and differentiation.  DPPIV is expressed in various normal tissues, including lung tissue, and its expression is lost in many types of human cancers.  DPPIV expression and its enzymic activity are detected in normal bronchial and alveolar epithelium but different histol. subtypes of lung carcinomas lose DPPIV expression.  To investigate the role of DPPIV in lung carcinoma, we examd. the expression of DPPIV at both mRNA and protein levels in non small cell lung cancer (NSCLC) cell lines and normal human bronchial epithelial cells.  DPPIV expression was detectable in normal lung epithelial cells, but was absent or markedly reduced in all NSCLC cell lines at both mRNA and protein levels.  Restoration of DPPIV expression in NSCLC cells resulted in profound morphol. changes, inhibition of cell proliferation, anchorage-independent growth, in vitro cell migration and tumorigenicity in nude mice.  DPPIV reexpression also correlated with increased p21 expression, leading to induction of apoptosis and cell cycle arrest in GI stage.  These effects were accompanied by increased expression of cell surface proteins, fibroblast-activating protein (Fapα) and CD44 that are assocd. with suppression of tumor growth and metastasis.  Thus, DPPIV functions as a tumor suppressor, and its downregulation may contribute to the loss of growth control in NSCLC cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2mC47eoN-77Vg90H21EOLACvtfcHk0lhXJisC3EODJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1ens74%253D&md5=aaa20647ae56c4e8fd285a914387b484</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fijc.20091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20091%26sid%3Dliteratum%253Aachs%26aulast%3DWesley%26aufirst%3DU.%2BV.%26aulast%3DTiwari%26aufirst%3DS.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DRole%2520for%2520dipeptidyl%2520peptidase%2520IV%2520in%2520tumor%2520suppression%2520of%2520human%2520non%2520small%2520cell%2520lung%2520carcinoma%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D109%26spage%3D855%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Bogenrieder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finstad, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papandreou, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanus, D. M.</span><span> </span><span class="NLM_article-title">Expression and localization of aminopeptidase A, aminopeptidase N and dipeptidyl peptidase IV in benign and malignant human prostate tissue</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1997&pages=225-232&author=T.+Bogenriederauthor=C.+L.+Finstadauthor=R.+H.+Freemanauthor=C.+N.+Papandreouauthor=H.+I.+Scherauthor=A.+P.+Albinoauthor=V.+E.+Reuterauthor=D.+M.+Nanus&title=Expression+and+localization+of+aminopeptidase+A%2C+aminopeptidase+N+and+dipeptidyl+peptidase+IV+in+benign+and+malignant+human+prostate+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogenrieder%26aufirst%3DT.%26aulast%3DFinstad%26aufirst%3DC.%2BL.%26aulast%3DFreeman%26aufirst%3DR.%2BH.%26aulast%3DPapandreou%26aufirst%3DC.%2BN.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26aulast%3DReuter%26aufirst%3DV.%2BE.%26aulast%3DNanus%26aufirst%3DD.%2BM.%26atitle%3DExpression%2520and%2520localization%2520of%2520aminopeptidase%2520A%252C%2520aminopeptidase%2520N%2520and%2520dipeptidyl%2520peptidase%2520IV%2520in%2520benign%2520and%2520malignant%2520human%2520prostate%2520tissue%26jtitle%3DProstate%26date%3D1997%26volume%3D33%26spage%3D225%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Asada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aratake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marutsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumiyoshi, A.</span><span> </span><span class="NLM_article-title">Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma</span> <span class="citation_source-journal">Histopathology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1993&pages=265-270&author=Y.+Asadaauthor=Y.+Aratakeauthor=T.+Kotaniauthor=K.+Marutsukaauthor=Y.+Arakiauthor=S.+Ohtakiauthor=A.+Sumiyoshi&title=Expression+of+dipeptidyl+aminopeptidase+IV+activity+in+human+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsada%26aufirst%3DY.%26aulast%3DAratake%26aufirst%3DY.%26aulast%3DKotani%26aufirst%3DT.%26aulast%3DMarutsuka%26aufirst%3DK.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DOhtaki%26aufirst%3DS.%26aulast%3DSumiyoshi%26aufirst%3DA.%26atitle%3DExpression%2520of%2520dipeptidyl%2520aminopeptidase%2520IV%2520activity%2520in%2520human%2520lung%2520carcinoma%26jtitle%3DHistopathology%26date%3D1993%26volume%3D23%26spage%3D265%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Kajiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span> </span><span class="NLM_article-title">Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">524</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2003&pages=245-248&author=H.+Kajiyamaauthor=F.+Kikkawaauthor=K.+Inoauthor=K.+Shibataauthor=S.+Mizutani&title=Expression+of+CD26%2Fdipeptidyl+peptidase+IV+in+endometrial+adenocarcinoma+and+its+negative+correlation+with+tumor+grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DKikkawa%26aufirst%3DF.%26aulast%3DIno%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DMizutani%26aufirst%3DS.%26atitle%3DExpression%2520of%2520CD26%252Fdipeptidyl%2520peptidase%2520IV%2520in%2520endometrial%2520adenocarcinoma%2520and%2520its%2520negative%2520correlation%2520with%2520tumor%2520grade%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2003%26volume%3D524%26spage%3D245%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Kikkawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitzutani, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV in tumor progression</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1751</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1751&publication_year=2005&pages=45-51&author=F.+Kikkawaauthor=H.+Kajiyamaauthor=K.+Shibataauthor=K.+Inoauthor=S.+Nomuraauthor=S.+Mitzutani&title=Dipeptidyl+peptidase+IV+in+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKikkawa%26aufirst%3DF.%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DIno%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DMitzutani%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520in%2520tumor%2520progression%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1751%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Kajiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2278</span><span class="NLM_x">–</span> <span class="NLM_lpage">2283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2278-2283&author=H.+Kajiyamaauthor=F.+Kikkawaauthor=E.+Khinauthor=K.+Shibataauthor=K.+Inoauthor=S.+Mizutani&title=Dipeptidyl+peptidase+IV+overexpression+induces+up-regulation+of+E-cadherin+and+tissue+inhibitors+of+matrix+metalloproteinases%2C+resulting+in+decreased+invasive+potential+in+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DKikkawa%26aufirst%3DF.%26aulast%3DKhin%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DIno%26aufirst%3DK.%26aulast%3DMizutani%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520overexpression%2520induces%2520up-regulation%2520of%2520E-cadherin%2520and%2520tissue%2520inhibitors%2520of%2520matrix%2520metalloproteinases%252C%2520resulting%2520in%2520decreased%2520invasive%2520potential%2520in%2520ovarian%2520carcinoma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2278%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet-Tschudi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duijvestijn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honegger, P.</span><span> </span><span class="NLM_article-title">Regulation of peptidase activity in a three-dimensional aggregate model of brain tumor vasculature</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1007%2Fs00441-002-0626-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=12483284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsV2nt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2003&pages=53-59&author=L.+Juillerat-Jeanneretauthor=F.+Monnet-Tschudiauthor=M.+G.+Z%C3%BCrichauthor=S.+Lohmauthor=A.+M.+Duijvestijnauthor=P.+Honegger&title=Regulation+of+peptidase+activity+in+a+three-dimensional+aggregate+model+of+brain+tumor+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of peptidase activity in a three-dimensional aggregate model of brain tumor vasculature</span></div><div class="casAuthors">Juillerat-Jeanneret, Lucienne; Monnet-Tschudi, Florianne; Zurich, Marie-Gabrielle; Lohm, Sylvia; Duijvestijn, Adrian M.; Honegger, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-59</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The abnormal vascular system of brain cancers inappropriately expresses membrane proteins, including proteolytic enzymes, ultimately resulting in blood extravasation.  The prodn. of inflammatory mediators, such as cytokines and nitric oxide, and tumor hypoxia have been implicated in these effects.  The authors have previously shown that the activity of aminopeptidase A is increased in the abnormal vascular system of human and rat brain tumors.  To study the mechanisms regulating the activities of peptidases in cerebral vasculature in brain tumors, the authors have developed a three-dimensional model of differentiated rat brain cells in aggregate cultures in which rat brain microvessels were incorporated.  The secretion of interleukin-6 (IL-6) in the culture medium of aggregates was used as an indicator of inflammatory activation.  Addn. to these aggregates of C6 glioma cell medium (C6-CM) conditioned under hypoxic or normoxic conditions or serum mimicked tumor-dependent hypoxia or conditions of dysfunction of brain tumor vasculature.  Hypoxic and normoxic C6-CM, but not serum, regulated peptidase activity in aggregates, and in particular it increased the activity of aminopeptidase A detd. using histoenzymog.  Serum, but not C6-CM, increased IL-6 prodn., but did not increase aminopeptidase A activity in aggregates.  Thus sol. glioma-derived factors, but not serum-derived factors, induce dysfunctions of cerebral vasculature by directly regulating the activity of peptidases, not involving inflammatory activation.  Tumor hypoxia is not necessary to modulate peptidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8hEqzFFf8H7Vg90H21EOLACvtfcHk0lgmBh-_UhRpfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsV2nt7k%253D&md5=005afa67cea2e84ac440a348903eb41a</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2Fs00441-002-0626-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-002-0626-8%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMonnet-Tschudi%26aufirst%3DF.%26aulast%3DZ%25C3%25BCrich%26aufirst%3DM.%2BG.%26aulast%3DLohm%26aufirst%3DS.%26aulast%3DDuijvestijn%26aufirst%3DA.%2BM.%26aulast%3DHonegger%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520peptidase%2520activity%2520in%2520a%2520three-dimensional%2520aggregate%2520model%2520of%2520brain%2520tumor%2520vasculature%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D311%26spage%3D53%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallner, B. P.</span><span> </span><span class="NLM_article-title">PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">–</span> <span class="NLM_lpage">5480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5471-5480&author=S.+Adamsauthor=G.+T.+Millerauthor=M.+I.+Jessonauthor=T.+Watanabeauthor=B.+Jonesauthor=B.+P.+Wallner&title=PT-100%2C+a+small+molecule+dipeptidyl+peptidase+inhibitor%2C+has+potent+antitumor+effects+and+augments+antibody-mediated+cytotoxicity+via+a+novel+immune+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DG.%2BT.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DWallner%26aufirst%3DB.%2BP.%26atitle%3DPT-100%252C%2520a%2520small%2520molecule%2520dipeptidyl%2520peptidase%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520effects%2520and%2520augments%2520antibody-mediated%2520cytotoxicity%2520via%2520a%2520novel%2520immune%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D5471%26epage%3D5480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Arwert, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mentink, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driskell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoste, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldie, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, F. M.</span><span> </span><span class="NLM_article-title">Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumor formation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=992-1000&author=E.+N.+Arwertauthor=R.+A.+Mentinkauthor=R.+R.+Driskellauthor=E.+Hosteauthor=S.+J.+Goldieauthor=S.+Quistauthor=F.+M.+Watt&title=Upregulation+of+CD26+expression+in+epithelial+cells+and+stromal+cells+during+wound-induced+skin+tumor+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArwert%26aufirst%3DE.%2BN.%26aulast%3DMentink%26aufirst%3DR.%2BA.%26aulast%3DDriskell%26aufirst%3DR.%2BR.%26aulast%3DHoste%26aufirst%3DE.%26aulast%3DGoldie%26aufirst%3DS.%2BJ.%26aulast%3DQuist%26aufirst%3DS.%26aulast%3DWatt%26aufirst%3DF.%2BM.%26atitle%3DUpregulation%2520of%2520CD26%2520expression%2520in%2520epithelial%2520cells%2520and%2520stromal%2520cells%2520during%2520wound-induced%2520skin%2520tumor%2520formation%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D992%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Steinbrecher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izikson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansorge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocke, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV in inflammatory CNS disease</span> <span class="citation_source-journal">Adv. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1007%2F0-306-46826-3_16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=10849741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2000&pages=145-153&author=A.+Steinbrecherauthor=D.+Reinholdauthor=L.+Quigleyauthor=A.+Gadoauthor=N.+Tresserauthor=L.+Iziksonauthor=I.+Bornauthor=J.+Faustauthor=K.+Neubertauthor=R.+Martinauthor=S.+Ansorgeauthor=S.+Brocke&title=Dipeptidyl+peptidase+IV+in+inflammatory+CNS+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV in inflammatory CNS disease</span></div><div class="casAuthors">Steinbrecher, Andreas; Reinhold, Dirk; Quigley, Laura; Gado, Ameer; Tresser, Nancy; Izikson, Leonid; Born, Ilona; Faust, Jurgen; Neubert, Klaus; Martin, Roland; Ansorge, Siegfried; Brocke, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">477</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-153</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Current pathogenic concepts of inflammatory demyelinating disorders such as multiple sclerosis (MS) are based on the hypothesis that a T cell-mediated autoimmune response is involved in the disease process.  One of the primary goals in the development of immunotherapies for autoimmune diseases has been to achieve inactivation of disease-inducing lymphocytes either by direct inhibition or suppression through regulatory cells and/or cytokines.  The CD26 antigen is identical with the cell surface ectopeptidase dipeptidyl peptidase IV (DP IV, EC 3.4.14.5) which is involved in regulating T cell activation and growth.  Activated T cells, including those specific for myelin antigens, express high levels of CD26/DP IV.  In vitro, reversible DP IV inhibitors suppress T cell proliferation and pro-inflammatory cytokine prodn. in response to myelin antigens.  Further studies will evaluate the role of DP IV inhibition in T cell-mediated inflammatory disease of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0zV8xBlFELVg90H21EOLACvtfcHk0lgmBh-_UhRpfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yhtbk%253D&md5=a5a1a911127b414c183a6e4be5df603a</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1007%2F0-306-46826-3_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F0-306-46826-3_16%26sid%3Dliteratum%253Aachs%26aulast%3DSteinbrecher%26aufirst%3DA.%26aulast%3DReinhold%26aufirst%3DD.%26aulast%3DQuigley%26aufirst%3DL.%26aulast%3DGado%26aufirst%3DA.%26aulast%3DTresser%26aufirst%3DN.%26aulast%3DIzikson%26aufirst%3DL.%26aulast%3DBorn%26aufirst%3DI.%26aulast%3DFaust%26aufirst%3DJ.%26aulast%3DNeubert%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DAnsorge%26aufirst%3DS.%26aulast%3DBrocke%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520in%2520inflammatory%2520CNS%2520disease%26jtitle%3DAdv.%2520Exp.%2520Biol.%2520Med.%26date%3D2000%26volume%3D477%26spage%3D145%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Wrenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrestani-Klaus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fengler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockel-Maschek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansorge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, D.</span><span> </span><span class="NLM_article-title">Downregulation of T-cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the throboxane A2 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22180</span><span class="NLM_x">–</span> <span class="NLM_lpage">22186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22180-22186&author=S.+Wrengerauthor=J.+Faustauthor=C.+Mrestani-Klausauthor=A.+Fenglerauthor=A.+Stockel-Maschekauthor=S.+Loreyauthor=T.+Kahneauthor=W.+Brandtauthor=K.+Neubertauthor=S.+Ansorgeauthor=D.+Reinhold&title=Downregulation+of+T-cell+activation+following+inhibition+of+dipeptidyl+peptidase+IV%2FCD26+by+the+N-terminal+part+of+the+throboxane+A2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrenger%26aufirst%3DS.%26aulast%3DFaust%26aufirst%3DJ.%26aulast%3DMrestani-Klaus%26aufirst%3DC.%26aulast%3DFengler%26aufirst%3DA.%26aulast%3DStockel-Maschek%26aufirst%3DA.%26aulast%3DLorey%26aufirst%3DS.%26aulast%3DKahne%26aufirst%3DT.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DNeubert%26aufirst%3DK.%26aulast%3DAnsorge%26aufirst%3DS.%26aulast%3DReinhold%26aufirst%3DD.%26atitle%3DDownregulation%2520of%2520T-cell%2520activation%2520following%2520inhibition%2520of%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520by%2520the%2520N-terminal%2520part%2520of%2520the%2520throboxane%2520A2%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22180%26epage%3D22186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Hillebrandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mönnikes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klapp, B. F.</span><span> </span><span class="NLM_article-title">Dipeptidylpeptidase IV (DP IV, CD26) in patients with inflammatory bowel disease</span> <span class="citation_source-journal">Scand. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1067-1072&author=M.+Hillebrandtauthor=M.+Roseauthor=J.+R%C3%BCterauthor=A.+Salamaauthor=H.+M%C3%B6nnikesauthor=B.+F.+Klapp&title=Dipeptidylpeptidase+IV+%28DP+IV%2C+CD26%29+in+patients+with+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHillebrandt%26aufirst%3DM.%26aulast%3DRose%26aufirst%3DM.%26aulast%3DR%25C3%25BCter%26aufirst%3DJ.%26aulast%3DSalama%26aufirst%3DA.%26aulast%3DM%25C3%25B6nnikes%26aufirst%3DH.%26aulast%3DKlapp%26aufirst%3DB.%2BF.%26atitle%3DDipeptidylpeptidase%2520IV%2520%2528DP%2520IV%252C%2520CD26%2529%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D2001%26volume%3D10%26spage%3D1067%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Sedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlasicova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vespalec, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simanek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrichova, J.</span><span> </span><span class="NLM_article-title">Quaternary benzo[<i>c</i>]phenanthridine alkaloids as inhibitors of aminopeptidase N and dipeptidyl peptidase IV</span> <span class="citation_source-journal">Phytother. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1002%2Fptr.969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=11807974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1Wisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=84-87&author=A.+Sedoauthor=K.+Vlasicovaauthor=P.+Bartakauthor=R.+Vespalecauthor=J.+Vicarauthor=V.+Simanekauthor=J.+Ulrichova&title=Quaternary+benzo%5Bc%5Dphenanthridine+alkaloids+as+inhibitors+of+aminopeptidase+N+and+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary benzo[c]phenanthridine alkaloids as inhibitors of aminopeptidase N and dipeptidyl peptidase IV</span></div><div class="casAuthors">Sedo, Aleksi; Vlasicova, Kvetoslava; Bartak, Petr; Vespalec, Radim; Vicar, Jaroslav; Simanek, Vilim; Ulrichova, Jitka</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Chelerythrine, sanguinarine and an alkaloid ext. from Macleaya cordata-sanguiritrine-were found to be inhibitors of aminopeptidase A and dipeptidyl peptidase IV, while fagaronine inhibited dipeptidyl peptidase IV only.  At 50 μM, chelerythrine, sanguinarine and sanguiritrine inhibited aminopeptidase N by 82%, 82%, 88%, DPP IV by 38%, 62%, 57%, and fagaronine by 34%, resp.  When bovine serum albumin (500 μg/mL) was added, the inhibition of both proteases by quaternary benzo[c]phenanthridine alkaloids (QBA) (50 μM) was significantly diminished.  Strong interaction of chelerythrine and sanguinarine with bovine and human serum albumin was proved by electrophoretic detn. of their resp. conditional binding consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQuZOIQfZiaLVg90H21EOLACvtfcHk0lhVczRvwBLf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1Wisbg%253D&md5=d5d46b29819dad8d0160fce1a0bfcd73</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fptr.969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.969%26sid%3Dliteratum%253Aachs%26aulast%3DSedo%26aufirst%3DA.%26aulast%3DVlasicova%26aufirst%3DK.%26aulast%3DBartak%26aufirst%3DP.%26aulast%3DVespalec%26aufirst%3DR.%26aulast%3DVicar%26aufirst%3DJ.%26aulast%3DSimanek%26aufirst%3DV.%26aulast%3DUlrichova%26aufirst%3DJ.%26atitle%3DQuaternary%2520benzo%255Bc%255Dphenanthridine%2520alkaloids%2520as%2520inhibitors%2520of%2520aminopeptidase%2520N%2520and%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DPhytother.%2520Res.%26date%3D2002%26volume%3D16%26spage%3D84%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Busso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagtmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chobaz-Péclat, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischof-Delaloye, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grouzman, E.</span><span> </span><span class="NLM_article-title">Circulating CD26 is negatively associated with inflammation in human and experimental arthritis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS0002-9440%2810%2962266-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15681827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2005&pages=433-442&author=N.+Bussoauthor=N.+Wagtmannauthor=C.+Herlingauthor=V.+Chobaz-P%C3%A9clatauthor=A.+Bischof-Delaloyeauthor=A.+Soauthor=E.+Grouzman&title=Circulating+CD26+is+negatively+associated+with+inflammation+in+human+and+experimental+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating CD26 is negatively associated with inflammation in human and experimental arthritis</span></div><div class="casAuthors">Busso, Nathalie; Wagtmann, Nicolai; Herling, Christian; Chobaz-Peclat, Veronique; Bischof-Delaloye, Angelika; So, Alexander; Grouzmann, Eric</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">433-442</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV, CD26), a protease-cleaving N-terminal X-Pro dipeptide from selected proteins including some chemokines, is expressed both as a sol. form in plasma and on the cell surface of various immune and nonimmune cell types.  To gain insights into the pathophysiol. role of CD26 in arthritis, the authors explored DPPIV/CD26 expression during murine antigen-induced arthritis (AIA), an exptl. model of arthritis.  AIA induction led to reduced plasma DPPIV activity.  In CD26-deficient mice, the severity of AIA was increased as assessed by enhanced technetium uptake and by increased histol. parameters of inflammation (synovial thickness and exudate).  The authors demonstrated that CD26 controls the in vivo half-life of the intact active form of the proinflammatory chemokine stromal cell-derived factor-1 (SDF-1).  CD26-deficient mice exhibited increased levels of circulating active SDF-1, assocd. with increased nos. of SDF-1 receptor (CXCR4)-pos. cells infiltrating arthritic joints.  In a clin. study, plasma levels of DPPIV/CD26 from rheumatoid arthritis patients were decreased when compared to those from osteoarthritis patients and inversely correlate with C-reactive protein levels.  Thus, decreased circulating CD26 levels in arthritis may influence CD26-mediated regulation of the chemotactic SDF-1/CXCR4 axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Ju4Nw5ywmrVg90H21EOLACvtfcHk0lhVczRvwBLf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGnu78%253D&md5=e51ad267e399d02b34604afbe7eb85ff</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962266-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962266-3%26sid%3Dliteratum%253Aachs%26aulast%3DBusso%26aufirst%3DN.%26aulast%3DWagtmann%26aufirst%3DN.%26aulast%3DHerling%26aufirst%3DC.%26aulast%3DChobaz-P%25C3%25A9clat%26aufirst%3DV.%26aulast%3DBischof-Delaloye%26aufirst%3DA.%26aulast%3DSo%26aufirst%3DA.%26aulast%3DGrouzman%26aufirst%3DE.%26atitle%3DCirculating%2520CD26%2520is%2520negatively%2520associated%2520with%2520inflammation%2520in%2520human%2520and%2520experimental%2520arthritis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D166%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Reinhold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansorge, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2000&pages=155-160&author=D.+Reinholdauthor=B.+Hemmerauthor=B.+Granauthor=A.+Steinbrecherauthor=S.+Brockeauthor=T.+Kahneauthor=S.+Wrengerauthor=I.+Bornauthor=J.+Faustauthor=K.+Neubertauthor=R.+Martinauthor=S.+Ansorge&title=Dipeptidyl+peptidase+IV+%28CD26%29%3A+role+in+T+cell+activation+and+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinhold%26aufirst%3DD.%26aulast%3DHemmer%26aufirst%3DB.%26aulast%3DGran%26aufirst%3DB.%26aulast%3DSteinbrecher%26aufirst%3DA.%26aulast%3DBrocke%26aufirst%3DS.%26aulast%3DKahne%26aufirst%3DT.%26aulast%3DWrenger%26aufirst%3DS.%26aulast%3DBorn%26aufirst%3DI.%26aulast%3DFaust%26aufirst%3DJ.%26aulast%3DNeubert%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DAnsorge%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520%2528CD26%2529%253A%2520role%2520in%2520T%2520cell%2520activation%2520and%2520autoimmune%2520disease%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2000%26volume%3D477%26spage%3D155%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Matsubara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fijiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaikita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinnouchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuyama, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span> </span><span class="NLM_article-title">A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.jacc.2011.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22240132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFGlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=265-276&author=J.+Matsubaraauthor=S.+Sigiyamaauthor=K.+Sugamuraauthor=T.+Nakamuraauthor=Y.+Fijiwaraauthor=E.+Akiyamaauthor=H.+Kurokawaauthor=T.+Nozakiauthor=K.+Ohbaauthor=M.+Konishiauthor=H.+Maedaauthor=Y.+Izumiyaauthor=K.+Kaikitaauthor=H.+Sumidaauthor=H.+Jinnouchiauthor=K.+Matsuiauthor=S.+K.+Mitsuyamaauthor=M.+Takeyaauthor=H.+Ogawa&title=A+dipeptidyl+peptidase-4+inhibitor%2C+des-fluoro-sitagliptin%2C+improves+endothelial+function+and+reduces+atherosclerotic+lesion+formation+in+apolipoprotein+E-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice</span></div><div class="casAuthors">Matsubara, Junichi; Sugiyama, Seigo; Sugamura, Koichi; Nakamura, Taishi; Fujiwara, Yukio; Akiyama, Eiichi; Kurokawa, Hirofumi; Nozaki, Toshimitsu; Ohba, Keisuke; Konishi, Masaaki; Maeda, Hirofumi; Izumiya, Yasuhiro; Kaikita, Koichi; Sumida, Hitoshi; Jinnouchi, Hideaki; Matsui, Kunihiko; Kim-Mitsuyama, Shokei; Takeya, Motohiro; Ogawa, Hisao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-276</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to investigate the antiatherogenic effects of the dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin (DFS).  Background: The new class of anti-type 2 diabetes drugs, dipeptidyl peptidase-4 inhibitors, improves glucose metab. by increasing levels of active glucagon-like peptide (GLP)-1.  Methods: Endothelial function was examd. by acetylcholine-induced endothelium-dependent vasorelaxation using aortic rings and atherosclerotic lesion development in the entire aorta in apolipoprotein E-deficient mice fed a high-fat diet with or without DFS, and the antiatherogenic effects of DFS were investigated in cultured human macrophages and endothelial cells.  Plasma levels of active GLP-1 were measured in patients with or without coronary artery disease.  Results: DFS significantly improved endothelial dysfunction (89.9 ± 3.9% vs. 79.2 ± 4.3% relaxation at 10-4 mol/l acetylcholine, p < 0.05) assocd. with increased endothelial nitric oxide synthase phosphorylation and reduced atherosclerotic lesion area (17.7% [15.6% to 25.8%] vs. 24.6% [19.3% to 34.6%], p < 0.01) compared with vehicle treatment.  In cultured human macrophages, DFS significantly increased GLP-1-induced cytosolic levels of cyclic adenosine monophosphate compared with GLP-1 alone, resulted in inhibiting phosphorylation of c-jun N-terminal kinase and extracellular signal-regulated kinase 1/2 and nuclear factor-kappa B p65 nuclear translocation through the cyclic adenosine monophosphate/protein kinase A pathway, and suppressed proinflammatory cytokines (i.e., interleukin-1-beta, interleukin-6, and tumor necrosis factor-alpha) and monocyte chemoattractant protein-1 prodn. in response to lipopolysaccharide.  DFS-enhanced GLP-1 activity sustained endothelial nitric oxide synthase phosphorylation and decreased endothelial senescence and apoptosis compared with GLP-1 alone.  In the human study, fasting levels of active GLP-1 were significantly lower in patients with coronary artery disease than those without (3.10 pmol/l [2.40 to 3.62 pmol/l] vs. 4.00 pmol/l [3.10 to 5.90 pmol/l], p < 0.001).  Conclusions: A DPP-4 inhibitor, DFS, exhibited antiatherogenic effects through augmenting GLP-1 activity in macrophages and endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM0MfaOinbf7Vg90H21EOLACvtfcHk0ljKltqHxRQX4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFGlsr8%253D&md5=15995db59edd9fbe9e01314e8729a791</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2011.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2011.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DJ.%26aulast%3DSigiyama%26aufirst%3DS.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DFijiwara%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DE.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DNozaki%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DK.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DIzumiya%26aufirst%3DY.%26aulast%3DKaikita%26aufirst%3DK.%26aulast%3DSumida%26aufirst%3DH.%26aulast%3DJinnouchi%26aufirst%3DH.%26aulast%3DMatsui%26aufirst%3DK.%26aulast%3DMitsuyama%26aufirst%3DS.%2BK.%26aulast%3DTakeya%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DH.%26atitle%3DA%2520dipeptidyl%2520peptidase-4%2520inhibitor%252C%2520des-fluoro-sitagliptin%252C%2520improves%2520endothelial%2520function%2520and%2520reduces%2520atherosclerotic%2520lesion%2520formation%2520in%2520apolipoprotein%2520E-deficient%2520mice%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2012%26volume%3D59%26spage%3D265%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Marchetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Carlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchiano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cristofaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capogrossi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germane, A.</span><span> </span><span class="NLM_article-title">High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=236-244&author=C.+Marchettiauthor=A.+Di+Carloauthor=F.+Facchianoauthor=C.+Senatoreauthor=R.+De+Cristofaroauthor=A.+Luziauthor=M.+Federiciauthor=M.+Romaniauthor=M.+Napolitanoauthor=M.+C.+Capogrossiauthor=A.+Germane&title=High+mobility+group+box+1+is+a+novel+substrate+of+dipeptidyl+peptidase-IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DDi%2BCarlo%26aufirst%3DA.%26aulast%3DFacchiano%26aufirst%3DF.%26aulast%3DSenatore%26aufirst%3DC.%26aulast%3DDe%2BCristofaro%26aufirst%3DR.%26aulast%3DLuzi%26aufirst%3DA.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DRomani%26aufirst%3DM.%26aulast%3DNapolitano%26aufirst%3DM.%26aulast%3DCapogrossi%26aufirst%3DM.%2BC.%26aulast%3DGermane%26aufirst%3DA.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520is%2520a%2520novel%2520substrate%2520of%2520dipeptidyl%2520peptidase-IV%26jtitle%3DDiabetologia%26date%3D2012%26volume%3D55%26spage%3D236%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Matheeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungrathmayr, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.pharmthera.2012.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22850530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2kt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2012&pages=267-282&author=V.+Matheeussenauthor=W.+Jungrathmayrauthor=I.+De+Meester&title=Dipeptidyl+peptidase+4+as+a+therapeutic+target+in+ischemia%2Freperfusion+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury</span></div><div class="casAuthors">Matheeussen, Veerle; Jungraithmayr, Wolfgang; De Meester, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-282</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase 4 (DPP4, DPPIV, CD26, EC 3.4.14.5) was discovered more than four decades ago as a serine protease that cleaves off N-terminal dipeptides from peptide substrates.  The development of potent DPP4 inhibitors during the past two decades has led to the identification of DPP4 as a target in the treatment of type 2 diabetes.  The favorable effect of DPP4 inhibitors is based on prevention of the in vivo inactivation of the incretin hormone, glucagon-like peptide-1 (GLP-1) by DPP4.  Apart from GLP-1, a no. of other biol. active peptides are truncated by DPP4.  For these peptides, the physiol. relevance of their truncation has yet to be fully elucidated.Within the last 10 years, DPP4 inhibitors have been employed in several animal models of lung and heart disease, in which injury was induced by an ischemic insult followed by subsequent reperfusion.  In this review, we present a state-of-the-art of the ischemia/reperfusion injury (IRI)-related pharmacol. actions of DPP4 substrates, including GLP-1, stromal cell-derived factor-1 alpha and vasoactive intestinal peptide.  Furthermore, we discuss the large body of exptl. work that now provides compelling evidence for the advantageous impact of DPP4 targeting in IRI.  However, possible risks as well as underlying mechanisms are yet to be elucidated before translating these promising treatment strategies into clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnZ2zL6HXLI7Vg90H21EOLACvtfcHk0ljKltqHxRQX4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2kt77K&md5=8b8b779e3a9f580f65bf3187d0cffb43</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DMatheeussen%26aufirst%3DV.%26aulast%3DJungrathmayr%26aufirst%3DW.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DDipeptidyl%2520peptidase%25204%2520as%2520a%2520therapeutic%2520target%2520in%2520ischemia%252Freperfusion%2520injury%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D136%26spage%3D267%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Jungraithmayr, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baerts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weder, W.</span><span> </span><span class="NLM_article-title">CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia–reperfusion injury in mouse lung transplantation</span> <span class="citation_source-journal">Eur. J. Cardio-Thorac. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1093%2Fejcts%2Fezr180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22219460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A280%3ADC%252BC38zpsl2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=1166-1173&author=W.+Jungraithmayrauthor=I.+De+Meesterauthor=V.+Matheeussenauthor=L.+Baertsauthor=S.+Arniauthor=W.+Weder&title=CD26%2FDPP-4+inhibition+recruits+regenerative+stem+cells+via+stromal+cell-derived+factor-1+and+beneficially+influences+ischaemia%E2%80%93reperfusion+injury+in+mouse+lung+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation</span></div><div class="casAuthors">Jungraithmayr Wolfgang; De Meester Ingrid; Matheeussen Veerle; Baerts Lesley; Arni Stephan; Weder Walter</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1166-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  The CD26 antigen is a transmembrane glycoprotein that is constitutively expressed on activated lymphocytes and in pulmonary parenchyma.  This molecule is also identified as dipeptidyl peptidase-4 (DPP-4) that cleaves a host of biologically active peptides.  Here, we aimed to identify an important substrate of CD26/DPP-4-stromal cell-derived factor-1 (SDF-1/CXCL12)-as a key modulator for stem-cell homing together with its receptor CXCR4 in response to ischaemic injury of the lung.  METHODS:  Orthotopic single lung transplantation (Tx) was performed between syngeneic C57BL/6 mice.  Inhibition of CD26/DPP-4 activity in recipients was achieved using vildagliptin (10 mg/kg, every 12 h) subcutaneously, and 6 h ischaemia time was applied prior to implantation.  Forty-eight hours after Tx, lung histology, SDF-1 levels (enzyme-linked immunosorbent assay) in lung, spleen and plasma, and expression of the SDF-1 receptor CXCR4 in blood and lung were assessed.  Homing of regenerative progenitor cells to the transplanted lung was evaluated using fluorescent-activated cell sorting.  RESULTS:  Compared with untreated lung transplanted mice, systemic DPP-4 inhibition of Tx recipients resulted in an increase in protein concentration of SDF-1 in plasma, spleen and lung.  Concordantly, the frequency of cells bearing the SDF-1 receptor CXCR4 rose significantly in the circulation and also in the lungs of DPP-4-inhibited recipients.  We found co-expression of CXCR4/CD34 in the grafts of animals treated with vildagliptin, and the stem-cell markers Flt-3 and c-kit were present on a significantly increased number of cells.  The morphology of grafts from DPP-4 inhibitor-treated recipients revealed less alveolar oedema when compared with untreated recipients.  CONCLUSIONS:  Targeting the SDF-1-CXCR4 axis through CD26/DPP-4 inhibition increased the intragraft number of progenitor cells contributing to the recovery from ischaemia-reperfusion lung injury.  Stabilization of endogenous SDF-1 is achievable and may be a promising strategy to intensify sequestration of regenerative stem cells and thus emerges as a novel therapeutic concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQb7cGa5w_HNmmbXvSEQle5fW6udTcc2ebOiB-yzmU_Nrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zpsl2qsQ%253D%253D&md5=46fb3154b2a11baaee57caf7c94a88aa</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1093%2Fejcts%2Fezr180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fejcts%252Fezr180%26sid%3Dliteratum%253Aachs%26aulast%3DJungraithmayr%26aufirst%3DW.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DMatheeussen%26aufirst%3DV.%26aulast%3DBaerts%26aufirst%3DL.%26aulast%3DArni%26aufirst%3DS.%26aulast%3DWeder%26aufirst%3DW.%26atitle%3DCD26%252FDPP-4%2520inhibition%2520recruits%2520regenerative%2520stem%2520cells%2520via%2520stromal%2520cell-derived%2520factor-1%2520and%2520beneficially%2520influences%2520ischaemia%25E2%2580%2593reperfusion%2520injury%2520in%2520mouse%2520lung%2520transplantation%26jtitle%3DEur.%2520J.%2520Cardio-Thorac.%2520Surg.%26date%3D2012%26volume%3D41%26spage%3D1166%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Corbett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunnett, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katona, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearns, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehoe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passmore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C.</span><span> </span><span class="NLM_article-title">Drug repositioning for Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=833-846&author=A.+Corbettauthor=J.+Pickettauthor=A.+Burnsauthor=J.+Corcoranauthor=S.+B.+Dunnettauthor=P.+Edisonauthor=J.+J.+Haganauthor=C.+Holmesauthor=E.+Jonesauthor=C.+Katonaauthor=I.+Kearnsauthor=P.+Kehoeauthor=A.+Mudherauthor=A.+Passmoreauthor=N.+Shepherdauthor=F.+Walshauthor=C.+Ballard&title=Drug+repositioning+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorbett%26aufirst%3DA.%26aulast%3DPickett%26aufirst%3DJ.%26aulast%3DBurns%26aufirst%3DA.%26aulast%3DCorcoran%26aufirst%3DJ.%26aulast%3DDunnett%26aufirst%3DS.%2BB.%26aulast%3DEdison%26aufirst%3DP.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DKatona%26aufirst%3DC.%26aulast%3DKearns%26aufirst%3DI.%26aulast%3DKehoe%26aufirst%3DP.%26aulast%3DMudher%26aufirst%3DA.%26aulast%3DPassmore%26aufirst%3DA.%26aulast%3DShepherd%26aufirst%3DN.%26aulast%3DWalsh%26aufirst%3DF.%26aulast%3DBallard%26aufirst%3DC.%26atitle%3DDrug%2520repositioning%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D833%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. Y.</span><span> </span><span class="NLM_article-title">Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.nbd.2011.12.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22245388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1OntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=52-58&author=D.+H.+Kimauthor=J.+W.+Huhauthor=M.+Jangauthor=J.+H.+Suhauthor=T.+W.+Kimauthor=J.+S.+Parkauthor=S.+Y.+Yoon&title=Sitagliptin+increases+tau+phosphorylation+in+the+hippocampus+of+rats+with+type+2+diabetes+and+in+primary+neuron+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures</span></div><div class="casAuthors">Kim, Dong-Hou; Huh, Jae-Wan; Jang, Mi; Suh, Jung-Hyun; Kim, Tae-Wan; Park, Jeong-Su; Yoon, Seung-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Increasing evidence supports an assocn. between Alzheimer's disease (AD) and diabetes.  In this context, anti-diabetic agents such as rosiglitazone and glucagon-like peptide (GLP)-1 have been reported to reduce pathologies assocd. with AD, including tau hyperphosphorylation, suggesting that such agents might be used to treat AD.  One such anti-diabetic agent is sitagliptin, which acts through inhibition of dipeptidyl peptidase (DPP)-IV to increase GLP-1 levels.  Given this action, sitagliptin would be predicted to reduce AD pathol.  Accordingly, we investigated whether sitagliptin is effective in attenuating AD pathologies, focusing on tau phosphorylation in the OLETF type 2 diabetic rat model.  Unexpectedly, we found that sitagliptin was not effective against pathol. tau phosphorylation in the hippocampus of OLETF type 2 diabetes rats, and instead aggravated it.  This paradoxically increased tau phosphorylation was attributed to activation of the tau kinase, GSK3β (glycogen synthase kinase 3β).  Sitagliptin also increased ser-616 phosphorylation of the insulin receptor substrate (IRS)-1, suggesting increased insulin resistance in the brain.  These phenomena were recapitulated in primary rat cortical neurons treated with sitagliptin, further confirming sitagliptin's effects on AD-related pathologies in neurons.  These results highlight the need for caution in considering the use of sitagliptin in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJhELhSe_Yz7Vg90H21EOLACvtfcHk0lgeJBTyZJZtNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1OntbY%253D&md5=10e96b48cd1a32b56da39e592022619b</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2011.12.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2011.12.043%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DHuh%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DM.%26aulast%3DSuh%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DT.%2BW.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26atitle%3DSitagliptin%2520increases%2520tau%2520phosphorylation%2520in%2520the%2520hippocampus%2520of%2520rats%2520with%2520type%25202%2520diabetes%2520and%2520in%2520primary%2520neuron%2520cultures%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D46%26spage%3D52%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 113 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Katarina Tomovic, Budimir S. Ilic, <span class="NLM_string-name hlFld-ContribAuthor">Andrija Smelcerovic</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship Analysis of Cocrystallized Gliptin-like Pyrrolidine, Trifluorophenyl, and Pyrimidine-2,4-Dione Dipeptidyl Peptidase-4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9639-9648. <a href="https://doi.org/10.1021/acs.jmedchem.1c00293" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00293%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252BAnalysis%252Bof%252BCocrystallized%252BGliptin-like%252BPyrrolidine%25252C%252BTrifluorophenyl%25252C%252Band%252BPyrimidine-2%25252C4-Dione%252BDipeptidyl%252BPeptidase-4%252BInhibitors%26aulast%3DTomovic%26aufirst%3DKatarina%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D15022021%26date%3D30062021%26volume%3D64%26issue%3D14%26spage%3D9639%26epage%3D9648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mengdi Chen, Daodong Pan, Tianqiong Zhou, Xinchang Gao, <span class="NLM_string-name hlFld-ContribAuthor">Yali Dang</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Umami Peptide IPIPATKT with Dual Dipeptidyl Peptidase-IV and Angiotensin I-Converting Enzyme Inhibitory Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2021,</strong> <em>69 </em>
                                    (19)
                                     , 5463-5470. <a href="https://doi.org/10.1021/acs.jafc.0c07138" title="DOI URL">https://doi.org/10.1021/acs.jafc.0c07138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.0c07138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.0c07138%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DNovel%252BUmami%252BPeptide%252BIPIPATKT%252Bwith%252BDual%252BDipeptidyl%252BPeptidase-IV%252Band%252BAngiotensin%252BI-Converting%252BEnzyme%252BInhibitory%252BActivities%26aulast%3DChen%26aufirst%3DMengdi%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2021%26date%3D06122020%26date%3D26042021%26date%3D25042021%26date%3D05052021%26volume%3D69%26issue%3D19%26spage%3D5463%26epage%3D5470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qing Xia, Yufei Li, Lan Cheng, Xin Liang, Chenlin Cao, Peng Dai, Hongping Deng, Weihua Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Qingmin Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Electron Donor–Acceptor Complex-Initiated Photochemical Cyanation for the Preparation of α-Amino Nitriles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (24)
                                     , 9638-9643. <a href="https://doi.org/10.1021/acs.orglett.0c03703" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03703</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03703%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DElectron%252BDonor%2525E2%252580%252593Acceptor%252BComplex-Initiated%252BPhotochemical%252BCyanation%252Bfor%252Bthe%252BPreparation%252Bof%252B%2525CE%2525B1-Amino%252BNitriles%26aulast%3DXia%26aufirst%3DQing%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07112020%26date%3D07122020%26volume%3D22%26issue%3D24%26spage%3D9638%26epage%3D9643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Liying Wang, Long Ding, Zhiyang Du, Zhipeng Yu, <span class="NLM_string-name hlFld-ContribAuthor">Jingbo Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrolysis and Transport of Egg White-Derived Peptides in Caco-2 Cell Monolayers and Everted Rat Sacs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2019,</strong> <em>67 </em>
                                    (17)
                                     , 4839-4848. <a href="https://doi.org/10.1021/acs.jafc.9b01904" title="DOI URL">https://doi.org/10.1021/acs.jafc.9b01904</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.9b01904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.9b01904%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DHydrolysis%252Band%252BTransport%252Bof%252BEgg%252BWhite-Derived%252BPeptides%252Bin%252BCaco-2%252BCell%252BMonolayers%252Band%252BEverted%252BRat%252BSacs%26aulast%3DWang%26aufirst%3DLiying%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D27032019%26date%3D10042019%26date%3D18042019%26date%3D10042019%26volume%3D67%26issue%3D17%26spage%3D4839%26epage%3D4848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feiran Xu, Yijun Yao, Xiaoying Xu, Mei Wang, Mengmeng Pan, Shengyang Ji, Jin Wu, Donglei Jiang, Xingrong Ju, <span class="NLM_string-name hlFld-ContribAuthor">Lifeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and Quantification of DPP-IV-Inhibitory Peptides from Hydrolyzed-Rapeseed-Protein-Derived Napin with Analysis of the Interactions between Key Residues and Protein Domains. </span><span class="cited-content_cbyCitation_journal-name">Journal of Agricultural and Food Chemistry</span><span> <strong>2019,</strong> <em>67 </em>
                                    (13)
                                     , 3679-3690. <a href="https://doi.org/10.1021/acs.jafc.9b01069" title="DOI URL">https://doi.org/10.1021/acs.jafc.9b01069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jafc.9b01069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jafc.9b01069%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Agricultural%2520and%2520Food%2520Chemistry%26atitle%3DIdentification%252Band%252BQuantification%252Bof%252BDPP-IV-Inhibitory%252BPeptides%252Bfrom%252BHydrolyzed-Rapeseed-Protein-Derived%252BNapin%252Bwith%252BAnalysis%252Bof%252Bthe%252BInteractions%252Bbetween%252BKey%252BResidues%252Band%252BProtein%252BDomains%26aulast%3DXu%26aufirst%3DFeiran%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D14022019%26date%3D11032019%26date%3D07032019%26date%3D18032019%26date%3D11032019%26volume%3D67%26issue%3D13%26spage%3D3679%26epage%3D3690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong-Heng Wang, Fan Zhang, Hongjuan Diao, <span class="NLM_string-name hlFld-ContribAuthor">Ruibo Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Inhibition Mechanism of Antidiabetic Drugs—Vildagliptin vs Saxagliptin. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , 2292-2302. <a href="https://doi.org/10.1021/acscatal.8b05051" title="DOI URL">https://doi.org/10.1021/acscatal.8b05051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.8b05051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.8b05051%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DCovalent%252BInhibition%252BMechanism%252Bof%252BAntidiabetic%252BDrugs%2525E2%252580%252594Vildagliptin%252Bvs%252BSaxagliptin%26aulast%3DWang%26aufirst%3DYong-Heng%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2019%26date%3D19122018%26date%3D25012019%26date%3D11022019%26date%3D05022019%26volume%3D9%26issue%3D3%26spage%3D2292%26epage%3D2302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic, <span class="NLM_string-name hlFld-ContribAuthor">Dela Golshayan</span>. </span><span class="cited-content_cbyCitation_article-title">Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9811-9840. <a href="https://doi.org/10.1021/acs.jmedchem.8b00294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFibrogenic%252BDisorders%252Bin%252BHuman%252BDiseases%25253A%252BFrom%252BInflammation%252Bto%252BOrgan%252BDysfunction%26aulast%3DJuillerat-Jeanneret%26aufirst%3DLucienne%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21022018%26date%3D17072018%26date%3D03072018%26volume%3D61%26issue%3D22%26spage%3D9811%26epage%3D9840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Tao Liu, Jing Ning, Bo Wang, Bin Dong, Song Li, Xiangge Tian, Zhenlong Yu, Yulin Peng, Chao Wang, Xinyu Zhao, Xiaokui Huo, Chengpeng Sun, Jingnan Cui, Lei Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xiaochi Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Activatable Near-Infrared Fluorescent Probe for Dipeptidyl Peptidase IV and Its Bioimaging Applications in Living Cells and Animals. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2018,</strong> <em>90 </em>
                                    (6)
                                     , 3965-3973. <a href="https://doi.org/10.1021/acs.analchem.7b04957" title="DOI URL">https://doi.org/10.1021/acs.analchem.7b04957</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.7b04957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.7b04957%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DActivatable%252BNear-Infrared%252BFluorescent%252BProbe%252Bfor%252BDipeptidyl%252BPeptidase%252BIV%252Band%252BIts%252BBioimaging%252BApplications%252Bin%252BLiving%252BCells%252Band%252BAnimals%26aulast%3DLiu%26aufirst%3DTao%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29112017%26date%3D01032018%26date%3D08032018%26date%3D01032018%26volume%3D90%26issue%3D6%26spage%3D3965%26epage%3D3973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shilva  Kayastha</span>, <span class="hlFld-ContribAuthor ">Dragos  Horvath</span>, <span class="hlFld-ContribAuthor ">Erik  Gilberg</span>, <span class="hlFld-ContribAuthor ">Michael  Gütschow</span>, <span class="hlFld-ContribAuthor ">Jürgen  Bajorath</span>, and <span class="hlFld-ContribAuthor ">Alexandre  Varnek</span>  . </span><span class="cited-content_cbyCitation_article-title">Privileged Structural Motif Detection and Analysis Using Generative Topographic Maps. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (5)
                                     , 1218-1232. <a href="https://doi.org/10.1021/acs.jcim.7b00128" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00128</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00128%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrivileged%252BStructural%252BMotif%252BDetection%252Band%252BAnalysis%252BUsing%252BGenerative%252BTopographic%252BMaps%26aulast%3DKayastha%26aufirst%3DShilva%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D02032017%26date%3D21042017%26date%3D22052017%26date%3D14042017%26volume%3D57%26issue%3D5%26spage%3D1218%26epage%3D1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Zhou</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Shuni  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, and <span class="hlFld-ContribAuthor ">Hong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 422-518. <a href="https://doi.org/10.1021/acs.chemrev.5b00392" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00392%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNext%252BGeneration%252Bof%252BFluorine-Containing%252BPharmaceuticals%25252C%252BCompounds%252BCurrently%252Bin%252BPhase%252BII%2525E2%252580%252593III%252BClinical%252BTrials%252Bof%252BMajor%252BPharmaceutical%252BCompanies%25253A%252BNew%252BStructural%252BTrends%252Band%252BTherapeutic%252BAreas%26aulast%3DZhou%26aufirst%3DYu%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D06072015%26date%3D12012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D422%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amarjit  Singh</span>, <span class="hlFld-ContribAuthor ">James  Falabella</span>, <span class="hlFld-ContribAuthor ">Thomas L  LaPorte</span>, and <span class="hlFld-ContribAuthor ">Animesh  Goswami</span>  . </span><span class="cited-content_cbyCitation_article-title">Enzymatic Process for N-Substituted (3S)- and (3R)-3-Hydroxypyrrolidin-2-ones. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (7)
                                     , 819-830. <a href="https://doi.org/10.1021/acs.oprd.5b00084" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00084%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEnzymatic%252BProcess%252Bfor%252BN-Substituted%252B%2525283S%252529-%252Band%252B%2525283R%252529-3-Hydroxypyrrolidin-2-ones%26aulast%3DSingh%26aufirst%3DAmarjit%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D16032015%26date%3D07072015%26date%3D17072015%26date%3D24062015%26volume%3D19%26issue%3D7%26spage%3D819%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolin  Schwehm</span>, <span class="hlFld-ContribAuthor ">Jin  Li</span>, <span class="hlFld-ContribAuthor ">Hongmei  Song</span>, <span class="hlFld-ContribAuthor ">Xiao  Hu</span>, <span class="hlFld-ContribAuthor ">Barrie  Kellam</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Stocks</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of New DPP-4 Inhibitors Based on a Novel Tricyclic Scaffold. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 324-328. <a href="https://doi.org/10.1021/ml500503n" title="DOI URL">https://doi.org/10.1021/ml500503n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500503n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500503n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252BNew%252BDPP-4%252BInhibitors%252BBased%252Bon%252Ba%252BNovel%252BTricyclic%252BScaffold%26aulast%3DSchwehm%26aufirst%3DCarolin%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D13012015%26date%3D14012015%26date%3D12032015%26date%3D13012015%26volume%3D6%26issue%3D3%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chutian  Shu</span>, <span class="hlFld-ContribAuthor ">Hu  Ge</span>, <span class="hlFld-ContribAuthor ">Michael  Song</span>, <span class="hlFld-ContribAuthor ">Jyun-hong  Chen</span>, <span class="hlFld-ContribAuthor ">Huimin  Zhou</span>, <span class="hlFld-ContribAuthor ">Qu  Qi</span>, <span class="hlFld-ContribAuthor ">Feng  Wang</span>, <span class="hlFld-ContribAuthor ">Xifeng  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Yang</span>, <span class="hlFld-ContribAuthor ">Genyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanwei  Ding</span>, <span class="hlFld-ContribAuthor ">Dapeng  Zhou</span>, <span class="hlFld-ContribAuthor ">Peng  Peng</span>, <span class="hlFld-ContribAuthor ">Cheng-kon  Shih</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>, and <span class="hlFld-ContribAuthor ">Frank  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (8)
                                     , 921-926. <a href="https://doi.org/10.1021/ml5001905" title="DOI URL">https://doi.org/10.1021/ml5001905</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5001905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5001905%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BImigliptin%25252C%252Ba%252BNovel%252BSelective%252BDPP-4%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BType%252B2%252BDiabetes%26aulast%3DShu%26aufirst%3DChutian%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D10052014%26date%3D09062014%26date%3D16062014%26date%3D14082014%26volume%3D5%26issue%3D8%26spage%3D921%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Rivero-Pino</span>, <span class="hlFld-ContribAuthor ">F. Javier  Espejo-Carpio</span>, <span class="hlFld-ContribAuthor ">Emilia M.  Guadix</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from vegetable protein sources. </span><span class="cited-content_cbyCitation_journal-name">Food Chemistry</span><span> <strong>2021,</strong> <em>354 </em>, 129473. <a href="https://doi.org/10.1016/j.foodchem.2021.129473" title="DOI URL">https://doi.org/10.1016/j.foodchem.2021.129473</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodchem.2021.129473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodchem.2021.129473%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Chemistry%26atitle%3DIdentification%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bpeptides%252Bfrom%252Bvegetable%252Bprotein%252Bsources%26aulast%3DRivero-Pino%26aufirst%3DFernando%26date%3D2021%26volume%3D354%26spage%3D129473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Lang</span>, <span class="hlFld-ContribAuthor ">Yishan  Song</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Xi  Xiang</span>, <span class="hlFld-ContribAuthor ">Ling  Ni</span>, <span class="hlFld-ContribAuthor ">Junjian  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Purification, identification, and molecular mechanism of DPP‐IV inhibitory peptides from defatted Antarctic krill powder. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Biochemistry</span><span> <strong>2021,</strong> <em>124 </em><a href="https://doi.org/10.1111/jfbc.13872" title="DOI URL">https://doi.org/10.1111/jfbc.13872</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jfbc.13872&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjfbc.13872%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Biochemistry%26atitle%3DPurification%25252C%252Bidentification%25252C%252Band%252Bmolecular%252Bmechanism%252Bof%252BDPP%2525E2%252580%252590IV%252Binhibitory%252Bpeptides%252Bfrom%252Bdefatted%252BAntarctic%252Bkrill%252Bpowder%26aulast%3DLang%26aufirst%3DMeng%26date%3D2021%26date%3D2021%26volume%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujia  Lu</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Olugbenga P.  Soladoye</span>, <span class="hlFld-ContribAuthor ">Rotimi E.  Aluko</span>, <span class="hlFld-ContribAuthor ">Yu  Fu</span>, <span class="hlFld-ContribAuthor ">Yuhao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Preparation, receptors, bioactivity and bioavailability of γ-glutamyl peptides: A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Trends in Food Science & Technology</span><span> <strong>2021,</strong> <em>113 </em>, 301-314. <a href="https://doi.org/10.1016/j.tifs.2021.04.051" title="DOI URL">https://doi.org/10.1016/j.tifs.2021.04.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tifs.2021.04.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tifs.2021.04.051%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Food%2520Science%2520%2526%2520Technology%26atitle%3DPreparation%25252C%252Breceptors%25252C%252Bbioactivity%252Band%252Bbioavailability%252Bof%252B%2525CE%2525B3-glutamyl%252Bpeptides%25253A%252BA%252Bcomprehensive%252Breview%26aulast%3DLu%26aufirst%3DYujia%26date%3D2021%26volume%3D113%26spage%3D301%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zimin  Chen</span>, <span class="hlFld-ContribAuthor ">Songlin  Zheng</span>, <span class="hlFld-ContribAuthor ">Zijie  Wang</span>, <span class="hlFld-ContribAuthor ">Zixuan  Liao</span>, <span class="hlFld-ContribAuthor ">Weiming  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">Electron Donor‐Acceptor Complex Enabled Photocyanation of Tertiary Amines with a Stable and User‐Friendly Cyanobenziodoxolone Reagent. </span><span class="cited-content_cbyCitation_journal-name">ChemPhotoChem</span><span> <strong>2021,</strong> <em>107 </em><a href="https://doi.org/10.1002/cptc.202100133" title="DOI URL">https://doi.org/10.1002/cptc.202100133</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cptc.202100133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcptc.202100133%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPhotoChem%26atitle%3DElectron%252BDonor%2525E2%252580%252590Acceptor%252BComplex%252BEnabled%252BPhotocyanation%252Bof%252BTertiary%252BAmines%252Bwith%252Ba%252BStable%252Band%252BUser%2525E2%252580%252590Friendly%252BCyanobenziodoxolone%252BReagent%26aulast%3DChen%26aufirst%3DZimin%26date%3D2021%26date%3D2021%26volume%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sibhghatulla  Shaikh</span>, <span class="hlFld-ContribAuthor ">Eun-Ju  Lee</span>, <span class="hlFld-ContribAuthor ">Khurshid  Ahmad</span>, <span class="hlFld-ContribAuthor ">Syed-Sayeed  Ahmad</span>, <span class="hlFld-ContribAuthor ">Jeong-Ho  Lim</span>, <span class="hlFld-ContribAuthor ">Inho  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2021,</strong> <em>14 </em>
                                    (6)
                                     , 591. <a href="https://doi.org/10.3390/ph14060591" title="DOI URL">https://doi.org/10.3390/ph14060591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph14060591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph14060591%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DA%252BComprehensive%252BReview%252Band%252BPerspective%252Bon%252BNatural%252BSources%252Bas%252BDipeptidyl%252BPeptidase-4%252BInhibitors%252Bfor%252BManagement%252Bof%252BDiabetes%26aulast%3DShaikh%26aufirst%3DSibhghatulla%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D6%26spage%3D591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haofeng  Gu</span>, <span class="hlFld-ContribAuthor ">Jing  Gao</span>, <span class="hlFld-ContribAuthor ">Qun  Shen</span>, <span class="hlFld-ContribAuthor ">Dongxiao  Gao</span>, <span class="hlFld-ContribAuthor ">Qian  Wang</span>, <span class="hlFld-ContribAuthor ">Muzi  Tangyu</span>, <span class="hlFld-ContribAuthor ">Xueying  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Dipeptidyl peptidase-IV inhibitory activity of millet protein peptides and the related mechanisms revealed by molecular docking. </span><span class="cited-content_cbyCitation_journal-name">LWT</span><span> <strong>2021,</strong> <em>138 </em>, 110587. <a href="https://doi.org/10.1016/j.lwt.2020.110587" title="DOI URL">https://doi.org/10.1016/j.lwt.2020.110587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lwt.2020.110587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lwt.2020.110587%26sid%3Dliteratum%253Aachs%26jtitle%3DLWT%26atitle%3DDipeptidyl%252Bpeptidase-IV%252Binhibitory%252Bactivity%252Bof%252Bmillet%252Bprotein%252Bpeptides%252Band%252Bthe%252Brelated%252Bmechanisms%252Brevealed%252Bby%252Bmolecular%252Bdocking%26aulast%3DGu%26aufirst%3DHaofeng%26date%3D2021%26volume%3D138%26spage%3D110587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  JI</span>, <span class="hlFld-ContribAuthor ">Chaohua  ZHANG</span>, <span class="hlFld-ContribAuthor ">Cai  SONG</span>, <span class="hlFld-ContribAuthor ">Hongwu  JI</span>. </span><span class="cited-content_cbyCitation_article-title">Three DPP-IV inhibitory peptides from Antarctic krill protein hydrolysate improve glucose levels in the zebrafish model of diabetes. </span><span class="cited-content_cbyCitation_journal-name">Food Science and Technology</span><span> <strong>2021,</strong> <em>63 </em><a href="https://doi.org/10.1590/fst.58920" title="DOI URL">https://doi.org/10.1590/fst.58920</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1590/fst.58920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1590%2Ffst.58920%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Science%2520and%2520Technology%26atitle%3DThree%252BDPP-IV%252Binhibitory%252Bpeptides%252Bfrom%252BAntarctic%252Bkrill%252Bprotein%252Bhydrolysate%252Bimprove%252Bglucose%252Blevels%252Bin%252Bthe%252Bzebrafish%252Bmodel%252Bof%252Bdiabetes%26aulast%3DJI%26aufirst%3DWei%26date%3D2021%26date%3D2021%26volume%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sampa  Gupta</span>, <span class="hlFld-ContribAuthor ">Amit Kumar  Rai</span>, <span class="hlFld-ContribAuthor ">Shubham  Pandey</span>, <span class="hlFld-ContribAuthor ">L. Ravithej  Singh</span>, <span class="hlFld-ContribAuthor ">Ruchir  Kant</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Tamrakar</span>, <span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted efficient synthesis of pyrazole-fibrate derivatives as stimulators of glucose uptake in skeletal muscle cells. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>34 </em>, 127760. <a href="https://doi.org/10.1016/j.bmcl.2020.127760" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127760</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127760%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DMicrowave-assisted%252Befficient%252Bsynthesis%252Bof%252Bpyrazole-fibrate%252Bderivatives%252Bas%252Bstimulators%252Bof%252Bglucose%252Buptake%252Bin%252Bskeletal%252Bmuscle%252Bcells%26aulast%3DGupta%26aufirst%3DSampa%26date%3D2021%26volume%3D34%26spage%3D127760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bassam M.  Ayoub</span>, <span class="hlFld-ContribAuthor ">Haidy E.  Michel</span>, <span class="hlFld-ContribAuthor ">Shereen  Mowaka</span>, <span class="hlFld-ContribAuthor ">Moataz S.  Hendy</span>, <span class="hlFld-ContribAuthor ">Mariam M.  Tadros</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 889. <a href="https://doi.org/10.3390/molecules26040889" title="DOI URL">https://doi.org/10.3390/molecules26040889</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26040889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26040889%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRepurposing%252Bof%252BOmarigliptin%252Bas%252Ba%252BNeuroprotective%252BAgent%252BBased%252Bon%252BDocking%252Bwith%252BA2A%252BAdenosine%252Band%252BAChE%252BReceptors%25252C%252BBrain%252BGLP-1%252BResponse%252Band%252BIts%252BBrain%25252FPlasma%252BConcentration%252BRatio%252Bafter%252B28%252BDays%252BMultiple%252BDoses%252Bin%252BRats%252BUsing%252BLC-MS%25252FMS%26aulast%3DAyoub%26aufirst%3DBassam%2BM.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruixian  Han</span>, <span class="hlFld-ContribAuthor ">Alan J.  Hernández Álvarez</span>, <span class="hlFld-ContribAuthor ">Joanne  Maycock</span>, <span class="hlFld-ContribAuthor ">Brent S.  Murray</span>, <span class="hlFld-ContribAuthor ">Christine  Boesch</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of alcalase- and pepsin-treated oilseed protein hydrolysates – Experimental validation of predicted antioxidant, antihypertensive and antidiabetic properties. </span><span class="cited-content_cbyCitation_journal-name">Current Research in Food Science</span><span> <strong>2021,</strong> <em>4 </em>, 141-149. <a href="https://doi.org/10.1016/j.crfs.2021.03.001" title="DOI URL">https://doi.org/10.1016/j.crfs.2021.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.crfs.2021.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.crfs.2021.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Research%2520in%2520Food%2520Science%26atitle%3DComparison%252Bof%252Balcalase-%252Band%252Bpepsin-treated%252Boilseed%252Bprotein%252Bhydrolysates%252B%2525E2%252580%252593%252BExperimental%252Bvalidation%252Bof%252Bpredicted%252Bantioxidant%25252C%252Bantihypertensive%252Band%252Bantidiabetic%252Bproperties%26aulast%3DHan%26aufirst%3DRuixian%26date%3D2021%26volume%3D4%26spage%3D141%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veymar G.  Tacias-Pascacio</span>, <span class="hlFld-ContribAuthor ">Roberto  Morellon-Sterling</span>, <span class="hlFld-ContribAuthor ">El-Hocine  Siar</span>, <span class="hlFld-ContribAuthor ">Olga  Tavano</span>, <span class="hlFld-ContribAuthor ">Ángel  Berenguer-Murcia</span>, <span class="hlFld-ContribAuthor ">Roberto  Fernandez-Lafuente</span>. </span><span class="cited-content_cbyCitation_article-title">Use of Alcalase in the production of bioactive peptides: A review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>165 </em>, 2143-2196. <a href="https://doi.org/10.1016/j.ijbiomac.2020.10.060" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DUse%252Bof%252BAlcalase%252Bin%252Bthe%252Bproduction%252Bof%252Bbioactive%252Bpeptides%25253A%252BA%252Breview%26aulast%3DTacias-Pascacio%26aufirst%3DVeymar%2BG.%26date%3D2020%26volume%3D165%26spage%3D2143%26epage%3D2196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Song  Gao</span>, <span class="hlFld-ContribAuthor ">Dapeng  Li</span>, <span class="hlFld-ContribAuthor ">Hui  Hong</span>, <span class="hlFld-ContribAuthor ">Rui  Shu</span>, <span class="hlFld-ContribAuthor ">Hao  Cheng</span>, <span class="hlFld-ContribAuthor ">Yongkang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of quality and nutritional attributes of pond‐cultured and container‐cultured snakehead (
              Channa argus argus
              ) fillets after being boiled, fried, and baked. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Science</span><span> <strong>2020,</strong> <em>85 </em>
                                    (12)
                                     , 4249-4259. <a href="https://doi.org/10.1111/1750-3841.15506" title="DOI URL">https://doi.org/10.1111/1750-3841.15506</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1750-3841.15506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1750-3841.15506%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Science%26atitle%3DComparison%252Bof%252Bquality%252Band%252Bnutritional%252Battributes%252Bof%252Bpond%2525E2%252580%252590cultured%252Band%252Bcontainer%2525E2%252580%252590cultured%252Bsnakehead%252B%252528%252BChanna%252Bargus%252Bargus%252B%252529%252Bfillets%252Bafter%252Bbeing%252Bboiled%25252C%252Bfried%25252C%252Band%252Bbaked%26aulast%3DGao%26aufirst%3DSong%26date%3D2020%26date%3D2020%26volume%3D85%26issue%3D12%26spage%3D4249%26epage%3D4259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Ohnishi</span>, <span class="hlFld-ContribAuthor ">Takeshi  Mizushima</span>, <span class="hlFld-ContribAuthor ">Junichi  Kodaira</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Ono</span>, <span class="hlFld-ContribAuthor ">Yutaka  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Kanako C.  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Yugo  Kuriki</span>, <span class="hlFld-ContribAuthor ">Mako  Kamiya</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Ehira</span>, <span class="hlFld-ContribAuthor ">Keisuke  Shinada</span>, <span class="hlFld-ContribAuthor ">Hiroaki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Yuichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Yasuteru  Urano</span>, <span class="hlFld-ContribAuthor ">Naoya  Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Detection of early adenocarcinoma of the esophagogastric junction by spraying an enzyme-activatable fluorescent probe targeting Dipeptidyl peptidase-IV. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-020-6537-9" title="DOI URL">https://doi.org/10.1186/s12885-020-6537-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-020-6537-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-020-6537-9%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DDetection%252Bof%252Bearly%252Badenocarcinoma%252Bof%252Bthe%252Besophagogastric%252Bjunction%252Bby%252Bspraying%252Ban%252Benzyme-activatable%252Bfluorescent%252Bprobe%252Btargeting%252BDipeptidyl%252Bpeptidase-IV%26aulast%3DYamamoto%26aufirst%3DKeiko%26date%3D2020%26date%3D2020%26volume%3D20%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Camille  Dugardin</span>, <span class="hlFld-ContribAuthor ">Benoit  Cudennec</span>, <span class="hlFld-ContribAuthor ">Mélissa  Tourret</span>, <span class="hlFld-ContribAuthor ">Juliette  Caron</span>, <span class="hlFld-ContribAuthor ">Laetitia  Guérin-Deremaux</span>, <span class="hlFld-ContribAuthor ">Josette  Behra-Miellet</span>, <span class="hlFld-ContribAuthor ">Catherine  Lefranc-Millot</span>, <span class="hlFld-ContribAuthor ">Rozenn  Ravallec</span>. </span><span class="cited-content_cbyCitation_article-title">Explorative Screening of Bioactivities Generated by Plant-Based Proteins after In Vitro Static Gastrointestinal Digestion. </span><span class="cited-content_cbyCitation_journal-name">Nutrients</span><span> <strong>2020,</strong> <em>12 </em>
                                    (12)
                                     , 3746. <a href="https://doi.org/10.3390/nu12123746" title="DOI URL">https://doi.org/10.3390/nu12123746</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/nu12123746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fnu12123746%26sid%3Dliteratum%253Aachs%26jtitle%3DNutrients%26atitle%3DExplorative%252BScreening%252Bof%252BBioactivities%252BGenerated%252Bby%252BPlant-Based%252BProteins%252Bafter%252BIn%252BVitro%252BStatic%252BGastrointestinal%252BDigestion%26aulast%3DDugardin%26aufirst%3DCamille%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D12%26spage%3D3746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amit  Singh</span>, <span class="hlFld-ContribAuthor ">Abha  Mishra</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation and free energy calculation studies of Coagulin L as dipeptidyl peptidase-4 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>27 </em>, 1-11. <a href="https://doi.org/10.1080/07391102.2020.1822917" title="DOI URL">https://doi.org/10.1080/07391102.2020.1822917</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1822917&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1822917%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Band%252Bfree%252Benergy%252Bcalculation%252Bstudies%252Bof%252BCoagulin%252BL%252Bas%252Bdipeptidyl%252Bpeptidase-4%252Binhibitor%26aulast%3DSingh%26aufirst%3DAmit%26date%3D2020%26date%3D2020%26volume%3D27%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Rivero-Pino</span>, <span class="hlFld-ContribAuthor ">F. Javier  Espejo-Carpio</span>, <span class="hlFld-ContribAuthor ">Emilia M.  Guadix</span>. </span><span class="cited-content_cbyCitation_article-title">Production and identification of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from discarded Sardine pilchardus protein. </span><span class="cited-content_cbyCitation_journal-name">Food Chemistry</span><span> <strong>2020,</strong> <em>328 </em>, 127096. <a href="https://doi.org/10.1016/j.foodchem.2020.127096" title="DOI URL">https://doi.org/10.1016/j.foodchem.2020.127096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodchem.2020.127096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodchem.2020.127096%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Chemistry%26atitle%3DProduction%252Band%252Bidentification%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bpeptides%252Bfrom%252Bdiscarded%252BSardine%252Bpilchardus%252Bprotein%26aulast%3DRivero-Pino%26aufirst%3DFernando%26date%3D2020%26volume%3D328%26spage%3D127096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed Auwal  Ibrahim</span>, <span class="hlFld-ContribAuthor ">June C.  Serem</span>, <span class="hlFld-ContribAuthor ">Megan J.  Bester</span>, <span class="hlFld-ContribAuthor ">Anabella R.M.  Gaspar</span>. </span><span class="cited-content_cbyCitation_article-title">The dipeptidyl peptidase IV inhibitory activity and multifunctional antidiabetic properties of SQSPA: Structure – Activity relationship evaluated with alanine scanning. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>160 </em>, 1220-1229. <a href="https://doi.org/10.1016/j.ijbiomac.2020.05.250" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.05.250</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.05.250&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.05.250%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DThe%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitory%252Bactivity%252Band%252Bmultifunctional%252Bantidiabetic%252Bproperties%252Bof%252BSQSPA%25253A%252BStructure%252B%2525E2%252580%252593%252BActivity%252Brelationship%252Bevaluated%252Bwith%252Balanine%252Bscanning%26aulast%3DIbrahim%26aufirst%3DMohammed%2BAuwal%26date%3D2020%26volume%3D160%26spage%3D1220%26epage%3D1229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Salvatore</span>, <span class="hlFld-ContribAuthor ">Nunzia  Gallo</span>, <span class="hlFld-ContribAuthor ">Maria Lucia  Natali</span>, <span class="hlFld-ContribAuthor ">Lorena  Campa</span>, <span class="hlFld-ContribAuthor ">Paola  Lunetti</span>, <span class="hlFld-ContribAuthor ">Marta  Madaghiele</span>, <span class="hlFld-ContribAuthor ">Federica Stella  Blasi</span>, <span class="hlFld-ContribAuthor ">Angelo  Corallo</span>, <span class="hlFld-ContribAuthor ">Loredana  Capobianco</span>, <span class="hlFld-ContribAuthor ">Alessandro  Sannino</span>. </span><span class="cited-content_cbyCitation_article-title">Marine collagen and its derivatives: Versatile and sustainable bio-resources for healthcare. </span><span class="cited-content_cbyCitation_journal-name">Materials Science and Engineering: C</span><span> <strong>2020,</strong> <em>113 </em>, 110963. <a href="https://doi.org/10.1016/j.msec.2020.110963" title="DOI URL">https://doi.org/10.1016/j.msec.2020.110963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.msec.2020.110963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.msec.2020.110963%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Science%2520and%2520Engineering%253A%2520C%26atitle%3DMarine%252Bcollagen%252Band%252Bits%252Bderivatives%25253A%252BVersatile%252Band%252Bsustainable%252Bbio-resources%252Bfor%252Bhealthcare%26aulast%3DSalvatore%26aufirst%3DLuca%26date%3D2020%26volume%3D113%26spage%3D110963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fernando  Rivero-Pino</span>, <span class="hlFld-ContribAuthor ">F. Javier  Espejo-Carpio</span>, <span class="hlFld-ContribAuthor ">Emilia M.  Guadix</span>. </span><span class="cited-content_cbyCitation_article-title">Antidiabetic Food-Derived Peptides for Functional Feeding: Production, Functionality and In Vivo Evidences. </span><span class="cited-content_cbyCitation_journal-name">Foods</span><span> <strong>2020,</strong> <em>9 </em>
                                    (8)
                                     , 983. <a href="https://doi.org/10.3390/foods9080983" title="DOI URL">https://doi.org/10.3390/foods9080983</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/foods9080983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Ffoods9080983%26sid%3Dliteratum%253Aachs%26jtitle%3DFoods%26atitle%3DAntidiabetic%252BFood-Derived%252BPeptides%252Bfor%252BFunctional%252BFeeding%25253A%252BProduction%25252C%252BFunctionality%252Band%252BIn%252BVivo%252BEvidences%26aulast%3DRivero-Pino%26aufirst%3DFernando%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D8%26spage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Gao</span>, <span class="hlFld-ContribAuthor ">Han  Gong</span>, <span class="hlFld-ContribAuthor ">Xueying  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Dipeptidyl Peptidase-IV Inhibitory Activity and Related Molecular Mechanism of Bovine α-Lactalbumin-Derived Peptides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (13)
                                     , 3009. <a href="https://doi.org/10.3390/molecules25133009" title="DOI URL">https://doi.org/10.3390/molecules25133009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25133009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25133009%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDipeptidyl%252BPeptidase-IV%252BInhibitory%252BActivity%252Band%252BRelated%252BMolecular%252BMechanism%252Bof%252BBovine%252B%2525CE%2525B1-Lactalbumin-Derived%252BPeptides%26aulast%3DGao%26aufirst%3DJing%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D13%26spage%3D3009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E.  Agarkova</span>, <span class="hlFld-ContribAuthor ">Ksenia A  Ryazantseva</span>, <span class="hlFld-ContribAuthor ">A.  Kruchinin</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Diabetic Activity of Whey Proteins. </span><span class="cited-content_cbyCitation_journal-name">Food Processing: Techniques and Technology</span><span> <strong>2020,</strong> <em>50 </em>
                                    (2)
                                     , 306-318. <a href="https://doi.org/10.21603/2074-9414-2020-2-306-318" title="DOI URL">https://doi.org/10.21603/2074-9414-2020-2-306-318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.21603/2074-9414-2020-2-306-318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.21603%2F2074-9414-2020-2-306-318%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Processing%253A%2520Techniques%2520and%2520Technology%26atitle%3DAnti-Diabetic%252BActivity%252Bof%252BWhey%252BProteins%26aulast%3DAgarkova%26aufirst%3DE.%26date%3D2020%26volume%3D50%26issue%3D2%26spage%3D306%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Gong</span>, <span class="hlFld-ContribAuthor ">J.  Gao</span>, <span class="hlFld-ContribAuthor ">Y.  Wang</span>, <span class="hlFld-ContribAuthor ">Q.W.  Luo</span>, <span class="hlFld-ContribAuthor ">K.R.  Guo</span>, <span class="hlFld-ContribAuthor ">F.Z.  Ren</span>, <span class="hlFld-ContribAuthor ">X.Y.  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel peptides from goat milk casein that ameliorate high-glucose-induced insulin resistance in HepG2 cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Dairy Science</span><span> <strong>2020,</strong> <em>103 </em>
                                    (6)
                                     , 4907-4918. <a href="https://doi.org/10.3168/jds.2019-17513" title="DOI URL">https://doi.org/10.3168/jds.2019-17513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3168/jds.2019-17513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3168%2Fjds.2019-17513%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Dairy%2520Science%26atitle%3DIdentification%252Bof%252Bnovel%252Bpeptides%252Bfrom%252Bgoat%252Bmilk%252Bcasein%252Bthat%252Bameliorate%252Bhigh-glucose-induced%252Binsulin%252Bresistance%252Bin%252BHepG2%252Bcells%26aulast%3DGong%26aufirst%3DH.%26date%3D2020%26volume%3D103%26issue%3D6%26spage%3D4907%26epage%3D4918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huimin  Guo</span>, <span class="hlFld-ContribAuthor ">Aurore  Richel</span>, <span class="hlFld-ContribAuthor ">Yuqiong  Hao</span>, <span class="hlFld-ContribAuthor ">Xin  Fan</span>, <span class="hlFld-ContribAuthor ">Nadia  Everaert</span>, <span class="hlFld-ContribAuthor ">Xiushi  Yang</span>, <span class="hlFld-ContribAuthor ">Guixing  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Novel dipeptidyl peptidase‐IV and angiotensin‐I‐converting enzyme inhibitory peptides released from quinoa protein by in silico proteolysis. </span><span class="cited-content_cbyCitation_journal-name">Food Science & Nutrition</span><span> <strong>2020,</strong> <em>8 </em>
                                    (3)
                                     , 1415-1422. <a href="https://doi.org/10.1002/fsn3.1423" title="DOI URL">https://doi.org/10.1002/fsn3.1423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/fsn3.1423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Ffsn3.1423%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Science%2520%2526%2520Nutrition%26atitle%3DNovel%252Bdipeptidyl%252Bpeptidase%2525E2%252580%252590IV%252Band%252Bangiotensin%2525E2%252580%252590I%2525E2%252580%252590converting%252Benzyme%252Binhibitory%252Bpeptides%252Breleased%252Bfrom%252Bquinoa%252Bprotein%252Bby%252Bin%252Bsilico%252Bproteolysis%26aulast%3DGuo%26aufirst%3DHuimin%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D3%26spage%3D1415%26epage%3D1422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulina  Kęska</span>, <span class="hlFld-ContribAuthor ">Joanna  Stadnik</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships study on biological activity of peptides as dipeptidyl peptidase IV inhibitors by chemometric modeling. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (2)
                                     , 291-301. <a href="https://doi.org/10.1111/cbdd.13643" title="DOI URL">https://doi.org/10.1111/cbdd.13643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13643%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bstudy%252Bon%252Bbiological%252Bactivity%252Bof%252Bpeptides%252Bas%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitors%252Bby%252Bchemometric%252Bmodeling%26aulast%3DK%25C4%2599ska%26aufirst%3DPaulina%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D2%26spage%3D291%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Tomovic</span>, <span class="hlFld-ContribAuthor ">Budimir S.  Ilic</span>, <span class="hlFld-ContribAuthor ">Zaklina  Smelcerovic</span>, <span class="hlFld-ContribAuthor ">Marija  Miljkovic</span>, <span class="hlFld-ContribAuthor ">Denitsa  Yancheva</span>, <span class="hlFld-ContribAuthor ">Milan  Kojic</span>, <span class="hlFld-ContribAuthor ">Anelia Ts  Mavrova</span>, <span class="hlFld-ContribAuthor ">Gordana  Kocic</span>, <span class="hlFld-ContribAuthor ">Andrija  Smelcerovic</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemico-Biological Interactions</span><span> <strong>2020,</strong> <em>315 </em>, 108873. <a href="https://doi.org/10.1016/j.cbi.2019.108873" title="DOI URL">https://doi.org/10.1016/j.cbi.2019.108873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbi.2019.108873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbi.2019.108873%26sid%3Dliteratum%253Aachs%26jtitle%3DChemico-Biological%2520Interactions%26atitle%3DBenzimidazole-based%252Bdual%252Bdipeptidyl%252Bpeptidase-4%252Band%252Bxanthine%252Boxidase%252Binhibitors%26aulast%3DTomovic%26aufirst%3DKatarina%26date%3D2020%26volume%3D315%26spage%3D108873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Yang</span>, <span class="hlFld-ContribAuthor ">Chong-Yin  Shi</span>, <span class="hlFld-ContribAuthor ">Jing  Xie</span>, <span class="hlFld-ContribAuthor ">Jia-He  Dai</span>, <span class="hlFld-ContribAuthor ">Shui-Lian  He</span>, <span class="hlFld-ContribAuthor ">Yang  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potential Dipeptidyl Peptidase (DPP)-IV Inhibitors among Moringa oleifera Phytochemicals by Virtual Screening, Molecular Docking Analysis, ADME/T-Based Prediction, and In Vitro Analyses. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (1)
                                     , 189. <a href="https://doi.org/10.3390/molecules25010189" title="DOI URL">https://doi.org/10.3390/molecules25010189</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25010189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25010189%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DIdentification%252Bof%252BPotential%252BDipeptidyl%252BPeptidase%252B%252528DPP%252529-IV%252BInhibitors%252Bamong%252BMoringa%252Boleifera%252BPhytochemicals%252Bby%252BVirtual%252BScreening%25252C%252BMolecular%252BDocking%252BAnalysis%25252C%252BADME%25252FT-Based%252BPrediction%25252C%252Band%252BIn%252BVitro%252BAnalyses%26aulast%3DYang%26aufirst%3DYang%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D1%26spage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jagatkumar  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Anuradha  Gajjar</span>, <span class="hlFld-ContribAuthor ">Bhanubhai N.  Suhagia</span>. </span><span class="cited-content_cbyCitation_article-title">Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Drug Discovery Technologies</span><span> <strong>2019,</strong> <em>16 </em>
                                    (4)
                                     , 426-436. <a href="https://doi.org/10.2174/1570163815666180926111558" title="DOI URL">https://doi.org/10.2174/1570163815666180926111558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570163815666180926111558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570163815666180926111558%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Drug%2520Discovery%2520Technologies%26atitle%3DCombined%252BLigand-Based%252Band%252BStructure-Based%252BVirtual%252BScreening%252BApproach%252Bfor%252BIdentification%252Bof%252BNew%252BDipeptidyl%252BPeptidase%252B4%252BInhibitors%26aulast%3DUpadhyay%26aufirst%3DJagatkumar%26date%3D2019%26volume%3D16%26issue%3D4%26spage%3D426%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moncef  Nasri</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive Peptides from Fish Collagen Byproducts. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 309-333. <a href="https://doi.org/10.1002/9781119383956.ch13" title="DOI URL">https://doi.org/10.1002/9781119383956.ch13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119383956.ch13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119383956.ch13%26sid%3Dliteratum%253Aachs%26atitle%3DBioactive%252BPeptides%252Bfrom%252BFish%252BCollagen%252BByproducts%26aulast%3DNasri%26aufirst%3DMoncef%26date%3D2019%26date%3D2019%26spage%3D309%26epage%3D333%26pub%3DWiley%26atitle%3DByproducts%252Bfrom%252BAgriculture%252Band%252BFisheries%26aulast%3DSimpson%26aufirst%3DBenjamin%2BK.%26date%3D2019%26date%3D2019%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pragya  Tiwari</span>, <span class="hlFld-ContribAuthor ">Ashish  Katyal</span>, <span class="hlFld-ContribAuthor ">Mohd F.  Khan</span>, <span class="hlFld-ContribAuthor ">Ghulam Md.  Ashraf</span>, <span class="hlFld-ContribAuthor ">Khurshid  Ahmad</span>. </span><span class="cited-content_cbyCitation_article-title">Lead Optimization Resources in Drug Discovery for Diabetes. </span><span class="cited-content_cbyCitation_journal-name">Endocrine, Metabolic & Immune Disorders - Drug Targets</span><span> <strong>2019,</strong> <em>19 </em>
                                    (6)
                                     , 754-774. <a href="https://doi.org/10.2174/1871530319666190304121826" title="DOI URL">https://doi.org/10.2174/1871530319666190304121826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871530319666190304121826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871530319666190304121826%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrine%252C%2520Metabolic%2520%2526%2520Immune%2520Disorders%2520-%2520Drug%2520Targets%26atitle%3DLead%252BOptimization%252BResources%252Bin%252BDrug%252BDiscovery%252Bfor%252BDiabetes%26aulast%3DTiwari%26aufirst%3DPragya%26date%3D2019%26volume%3D19%26issue%3D6%26spage%3D754%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María J  Ojeda-Montes</span>, <span class="hlFld-ContribAuthor ">Àngela  Casanova-Martí</span>, <span class="hlFld-ContribAuthor ">Aleix  Gimeno</span>, <span class="hlFld-ContribAuthor ">Sarah  Tomás-Hernández</span>, <span class="hlFld-ContribAuthor ">Adrià  Cereto-Massagué</span>, <span class="hlFld-ContribAuthor ">Gerhard  Wolber</span>, <span class="hlFld-ContribAuthor ">Raúl  Beltrán-Debón</span>, <span class="hlFld-ContribAuthor ">Cristina  Valls</span>, <span class="hlFld-ContribAuthor ">Miquel  Mulero</span>, <span class="hlFld-ContribAuthor ">Montserrat  Pinent</span>, <span class="hlFld-ContribAuthor ">Gerard  Pujadas</span>, <span class="hlFld-ContribAuthor ">Santiago  Garcia-Vallvé</span>. </span><span class="cited-content_cbyCitation_article-title">Mining large databases to find new leads with low similarity to known actives: application to find new DPP-IV inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 1387-1401. <a href="https://doi.org/10.4155/fmc-2018-0597" title="DOI URL">https://doi.org/10.4155/fmc-2018-0597</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2018-0597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2018-0597%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMining%252Blarge%252Bdatabases%252Bto%252Bfind%252Bnew%252Bleads%252Bwith%252Blow%252Bsimilarity%252Bto%252Bknown%252Bactives%25253A%252Bapplication%252Bto%252Bfind%252Bnew%252BDPP-IV%252Binhibitors%26aulast%3DOjeda-Montes%26aufirst%3DMar%25C3%25ADa%2BJ%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D1387%26epage%3D1401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  O’Halloran</span>, <span class="hlFld-ContribAuthor ">Michael  O’Sullivan</span>, <span class="hlFld-ContribAuthor ">Eoin  Casey</span>. </span><span class="cited-content_cbyCitation_article-title">Production of Whey-Derived DPP-IV Inhibitory Peptides Using an Enzymatic Membrane Reactor. </span><span class="cited-content_cbyCitation_journal-name">Food and Bioprocess Technology</span><span> <strong>2019,</strong> <em>12 </em>
                                    (5)
                                     , 799-808. <a href="https://doi.org/10.1007/s11947-019-02253-7" title="DOI URL">https://doi.org/10.1007/s11947-019-02253-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11947-019-02253-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11947-019-02253-7%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520and%2520Bioprocess%2520Technology%26atitle%3DProduction%252Bof%252BWhey-Derived%252BDPP-IV%252BInhibitory%252BPeptides%252BUsing%252Ban%252BEnzymatic%252BMembrane%252BReactor%26aulast%3DO%25E2%2580%2599Halloran%26aufirst%3DJohn%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D5%26spage%3D799%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ghulam  Abbas</span>, <span class="hlFld-ContribAuthor ">Ahmed  Al Harrasi</span>, <span class="hlFld-ContribAuthor ">Hidayat  Hussain</span>, <span class="hlFld-ContribAuthor ">Ahmed  Hamaed</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 305-315. <a href="https://doi.org/10.1016/j.bioorg.2019.02.009" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.02.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.02.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bmanagement%252Bof%252Bdiabetes%252Bmellitus-imperative%252Brole%252Bof%252Bnatural%252Bproducts%252Bagainst%252Bdipeptidyl%252Bpeptidase-4%25252C%252B%2525CE%2525B1-glucosidase%252Band%252Bsodium-dependent%252Bglucose%252Bco-transporter%252B2%252B%252528SGLT2%252529%26aulast%3DAbbas%26aufirst%3DGhulam%26date%3D2019%26volume%3D86%26spage%3D305%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Jianming  Cheng</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (3)
                                     , 463. <a href="https://doi.org/10.3390/ijms20030463" title="DOI URL">https://doi.org/10.3390/ijms20030463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20030463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20030463%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252BFood-Derived%252BDipeptidyl%252BPeptidase%252BIV%252BInhibitory%252BPeptides%25253A%252BA%252BReview%26aulast%3DLiu%26aufirst%3DRui%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D3%26spage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Tomovic</span>, <span class="hlFld-ContribAuthor ">Jelena  Lazarevic</span>, <span class="hlFld-ContribAuthor ">Gordana  Kocic</span>, <span class="hlFld-ContribAuthor ">Marina  Deljanin-Ilic</span>, <span class="hlFld-ContribAuthor ">Marko  Anderluh</span>, <span class="hlFld-ContribAuthor ">Andrija  Smelcerovic</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (1)
                                     , 404-422. <a href="https://doi.org/10.1002/med.21513" title="DOI URL">https://doi.org/10.1002/med.21513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21513%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DMechanisms%252Band%252Bpathways%252Bof%252Banti-inflammatory%252Bactivity%252Bof%252BDPP-4%252Binhibitors%252Bin%252Bcardiovascular%252Band%252Brenal%252Bprotection%26aulast%3DTomovic%26aufirst%3DKatarina%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D1%26spage%3D404%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingchao  Liu</span>, <span class="hlFld-ContribAuthor ">Zhangjian  Huang</span>, <span class="hlFld-ContribAuthor ">Wenhuan  Ma</span>, <span class="hlFld-ContribAuthor ">Sixun  Peng</span>, <span class="hlFld-ContribAuthor ">Yunman  Li</span>, <span class="hlFld-ContribAuthor ">Katrina M.  Miranda</span>, <span class="hlFld-ContribAuthor ">Jide  Tian</span>, <span class="hlFld-ContribAuthor ">Yihua  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of rosiglitazone-ferulic acid-nitric oxide donor trihybrids for improving glucose tolerance. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 650-665. <a href="https://doi.org/10.1016/j.ejmech.2018.10.006" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Brosiglitazone-ferulic%252Bacid-nitric%252Boxide%252Bdonor%252Btrihybrids%252Bfor%252Bimproving%252Bglucose%252Btolerance%26aulast%3DLiu%26aufirst%3DJingchao%26date%3D2019%26volume%3D162%26spage%3D650%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yating  Lu</span>, <span class="hlFld-ContribAuthor ">Peng  Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Fang</span>, <span class="hlFld-ContribAuthor ">Jianming  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaochang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Dipeptidyl Peptidase IV Inhibitory Tea Peptide Improves Pancreatic β-Cell Function and Reduces α-Cell Proliferation in Streptozotocin-Induced Diabetic Mice. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (2)
                                     , 322. <a href="https://doi.org/10.3390/ijms20020322" title="DOI URL">https://doi.org/10.3390/ijms20020322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20020322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20020322%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DA%252BNovel%252BDipeptidyl%252BPeptidase%252BIV%252BInhibitory%252BTea%252BPeptide%252BImproves%252BPancreatic%252B%2525CE%2525B2-Cell%252BFunction%252Band%252BReduces%252B%2525CE%2525B1-Cell%252BProliferation%252Bin%252BStreptozotocin-Induced%252BDiabetic%252BMice%26aulast%3DLu%26aufirst%3DYating%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D2%26spage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sourav  De</span>, <span class="hlFld-ContribAuthor ">Subhasis  Banerjee</span>, <span class="hlFld-ContribAuthor ">S.K. Ashok  Kumar</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2018,</strong> <em>19 </em>
                                    (2)
                                     , 88-97. <a href="https://doi.org/10.2174/1389557518666180423112154" title="DOI URL">https://doi.org/10.2174/1389557518666180423112154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557518666180423112154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557518666180423112154%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DCritical%252BRole%252Bof%252BDipeptidyl%252BPeptidase%252BIV%25253A%252BA%252BTherapeutic%252BTarget%252Bfor%252BDiabetes%252Band%252BCancer%26aulast%3DDe%26aufirst%3DSourav%26date%3D2018%26volume%3D19%26issue%3D2%26spage%3D88%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-rong  Zhu</span>, <span class="hlFld-ContribAuthor ">Jie  Zhou</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Li-Hui  Gao</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Jun-Ru  Yang</span>, <span class="hlFld-ContribAuthor ">Chun-Mei  Lu</span>, <span class="hlFld-ContribAuthor ">Qi Hua  Zhao</span>, <span class="hlFld-ContribAuthor ">Ming-jin  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">A manganese-salen complex as dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2018,</strong> <em>120 </em>, 1232-1239. <a href="https://doi.org/10.1016/j.ijbiomac.2018.08.089" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2018.08.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2018.08.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2018.08.089%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DA%252Bmanganese-salen%252Bcomplex%252Bas%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%26aulast%3DZhu%26aufirst%3DMing-rong%26date%3D2018%26volume%3D120%26spage%3D1232%26epage%3D1239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saori  Roppongi</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Chika  Tateoka</span>, <span class="hlFld-ContribAuthor ">Mayu  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Saori  Morisawa</span>, <span class="hlFld-ContribAuthor ">Ippei  Iizuka</span>, <span class="hlFld-ContribAuthor ">Akihiro  Nakamura</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Honma</span>, <span class="hlFld-ContribAuthor ">Yosuke  Shida</span>, <span class="hlFld-ContribAuthor ">Wataru  Ogasawara</span>, <span class="hlFld-ContribAuthor ">Nobutada  Tanaka</span>, <span class="hlFld-ContribAuthor ">Yasumitsu  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Takamasa  Nonaka</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-21056-y" title="DOI URL">https://doi.org/10.1038/s41598-018-21056-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-21056-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-21056-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DCrystal%252Bstructures%252Bof%252Ba%252Bbacterial%252Bdipeptidyl%252Bpeptidase%252BIV%252Breveal%252Ba%252Bnovel%252Bsubstrate%252Brecognition%252Bmechanism%252Bdistinct%252Bfrom%252Bthat%252Bof%252Bmammalian%252Borthologues%26aulast%3DRoppongi%26aufirst%3DSaori%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Lafarga</span>. </span><span class="cited-content_cbyCitation_article-title">Potential Applications of Plant-Derived Proteins in the Food Industry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 117-137. <a href="https://doi.org/10.1002/9781119385332.ch6" title="DOI URL">https://doi.org/10.1002/9781119385332.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119385332.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119385332.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DPotential%252BApplications%252Bof%252BPlant-Derived%252BProteins%252Bin%252Bthe%252BFood%252BIndustry%26aulast%3DLafarga%26aufirst%3DTomas%26date%3D2018%26date%3D2018%26spage%3D117%26epage%3D137%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DNovel%252BProteins%252Bfor%252BFood%25252C%252BPharmaceuticals%252Band%252BAgriculture%26aulast%3DHayes%26aufirst%3DMaria%26date%3D2018%26volume%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. A.  Mazorra-Manzano</span>, <span class="hlFld-ContribAuthor ">J. C.  Ramírez-Suarez</span>, <span class="hlFld-ContribAuthor ">R. Y.  Yada</span>. </span><span class="cited-content_cbyCitation_article-title">Plant proteases for bioactive peptides release: A review. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Food Science and Nutrition</span><span> <strong>2018,</strong> <em>58 </em>
                                    (13)
                                     , 2147-2163. <a href="https://doi.org/10.1080/10408398.2017.1308312" title="DOI URL">https://doi.org/10.1080/10408398.2017.1308312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10408398.2017.1308312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10408398.2017.1308312%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Food%2520Science%2520and%2520Nutrition%26atitle%3DPlant%252Bproteases%252Bfor%252Bbioactive%252Bpeptides%252Brelease%25253A%252BA%252Breview%26aulast%3DMazorra-Manzano%26aufirst%3DM.%2BA.%26date%3D2018%26date%3D2017%26volume%3D58%26issue%3D13%26spage%3D2147%26epage%3D2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María José  Ojeda-Montes</span>, <span class="hlFld-ContribAuthor ">Aleix  Gimeno</span>, <span class="hlFld-ContribAuthor ">Sarah  Tomas-Hernández</span>, <span class="hlFld-ContribAuthor ">Adrià  Cereto-Massagué</span>, <span class="hlFld-ContribAuthor ">Raúl  Beltrán-Debón</span>, <span class="hlFld-ContribAuthor ">Cristina  Valls</span>, <span class="hlFld-ContribAuthor ">Miquel  Mulero</span>, <span class="hlFld-ContribAuthor ">Gerard  Pujadas</span>, <span class="hlFld-ContribAuthor ">Santiago  Garcia-Vallvé</span>. </span><span class="cited-content_cbyCitation_article-title">Activity and selectivity cliffs for DPP-IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 1874-1915. <a href="https://doi.org/10.1002/med.21499" title="DOI URL">https://doi.org/10.1002/med.21499</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21499&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21499%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DActivity%252Band%252Bselectivity%252Bcliffs%252Bfor%252BDPP-IV%252Binhibitors%25253A%252BLessons%252Bwe%252Bcan%252Blearn%252Bfrom%252BSAR%252Bstudies%252Band%252Btheir%252Bapplication%252Bto%252Bvirtual%252Bscreening%26aulast%3DOjeda-Montes%26aufirst%3DMar%25C3%25ADa%2BJos%25C3%25A9%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D1874%26epage%3D1915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajesh B.  Patil</span>, <span class="hlFld-ContribAuthor ">Euzebio G.  Barbosa</span>, <span class="hlFld-ContribAuthor ">Jaiprakash N.  Sangshetti</span>, <span class="hlFld-ContribAuthor ">Vishal P.  Zambre</span>, <span class="hlFld-ContribAuthor ">Sanjay D.  Sawant</span>. </span><span class="cited-content_cbyCitation_article-title">Structural insights of dipeptidyl peptidase-IV inhibitors through molecular dynamics-guided receptor-dependent 4D-QSAR studies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2018,</strong> <em>22 </em>
                                    (3)
                                     , 575-583. <a href="https://doi.org/10.1007/s11030-018-9815-6" title="DOI URL">https://doi.org/10.1007/s11030-018-9815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9815-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DStructural%252Binsights%252Bof%252Bdipeptidyl%252Bpeptidase-IV%252Binhibitors%252Bthrough%252Bmolecular%252Bdynamics-guided%252Breceptor-dependent%252B4D-QSAR%252Bstudies%26aulast%3DPatil%26aufirst%3DRajesh%2BB.%26date%3D2018%26date%3D2018%26volume%3D22%26issue%3D3%26spage%3D575%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeshi  Mizushima</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Ohnishi</span>, <span class="hlFld-ContribAuthor ">Yuichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Yutaka  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Kanako C.  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Yugo  Kuriki</span>, <span class="hlFld-ContribAuthor ">Mako  Kamiya</span>, <span class="hlFld-ContribAuthor ">Akihiro  Homma</span>, <span class="hlFld-ContribAuthor ">Keiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Shouko  Ono</span>, <span class="hlFld-ContribAuthor ">Yasuteru  Urano</span>, <span class="hlFld-ContribAuthor ">Naoya  Sakamoto</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid detection of superficial head and neck squamous cell carcinoma by topically spraying fluorescent probe targeting dipeptidyl peptidase-IV. </span><span class="cited-content_cbyCitation_journal-name">Head & Neck</span><span> <strong>2018,</strong> <em>40 </em>
                                    (7)
                                     , 1466-1475. <a href="https://doi.org/10.1002/hed.25126" title="DOI URL">https://doi.org/10.1002/hed.25126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hed.25126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhed.25126%26sid%3Dliteratum%253Aachs%26jtitle%3DHead%2520%2526%2520Neck%26atitle%3DRapid%252Bdetection%252Bof%252Bsuperficial%252Bhead%252Band%252Bneck%252Bsquamous%252Bcell%252Bcarcinoma%252Bby%252Btopically%252Bspraying%252Bfluorescent%252Bprobe%252Btargeting%252Bdipeptidyl%252Bpeptidase-IV%26aulast%3DMizushima%26aufirst%3DTakeshi%26date%3D2018%26date%3D2018%26volume%3D40%26issue%3D7%26spage%3D1466%26epage%3D1475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Luca  Dellafiora</span>, <span class="hlFld-ContribAuthor ">Sara  Paolella</span>, <span class="hlFld-ContribAuthor ">Gianni  Galaverna</span>, <span class="hlFld-ContribAuthor ">Pietro  Cozzini</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">In Silico Approaches Applied to the Study of Peptide Analogs of Ile-Pro-Ile in Relation to Their Dipeptidyl Peptidase IV Inhibitory Properties. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Endocrinology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fendo.2018.00329" title="DOI URL">https://doi.org/10.3389/fendo.2018.00329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fendo.2018.00329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffendo.2018.00329%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Endocrinology%26atitle%3DIn%252BSilico%252BApproaches%252BApplied%252Bto%252Bthe%252BStudy%252Bof%252BPeptide%252BAnalogs%252Bof%252BIle-Pro-Ile%252Bin%252BRelation%252Bto%252BTheir%252BDipeptidyl%252BPeptidase%252BIV%252BInhibitory%252BProperties%26aulast%3DNongonierma%26aufirst%3DAlice%2BB.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Poonam  Giri</span>, <span class="hlFld-ContribAuthor ">Shuchi  Joshi</span>, <span class="hlFld-ContribAuthor ">Nuggehally R  Srinivas</span>. </span><span class="cited-content_cbyCitation_article-title">Regression modeling strategy for prediction of AUC of evogliptin, a novel dipeptidyl peptidase IV inhibitor in humans, using single dose PK data. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmacokinetics</span><span> <strong>2018,</strong> <em>3 </em>
                                    (1)
                                     , 23-38. <a href="https://doi.org/10.4155/ipk-2017-0015" title="DOI URL">https://doi.org/10.4155/ipk-2017-0015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ipk-2017-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fipk-2017-0015%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmacokinetics%26atitle%3DRegression%252Bmodeling%252Bstrategy%252Bfor%252Bprediction%252Bof%252BAUC%252Bof%252Bevogliptin%25252C%252Ba%252Bnovel%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitor%252Bin%252Bhumans%25252C%252Busing%252Bsingle%252Bdose%252BPK%252Bdata%26aulast%3DGiri%26aufirst%3DPoonam%26date%3D2018%26volume%3D3%26issue%3D1%26spage%3D23%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir V.  Kouznetsov</span>, <span class="hlFld-ContribAuthor ">Carlos E. Puerto  Galvis</span>. </span><span class="cited-content_cbyCitation_article-title">Strecker reaction and α-amino nitriles: Recent advances in their chemistry, synthesis, and biological properties. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (8)
                                     , 773-810. <a href="https://doi.org/10.1016/j.tet.2018.01.005" title="DOI URL">https://doi.org/10.1016/j.tet.2018.01.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.01.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DStrecker%252Breaction%252Band%252B%2525CE%2525B1-amino%252Bnitriles%25253A%252BRecent%252Badvances%252Bin%252Btheir%252Bchemistry%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bproperties%26aulast%3DKouznetsov%26aufirst%3DVladimir%2BV.%26date%3D2018%26volume%3D74%26issue%3D8%26spage%3D773%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alison L.E.  Pereira</span>, <span class="hlFld-ContribAuthor ">Gabriela B.  dos Santos</span>, <span class="hlFld-ContribAuthor ">Márcia S.F.  Franco</span>, <span class="hlFld-ContribAuthor ">Leonardo B.  Federico</span>, <span class="hlFld-ContribAuthor ">Carlos H.T.P.  da Silva</span>, <span class="hlFld-ContribAuthor ">Cleydson B.R.  Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling and statistical analysis in the design of derivatives of human dipeptidyl peptidase IV. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (2)
                                     , 318-334. <a href="https://doi.org/10.1080/07391102.2016.1277163" title="DOI URL">https://doi.org/10.1080/07391102.2016.1277163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1277163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1277163%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bmodeling%252Band%252Bstatistical%252Banalysis%252Bin%252Bthe%252Bdesign%252Bof%252Bderivatives%252Bof%252Bhuman%252Bdipeptidyl%252Bpeptidase%252BIV%26aulast%3DPereira%26aufirst%3DAlison%2BL.E.%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D2%26spage%3D318%26epage%3D334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina M.  Alcántara</span>, <span class="hlFld-ContribAuthor ">Andrés R.  Alcántara</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalyzed synthesis of antidiabetic drugs: A review. </span><span class="cited-content_cbyCitation_journal-name">Biocatalysis and Biotransformation</span><span> <strong>2018,</strong> <em>36 </em>
                                    (1)
                                     , 12-46. <a href="https://doi.org/10.1080/10242422.2017.1323887" title="DOI URL">https://doi.org/10.1080/10242422.2017.1323887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10242422.2017.1323887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10242422.2017.1323887%26sid%3Dliteratum%253Aachs%26jtitle%3DBiocatalysis%2520and%2520Biotransformation%26atitle%3DBiocatalyzed%252Bsynthesis%252Bof%252Bantidiabetic%252Bdrugs%25253A%252BA%252Breview%26aulast%3DAlc%25C3%25A1ntara%26aufirst%3DCristina%2BM.%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D1%26spage%3D12%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hamida  Ghorab</span>, <span class="hlFld-ContribAuthor ">Carmen  Lammi</span>, <span class="hlFld-ContribAuthor ">Anna  Arnoldi</span>, <span class="hlFld-ContribAuthor ">Zahia  Kabouche</span>, <span class="hlFld-ContribAuthor ">Gilda  Aiello</span>. </span><span class="cited-content_cbyCitation_article-title">Proteomic analysis of sweet algerian apricot kernels (Prunus armeniaca L.) by combinatorial peptide ligand libraries and LC–MS/MS. </span><span class="cited-content_cbyCitation_journal-name">Food Chemistry</span><span> <strong>2018,</strong> <em>239 </em>, 935-945. <a href="https://doi.org/10.1016/j.foodchem.2017.07.054" title="DOI URL">https://doi.org/10.1016/j.foodchem.2017.07.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodchem.2017.07.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodchem.2017.07.054%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Chemistry%26atitle%3DProteomic%252Banalysis%252Bof%252Bsweet%252Balgerian%252Bapricot%252Bkernels%252B%252528Prunus%252Barmeniaca%252BL.%252529%252Bby%252Bcombinatorial%252Bpeptide%252Bligand%252Blibraries%252Band%252BLC%2525E2%252580%252593MS%25252FMS%26aulast%3DGhorab%26aufirst%3DHamida%26date%3D2018%26volume%3D239%26spage%3D935%26epage%3D945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Candice  Lamoureux</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides during the enzymatic hydrolysis of tropical banded cricket (
              Gryllodes sigillatus
              ) proteins. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     , 407-416. <a href="https://doi.org/10.1039/C7FO01568B" title="DOI URL">https://doi.org/10.1039/C7FO01568B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7FO01568B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7FO01568B%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DGeneration%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bpeptides%252Bduring%252Bthe%252Benzymatic%252Bhydrolysis%252Bof%252Btropical%252Bbanded%252Bcricket%252B%252528%252BGryllodes%252Bsigillatus%252B%252529%252Bproteins%26aulast%3DNongonierma%26aufirst%3DAlice%2BB.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Huaigao  Liu</span>, <span class="hlFld-ContribAuthor ">Shangwu  Chen</span>, <span class="hlFld-ContribAuthor ">Yongkang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluating the effects of IADHFL on inhibiting DPP-IV activity and expression in Caco-2 cells and contributing to the amount of insulin released from INS-1 cells
              in vitro. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2018,</strong> <em>9 </em>
                                    (4)
                                     , 2240-2250. <a href="https://doi.org/10.1039/C7FO01950E" title="DOI URL">https://doi.org/10.1039/C7FO01950E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7FO01950E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7FO01950E%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DEvaluating%252Bthe%252Beffects%252Bof%252BIADHFL%252Bon%252Binhibiting%252BDPP-IV%252Bactivity%252Band%252Bexpression%252Bin%252BCaco-2%252Bcells%252Band%252Bcontributing%252Bto%252Bthe%252Bamount%252Bof%252Binsulin%252Breleased%252Bfrom%252BINS-1%252Bcells%252Bin%252Bvitro%26aulast%3DZhang%26aufirst%3DChi%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D4%26spage%3D2240%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José  García-Calvo</span>, <span class="hlFld-ContribAuthor ">Patricia  Calvo-Gredilla</span>, <span class="hlFld-ContribAuthor ">Saúl  Vallejos</span>, <span class="hlFld-ContribAuthor ">José Miguel  García</span>, <span class="hlFld-ContribAuthor ">José Vicente  Cuevas-Vicario</span>, <span class="hlFld-ContribAuthor ">Gabriel  García-Herbosa</span>, <span class="hlFld-ContribAuthor ">Manuel  Avella</span>, <span class="hlFld-ContribAuthor ">Tomás  Torroba</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium nanodendrites uniformly deposited on the surface of polymers as an efficient and recyclable catalyst for direct drug modification
              via Z
              -selective semihydrogenation of alkynes. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2018,</strong> <em>20 </em>
                                    (16)
                                     , 3875-3883. <a href="https://doi.org/10.1039/C8GC01522H" title="DOI URL">https://doi.org/10.1039/C8GC01522H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8GC01522H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8GC01522H%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DPalladium%252Bnanodendrites%252Buniformly%252Bdeposited%252Bon%252Bthe%252Bsurface%252Bof%252Bpolymers%252Bas%252Ban%252Befficient%252Band%252Brecyclable%252Bcatalyst%252Bfor%252Bdirect%252Bdrug%252Bmodification%252Bvia%252BZ%252B-selective%252Bsemihydrogenation%252Bof%252Balkynes%26aulast%3DGarc%25C3%25ADa-Calvo%26aufirst%3DJos%25C3%25A9%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D16%26spage%3D3875%26epage%3D3883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solène  Le Maux</span>, <span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Claire  Lardeux</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of enzyme inactivation conditions during the generation of whey protein hydrolysates on their physicochemical and bioactive properties. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Food Science & Technology</span><span> <strong>2018,</strong> <em>53 </em>
                                    (1)
                                     , 219-227. <a href="https://doi.org/10.1111/ijfs.13576" title="DOI URL">https://doi.org/10.1111/ijfs.13576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ijfs.13576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fijfs.13576%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Food%2520Science%2520%2526%2520Technology%26atitle%3DImpact%252Bof%252Benzyme%252Binactivation%252Bconditions%252Bduring%252Bthe%252Bgeneration%252Bof%252Bwhey%252Bprotein%252Bhydrolysates%252Bon%252Btheir%252Bphysicochemical%252Band%252Bbioactive%252Bproperties%26aulast%3DLe%2BMaux%26aufirst%3DSol%25C3%25A8ne%26date%3D2018%26date%3D2017%26volume%3D53%26issue%3D1%26spage%3D219%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. K.  Bayrasheva</span>, <span class="hlFld-ContribAuthor ">A. Y.  Babenko</span>, <span class="hlFld-ContribAuthor ">A. A.  Bayramov</span>, <span class="hlFld-ContribAuthor ">S. G.  Chefu</span>, <span class="hlFld-ContribAuthor ">I. S.  Shatalov</span>, <span class="hlFld-ContribAuthor ">I. Y.  Pchelin</span>, <span class="hlFld-ContribAuthor ">A. N.  Arefieva</span>, <span class="hlFld-ContribAuthor ">E. N.  Grineva</span>. </span><span class="cited-content_cbyCitation_article-title">PROSPECTS OF NEPHROPROTECTION AGAINST TYPE 2 DIABETES USING THE DPP-4 INHIBITOR VILDAGLIPTIN. </span><span class="cited-content_cbyCitation_journal-name">Medical Council</span><span> <strong>2017,</strong> <em> </em>
                                    (3)
                                     , 8-16. <a href="https://doi.org/10.21518/2079-701X-2017-3-8-16" title="DOI URL">https://doi.org/10.21518/2079-701X-2017-3-8-16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.21518/2079-701X-2017-3-8-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.21518%2F2079-701X-2017-3-8-16%26sid%3Dliteratum%253Aachs%26jtitle%3DMedical%2520Council%26atitle%3DPROSPECTS%252BOF%252BNEPHROPROTECTION%252BAGAINST%252BTYPE%252B2%252BDIABETES%252BUSING%252BTHE%252BDPP-4%252BINHIBITOR%252BVILDAGLIPTIN%26aulast%3DBayrasheva%26aufirst%3DV.%2BK.%26date%3D2017%26date%3D2017%26issue%3D3%26spage%3D8%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sharat  Chandra</span>, <span class="hlFld-ContribAuthor ">Jyotsana  Pandey</span>, <span class="hlFld-ContribAuthor ">Akhilesh K.  Tamrakar</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">SVMDLF: A novel R-based Web application for prediction of dipeptidyl peptidase 4 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (6)
                                     , 1173-1183. <a href="https://doi.org/10.1111/cbdd.13037" title="DOI URL">https://doi.org/10.1111/cbdd.13037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13037%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DSVMDLF%25253A%252BA%252Bnovel%252BR-based%252BWeb%252Bapplication%252Bfor%252Bprediction%252Bof%252Bdipeptidyl%252Bpeptidase%252B4%252Binhibitors%26aulast%3DChandra%26aufirst%3DSharat%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D6%26spage%3D1173%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Lafarga</span>, <span class="hlFld-ContribAuthor ">Carlos  Álvarez</span>, <span class="hlFld-ContribAuthor ">Maria  Hayes</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive peptides derived from bovine and porcine co-products: A review. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Biochemistry</span><span> <strong>2017,</strong> <em>41 </em>
                                    (6)
                                     , e12418. <a href="https://doi.org/10.1111/jfbc.12418" title="DOI URL">https://doi.org/10.1111/jfbc.12418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jfbc.12418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjfbc.12418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Biochemistry%26atitle%3DBioactive%252Bpeptides%252Bderived%252Bfrom%252Bbovine%252Band%252Bporcine%252Bco-products%25253A%252BA%252Breview%26aulast%3DLafarga%26aufirst%3DTomas%26date%3D2017%26date%3D2017%26volume%3D41%26issue%3D6%26spage%3De12418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengbin  Zhou</span>, <span class="hlFld-ContribAuthor ">Yanan  Duan</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Haifeng  Sun</span>, <span class="hlFld-ContribAuthor ">Haowen  Jiang</span>, <span class="hlFld-ContribAuthor ">Zhanni  Gu</span>, <span class="hlFld-ContribAuthor ">Junhua  Tong</span>, <span class="hlFld-ContribAuthor ">Jingya  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 4,7,12,12a-tetrahydro-5 H -thieno[3′,2’:3,4]pyrido[1,2- b ]isoquinolines as novel adenosine 5′-monophosphate-activated protein kinase (AMPK) indirect activators for the treatment of type 2 diabetes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>140 </em>, 448-464. <a href="https://doi.org/10.1016/j.ejmech.2017.09.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.09.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.09.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4%25252C7%25252C12%25252C12a-tetrahydro-5%252BH%252B-thieno%25255B3%2525E2%252580%2525B2%25252C2%2525E2%252580%252599%25253A3%25252C4%25255Dpyrido%25255B1%25252C2-%252Bb%252B%25255Disoquinolines%252Bas%252Bnovel%252Badenosine%252B5%2525E2%252580%2525B2-monophosphate-activated%252Bprotein%252Bkinase%252B%252528AMPK%252529%252Bindirect%252Bactivators%252Bfor%252Bthe%252Btreatment%252Bof%252Btype%252B2%252Bdiabetes%26aulast%3DZhou%26aufirst%3DShengbin%26date%3D2017%26volume%3D140%26spage%3D448%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucienne  Juillerat-Jeanneret</span>, <span class="hlFld-ContribAuthor ">Petra  Tafelmeyer</span>, <span class="hlFld-ContribAuthor ">Dela  Golshayan</span>. </span><span class="cited-content_cbyCitation_article-title">Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2017,</strong> <em>21 </em>
                                    (10)
                                     , 977-991. <a href="https://doi.org/10.1080/14728222.2017.1370455" title="DOI URL">https://doi.org/10.1080/14728222.2017.1370455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2017.1370455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2017.1370455%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DFibroblast%252Bactivation%252Bprotein-%2525CE%2525B1%252Bin%252Bfibrogenic%252Bdisorders%252Band%252Bcancer%25253A%252Bmore%252Bthan%252Ba%252Bprolyl-specific%252Bpeptidase%25253F%26aulast%3DJuillerat-Jeanneret%26aufirst%3DLucienne%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D10%26spage%3D977%26epage%3D991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming-jin  Xie</span>, <span class="hlFld-ContribAuthor ">Ming-rong  Zhu</span>, <span class="hlFld-ContribAuthor ">Chun-Mei  Lu</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Li-Hui  Gao</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Zhou</span>, <span class="hlFld-ContribAuthor ">Fan-fang  Li</span>, <span class="hlFld-ContribAuthor ">Qi Hua  Zhao</span>, <span class="hlFld-ContribAuthor ">Hong-Ke  Liu</span>, <span class="hlFld-ContribAuthor ">Peter J.  Sadler</span>, <span class="hlFld-ContribAuthor ">Carlos  Sanchez-Cano</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and characterization of oxidovanadium complexes as enzyme inhibitors targeting dipeptidyl peptidase IV. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2017,</strong> <em>175 </em>, 29-35. <a href="https://doi.org/10.1016/j.jinorgbio.2017.06.014" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2017.06.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2017.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2017.06.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DSynthesis%252Band%252Bcharacterization%252Bof%252Boxidovanadium%252Bcomplexes%252Bas%252Benzyme%252Binhibitors%252Btargeting%252Bdipeptidyl%252Bpeptidase%252BIV%26aulast%3DXie%26aufirst%3DMing-jin%26date%3D2017%26volume%3D175%26spage%3D29%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Liu</span>, <span class="hlFld-ContribAuthor ">Lei  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Nai-Juan  Sheng</span>, <span class="hlFld-ContribAuthor ">Zhi-Kang  Wang</span>, <span class="hlFld-ContribAuthor ">Ti-Zhi  Wu</span>, <span class="hlFld-ContribAuthor ">Xin-Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (10)
                                     , 1714. <a href="https://doi.org/10.3390/molecules22101714" title="DOI URL">https://doi.org/10.3390/molecules22101714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22101714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22101714%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRapid%252BIdentification%252Bof%252BDipeptidyl%252BPeptidase-IV%252B%252528DPP-IV%252529%252BInhibitory%252BPeptides%252Bfrom%252BRuditapes%252Bphilippinarum%252BHydrolysate%26aulast%3DLiu%26aufirst%3DRui%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D10%26spage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Mehdeeyah  Lalmahomed</span>, <span class="hlFld-ContribAuthor ">Sara  Paolella</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Milk protein isolate (MPI) as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. </span><span class="cited-content_cbyCitation_journal-name">Food Chemistry</span><span> <strong>2017,</strong> <em>231 </em>, 202-211. <a href="https://doi.org/10.1016/j.foodchem.2017.03.123" title="DOI URL">https://doi.org/10.1016/j.foodchem.2017.03.123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodchem.2017.03.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodchem.2017.03.123%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Chemistry%26atitle%3DMilk%252Bprotein%252Bisolate%252B%252528MPI%252529%252Bas%252Ba%252Bsource%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bpeptides%26aulast%3DNongonierma%26aufirst%3DAlice%2BB.%26date%3D2017%26volume%3D231%26spage%3D202%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solène  Le Maux</span>, <span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide composition and dipeptidyl peptidase IV inhibitory properties of β-lactoglobulin hydrolysates having similar extents of hydrolysis while generated using different enzyme-to-substrate ratios. </span><span class="cited-content_cbyCitation_journal-name">Food Research International</span><span> <strong>2017,</strong> <em>99 </em>, 84-90. <a href="https://doi.org/10.1016/j.foodres.2017.05.012" title="DOI URL">https://doi.org/10.1016/j.foodres.2017.05.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodres.2017.05.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodres.2017.05.012%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Research%2520International%26atitle%3DPeptide%252Bcomposition%252Band%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitory%252Bproperties%252Bof%252B%2525CE%2525B2-lactoglobulin%252Bhydrolysates%252Bhaving%252Bsimilar%252Bextents%252Bof%252Bhydrolysis%252Bwhile%252Bgenerated%252Busing%252Bdifferent%252Benzyme-to-substrate%252Bratios%26aulast%3DLe%2BMaux%26aufirst%3DSol%25C3%25A8ne%26date%3D2017%26volume%3D99%26spage%3D84%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuqi  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiying  Wang</span>, <span class="hlFld-ContribAuthor ">Shangwu  Chen</span>, <span class="hlFld-ContribAuthor ">Yongkang  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Production and identification of antioxidant and angiotensin-converting enzyme inhibition and dipeptidyl peptidase IV inhibitory peptides from bighead carp (Hypophthalmichthys nobilis) muscle hydrolysate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2017,</strong> <em>35 </em>, 224-235. <a href="https://doi.org/10.1016/j.jff.2017.05.032" title="DOI URL">https://doi.org/10.1016/j.jff.2017.05.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2017.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2017.05.032%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DProduction%252Band%252Bidentification%252Bof%252Bantioxidant%252Band%252Bangiotensin-converting%252Benzyme%252Binhibition%252Band%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitory%252Bpeptides%252Bfrom%252Bbighead%252Bcarp%252B%252528Hypophthalmichthys%252Bnobilis%252529%252Bmuscle%252Bhydrolysate%26aulast%3DZhang%26aufirst%3DChi%26date%3D2017%26volume%3D35%26spage%3D224%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeynep  Agirbasli</span>, <span class="hlFld-ContribAuthor ">Levent  Cavas</span>. </span><span class="cited-content_cbyCitation_article-title">In silico evaluation of bioactive peptides from the green algae Caulerpa. </span><span class="cited-content_cbyCitation_journal-name">Journal of Applied Phycology</span><span> <strong>2017,</strong> <em>29 </em>
                                    (3)
                                     , 1635-1646. <a href="https://doi.org/10.1007/s10811-016-1045-7" title="DOI URL">https://doi.org/10.1007/s10811-016-1045-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10811-016-1045-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10811-016-1045-7%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Applied%2520Phycology%26atitle%3DIn%252Bsilico%252Bevaluation%252Bof%252Bbioactive%252Bpeptides%252Bfrom%252Bthe%252Bgreen%252Balgae%252BCaulerpa%26aulast%3DAgirbasli%26aufirst%3DZeynep%26date%3D2017%26date%3D2017%26volume%3D29%26issue%3D3%26spage%3D1635%26epage%3D1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Lafarga</span>, <span class="hlFld-ContribAuthor ">Maria  Hayes</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive protein hydrolysates in the functional food ingredient industry: Overcoming current challenges. </span><span class="cited-content_cbyCitation_journal-name">Food Reviews International</span><span> <strong>2017,</strong> <em>33 </em>
                                    (3)
                                     , 217-246. <a href="https://doi.org/10.1080/87559129.2016.1175013" title="DOI URL">https://doi.org/10.1080/87559129.2016.1175013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/87559129.2016.1175013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F87559129.2016.1175013%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Reviews%2520International%26atitle%3DBioactive%252Bprotein%252Bhydrolysates%252Bin%252Bthe%252Bfunctional%252Bfood%252Bingredient%252Bindustry%25253A%252BOvercoming%252Bcurrent%252Bchallenges%26aulast%3DLafarga%26aufirst%3DTomas%26date%3D2017%26date%3D2016%26volume%3D33%26issue%3D3%26spage%3D217%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Cai</span>, <span class="hlFld-ContribAuthor ">Chanjuan  Li</span>, <span class="hlFld-ContribAuthor ">Zhihong  Liu</span>, <span class="hlFld-ContribAuthor ">Jiewen  Du</span>, <span class="hlFld-ContribAuthor ">Jiming  Ye</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Predicting DPP-IV inhibitors with machine learning approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2017,</strong> <em>31 </em>
                                    (4)
                                     , 393-402. <a href="https://doi.org/10.1007/s10822-017-0009-6" title="DOI URL">https://doi.org/10.1007/s10822-017-0009-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-017-0009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-017-0009-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DPredicting%252BDPP-IV%252Binhibitors%252Bwith%252Bmachine%252Blearning%252Bapproaches%26aulast%3DCai%26aufirst%3DJie%26date%3D2017%26date%3D2017%26volume%3D31%26issue%3D4%26spage%3D393%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Caterina  Mazzocchi</span>, <span class="hlFld-ContribAuthor ">Sara  Paolella</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Release of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides from milk protein isolate (MPI) during enzymatic hydrolysis. </span><span class="cited-content_cbyCitation_journal-name">Food Research International</span><span> <strong>2017,</strong> <em>94 </em>, 79-89. <a href="https://doi.org/10.1016/j.foodres.2017.02.004" title="DOI URL">https://doi.org/10.1016/j.foodres.2017.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodres.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodres.2017.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Research%2520International%26atitle%3DRelease%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bpeptides%252Bfrom%252Bmilk%252Bprotein%252Bisolate%252B%252528MPI%252529%252Bduring%252Benzymatic%252Bhydrolysis%26aulast%3DNongonierma%26aufirst%3DAlice%2BB.%26date%3D2017%26volume%3D94%26spage%3D79%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">En-Qin  Xia</span>, <span class="hlFld-ContribAuthor ">Shan-Shan  Zhu</span>, <span class="hlFld-ContribAuthor ">Min-Jing  He</span>, <span class="hlFld-ContribAuthor ">Fei  Luo</span>, <span class="hlFld-ContribAuthor ">Cheng-Zhan  Fu</span>, <span class="hlFld-ContribAuthor ">Tang-Bin  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2017,</strong> <em>15 </em>
                                    (4)
                                     , 88. <a href="https://doi.org/10.3390/md15040088" title="DOI URL">https://doi.org/10.3390/md15040088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md15040088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd15040088%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DMarine%252BPeptides%252Bas%252BPotential%252BAgents%252Bfor%252Bthe%252BManagement%252Bof%252BType%252B2%252BDiabetes%252BMellitus%2525E2%252580%252594A%252BProspect%26aulast%3DXia%26aufirst%3DEn-Qin%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D4%26spage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Solène Le  Maux</span>, <span class="hlFld-ContribAuthor ">Claire  Esteveny</span>, <span class="hlFld-ContribAuthor ">Richard J  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Response surface methodology applied to the generation of casein hydrolysates with antioxidant and dipeptidyl peptidase IV inhibitory properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Science of Food and Agriculture</span><span> <strong>2017,</strong> <em>97 </em>
                                    (4)
                                     , 1093-1101. <a href="https://doi.org/10.1002/jsfa.7834" title="DOI URL">https://doi.org/10.1002/jsfa.7834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jsfa.7834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjsfa.7834%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Science%2520of%2520Food%2520and%2520Agriculture%26atitle%3DResponse%252Bsurface%252Bmethodology%252Bapplied%252Bto%252Bthe%252Bgeneration%252Bof%252Bcasein%252Bhydrolysates%252Bwith%252Bantioxidant%252Band%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitory%252Bproperties%26aulast%3DNongonierma%26aufirst%3DAlice%2BB%26date%3D2017%26date%3D2016%26volume%3D97%26issue%3D4%26spage%3D1093%26epage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">M.  Hennemann</span>, <span class="hlFld-ContribAuthor ">S.  Paolella</span>, <span class="hlFld-ContribAuthor ">R. J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of wheat gluten hydrolysates with dipeptidyl peptidase IV (DPP-IV) inhibitory properties. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 2249-2257. <a href="https://doi.org/10.1039/C7FO00165G" title="DOI URL">https://doi.org/10.1039/C7FO00165G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7FO00165G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7FO00165G%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DGeneration%252Bof%252Bwheat%252Bgluten%252Bhydrolysates%252Bwith%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bproperties%26aulast%3DNongonierma%26aufirst%3DA.%2BB.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D2249%26epage%3D2257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Pihlanto</span>, <span class="hlFld-ContribAuthor ">P.  Mattila</span>, <span class="hlFld-ContribAuthor ">S.  Mäkinen</span>, <span class="hlFld-ContribAuthor ">A.-M.  Pajari</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactivities of alternative protein sources and their potential health benefits. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 3443-3458. <a href="https://doi.org/10.1039/C7FO00302A" title="DOI URL">https://doi.org/10.1039/C7FO00302A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7FO00302A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7FO00302A%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DBioactivities%252Bof%252Balternative%252Bprotein%252Bsources%252Band%252Btheir%252Bpotential%252Bhealth%252Bbenefits%26aulast%3DPihlanto%26aufirst%3DA.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D10%26spage%3D3443%26epage%3D3458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan  Connolly</span>, <span class="hlFld-ContribAuthor ">Martina B.  O'Keeffe</span>, <span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Charles O.  Piggott</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Isolation of peptides from a novel brewers spent grain protein isolate with potential to modulate glycaemic response. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Food Science & Technology</span><span> <strong>2017,</strong> <em>52 </em>
                                    (1)
                                     , 146-153. <a href="https://doi.org/10.1111/ijfs.13260" title="DOI URL">https://doi.org/10.1111/ijfs.13260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/ijfs.13260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fijfs.13260%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Food%2520Science%2520%2526%2520Technology%26atitle%3DIsolation%252Bof%252Bpeptides%252Bfrom%252Ba%252Bnovel%252Bbrewers%252Bspent%252Bgrain%252Bprotein%252Bisolate%252Bwith%252Bpotential%252Bto%252Bmodulate%252Bglycaemic%252Bresponse%26aulast%3DConnolly%26aufirst%3DAlan%26date%3D2017%26date%3D2016%26volume%3D52%26issue%3D1%26spage%3D146%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Yanxia  Qi</span>, <span class="hlFld-ContribAuthor ">Fangjun  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaze  Yan</span>, <span class="hlFld-ContribAuthor ">Hanfa  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide profiling and the bioactivity character of yogurt in the simulated gastrointestinal digestion. </span><span class="cited-content_cbyCitation_journal-name">Journal of Proteomics</span><span> <strong>2016,</strong> <em>141 </em>, 24-46. <a href="https://doi.org/10.1016/j.jprot.2016.04.010" title="DOI URL">https://doi.org/10.1016/j.jprot.2016.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jprot.2016.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jprot.2016.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Proteomics%26atitle%3DPeptide%252Bprofiling%252Band%252Bthe%252Bbioactivity%252Bcharacter%252Bof%252Byogurt%252Bin%252Bthe%252Bsimulated%252Bgastrointestinal%252Bdigestion%26aulast%3DJin%26aufirst%3DYan%26date%3D2016%26volume%3D141%26spage%3D24%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomas  Lafarga</span>, <span class="hlFld-ContribAuthor ">Matthias  Wilm</span>, <span class="hlFld-ContribAuthor ">Kieran  Wynne</span>, <span class="hlFld-ContribAuthor ">Maria  Hayes</span>. </span><span class="cited-content_cbyCitation_article-title">Bioactive hydrolysates from bovine blood globulins: Generation, characterisation, and in silico prediction of toxicity and allergenicity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2016,</strong> <em>24 </em>, 142-155. <a href="https://doi.org/10.1016/j.jff.2016.03.031" title="DOI URL">https://doi.org/10.1016/j.jff.2016.03.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2016.03.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2016.03.031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DBioactive%252Bhydrolysates%252Bfrom%252Bbovine%252Bblood%252Bglobulins%25253A%252BGeneration%25252C%252Bcharacterisation%25252C%252Band%252Bin%252Bsilico%252Bprediction%252Bof%252Btoxicity%252Band%252Ballergenicity%26aulast%3DLafarga%26aufirst%3DTomas%26date%3D2016%26volume%3D24%26spage%3D142%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solène  Le Maux</span>, <span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Chloé  Barre</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymatic generation of whey protein hydrolysates under pH-controlled and non pH-controlled conditions: Impact on physicochemical and bioactive properties. </span><span class="cited-content_cbyCitation_journal-name">Food Chemistry</span><span> <strong>2016,</strong> <em>199 </em>, 246-251. <a href="https://doi.org/10.1016/j.foodchem.2015.12.021" title="DOI URL">https://doi.org/10.1016/j.foodchem.2015.12.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodchem.2015.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodchem.2015.12.021%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Chemistry%26atitle%3DEnzymatic%252Bgeneration%252Bof%252Bwhey%252Bprotein%252Bhydrolysates%252Bunder%252BpH-controlled%252Band%252Bnon%252BpH-controlled%252Bconditions%25253A%252BImpact%252Bon%252Bphysicochemical%252Band%252Bbioactive%252Bproperties%26aulast%3DLe%2BMaux%26aufirst%3DSol%25C3%25A8ne%26date%3D2016%26volume%3D199%26spage%3D246%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Richard J  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Prospects for the management of type 2 diabetes using food protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Food Science</span><span> <strong>2016,</strong> <em>8 </em>, 19-24. <a href="https://doi.org/10.1016/j.cofs.2016.01.007" title="DOI URL">https://doi.org/10.1016/j.cofs.2016.01.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cofs.2016.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cofs.2016.01.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Food%2520Science%26atitle%3DProspects%252Bfor%252Bthe%252Bmanagement%252Bof%252Btype%252B2%252Bdiabetes%252Busing%252Bfood%252Bprotein-derived%252Bpeptides%252Bwith%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bactivity%26aulast%3DNongonierma%26aufirst%3DAlice%2BB%26date%3D2016%26volume%3D8%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cheng-Hong  Hsieh</span>, <span class="hlFld-ContribAuthor ">Tzu-Yuan  Wang</span>, <span class="hlFld-ContribAuthor ">Chuan-Chuan  Hung</span>, <span class="hlFld-ContribAuthor ">Chia-Ling  Jao</span>, <span class="hlFld-ContribAuthor ">You-Liang  Hsieh</span>, <span class="hlFld-ContribAuthor ">Si-Xian  Wu</span>, <span class="hlFld-ContribAuthor ">Kuo-Chiang  Hsu</span>. </span><span class="cited-content_cbyCitation_article-title">In silico, in vitro and in vivo analyses of dipeptidyl peptidase IV inhibitory activity and the antidiabetic effect of sodium caseinate hydrolysate. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2016,</strong> <em>7 </em>
                                    (2)
                                     , 1122-1128. <a href="https://doi.org/10.1039/C5FO01324K" title="DOI URL">https://doi.org/10.1039/C5FO01324K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5FO01324K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5FO01324K%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DIn%252Bsilico%25252C%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Banalyses%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitory%252Bactivity%252Band%252Bthe%252Bantidiabetic%252Beffect%252Bof%252Bsodium%252Bcaseinate%252Bhydrolysate%26aulast%3DHsieh%26aufirst%3DCheng-Hong%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D2%26spage%3D1122%26epage%3D1128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Solène  Le Maux</span>, <span class="hlFld-ContribAuthor ">Joël  Hamayon</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for the release of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides in an enzymatic hydrolyzate of α-lactalbumin. </span><span class="cited-content_cbyCitation_journal-name">Food & Function</span><span> <strong>2016,</strong> <em>7 </em>
                                    (8)
                                     , 3437-3443. <a href="https://doi.org/10.1039/C6FO00239K" title="DOI URL">https://doi.org/10.1039/C6FO00239K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6FO00239K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6FO00239K%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520%2526%2520Function%26atitle%3DStrategies%252Bfor%252Bthe%252Brelease%252Bof%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Bpeptides%252Bin%252Ban%252Benzymatic%252Bhydrolyzate%252Bof%252B%2525CE%2525B1-lactalbumin%26aulast%3DNongonierma%26aufirst%3DAlice%2BB.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D8%26spage%3D3437%26epage%3D3443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alicia  Arizpe</span>, <span class="hlFld-ContribAuthor ">María  Rodríguez-Mata</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Sayago</span>, <span class="hlFld-ContribAuthor ">María J.  Pueyo</span>, <span class="hlFld-ContribAuthor ">Vicente  Gotor</span>, <span class="hlFld-ContribAuthor ">Ana I.  Jiménez</span>, <span class="hlFld-ContribAuthor ">Vicente  Gotor-Fernández</span>, <span class="hlFld-ContribAuthor ">Carlos  Cativiela</span>. </span><span class="cited-content_cbyCitation_article-title">Enzymatic and chromatographic resolution procedures applied to the synthesis of the phosphoproline enantiomers. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron: Asymmetry</span><span> <strong>2015,</strong> <em>26 </em>
                                    (24)
                                     , 1469-1477. <a href="https://doi.org/10.1016/j.tetasy.2015.10.016" title="DOI URL">https://doi.org/10.1016/j.tetasy.2015.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetasy.2015.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetasy.2015.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%253A%2520Asymmetry%26atitle%3DEnzymatic%252Band%252Bchromatographic%252Bresolution%252Bprocedures%252Bapplied%252Bto%252Bthe%252Bsynthesis%252Bof%252Bthe%252Bphosphoproline%252Benantiomers%26aulast%3DArizpe%26aufirst%3DAlicia%26date%3D2015%26volume%3D26%26issue%3D24%26spage%3D1469%26epage%3D1477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yukihisa S.  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yoshika  Yasuda</span>, <span class="hlFld-ContribAuthor ">Yuko  Kojima</span>, <span class="hlFld-ContribAuthor ">Shino  Okada</span>, <span class="hlFld-ContribAuthor ">Tomoko  Motoyama</span>, <span class="hlFld-ContribAuthor ">Ryo  Takahashi</span>, <span class="hlFld-ContribAuthor ">Mitsuru  Oka</span>. </span><span class="cited-content_cbyCitation_article-title">Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2015,</strong> <em>30 </em>
                                    (6)
                                     , 981-988. <a href="https://doi.org/10.3109/14756366.2014.1002402" title="DOI URL">https://doi.org/10.3109/14756366.2014.1002402</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/14756366.2014.1002402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F14756366.2014.1002402%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DAnagliptin%25252C%252Ba%252Bpotent%252Bdipeptidyl%252Bpeptidase%252BIV%252Binhibitor%25253A%252Bits%252Bsingle-crystal%252Bstructure%252Band%252Benzyme%252Binteractions%26aulast%3DWatanabe%26aufirst%3DYukihisa%2BS.%26date%3D2015%26date%3D2015%26volume%3D30%26issue%3D6%26spage%3D981%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Solène  Le Maux</span>, <span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Brian  Murray</span>, <span class="hlFld-ContribAuthor ">Phil M.  Kelly</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of short peptide sequences in the nanofiltration permeate of a bioactive whey protein hydrolysate. </span><span class="cited-content_cbyCitation_journal-name">Food Research International</span><span> <strong>2015,</strong> <em>77 </em>, 534-539. <a href="https://doi.org/10.1016/j.foodres.2015.09.012" title="DOI URL">https://doi.org/10.1016/j.foodres.2015.09.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodres.2015.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodres.2015.09.012%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Research%2520International%26atitle%3DIdentification%252Bof%252Bshort%252Bpeptide%252Bsequences%252Bin%252Bthe%252Bnanofiltration%252Bpermeate%252Bof%252Ba%252Bbioactive%252Bwhey%252Bprotein%252Bhydrolysate%26aulast%3DLe%2BMaux%26aufirst%3DSol%25C3%25A8ne%26date%3D2015%26volume%3D77%26spage%3D534%26epage%3D539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sneha R.  Sagar</span>, <span class="hlFld-ContribAuthor ">Jessica K.  Agarwal</span>, <span class="hlFld-ContribAuthor ">Dhaivat H.  Pandya</span>, <span class="hlFld-ContribAuthor ">Ranjeet Prasad  Dash</span>, <span class="hlFld-ContribAuthor ">Manish  Nivsarkar</span>, <span class="hlFld-ContribAuthor ">Kamala K.  Vasu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4428-4433. <a href="https://doi.org/10.1016/j.bmcl.2015.09.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrazolo-pyrimidinones%252Bas%252BDPP-IV%252Binhibitors%252Bin%252Bdiabetes%26aulast%3DSagar%26aufirst%3DSneha%2BR.%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4428%26epage%3D4433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miguel E.  Oseguera-Toledo</span>, <span class="hlFld-ContribAuthor ">Elvira  Gonzalez de Mejia</span>, <span class="hlFld-ContribAuthor ">Silvia L.  Amaya-Llano</span>. </span><span class="cited-content_cbyCitation_article-title">Hard-to-cook bean ( Phaseolus vulgaris L.) proteins hydrolyzed by alcalase and bromelain produced bioactive peptide fractions that inhibit targets of type-2 diabetes and oxidative stress. </span><span class="cited-content_cbyCitation_journal-name">Food Research International</span><span> <strong>2015,</strong> <em>76 </em>, 839-851. <a href="https://doi.org/10.1016/j.foodres.2015.07.046" title="DOI URL">https://doi.org/10.1016/j.foodres.2015.07.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.foodres.2015.07.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.foodres.2015.07.046%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Research%2520International%26atitle%3DHard-to-cook%252Bbean%252B%252528%252BPhaseolus%252Bvulgaris%252BL.%252529%252Bproteins%252Bhydrolyzed%252Bby%252Balcalase%252Band%252Bbromelain%252Bproduced%252Bbioactive%252Bpeptide%252Bfractions%252Bthat%252Binhibit%252Btargets%252Bof%252Btype-2%252Bdiabetes%252Band%252Boxidative%252Bstress%26aulast%3DOseguera-Toledo%26aufirst%3DMiguel%2BE.%26date%3D2015%26volume%3D76%26spage%3D839%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Jiaze  Yan</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Yanxia  Qi</span>. </span><span class="cited-content_cbyCitation_article-title">Screening and identification of DPP-IV inhibitory peptides from deer skin hydrolysates by an integrated approach of LC–MS/MS and in silico analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Functional Foods</span><span> <strong>2015,</strong> <em>18 </em>, 344-357. <a href="https://doi.org/10.1016/j.jff.2015.07.015" title="DOI URL">https://doi.org/10.1016/j.jff.2015.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jff.2015.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jff.2015.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Functional%2520Foods%26atitle%3DScreening%252Band%252Bidentification%252Bof%252BDPP-IV%252Binhibitory%252Bpeptides%252Bfrom%252Bdeer%252Bskin%252Bhydrolysates%252Bby%252Ban%252Bintegrated%252Bapproach%252Bof%252BLC%2525E2%252580%252593MS%25252FMS%252Band%252Bin%252Bsilico%252Banalysis%26aulast%3DJin%26aufirst%3DYan%26date%3D2015%26volume%3D18%26spage%3D344%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alice B.  Nongonierma</span>, <span class="hlFld-ContribAuthor ">Solène  Le Maux</span>, <span class="hlFld-ContribAuthor ">Cécile  Dubrulle</span>, <span class="hlFld-ContribAuthor ">Chloé  Barre</span>, <span class="hlFld-ContribAuthor ">Richard J.  FitzGerald</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoa (Chenopodium quinoa Willd.) protein hydrolysates with in vitro dipeptidyl peptidase IV (DPP-IV) inhibitory and antioxidant properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cereal Science</span><span> <strong>2015,</strong> <em>65 </em>, 112-118. <a href="https://doi.org/10.1016/j.jcs.2015.07.004" title="DOI URL">https://doi.org/10.1016/j.jcs.2015.07.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jcs.2015.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jcs.2015.07.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cereal%2520Science%26atitle%3DQuinoa%252B%252528Chenopodium%252Bquinoa%252BWilld.%252529%252Bprotein%252Bhydrolysates%252Bwith%252Bin%2525C2%2525A0vitro%252Bdipeptidyl%252Bpeptidase%252BIV%252B%252528DPP-IV%252529%252Binhibitory%252Band%252Bantioxidant%252Bproperties%26aulast%3DNongonierma%26aufirst%3DAlice%2BB.%26date%3D2015%26volume%3D65%26spage%3D112%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Piotr  Minkiewicz</span>, <span class="hlFld-ContribAuthor ">Małgorzata  Darewicz</span>, <span class="hlFld-ContribAuthor ">Anna  Iwaniak</span>, <span class="hlFld-ContribAuthor ">Jolanta  Sokołowska</span>, <span class="hlFld-ContribAuthor ">Piotr  Starowicz</span>, <span class="hlFld-ContribAuthor ">Justyna  Bucholska</span>, <span class="hlFld-ContribAuthor ">Monika  Hrynkiewicz</span>. </span><span class="cited-content_cbyCitation_article-title">Common Amino Acid Subsequences in a Universal Proteome—Relevance for Food Science. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2015,</strong> <em>16 </em>
                                    (9)
                                     , 20748-20773. <a href="https://doi.org/10.3390/ijms160920748" title="DOI URL">https://doi.org/10.3390/ijms160920748</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms160920748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms160920748%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DCommon%252BAmino%252BAcid%252BSubsequences%252Bin%252Ba%252BUniversal%252BProteome%2525E2%252580%252594Relevance%252Bfor%252BFood%252BScience%26aulast%3DMinkiewicz%26aufirst%3DPiotr%26date%3D2015%26date%3D2015%26volume%3D16%26issue%3D9%26spage%3D20748%26epage%3D20773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm400658e&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-6%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm400658e&amp;citedByCount=113&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0008.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Amino Acids Involved in the Binding of Inhibitors to DPP IV</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Binding Modes of the Different Scaffold-Based Analogues in the DPP IV Enzyme [Adapted from Ref <a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">61</a>]</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. DPP IV Inhibitors Evaluated in Initial Clinical Trials</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/medium/jm-2013-00658e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Examples of Recent Development of DPP IV Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-6/jm400658e/production/images/large/jm-2013-00658e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400658e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>In this scheme, the compound codes in parentheses represent the designations attributed to the compounds by the authors in the original publications.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i19">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14014" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14014" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 130 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Yaron, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naider, F.</span><span> </span><span class="NLM_article-title">Proline-dependent structural and biological properties of peptides and proteins</span> <span class="citation_source-journal">Crit. Rev. Biochem. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.3109%2F10409239309082572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=8444042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADyaK3sXit1ylu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1993&pages=31-81&author=A.+Yaronauthor=F.+Naider&title=Proline-dependent+structural+and+biological+properties+of+peptides+and+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Proline-dependent structural and biological properties of peptides and proteins</span></div><div class="casAuthors">Yaron, Arieh; Naider, Fred</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Biochemistry and Molecular Biology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-81</span>CODEN:
                <span class="NLM_cas:coden">CRBBEJ</span>;
        ISSN:<span class="NLM_cas:issn">1040-9238</span>.
    </div><div class="casAbstract">A review, with 383 refs.  Proline residues confer unique structural constraints on peptide chains and markedly influence the susceptibility of proximal peptide bonds to protease activity.  A crit. anal. of peptidases involved in the cleavage of proline-contg. peptide bonds is presented, with particular attention to the role of proline peptidases in the regulation of the lifetime of biol. active peptides.  Peptidases discussed include aminopeptidase P, prolidase, dipeptidyl peptidase IV, prolyl endopeptidase, and prolyl iminopeptidase.  Attention is also given to HIV-1 protease, because this key enzyme processes an Xaa-Pro peptide bond.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr89TQn-XtgJrVg90H21EOLACvtfcHk0lhg_-RIYe01qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1ylu70%253D&md5=67f47aa3fbe158ca0e236c7ba8665cde</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3109%2F10409239309082572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10409239309082572%26sid%3Dliteratum%253Aachs%26aulast%3DYaron%26aufirst%3DA.%26aulast%3DNaider%26aufirst%3DF.%26atitle%3DProline-dependent%2520structural%2520and%2520biological%2520properties%2520of%2520peptides%2520and%2520proteins%26jtitle%3DCrit.%2520Rev.%2520Biochem.%2520Mol.%2520Biol.%26date%3D1993%26volume%3D28%26spage%3D31%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Busek, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedo, A.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer</span> <span class="citation_source-journal">Int. J. Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">408</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS1357-2725%2803%2900262-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=14687920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVWgu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=408-421&author=P.+Busekauthor=R.+Malikauthor=A.+Sedo&title=Dipeptidyl+peptidase+IV+activity+and%2For+structure+homologues+%28DASH%29+and+their+substrates+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer</span></div><div class="casAuthors">Busek, Petr; Malik, Radek; Sedo, Aleksi</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">408-421</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  Post-translational modification of proteins is an important regulatory event.  Numerous biol. active peptides that play an essential role in cancerogenesis contain an evolutionary conserved proline residue as a proteolytic-processing regulatory element.  Proline-specific proteases could therefore be viewed as important "check-points".  Limited proteolysis of such peptides may lead to quant. but, importantly, due to the change of receptor preference, also qual. changes of their signaling potential.  Dipeptidyl peptidase-IV (DPP-IV, EC 3.4.14.5, identical with CD26) was for many years believed to be a unique cell membrane protease cleaving X-Pro dipeptides from the N-terminal end of peptides and proteins.  Subsequently, a no. of other mols. were discovered, exhibiting various degree of structural homol. and DPP-IV-like enzyme activity, capable of cleaving similar set of substrates.  These comprise for example, seprase, fibroblast activation protein α, DPP6, DPP8, DPP9, attractin, N-acetylated-α-linked-acidic dipeptidases I, II and L, quiescent cell proline dipeptidase, thymus-specific serine protease and DPP IV-β.  It is tempting to speculate their potential participation on DPP-IV biol. function(s).  Disrupted expression and enzymic activity of "DPP-IV activity and/or structure homologs" (DASH) might corrupt the message carried by their substrates, promoting abnormal cell behavior.  Consequently, modulation of particular enzyme activity using e.g.  DASH inhibitors, specific antibodies or DASH expression modification may be an attractive therapeutic concept in cancer treatment.  This review summarizes recent information on the interactions between DASH members and their substrates with respect to their possible role in cancer biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqoAqZiP-Z1rVg90H21EOLACvtfcHk0liyuC-nkjDTIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVWgu7o%253D&md5=0472b5bc6e382a602719dc44159b03c7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2803%2900262-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252803%252900262-0%26sid%3Dliteratum%253Aachs%26aulast%3DBusek%26aufirst%3DP.%26aulast%3DMalik%26aufirst%3DR.%26aulast%3DSedo%26aufirst%3DA.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520activity%2520and%252For%2520structure%2520homologues%2520%2528DASH%2529%2520and%2520their%2520substrates%2520in%2520cancer%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2004%26volume%3D36%26spage%3D408%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Chen, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghersi, G.</span><span> </span><span class="NLM_article-title">DPPIV, seprase and related serine peptidases in multiple cellular functions</span> <span class="citation_source-journal">Curr. Top. Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2003&pages=207-232&author=W.+T.+Chenauthor=T.+Kellyauthor=G.+Ghersi&title=DPPIV%2C+seprase+and+related+serine+peptidases+in+multiple+cellular+functions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%2BT.%26aulast%3DKelly%26aufirst%3DT.%26aulast%3DGhersi%26aufirst%3DG.%26atitle%3DDPPIV%252C%2520seprase%2520and%2520related%2520serine%2520peptidases%2520in%2520multiple%2520cellular%2520functions%26jtitle%3DCurr.%2520Top.%2520Dev.%2520Biol.%26date%3D2003%26volume%3D54%26spage%3D207%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mentlein, R.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV (CD26)—role in the inactivation of regulatory peptides</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS0167-0115%2899%2900089-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=10588446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADyaK1MXntVCitLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1999&pages=9-24&author=R.+Mentlein&title=Dipeptidyl-peptidase+IV+%28CD26%29%E2%80%94role+in+the+inactivation+of+regulatory+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides</span></div><div class="casAuthors">Mentlein, R.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-24</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 112 refs.  Dipeptidyl-peptidase IV (DPP IV/CD26) has a dual function as a regulatory protease and as a binding protein.  Its role in the inactivation of bioactive peptides was recognized 20 yr ago due to its unique ability to liberate Xaa-Pro or Xaa-Ala dipeptides from the N-terminus of regulatory peptides, but further examples are now emerging from in vitro and vivo expts.  Despite the minimal N-terminal truncation by DPP IV, many mammalian regulatory peptides are inactivated - either totally or only differentially - for certain receptor subtypes.  Important DPP IV substrates include neuropeptides like neuropeptide Y or endomorphin, circulating peptide hormones like peptide YY, growth hormone-releasing hormone, glucagon-like peptides(GLP)-1 and -2, gastric inhibitory polypeptide as well as paracrine chemokines like RANTES (regulated on activation normal T cell expressed and secreted), stromal cell-derived factor, eotaxin and macrophage-derived chemokine.  Based on these findings the potential clin. uses of selective DPP IV inhibitors or DPP IV-resistant analogs, esp. for the insulinotropic hormone GLP-1, have been tested to enhance insulin secretion and to improve glucose tolerance in diabetic animals.  Thus, DPP IV appears to be a major physiol. regulator for some regulatory peptides, neuropeptides, circulating hormones and chemokines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsOF6uG5OnTrVg90H21EOLACvtfcHk0liyuC-nkjDTIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntVCitLs%253D&md5=5e2ec3c86e1b2d77f5259bbd33b26c37</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0167-0115%2899%2900089-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-0115%252899%252900089-0%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26atitle%3DDipeptidyl-peptidase%2520IV%2520%2528CD26%2529%25E2%2580%2594role%2520in%2520the%2520inactivation%2520of%2520regulatory%2520peptides%26jtitle%3DRegul.%2520Pept.%26date%3D1999%26volume%3D85%26spage%3D9%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Polgar, L.</span><span> </span><span class="NLM_article-title">The prolyl oligopeptidase family</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=349-362&author=L.+Polgar&title=The+prolyl+oligopeptidase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPolgar%26aufirst%3DL.%26atitle%3DThe%2520prolyl%2520oligopeptidase%2520family%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2002%26volume%3D59%26spage%3D349%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rosenblum, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosarich, J. W.</span><span> </span><span class="NLM_article-title">Prolyl peptidases: a serine protease subfamily with high potential in drug discovery</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS1367-5931%2803%2900084-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=12941425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmslemsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2003&pages=496-504&author=J.+S.+Rosenblumauthor=J.+W.+Kosarich&title=Prolyl+peptidases%3A+a+serine+protease+subfamily+with+high+potential+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl peptidases: a serine protease subfamily with high potential for drug discovery</span></div><div class="casAuthors">Rosenblum, Jonathan S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">496-504</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review and discussion.  Much attention has recently been given to a class of proteases that cleave proteins and peptides after Pro residues.  This class includes esp. dipeptidyl peptidase IV (DPP IV; also termed CD26) and fibroblast activation protein α (FAP; seprase), but also includes DPP7 (DPP II; quiescent cell proline dipeptidase), DPP8, DPP9, and prolyl carboxypeptidase (PCP; angiotensinase C).  More distant members include prolyl oligopeptidase (POP; post-proline cleaving enzyme) and acylaminoacylpeptidase (AAP; acylpeptide hydrolase).  The DPPs and related proteins contain both membrane-bound and sol. members and span a broad range of expression patterns, tissue distributions and compartmentalization.  These proteins have important roles in regulation of signaling by peptide hormones, and are emerging targets for diabetes, oncol., and other indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMVbHHOPDw7Vg90H21EOLACvtfcHk0lg-CA_CgQmj3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmslemsrk%253D&md5=5c7d9bb0b121fd8d29c675270898b89f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2803%2900084-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252803%252900084-X%26sid%3Dliteratum%253Aachs%26aulast%3DRosenblum%26aufirst%3DJ.%2BS.%26aulast%3DKosarich%26aufirst%3DJ.%2BW.%26atitle%3DProlyl%2520peptidases%253A%2520a%2520serine%2520protease%2520subfamily%2520with%2520high%2520potential%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2003%26volume%3D7%26spage%3D496%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Cunningham, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, B.</span><span> </span><span class="NLM_article-title">Proline specific peptidases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1343</span><span class="NLM_x">, </span> <span class="NLM_fpage">160</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1343&publication_year=1997&pages=160-186&author=D.+F.+Cunninghamauthor=B.+O%E2%80%99Connor&title=Proline+specific+peptidases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DD.%2BF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DB.%26atitle%3DProline%2520specific%2520peptidases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1997%26volume%3D1343%26spage%3D160%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Sedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, R.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities</span> <span class="citation_source-journal">Biochem. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1550</span><span class="NLM_x">, </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS0167-4838%2801%2900278-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=11755200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1550&publication_year=2001&pages=107-116&author=A.+Sedoauthor=R.+Malik&title=Dipeptidyl+peptidase+IV-like+molecules%3A+homologous+proteins+or+homologous+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?</span></div><div class="casAuthors">Sedo, Aleksi; Malik, Radek</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure and Molecular Enzymology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1550</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-116</span>CODEN:
                <span class="NLM_cas:coden">BBAEDZ</span>;
        ISSN:<span class="NLM_cas:issn">0167-4838</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Membrane-bound proteases are widely distributed among various cell systems.  Their expression in a particular cell type is finely regulated, reflecting the specific functional cell implications and engagement in defined physiol. pathways.  Protein turnover, ontogeny, inflammation, tissue remodeling, cell migration and tumor invasion are among the many physiol. and pathol. events in which membrane proteases play a crucial role, both as effector as well as regulatory mols.  The presence of proline residues gives unique structural features to peptide chains, substantially influencing the susceptibility of proximal peptide bond to protease cleavage.  Among the rare group of proline-specific proteases, dipeptidyl peptidase IV (DPP-IV, EC 3.4.14.5) was originally believed to be the only membrane-bound enzyme specific for proline as the penultimate residue at the amino-terminus of the polypeptide chain.  However, other mols., even structurally non-homologous with the DPP-IV but bearing corresponding enzyme activity, have been identified recently.  This review summarizes the present knowledge of 'DPP-IV activity- and/or structure-homologs' (DASH) and provides some insight into their multifunctional roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9ov8OGHsknrVg90H21EOLACvtfcHk0lg-CA_CgQmj3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWi&md5=8a7c5761fa97851f207f3a38effd42c2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0167-4838%2801%2900278-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-4838%252801%252900278-3%26sid%3Dliteratum%253Aachs%26aulast%3DSedo%26aufirst%3DA.%26aulast%3DMalik%26aufirst%3DR.%26atitle%3DDipeptidyl%2520peptidase%2520IV-like%2520molecules%253A%2520homologous%2520proteins%2520or%2520homologous%2520activities%26jtitle%3DBiochem.%2520Biophys.%2520Acta%26date%3D2001%26volume%3D1550%26spage%3D107%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fleischer, B.</span><span> </span><span class="NLM_article-title">CD26: a surface protease involved in T-cell activation</span> <span class="citation_source-journal">Immunol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">180</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2F0167-5699%2894%2990316-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=7911022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADyaK2cXis1Omu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1994&pages=180-184&author=B.+Fleischer&title=CD26%3A+a+surface+protease+involved+in+T-cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">CD26: a surface protease involved in T-cell activation</span></div><div class="casAuthors">Fleischer, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">180-4</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    </div><div class="casAbstract">A review, with 45 refs.  CD26 is a proteolytic enzyme (dipeptidylpeptidase IV) with a wide tissue distribution and a unique specificity.  Recent developments indicate that CD26 is a multifunctional mol. that may have important functions in the immune system.  Here, the current knowledge of CD26 and the possible functions of this mol. in T lymphocytes are discussed..</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRnmqKAop_frVg90H21EOLACvtfcHk0lihBuT4Mj3lFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXis1Omu7w%253D&md5=d2ce3a14fa4a85c06e638dcf18cfa7bc</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2F0167-5699%2894%2990316-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-5699%252894%252990316-6%26sid%3Dliteratum%253Aachs%26aulast%3DFleischer%26aufirst%3DB.%26atitle%3DCD26%253A%2520a%2520surface%2520protease%2520involved%2520in%2520T-cell%2520activation%26jtitle%3DImmunol.%2520Today%26date%3D1994%26volume%3D15%26spage%3D180%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gorrell, M. D.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span> <span class="citation_source-journal">Clin. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1042%2FCS20040302" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15584901" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2005&pages=277-292&author=M.+D.+Gorrell&title=Dipeptidyl+peptidase+IV+and+related+enzymes+in+cell+biology+and+liver+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders</span></div><div class="casAuthors">Gorrell, Mark D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">108</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">277-292</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">0143-5221</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  DP (dipeptidyl peptidase) IV is the archetypal member of its six-member gene family.  Four members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare substrate specificity, hydrolysis of a prolyl bond two residues from the N-terminus.  The ubiquitous DPIV glycoprotein has proved interesting in the fields of immunol., endocrinol., haematol. and endothelial cell and cancer biol. and DPIV has become a novel target for Type II diabetes therapy.  The crystal structure shows that the sol. form of DPIV comprises two domains, an α/β-hydrolase domain and an eight-blade β-propeller domain.  The propeller domain contains the ADA (adenosine deaminase) binding site, a dimerization site, antibody epitopes and two openings for substrate access to the internal active site.  FAP is structurally very similar to DPIV, but FAP protein expression is largely confined to diseased and damaged tissue, notably the tissue remodelling interface in chronically injured liver.  DPIV has a variety of peptide substrates, the best studied being GLP-1 (glucagon-like peptide-1), NPY (neuropeptide Y) and CXCL12.  The DPIV family has roles in bone marrow mobilization.  The functional interactions of DPIV and FAP with extracellular matrix confer roles for these proteins in cancer biol.  DP8 and DP9 are widely distributed and indirectly implicated in immune function.  The DPL (DP-like) glycoproteins that lack peptidase activity, DPL1 and DPL2, are brain-expressed potassium channel modulators.  Thus the six members of the DPIV gene family exhibit diverse biol. roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJupx2RWQPHbVg90H21EOLACvtfcHk0lihBuT4Mj3lFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisV2jtrY%253D&md5=64bbb7dbec2fa9c0c49a2e54c0be908e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1042%2FCS20040302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20040302%26sid%3Dliteratum%253Aachs%26aulast%3DGorrell%26aufirst%3DM.%2BD.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520and%2520related%2520enzymes%2520in%2520cell%2520biology%2520and%2520liver%2520disorders%26jtitle%3DClin.%2520Sci.%26date%3D2005%26volume%3D108%26spage%3D277%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">Glucagon-like peptides 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">Curr. in. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">589</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.coph.2004.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptl2ksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=589-596&author=J.+J.+Holstauthor=C.+F.+Deacon&title=Glucagon-like+peptides+1+and+inhibitors+of+dipeptidyl+peptidase+IV+in+the+treatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus</span></div><div class="casAuthors">Holst, Jens Juul; Deacon, Carolyn F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">589-596</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Proof-of-concept for the efficacy of a glucagon-like peptide 1 (GLP-1)-based therapy of patients with type 2 diabetes was provided in 2002 by prolonged continuous s.c. infusion of native GLP-1.  Since then, several long-acting analogs of GLP-1, as well as inhibitors of dipeptidyl peptidase IV, the enzyme that rapidly inactivates endogenous GLP-1, have demonstrated efficacy in long term clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXKDwEWvb257Vg90H21EOLACvtfcHk0lihBuT4Mj3lFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptl2ksbo%253D&md5=35a828501cde38c10e44f91677441cb2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2004.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2004.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DGlucagon-like%2520peptides%25201%2520and%2520inhibitors%2520of%2520dipeptidyl%2520peptidase%2520IV%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DCurr.%2520in.%2520Pharmacol.%26date%3D2004%26volume%3D4%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Berger, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapuis Bernasconi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Determination of intracellular prolyl/glycyl-specific proteases in intact living human cells using protoporphyrin IX production as a reporter system</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">867</span><span class="NLM_x">–</span> <span class="NLM_lpage">872</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.chembiol.2005.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=16125098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVeksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=867-872&author=Y.+Bergerauthor=C.+Chapuis+Bernasconiauthor=R.+Neierauthor=L.+Juillerat-Jeanneret&title=Determination+of+intracellular+prolyl%2Fglycyl-specific+proteases+in+intact+living+human+cells+using+protoporphyrin+IX+production+as+a+reporter+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Determination of Intracellular Prolyl/Glycyl Proteases in Intact Living Human Cells and Protoporphyrin IX Production as a Reporter System</span></div><div class="casAuthors">Berger, Yann; Chapuis Bernasconi, Catherine; Schmitt, Frederic; Neier, Reinhard; Juillerat-Jeanneret, Lucienne</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">867-872</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The detn. of enzyme activity or inhibition in intact living cells is a problem in the development of inhibitors for intracellular proteases.  The prodn. of fluorescent protoporphyrin IX (PpIX) from the nonfluorescent (N)-Gly/Pro-5-aminolevulinic acid (ALA) substrates was used to evaluate the prolyl/glycyl-specific dipeptidylpeptidase IV (DPPIV)-like and prolyloligopeptidase (POP)-like activities of human cells.  The results demonstrated that whereas POP-like activity could be attributed to the actual POP, the DPPIV-like activity could be related to actual DPPIV only in one colon cell line.  In the other breast and colon cell lines, DPPIV-like activity was intracellular and displayed by other prolyl-specific aminopeptidases.  Our expts. also demonstrated the involvement of glycyl-specific proteases in the processing of ALA precursors.  These observations have important consequences for the development and evaluation of selective inhibitors for these enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqREpFhOCyW3bVg90H21EOLACvtfcHk0liW_2vT7eUK7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVeksbc%253D&md5=9a4b532fac2976eed6b2c6b0c618f591</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DY.%26aulast%3DChapuis%2BBernasconi%26aufirst%3DC.%26aulast%3DNeier%26aufirst%3DR.%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DDetermination%2520of%2520intracellular%2520prolyl%252Fglycyl-specific%2520proteases%2520in%2520intact%2520living%2520human%2520cells%2520using%2520protoporphyrin%2520IX%2520production%2520as%2520a%2520reporter%2520system%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D867%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Engel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefersauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demuth, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandstetter, H.</span><span> </span><span class="NLM_article-title">The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanisms</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">5063</span><span class="NLM_x">–</span> <span class="NLM_lpage">5068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=5063-5068&author=M.+Engelauthor=T.+Hoffmannauthor=L.+Wagnerauthor=M.+Wermannauthor=U.+Heiserauthor=R.+Kiefersauerauthor=R.+Huberauthor=W.+Bodeauthor=H.+U.+Demuthauthor=H.+Brandstetter&title=The+crystal+structure+of+dipeptidyl+peptidase+IV+%28CD26%29+reveals+its+functional+regulation+and+enzymatic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DHoffmann%26aufirst%3DT.%26aulast%3DWagner%26aufirst%3DL.%26aulast%3DWermann%26aufirst%3DM.%26aulast%3DHeiser%26aufirst%3DU.%26aulast%3DKiefersauer%26aufirst%3DR.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DBode%26aufirst%3DW.%26aulast%3DDemuth%26aufirst%3DH.%2BU.%26aulast%3DBrandstetter%26aufirst%3DH.%26atitle%3DThe%2520crystal%2520structure%2520of%2520dipeptidyl%2520peptidase%2520IV%2520%2528CD26%2529%2520reveals%2520its%2520functional%2520regulation%2520and%2520enzymatic%2520mechanisms%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D5063%26epage%3D5068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hiramatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, R.</span><span> </span><span class="NLM_article-title">The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with diprotin A</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">385</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2004&pages=561-564&author=H.+Hiramatsuauthor=A.+Yamamotoauthor=K.+Kyonoauthor=Y.+Higashiyamaauthor=C.+Fukushimaauthor=H.+Shimaauthor=S.+Sugiyamaauthor=K.+Inakaauthor=R.+Shimizu&title=The+crystal+structure+of+human+dipeptidyl+peptidase+IV+%28DPPIV%29+complex+with+diprotin+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DA.%26aulast%3DKyono%26aufirst%3DK.%26aulast%3DHigashiyama%26aufirst%3DY.%26aulast%3DFukushima%26aufirst%3DC.%26aulast%3DShima%26aufirst%3DH.%26aulast%3DSugiyama%26aufirst%3DS.%26aulast%3DInaka%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DR.%26atitle%3DThe%2520crystal%2520structure%2520of%2520human%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPPIV%2529%2520complex%2520with%2520diprotin%2520A%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D385%26spage%3D561%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rasmussen, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiberg, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagtmann, N.</span><span> </span><span class="NLM_article-title">Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=19-25&author=H.+B.+Rasmussenauthor=S.+Brannerauthor=F.+C.+Wibergauthor=N.+Wagtmann&title=Crystal+structure+of+human+dipeptidyl+peptidase+IV%2FCD26+in+complex+with+a+substrate+analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRasmussen%26aufirst%3DH.%2BB.%26aulast%3DBranner%26aufirst%3DS.%26aulast%3DWiberg%26aufirst%3DF.%2BC.%26aulast%3DWagtmann%26aufirst%3DN.%26atitle%3DCrystal%2520structure%2520of%2520human%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520in%2520complex%2520with%2520a%2520substrate%2520analog%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mac Sweeney, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardiner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, G. E.</span><span> </span><span class="NLM_article-title">High-resolution structure of human apo dipeptidyl peptidase IV/CD26 and its complex with 1-[({2-[85-iodopyridin-2-yl)aminoethyl}amino)acetyl]-2-cyano-(<i>S</i>)-pyrrolodine</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">D59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D59&publication_year=2003&pages=1206-1212&author=C.+Oefnerauthor=A.+D%E2%80%99Arcyauthor=A.+Mac+Sweeneyauthor=S.+Pierauauthor=R.+Gardinerauthor=G.+E.+Dale&title=High-resolution+structure+of+human+apo+dipeptidyl+peptidase+IV%2FCD26+and+its+complex+with+1-%5B%28%7B2-%5B85-iodopyridin-2-yl%29aminoethyl%7Damino%29acetyl%5D-2-cyano-%28S%29-pyrrolodine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DMac%2BSweeney%26aufirst%3DA.%26aulast%3DPierau%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DR.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DHigh-resolution%2520structure%2520of%2520human%2520apo%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520and%2520its%2520complex%2520with%25201-%255B%2528%257B2-%255B85-iodopyridin-2-yl%2529aminoethyl%257Damino%2529acetyl%255D-2-cyano-%2528S%2529-pyrrolodine%26jtitle%3DActa%2520Crystallogr.%26date%3D2003%26volume%3DD59%26spage%3D1206%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Thoma, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löffler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stihle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huber, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruf, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henning, M.</span><span> </span><span class="NLM_article-title">Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase IV</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">947</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=947-959&author=R.+Thomaauthor=B.+L%C3%B6fflerauthor=M.+Stihleauthor=W.+Huberauthor=A.+Rufauthor=M.+Henning&title=Structural+basis+of+proline-specific+exopeptidase+activity+as+observed+in+human+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DR.%26aulast%3DL%25C3%25B6ffler%26aufirst%3DB.%26aulast%3DStihle%26aufirst%3DM.%26aulast%3DHuber%26aufirst%3DW.%26aulast%3DRuf%26aufirst%3DA.%26aulast%3DHenning%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520of%2520proline-specific%2520exopeptidase%2520activity%2520as%2520observed%2520in%2520human%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DStructure%26date%3D2003%26volume%3D11%26spage%3D947%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fülöp, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böcskei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polgar, L.</span><span> </span><span class="NLM_article-title">Prolyl oligopeptidase: an unusual β-propeller domain regulates proteolysis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1998&pages=161-170&author=V.+F%C3%BCl%C3%B6pauthor=Z.+B%C3%B6cskeiauthor=L.+Polgar&title=Prolyl+oligopeptidase%3A+an+unusual+%CE%B2-propeller+domain+regulates+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCl%25C3%25B6p%26aufirst%3DV.%26aulast%3DB%25C3%25B6cskei%26aufirst%3DZ.%26aulast%3DPolgar%26aufirst%3DL.%26atitle%3DProlyl%2520oligopeptidase%253A%2520an%2520unusual%2520%25CE%25B2-propeller%2520domain%2520regulates%2520proteolysis%26jtitle%3DCell%26date%3D1998%26volume%3D94%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Edmondson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastracchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E. R.</span><span> </span><span class="NLM_article-title">Potent and selective proline derived dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5151</span><span class="NLM_x">–</span> <span class="NLM_lpage">5155</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5151-5155&author=S.+D.+Edmondsonauthor=A.+Mastracchioauthor=M.+Beconiauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=S.+Kumarauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=A.+Maoauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Potent+and+selective+proline+derived+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26aulast%3DMastracchio%26aufirst%3DA.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMao%26aufirst%3DA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DPotent%2520and%2520selective%2520proline%2520derived%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5151%26epage%3D5155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ok, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habulihaz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmee, E. R.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective beta-homophenylalanine based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4759</span><span class="NLM_x">–</span> <span class="NLM_lpage">4762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4759-4762&author=J.+Xuauthor=H.+O.+Okauthor=E.+J.+Gonzalezauthor=L.+F.+Colwellauthor=B.+Habulihazauthor=H.+Heauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=E.+R.+Parmee&title=Discovery+of+potent+and+selective+beta-homophenylalanine+based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DOk%26aufirst%3DH.%2BO.%26aulast%3DGonzalez%26aufirst%3DE.%2BJ.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DHabulihaz%26aufirst%3DB.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DParmee%26aufirst%3DE.%2BR.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520beta-homophenylalanine%2520based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4759%26epage%3D4762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A .E.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2533</span><span class="NLM_x">–</span> <span class="NLM_lpage">2536</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.bmcl.2005.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15863311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2533-2536&author=J.+Xuauthor=L.+Weiauthor=R.+Mathvinkauthor=J.+Heauthor=Y.+J.+Parkauthor=H.+Heauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A+.E.+Weber&title=Discovery+of+potent+and+selective+phenylalanine+based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of potent and selective phenylalanine based dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Xu, Jinyou; Wei, Lan; Mathvink, Robert; He, Jiafang; Park, You-Jung; He, Huaibing; Leiting, Barbara; Lyons, Kathryn A.; Marsilio, Frank; Patel, Reshma A.; Wu, Joseph K.; Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2533-2536</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Anti-Substituted β-methylphenylalanine derived amides have been shown to be potent DPP-IV inhibitors exhibiting excellent selectivity over both DPP8 and DPP9.  These are among the most potent compds. reported to date lacking an electrophilic trap.  The most potent compd. among these is 5-oxo-1,2,4-oxadiazole I, which is a 3 nM DPP-IV inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRQ1sHQJH4ebVg90H21EOLACvtfcHk0lgh11Yd3Ucplw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjslyrur8%253D&md5=14bb621ee7b95eb2e00ac0bd5c8c99eb</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DY.%2BJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA%2B.E.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520phenylalanine%2520based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2533%26epage%3D2536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathvink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmonson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Discovery of potent,selective, and orally bioavailable oxadiazole-based dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5373</span><span class="NLM_x">–</span> <span class="NLM_lpage">5377</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5373-5377&author=J.+Xuauthor=L.+Weiauthor=R.+Mathvinkauthor=S.+D.+Edmonsonauthor=G.+J.+Eiermannauthor=H.+Heauthor=J.+F.+Leoneauthor=B.+Leitingauthor=K.+A.+Lyonsauthor=F.+Marsilioauthor=R.+A.+Patelauthor=S.+B.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=J.+K.+Wuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Discovery+of+potent%2Cselective%2C+and+orally+bioavailable+oxadiazole-based+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DMathvink%26aufirst%3DR.%26aulast%3DEdmonson%26aufirst%3DS.%2BD.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLeone%26aufirst%3DJ.%2BF.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520potent%252Cselective%252C%2520and%2520orally%2520bioavailable%2520oxadiazole-based%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5373%26epage%3D5377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, J. T.</span><span> </span><span class="NLM_article-title">Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptido-mimetic</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">207</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=207-215&author=K.+Zhaoauthor=D.+S.+Limauthor=T.+Funakiauthor=J.+T.+Welch&title=Inhibition+of+dipeptidyl+peptidase+IV+%28DPP+IV%29+by+2-%282-amino-1-fluoro-propylidene%29-cyclopentanecarbonitrile%2C+a+fluoroolefin+containing+peptido-mimetic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DLim%26aufirst%3DD.%2BS.%26aulast%3DFunaki%26aufirst%3DT.%26aulast%3DWelch%26aufirst%3DJ.%2BT.%26atitle%3DInhibition%2520of%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP%2520IV%2529%2520by%25202-%25282-amino-1-fluoro-propylidene%2529-cyclopentanecarbonitrile%252C%2520a%2520fluoroolefin%2520containing%2520peptido-mimetic%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D207%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitkof, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Diprolyl nitriles as potent dipeptidylpeptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3992</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=3992-3995&author=G.+Zhaoauthor=P.+C.+Taunkauthor=D.+R.+Magninauthor=L.+M.+Simpkinsauthor=J.+A.+Roblauthor=A.+Wangauthor=J.+G.+Robertsonauthor=J.+Marcinkevicieneauthor=D.+F.+Sitkofauthor=R.+A.+Parkerauthor=M.+S.+Kirbyauthor=L.+G.+Hamann&title=Diprolyl+nitriles+as+potent+dipeptidylpeptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DTaunk%26aufirst%3DP.%2BC.%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DSitkof%26aufirst%3DD.%2BF.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DDiprolyl%2520nitriles%2520as%2520potent%2520dipeptidylpeptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D3992%26epage%3D3995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Mentlein, R.</span><span> </span><span class="NLM_article-title">Therapeutic assessement of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">64</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=57-64&author=R.+Mentlein&title=Therapeutic+assessement+of+glucagon-like+peptide-1+agonists+compared+with+dipeptidyl+peptidase+IV+inhibitors+as+potential+antidiabetic+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMentlein%26aufirst%3DR.%26atitle%3DTherapeutic%2520assessement%2520of%2520glucagon-like%2520peptide-1%2520agonists%2520compared%2520with%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520as%2520potential%2520antidiabetic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D57%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span> </span><span class="NLM_article-title">Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">532</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=525-532&author=B.+Leitingauthor=K.+A.+Pryorauthor=J.+K.+Wuauthor=F.+Marsilioauthor=R.+A.+Patelauthor=C.+S.+Craikauthor=J.+A.+Ellmanauthor=R.+T.+Cummingsauthor=N.+A.+Thornberry&title=Catalytic+properties+and+inhibition+of+proline-specific+dipeptidyl+peptidases+II%2C+IV+and+VII"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BA.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DCraik%26aufirst%3DC.%2BS.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26atitle%3DCatalytic%2520properties%2520and%2520inhibition%2520of%2520proline-specific%2520dipeptidyl%2520peptidases%2520II%252C%2520IV%2520and%2520VII%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D525%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Evans, D. M.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">IDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=12802706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFyitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=577-585&author=D.+M.+Evans&title=Dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Evans, D. Michael</div><div class="citationInfo"><span class="NLM_cas:title">IDrugs</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">577-585</span>CODEN:
                <span class="NLM_cas:coden">IDRUFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-7056</span>.
    
            (<span class="NLM_cas:orgname">PharmaPress Ltd.</span>)
        </div><div class="casAbstract">A review.  The patent literature for dipeptidyl peptidase IV (DPP-IV) inhibitors for the period of Jan. 2001 to May 2002 is reviewed.  There has been increased interest in DPP-IV inhibitors since their potential for the treatment of diabetes was identified.  This review will focus on reversible inhibitors of the enzyme, for which the primary interest has been for use in the treatment of Type II diabetes.  The majority of the new chem. entities reported are dipeptide-like inhibitors that mimic the preferred substrates and the best of these display nanomolar activity.  There have been fewer reports of non-peptide inhibitors suggesting that it is much more difficult to identify new classes of inhibitors.  In addn. to new chem. entities this review will cover new indications for DPP-IV inhibitors that have been identified using previously reported inhibitors as research tools.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp09hVqU-_miLVg90H21EOLACvtfcHk0lhUfOeiW-Okdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFyitrs%253D&md5=80066694d62995b845b223bf404fe51e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DD.%2BM.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DIDrugs%26date%3D2002%26volume%3D5%26spage%3D577%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibitors for the treatment of diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4141</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030628v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4135-4141&author=A.+E.+Weber&title=Dipeptidyl+peptidase+IV+inhibitors+for+the+treatment+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm030628v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030628v%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibitors%2520for%2520the%2520treatment%2520of%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4135%26epage%3D4141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">MK-431 Merck</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=419-426&author=C.+F.+Deacon&title=MK-431+Merck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DMK-431%2520Merck%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D6%26spage%3D419%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">Inhibition of the activity of dipeptidyl peptidase IV as a treatment for type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1663</span><span class="NLM_x">–</span> <span class="NLM_lpage">1670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=1663-1670&author=J.+J.+Holstauthor=C.+F.+Deacon&title=Inhibition+of+the+activity+of+dipeptidyl+peptidase+IV+as+a+treatment+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DInhibition%2520of%2520the%2520activity%2520of%2520dipeptidyl%2520peptidase%2520IV%2520as%2520a%2520treatment%2520for%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D1998%26volume%3D47%26spage%3D1663%26epage%3D1670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span> </span><span class="NLM_article-title">Prolyl-specific peptidases and their inhibitors in biological processes</span> <span class="citation_source-journal">Curr. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1998&pages=97-109&author=L.+Juillerat-Jeanneret&title=Prolyl-specific+peptidases+and+their+inhibitors+in+biological+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26atitle%3DProlyl-specific%2520peptidases%2520and%2520their%2520inhibitors%2520in%2520biological%2520processes%26jtitle%3DCurr.%2520Chem.%2520Biol.%26date%3D1998%26volume%3D2%26spage%3D97%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber-Lemaire, S.</span><span> </span><span class="NLM_article-title">The prolyl-aminodipeptidases and their inhibitors as therapeutic targets for fibrogenic disorders</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">215</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=215-226&author=L.+Juillerat-Jeanneretauthor=S.+Gerber-Lemaire&title=The+prolyl-aminodipeptidases+and+their+inhibitors+as+therapeutic+targets+for+fibrogenic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DGerber-Lemaire%26aufirst%3DS.%26atitle%3DThe%2520prolyl-aminodipeptidases%2520and%2520their%2520inhibitors%2520as%2520therapeutic%2520targets%2520for%2520fibrogenic%2520disorders%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D215%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Plamboeck, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deacon, C. F.</span><span> </span><span class="NLM_article-title">Neutral endopeptodase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaestised pig</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1882</span><span class="NLM_x">–</span> <span class="NLM_lpage">1890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1882-1890&author=A.+Plamboeckauthor=J.+J.+Holstauthor=R.+D.+Carrauthor=C.+F.+Deacon&title=Neutral+endopeptodase+24.11+and+dipeptidyl+peptidase+IV+are+both+mediators+of+the+degradation+of+glucagon-like+peptide+1+in+the+anaestised+pig"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlamboeck%26aufirst%3DA.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DCarr%26aufirst%3DR.%2BD.%26aulast%3DDeacon%26aufirst%3DC.%2BF.%26atitle%3DNeutral%2520endopeptodase%252024.11%2520and%2520dipeptidyl%2520peptidase%2520IV%2520are%2520both%2520mediators%2520of%2520the%2520degradation%2520of%2520glucagon-like%2520peptide%25201%2520in%2520the%2520anaestised%2520pig%26jtitle%3DDiabetologia%26date%3D2005%26volume%3D48%26spage%3D1882%26epage%3D1890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span> </span><span class="NLM_article-title">Synthesis, biological evaluation and structural determination of β-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2622</span><span class="NLM_x">–</span> <span class="NLM_lpage">2628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2622-2628&author=J.+H.+Ahnauthor=M.+S.+Shinauthor=M.+A.+Junauthor=S.+H.+Jungauthor=S.+K.+Kangauthor=K.+R.+Kimauthor=S.+D.+Rheeauthor=N.+S.+Kangauthor=S.+Y.+Kimauthor=S.+K.+Sohnauthor=S.+G.+Kimauthor=M.+S.+Jinauthor=J.+O.+Leeauthor=H.+G.+Cheonauthor=S.+S.+Kim&title=Synthesis%2C+biological+evaluation+and+structural+determination+of+%CE%B2-aminoacyl-containing+cyclic+hydrazine+derivatives+as+dipeptidyl+peptidase+IV+%28DPP-IV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DShin%26aufirst%3DM.%2BS.%26aulast%3DJun%26aufirst%3DM.%2BA.%26aulast%3DJung%26aufirst%3DS.%2BH.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BR.%26aulast%3DRhee%26aufirst%3DS.%2BD.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DSohn%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DM.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BO.%26aulast%3DCheon%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BS.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520structural%2520determination%2520of%2520%25CE%25B2-aminoacyl-containing%2520cyclic%2520hydrazine%2520derivatives%2520as%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2622%26epage%3D2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ahn, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohn, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheon, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. S.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6525</span><span class="NLM_x">–</span> <span class="NLM_lpage">6529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=6525-6529&author=J.+H.+Ahnauthor=W.+S.+Parkauthor=M.+A.+Junauthor=M.+S.+Shinauthor=S.+K.+Kangauthor=K.+Y.+Kimauthor=S.+D.+Rheeauthor=M.+A.+Baeauthor=K.+R.+Kimauthor=S.+G.+Kimauthor=S.+Y.+Kimauthor=S.+K.+Sohnauthor=N.+S.+Kangauthor=J.+O.+Leeauthor=D.+H.+Leeauthor=H.+G.+Cheonauthor=S.+S.+Kim&title=Synthesis+and+biological+evaluation+of+homopiperazine+derivatives+with+beta-aminoacyl+group+as+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DJ.%2BH.%26aulast%3DPark%26aufirst%3DW.%2BS.%26aulast%3DJun%26aufirst%3DM.%2BA.%26aulast%3DShin%26aufirst%3DM.%2BS.%26aulast%3DKang%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DK.%2BY.%26aulast%3DRhee%26aufirst%3DS.%2BD.%26aulast%3DBae%26aufirst%3DM.%2BA.%26aulast%3DKim%26aufirst%3DK.%2BR.%26aulast%3DKim%26aufirst%3DS.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DSohn%26aufirst%3DS.%2BK.%26aulast%3DKang%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BO.%26aulast%3DLee%26aufirst%3DD.%2BH.%26aulast%3DCheon%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DS.%2BS.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520homopiperazine%2520derivatives%2520with%2520beta-aminoacyl%2520group%2520as%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D18%26spage%3D6525%26epage%3D6529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattei, P.</span><span> </span><span class="NLM_article-title">Molecular recognition of ligands in dipeptidyl peptidase IV</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">619</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=609-619&author=B.+Kuhnauthor=M.+Hennigauthor=P.+Mattei&title=Molecular+recognition+of+ligands+in+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of ligands in dipeptidyl peptidase IV</span></div><div class="casAuthors">Kuhn, Bernd; Hennig, Michael; Mattei, Patrizio</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-619</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The serine protease dipeptidyl peptidase IV (DPP-IV) is a clin. validated target for the treatment of type II diabetes and has received considerable interest from the pharmaceutical industry over the last years.  Concomitant with a large variety of published small mol. DPP-IV inhibitors almost twenty co-crystal structures have been released to the public as of May 2006.  In this review, we discuss the structural characteristics of the DPP-IV binding site and use the available x-ray information together with published structure-activity relationship data to identify the mol. interactions that are most important for tight enzyme-inhibitor binding.  Optimized interactions with the two key recognition motifs, i.e. the lipophilic S1 pocket and the neg. charged Glu 205/206 pair, result in large gains in binding free energy, which can be further improved by addnl. favorable contacts to side chains that flank the active site.  First examples show that the lessons learned from the x-ray structures can be successfully incorporated into the design of novel DPP-IV inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTQohM2c75l7Vg90H21EOLACvtfcHk0lgU8b_AxHrJlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers7s%253D&md5=f7e9b1cdff1f900a3fc83a6a758f1eea</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.2174%2F156802607780091064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091064%26sid%3Dliteratum%253Aachs%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DMattei%26aufirst%3DP.%26atitle%3DMolecular%2520recognition%2520of%2520ligands%2520in%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D609%26epage%3D619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Discovery of JANUVIA (sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type-2 diabetes</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">568</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFersrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=557-568&author=N.+A.+Thornberryauthor=A.+E.+Weber&title=Discovery+of+JANUVIA+%28sitagliptin%29%2C+a+selective+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type-2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of JANUVIA (sitagliptin), a selective dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span></div><div class="casAuthors">Thornberry, Nancy A.; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">557-568</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The emergence of glucagon-like peptide 1 (GLP-1) as a well validated approach to the treatment of type 2 diabetes and preclin. validation of dipeptidyl peptidase IV (DPP-4) inhibition as an alternate, oral approach to GLP-1 therapy prompted the initiation of a DPP-4 inhibitor program at Merck in 1999.  DPP-4 inhibitors threo- and allo-isoleucyl thiazolidide were in-licensed to jump start the program; however, development was discontinued due to profound toxicity in rat and dog safety studies.  The observation that both compds. inhibit the related proline peptidases DPP8 and DPP9 led to the hypothesis that inhibition of DPP8 and/or DPP9 could evoke severe toxicities in preclin. species.  Indeed, the obsd. toxicities were recapitulated with a selective dual DPP8/9 inhibitor but not with an inhibitor selective for DPP-4.  Thus, medicinal chem. efforts focused on identifying a highly selective DPP-4 inhibitor for clin. development.  Initial work in an α-amino acid series related to isoleucyl thiazolidide was discontinued due to lack of selectivity; however, SAR studies on two screening leads led to the identification of a highly selective β-amino acid piperazine series.  In an effort to stabilize the piperazine moiety, which was extensively metabolized in vivo, a series of bicyclic derivs. were prepd., culminating in the identification of a potent and selective triazolopiperazine series.  Unlike their monocyclic counterparts, these analogs typically showed excellent pharmacokinetic properties in preclin. species.  Optimization of this series led to the discovery of JANUVIA (sitagliptin), a highly selective DPP-4 inhibitor for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY2DdNBCPea7Vg90H21EOLACvtfcHk0lgU8b_AxHrJlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFersrY%253D&md5=8221de915c797c517f6116acb9c03cd1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.2174%2F156802607780091028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091028%26sid%3Dliteratum%253Aachs%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520JANUVIA%2520%2528sitagliptin%2529%252C%2520a%2520selective%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type-2%2520diabetes%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D557%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">White, J.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-IV inhibitors: pharmacological profile and clinical use</span> <span class="citation_source-journal">Clin. Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2337%2Fdiaclin.26.2.53" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=53-57&author=J.+White&title=Dipeptidyl+peptidase-IV+inhibitors%3A+pharmacological+profile+and+clinical+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.2337%2Fdiaclin.26.2.53&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiaclin.26.2.53%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%26atitle%3DDipeptidyl%2520peptidase-IV%2520inhibitors%253A%2520pharmacological%2520profile%2520and%2520clinical%2520use%26jtitle%3DClin.%2520Diabetes%26date%3D2008%26volume%3D26%26spage%3D53%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Feng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stafford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldor, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kassel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, L.</span><span> </span><span class="NLM_article-title">Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2297</span><span class="NLM_x">–</span> <span class="NLM_lpage">2300</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070104l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2297-2300&author=J.+Fengauthor=Z.+Zhangauthor=M.+Wallaceauthor=J.+Staffordauthor=S.+Kaldorauthor=D.+Kasselauthor=M.+Navreauthor=L.+Shi&title=Discovery+of+alogliptin%3A+a+potent%2C+selective%2C+bioavailable%2C+and+efficacious+inhibitor+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm070104l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070104l%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DWallace%26aufirst%3DM.%26aulast%3DStafford%26aufirst%3DJ.%26aulast%3DKaldor%26aufirst%3DS.%26aulast%3DKassel%26aufirst%3DD.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DShi%26aufirst%3DL.%26atitle%3DDiscovery%2520of%2520alogliptin%253A%2520a%2520potent%252C%2520selective%252C%2520bioavailable%252C%2520and%2520efficacious%2520inhibitor%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2297%26epage%3D2300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Belyae, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambeir, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vedemikova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharpe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span> </span><span class="NLM_article-title">Structure–activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1041</span><span class="NLM_x">–</span> <span class="NLM_lpage">1052</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1041-1052&author=A.+Belyaeauthor=X.+Zhangauthor=K.+Augustynsauthor=A.+M.+Lambeirauthor=I.+De+Meesterauthor=I.+Vedemikovaauthor=S.+Scharpeauthor=A.+Haemers&title=Structure%E2%80%93activity+relationship+of+diaryl+phosphonate+esters+as+potent+irreversible+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelyae%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DLambeir%26aufirst%3DA.%2BM.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DVedemikova%26aufirst%3DI.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DHaemers%26aufirst%3DA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520of%2520diaryl%2520phosphonate%2520esters%2520as%2520potent%2520irreversible%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1041%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Villhauer, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naderi, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russel, M .E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, T. E.</span><span> </span><span class="NLM_article-title">1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino] acetyl-2-(<i>S</i>)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2362</span><span class="NLM_x">–</span> <span class="NLM_lpage">2365</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025522z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2362-2365&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+E.+Dunningauthor=B.+L.+Mangoldauthor=M.+D.+Moneauthor=M+.E.+Russelauthor=S.+C.+Weldonauthor=T.+E.+Hughes&title=1-%5B2-%5B%285-Cyanopyridin-2-yl%29amino%5Dethylamino%5D+acetyl-2-%28S%29-pyrrolidinecarbonitrile%3A+a+potent%2C+selective%2C+and+orally+bioavailable+dipeptidyl+peptidase+IV+inhibitor+with+antihyperglycemic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm025522z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025522z%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DMone%26aufirst%3DM.%2BD.%26aulast%3DRussel%26aufirst%3DM%2B.E.%26aulast%3DWeldon%26aufirst%3DS.%2BC.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-%255B2-%255B%25285-Cyanopyridin-2-yl%2529amino%255Dethylamino%255D%2520acetyl-2-%2528S%2529-pyrrolidinecarbonitrile%253A%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520with%2520antihyperglycemic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2362%26epage%3D2365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Villhauer, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naderi, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkey, B. N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunning, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangold, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, T. E.</span><span> </span><span class="NLM_article-title">1-3[(3-Hydroxy-1-adamantyl)amino] acetyl-2-cyano-(<i>S</i>)-pyrrolidine, a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2774</span><span class="NLM_x">–</span> <span class="NLM_lpage">2789</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030091l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2774-2789&author=E.+B.+Villhauerauthor=J.+A.+Brinkmanauthor=G.+B.+Naderiauthor=B.+N.+F.+Burkeyauthor=B.+E.+Dunningauthor=K.+Prasadauthor=B.+L.+Mangoldauthor=M.+E.+Russellauthor=T.+E.+Hughes&title=1-3%5B%283-Hydroxy-1-adamantyl%29amino%5D+acetyl-2-cyano-%28S%29-pyrrolidine%2C+a+potent%2C+selective%2C+and+orally+bioavailable+dipeptidyl+peptidase+IV+inhibitor+with+antihyperglycemic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm030091l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030091l%26sid%3Dliteratum%253Aachs%26aulast%3DVillhauer%26aufirst%3DE.%2BB.%26aulast%3DBrinkman%26aufirst%3DJ.%2BA.%26aulast%3DNaderi%26aufirst%3DG.%2BB.%26aulast%3DBurkey%26aufirst%3DB.%2BN.%2BF.%26aulast%3DDunning%26aufirst%3DB.%2BE.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DMangold%26aufirst%3DB.%2BL.%26aulast%3DRussell%26aufirst%3DM.%2BE.%26aulast%3DHughes%26aufirst%3DT.%2BE.%26atitle%3D1-3%255B%25283-Hydroxy-1-adamantyl%2529amino%255D%2520acetyl-2-cyano-%2528S%2529-pyrrolidine%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520with%2520antihyperglycemic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2774%26epage%3D2789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lautar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wozniak, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalish, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyakoy, S.</span><span> </span><span class="NLM_article-title">Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5579</span><span class="NLM_x">–</span> <span class="NLM_lpage">5583</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=5579-5583&author=D.+Ferrarisauthor=Y.+S.+Koauthor=D.+Calvinauthor=T.+Chiouauthor=S.+Lautarauthor=B.+Thomasauthor=K.+Wozniakauthor=C.+Rojasauthor=V.+Kalishauthor=S.+Belyakoy&title=Ketopyrrolidines+and+ketoazetidines+as+potent+dipeptidyl+peptidase+IV+%28DPP+IV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DKo%26aufirst%3DY.%2BS.%26aulast%3DCalvin%26aufirst%3DD.%26aulast%3DChiou%26aufirst%3DT.%26aulast%3DLautar%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DB.%26aulast%3DWozniak%26aufirst%3DK.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DKalish%26aufirst%3DV.%26aulast%3DBelyakoy%26aufirst%3DS.%26atitle%3DKetopyrrolidines%2520and%2520ketoazetidines%2520as%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP%2520IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D5579%26epage%3D5583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Magnin, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulsky, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanks, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitkoff, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L. G.</span><span> </span><span class="NLM_article-title">Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5- methanoprolinenitrile-based inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2598</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049924d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2587-2598&author=D.+R.+Magninauthor=J.+A.+Roblauthor=R.+B.+Sulskyauthor=D.+J.+Augeriauthor=Y.+Huangauthor=L.+M.+Simpkinsauthor=P.+C.+Tanksauthor=D.+A.+Betebennerauthor=J.+G.+Robertsonauthor=B.+E.+Abboa-Offeiauthor=A.+Wangauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=D.+F.+Sitkoffauthor=M.+F.+Malleyauthor=J.+Z.+Gougoutasauthor=A.+Khannaauthor=Q.+Huangauthor=S.+P.+Hanauthor=R.+A.+Parkerauthor=L.+G.+Hamann&title=Synthesis+of+novel+potent+dipeptidyl+peptidase+IV+inhibitors+with+enhanced+chemical+stability%3A+interplay+between+the+N-terminal+amino+acid+alkyl+side+chain+and+the+cyclopropyl+group+of+alpha-aminoacyl-l-cis-4%2C5-+methanoprolinenitrile-based+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm049924d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049924d%26sid%3Dliteratum%253Aachs%26aulast%3DMagnin%26aufirst%3DD.%2BR.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DSulsky%26aufirst%3DR.%2BB.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTanks%26aufirst%3DP.%2BC.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DAbboa-Offei%26aufirst%3DB.%2BE.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DSitkoff%26aufirst%3DD.%2BF.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL.%2BG.%26atitle%3DSynthesis%2520of%2520novel%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520with%2520enhanced%2520chemical%2520stability%253A%2520interplay%2520between%2520the%2520N-terminal%2520amino%2520acid%2520alkyl%2520side%2520chain%2520and%2520the%2520cyclopropyl%2520group%2520of%2520alpha-aminoacyl-l-cis-4%252C5-%2520methanoprolinenitrile-based%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2587%26epage%3D2598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Peters, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kritter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehringer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hennig, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loeffler, B. M.</span><span> </span><span class="NLM_article-title">Aminomethylpyrimidines as novel DPP-IV inhibitors: a 105-fold activity increase by optimization of aromatic substituents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1491-1493&author=J.+U.+Petersauthor=S.+Weberauthor=S.+Kritterauthor=P.+Weissauthor=A.+Wallierauthor=M.+Boehringerauthor=M.+Hennigauthor=B.+Kuhnauthor=B.+M.+Loeffler&title=Aminomethylpyrimidines+as+novel+DPP-IV+inhibitors%3A+a+105-fold+activity+increase+by+optimization+of+aromatic+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26aulast%3DWeber%26aufirst%3DS.%26aulast%3DKritter%26aufirst%3DS.%26aulast%3DWeiss%26aufirst%3DP.%26aulast%3DWallier%26aufirst%3DA.%26aulast%3DBoehringer%26aufirst%3DM.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DLoeffler%26aufirst%3DB.%2BM.%26atitle%3DAminomethylpyrimidines%2520as%2520novel%2520DPP-IV%2520inhibitors%253A%2520a%2520105-fold%2520activity%2520increase%2520by%2520optimization%2520of%2520aromatic%2520substituents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D1491%26epage%3D1493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">1-((S)-γ-Substituted prolyl)-(<i>S</i>)-2-cyanopyrrolidine as a novel series of highly potent DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2441</span><span class="NLM_x">–</span> <span class="NLM_lpage">2445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2441-2445&author=H.+Sakashitaauthor=H.+Kitajimaauthor=M.+Nakamuraauthor=F.+Akahoshiauthor=Y.+Hayashi&title=1-%28%28S%29-%CE%B3-Substituted+prolyl%29-%28S%29-2-cyanopyrrolidine+as+a+novel+series+of+highly+potent+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DKitajima%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3D1-%2528%2528S%2529-%25CE%25B3-Substituted%2520prolyl%2529-%2528S%2529-2-cyanopyrrolidine%2520as%2520a%2520novel%2520series%2520of%2520highly%2520potent%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2441%26epage%3D2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumiuchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">[(<i>S</i>)-γ-(Arylamino)prolyl]thiazolidine compounds as a novel series of potent and stable DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3662</span><span class="NLM_x">–</span> <span class="NLM_lpage">3671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3662-3671&author=H.+Sakashitaauthor=F.+Akahoshiauthor=H.+Kitajimaauthor=R.+Tsutsumiuchiauthor=Y.+Hayashi&title=%5B%28S%29-%CE%B3-%28Arylamino%29prolyl%5Dthiazolidine+compounds+as+a+novel+series+of+potent+and+stable+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DKitajima%26aufirst%3DH.%26aulast%3DTsutsumiuchi%26aufirst%3DR.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3D%255B%2528S%2529-%25CE%25B3-%2528Arylamino%2529prolyl%255Dthiazolidine%2520compounds%2520as%2520a%2520novel%2520series%2520of%2520potent%2520and%2520stable%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3662%26epage%3D3671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashina, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumiuchi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, S.</span><span> </span><span class="NLM_article-title">Lead optimization of [(<i>S</i>)-γ-(arylamino)prolyl]thiazolidine focused on γ-substituent: indoline compounds as potent DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">655</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=641-655&author=H.+Sakashitaauthor=F.+Akahoshiauthor=T.+Yoshidaauthor=H.+Kitajimaauthor=Y.+Hayashiauthor=S.+Ishiiauthor=Y.+Takashinaauthor=R.+Tsutsumiuchiauthor=S.+Ono&title=Lead+optimization+of+%5B%28S%29-%CE%B3-%28arylamino%29prolyl%5Dthiazolidine+focused+on+%CE%B3-substituent%3A+indoline+compounds+as+potent+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DKitajima%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DS.%26aulast%3DTakashina%26aufirst%3DY.%26aulast%3DTsutsumiuchi%26aufirst%3DR.%26aulast%3DOno%26aufirst%3DS.%26atitle%3DLead%2520optimization%2520of%2520%255B%2528S%2529-%25CE%25B3-%2528arylamino%2529prolyl%255Dthiazolidine%2520focused%2520on%2520%25CE%25B3-substituent%253A%2520indoline%2520compounds%2520as%2520potent%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D641%26epage%3D655" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Haffner, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDougald, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reister, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conlee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenhard, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croom, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secosky-Chang, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McConn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, P. R.</span><span> </span><span class="NLM_article-title">2-Cyano-4-fluoro-1-thiovalylpyrrolidine analogues as potent inhibitors of DPP-IV</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">5257</span><span class="NLM_x">–</span> <span class="NLM_lpage">5261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=5257-5261&author=C.+D.+Haffnerauthor=D.+L.+McDougaldauthor=S.+M.+Reisterauthor=B.+D.+Thompsonauthor=C.+Conleeauthor=J.+Fangauthor=J.+Bassauthor=J.+M.+Lenhardauthor=D.+Croomauthor=M.+B.+Secosky-Changauthor=T.+Tomaszekauthor=D.+McConnauthor=K.+Wells-Knechtauthor=P.+R.+Johnson&title=2-Cyano-4-fluoro-1-thiovalylpyrrolidine+analogues+as+potent+inhibitors+of+DPP-IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaffner%26aufirst%3DC.%2BD.%26aulast%3DMcDougald%26aufirst%3DD.%2BL.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DThompson%26aufirst%3DB.%2BD.%26aulast%3DConlee%26aufirst%3DC.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DBass%26aufirst%3DJ.%26aulast%3DLenhard%26aufirst%3DJ.%2BM.%26aulast%3DCroom%26aufirst%3DD.%26aulast%3DSecosky-Chang%26aufirst%3DM.%2BB.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DMcConn%26aufirst%3DD.%26aulast%3DWells-Knecht%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DP.%2BR.%26atitle%3D2-Cyano-4-fluoro-1-thiovalylpyrrolidine%2520analogues%2520as%2520potent%2520inhibitors%2520of%2520DPP-IV%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D5257%26epage%3D5261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Fukushima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiratate, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munetomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of potent 3- or 4-substituted-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">6053</span><span class="NLM_x">–</span> <span class="NLM_lpage">6061</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=6053-6061&author=H.+Fukushimaauthor=A.+Hiratateauthor=M.+Takahashiauthor=M.+Satioauthor=E.+Munetomoauthor=K.+Kitanoauthor=H.+Saitoauthor=Y.+Takaokaauthor=K.+Yamamoto&title=Synthesis+and+structure%E2%80%93activity+relationships+of+potent+3-+or+4-substituted-2-cyanopyrrolidine+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFukushima%26aufirst%3DH.%26aulast%3DHiratate%26aufirst%3DA.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DSatio%26aufirst%3DM.%26aulast%3DMunetomo%26aufirst%3DE.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DTakaoka%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520potent%25203-%2520or%25204-substituted-2-cyanopyrrolidine%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D6053%26epage%3D6061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Abe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umezawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, Y. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muraoka, Y.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">785</span><span class="NLM_x">–</span> <span class="NLM_lpage">797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=785-797&author=M.+Abeauthor=T.+Akiyamaauthor=Y.+Umezawaauthor=K.+Yamamotoauthor=M.+Nagaiauthor=H.+Yamazakiauthor=Y.+I.+Ichikawaauthor=Y.+Muraoka&title=Synthesis+and+biological+activity+of+sulphostin+analogues%2C+novel+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbe%26aufirst%3DM.%26aulast%3DAkiyama%26aufirst%3DT.%26aulast%3DUmezawa%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DK.%26aulast%3DNagai%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DH.%26aulast%3DIchikawa%26aufirst%3DY.%2BI.%26aulast%3DMuraoka%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520sulphostin%2520analogues%252C%2520novel%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D785%26epage%3D797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Gilmore, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McShane, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, B.</span><span> </span><span class="NLM_article-title">Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2006&pages=373-379&author=B.+F.+Gilmoreauthor=L.+Carsonauthor=L.+L.+McShaneauthor=D.+Quinnauthor=W.+A.+Coulterauthor=B.+Walker&title=Synthesis%2C+kinetic+evaluation%2C+and+utilization+of+a+biotinylated+dipeptide+proline+diphenyl+phosphonate+for+the+disclosure+of+dipeptidyl+peptidase+IV-like+serine+proteases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilmore%26aufirst%3DB.%2BF.%26aulast%3DCarson%26aufirst%3DL.%26aulast%3DMcShane%26aufirst%3DL.%2BL.%26aulast%3DQuinn%26aufirst%3DD.%26aulast%3DCoulter%26aufirst%3DW.%2BA.%26aulast%3DWalker%26aufirst%3DB.%26atitle%3DSynthesis%252C%2520kinetic%2520evaluation%252C%2520and%2520utilization%2520of%2520a%2520biotinylated%2520dipeptide%2520proline%2520diphenyl%2520phosphonate%2520for%2520the%2520disclosure%2520of%2520dipeptidyl%2520peptidase%2520IV-like%2520serine%2520proteases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D347%26spage%3D373%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Yoshida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakashita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahoshi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">[(<i>S</i>)-γ-(4-Aryl-1-piperazinyl)-l-prolyl] thiazolidines as a novel series of highly potent and long-lasting DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2618</span><span class="NLM_x">–</span> <span class="NLM_lpage">2621</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2618-2621&author=T.+Yoshidaauthor=H.+Sakashitaauthor=F.+Akahoshiauthor=Y.+Hayashi&title=%5B%28S%29-%CE%B3-%284-Aryl-1-piperazinyl%29-l-prolyl%5D+thiazolidines+as+a+novel+series+of+highly+potent+and+long-lasting+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DT.%26aulast%3DSakashita%26aufirst%3DH.%26aulast%3DAkahoshi%26aufirst%3DF.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3D%255B%2528S%2529-%25CE%25B3-%25284-Aryl-1-piperazinyl%2529-l-prolyl%255D%2520thiazolidines%2520as%2520a%2520novel%2520series%2520of%2520highly%2520potent%2520and%2520long-lasting%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2618%26epage%3D2621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryor, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-IV) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5934</span><span class="NLM_x">–</span> <span class="NLM_lpage">5939</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5934-5939&author=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+D.+Pryorauthor=F.+Marsilioauthor=J.+K.+Wuauthor=H.+Heauthor=K.+A.+Lyonsauthor=G.+J.+Eiermannauthor=A.+Petrovauthor=G.+Scapinauthor=R.+A.+Patelauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=D.+Kim&title=Design%2C+synthesis%2C+and+biological+evaluation+of+triazolopiperazine-based+%CE%B2-amino+amides+as+potent%2C+orally+active+dipeptidyl+peptidase+IV+%28DPP-IV%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DPryor%26aufirst%3DK.%2BD.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DKim%26aufirst%3DD.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520triazolopiperazine-based%2520%25CE%25B2-amino%2520amides%2520as%2520potent%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-IV%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5934%26epage%3D5939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Corbett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dirico, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boscoe, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ammirati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanVolkenburg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPherson, R .K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, E. D.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent amido- and benzyl-substituted cis-3-amino-4-(2-cyanopyrrolidide) pyrrolidinyl DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6707</span><span class="NLM_x">–</span> <span class="NLM_lpage">6713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6707-6713&author=J.+W.+Corbettauthor=K.+Diricoauthor=W.+Songauthor=B.+P.+Boscoeauthor=S.+D.+Doranauthor=D.+Boyerauthor=X.+Qiuauthor=M.+Ammiratiauthor=M.+A.+VanVolkenburgauthor=R+.K.+McPhersonauthor=J.+C.+Parkerauthor=E.+D.+Cox&title=Design+and+synthesis+of+potent+amido-+and+benzyl-substituted+cis-3-amino-4-%282-cyanopyrrolidide%29+pyrrolidinyl+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorbett%26aufirst%3DJ.%2BW.%26aulast%3DDirico%26aufirst%3DK.%26aulast%3DSong%26aufirst%3DW.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DBoyer%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DVanVolkenburg%26aufirst%3DM.%2BA.%26aulast%3DMcPherson%26aufirst%3DR%2B.K.%26aulast%3DParker%26aufirst%3DJ.%2BC.%26aulast%3DCox%26aufirst%3DE.%2BD.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%2520amido-%2520and%2520benzyl-substituted%2520cis-3-amino-4-%25282-cyanopyrrolidide%2529%2520pyrrolidinyl%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6707%26epage%3D6713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Coumar, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chao, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiaang, W. T.</span><span> </span><span class="NLM_article-title">3-[2-((2<i>S</i>)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methylbutyramide analogues as selective DPP-IV inhibitors for the treatement of type-II diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2077</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1274</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2077&pages=1274-1279&author=M.+S.+Coumarauthor=C.+N.+Changauthor=C.+T.+Chenauthor=X.+Chenauthor=C.+H.+Chienauthor=T.+Y.+Tsaiauthor=J.+H.+Chengauthor=H.+Y.+Wuauthor=C.+H.+Hanauthor=S.+H.+Wuauthor=Y.+W.+Huangauthor=T.+Hsuauthor=L.+J.+Hsuauthor=Y.+S.+Chaoauthor=H.+P.+Hsiehauthor=W.+T.+Jiaang&title=3-%5B2-%28%282S%29-2-Cyano-pyrrolidin-1-yl%29-2-oxo-ethylamino%5D-3-methylbutyramide+analogues+as+selective+DPP-IV+inhibitors+for+the+treatement+of+type-II+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoumar%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DC.%2BN.%26aulast%3DChen%26aufirst%3DC.%2BT.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChien%26aufirst%3DC.%2BH.%26aulast%3DTsai%26aufirst%3DT.%2BY.%26aulast%3DCheng%26aufirst%3DJ.%2BH.%26aulast%3DWu%26aufirst%3DH.%2BY.%26aulast%3DHan%26aufirst%3DC.%2BH.%26aulast%3DWu%26aufirst%3DS.%2BH.%26aulast%3DHuang%26aufirst%3DY.%2BW.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DHsu%26aufirst%3DL.%2BJ.%26aulast%3DChao%26aufirst%3DY.%2BS.%26aulast%3DHsieh%26aufirst%3DH.%2BP.%26aulast%3DJiaang%26aufirst%3DW.%2BT.%26atitle%3D3-%255B2-%2528%25282S%2529-2-Cyano-pyrrolidin-1-yl%2529-2-oxo-ethylamino%255D-3-methylbutyramide%2520analogues%2520as%2520selective%2520DPP-IV%2520inhibitors%2520for%2520the%2520treatement%2520of%2520type-II%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2077%26volume%3D17%26spage%3D1274%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Biftu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doss, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-IV inhibitors by application of molecular modeling and X-ray crystallography of sitaliptin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3384</span><span class="NLM_x">–</span> <span class="NLM_lpage">3387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3384-3387&author=T.+Biftuauthor=G.+Scapinauthor=S.+Singhauthor=D.+Fengauthor=J.+W.+Beckerauthor=G.+Eiermannauthor=H.+Heauthor=K.+Lyonsauthor=S.+Patelauthor=A.+Petrovauthor=R.+S.+Royauthor=B.+Zhangauthor=J.+Wuauthor=X.+Zhangauthor=G.+A.+Dossauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=Rational+design+of+a+novel%2C+potent%2C+and+orally+bioavailable+cyclohexylamine+DPP-IV+inhibitors+by+application+of+molecular+modeling+and+X-ray+crystallography+of+sitaliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBiftu%26aufirst%3DT.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DEiermann%26aufirst%3DG.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DDoss%26aufirst%3DG.%2BA.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DRational%2520design%2520of%2520a%2520novel%252C%2520potent%252C%2520and%2520orally%2520bioavailable%2520cyclohexylamine%2520DPP-IV%2520inhibitors%2520by%2520application%2520of%2520molecular%2520modeling%2520and%2520X-ray%2520crystallography%2520of%2520sitaliptin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3384%26epage%3D3387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Gao, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheridan, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biftu, T.</span><span> </span><span class="NLM_article-title">Modeling assisted rational design of novel, potent, and selective pyrrolopyrimidine DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3877</span><span class="NLM_x">–</span> <span class="NLM_lpage">3879</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3877-3879&author=Y.+D.+Gaoauthor=D.+Fengauthor=R.+P.+Sheridanauthor=G.+Scapinauthor=S.+B.+Patelauthor=J.+K.+Wuauthor=X.+Zhangauthor=R.+S.+Royauthor=N.+A.+Thornberryauthor=A.+E.+Weberauthor=T.+Biftu&title=Modeling+assisted+rational+design+of+novel%2C+potent%2C+and+selective+pyrrolopyrimidine+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DY.%2BD.%26aulast%3DFeng%26aufirst%3DD.%26aulast%3DSheridan%26aufirst%3DR.%2BP.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRoy%26aufirst%3DR.%2BS.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26aulast%3DBiftu%26aufirst%3DT.%26atitle%3DModeling%2520assisted%2520rational%2520design%2520of%2520novel%252C%2520potent%252C%2520and%2520selective%2520pyrrolopyrimidine%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3877%26epage%3D3879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kondo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nekado, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinoshita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatayama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1613</span><span class="NLM_x">–</span> <span class="NLM_lpage">1631</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1613-1631&author=T.+Kondoauthor=T.+Nekadoauthor=I.+Sugimotoauthor=K.+Ochiauthor=S.+Takaiauthor=A.+Kinoshitaauthor=A.+Hatayamaauthor=S.+Yamamotoauthor=K.+Kishikawaauthor=H.+Nakaiauthor=M.+Toda&title=Design+and+synthesis+of+DPP-IV+inhibitors+lacking+the+electrophilic+nitrile+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DNekado%26aufirst%3DT.%26aulast%3DSugimoto%26aufirst%3DI.%26aulast%3DOchi%26aufirst%3DK.%26aulast%3DTakai%26aufirst%3DS.%26aulast%3DKinoshita%26aufirst%3DA.%26aulast%3DHatayama%26aufirst%3DA.%26aulast%3DYamamoto%26aufirst%3DS.%26aulast%3DKishikawa%26aufirst%3DK.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520DPP-IV%2520inhibitors%2520lacking%2520the%2520electrophilic%2520nitrile%2520group%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D16%26spage%3D1613%26epage%3D1631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Peters, J. U.</span><span> </span><span class="NLM_article-title">11 years of cyanopyrrolidines as DPP-IV inhibitors</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">579</span><span class="NLM_x">–</span> <span class="NLM_lpage">595</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352679" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=579-595&author=J.+U.+Peters&title=11+years+of+cyanopyrrolidines+as+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">11 years of cyanopyrrolidines as DPP-IV inhibitors</span></div><div class="casAuthors">Peters, Jens-Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-595</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyanopyrrolidines (cyanopyrrolidides, pyrrolidine-2-nitriles, prolinenitriles) as inhibitors of the serine protease dipeptidyl peptidase IV (DPP-IV, DP IV, CD26, EC 3.4.14.5) were first reported in 1995.  The interest in this compd. class grew immensely when DPP-IV was discovered as a target for the treatment of type 2 diabetes.  The research on cyanopyrrolidines cumulated in the discoveries of vildagliptin (LAF237, NVP-LAF237) and saxagliptin (BMS-477118).  These compds. entered Phase III clin. trials in 2004 and 2005, resp., and an application for market approval has been filed for vildagliptin in 2006.  Today cyanopyrrolidines are, as judged by the nos. of patent applications, the most prominent of several series of DPP-IV inhibitors, and have the potential to become valuable medicines for type 2 diabetes in the near future.  This review summarizes some historical aspects of the discovery of cyanopyrrolidine DPP-IV inhibitors, and then focuses mainly on structure-activity-relationships, the evolution of different subseries, the possibilities to improve on the chem. instability that is assocd. with this compd. class, and on the discoveries of vildagliptin and saxagliptin.  Within this context, the properties of individual compds. and results from biol. studies are discussed.  The rationale of DPP-IV inhibition, clin. data, and the relevance of selectivity over related proteases are extensively reviewed in other contributions to this issue of Curr.  Top. Med. Chem., and are therefore only very briefly touched.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMheLlajHi0LVg90H21EOLACvtfcHk0li6GhdhSyE7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers78%253D&md5=1aed687f83d3d35a2a581956ce4b82e0</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F156802607780091000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091000%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DJ.%2BU.%26atitle%3D11%2520years%2520of%2520cyanopyrrolidines%2520as%2520DPP-IV%2520inhibitors%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D579%26epage%3D595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, T.</span><span> </span><span class="NLM_article-title">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F092986712802002491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22709010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=3982-3999&author=Y.+Liuauthor=Y.+Huauthor=T.+Liu&title=Recent+advances+in+non-peptidomimetic+dipeptidyl+peptidase+4+inhibitors%3A+medicinal+chemistry+and+preclinical+aspects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in non-peptidomimetic dipeptidyl peptidase 4 inhibitors: medicinal chemistry and preclinical aspects</span></div><div class="casAuthors">Liu, Y.; Hu, Y.; Liu, T.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3982-3999</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase 4 (DPP-4), a substrate-specific serine protease, has been validated as a promising drug target for the treatment of type 2 diabetes.  DPP-4 inhibitors significantly lowered blood glucose levels in patients with type 2 diabetes without common body wt. gain, hypoglycemia and gastrointestinal disturbance side effects.  Therefore, DPP-4 inhibitors attracted more and more attention.  In particular, non-peptidomimetic DPP-4 inhibitors have been a focus of research and development and made great progress in recent years, which resulted in the discovery of a wide variety of potent non-peptidomimetic DPP-4 inhibitors.  Some of them, such as sitagliptin, alogliptin and linagliptin have already been used as marketed drugs, while others have been into clin. trials.  Based on the core structural features of non-peptidomimetic DPP-4 inhibitors, seven types were classified in the article.  For each type, we focused on the description of strategies for design and optimization, together with a discussion on concluded structure-activity relationships (SAR).  In addn., the contribution of specific substituents to the inhibition of DPP-4 was summarized.  Selectivity towards the inhibition of DPP-4 over dipeptidyl peptidase 8 (DPP-8) and dipeptidyl peptidase 9 (DPP-9) was also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLqQuB1LrfarVg90H21EOLACvtfcHk0li6GhdhSyE7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12nu7rI&md5=3ad3980483dcdcb29868b34a8bf77e6b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.2174%2F092986712802002491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712802002491%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DT.%26atitle%3DRecent%2520advances%2520in%2520non-peptidomimetic%2520dipeptidyl%2520peptidase%25204%2520inhibitors%253A%2520medicinal%2520chemistry%2520and%2520preclinical%2520aspects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D3982%26epage%3D3999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Miyamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikedo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsubotani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maezaki, H.</span><span> </span><span class="NLM_article-title">Discovery of a 3-pyridylacetamide derivative (TAK-100) as a potent, selective and orally active dipeptidyl peptidase IV (DPP-IV) inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">831</span><span class="NLM_x">–</span> <span class="NLM_lpage">850</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101236h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=831-850&author=Y.+Miyamotoauthor=Y.+Bannoauthor=T.+Yamashitaauthor=T.+Fujimotoauthor=S.+Oiauthor=Y.+Moritohauthor=T.+Asakawaauthor=O.+Kataokaauthor=K.+Takeuchiauthor=N.+Suzukiauthor=K.+Ikedoauthor=T.+Kosakaauthor=S.+Tsubotaniauthor=A.+Taniauthor=M.+Sasakiauthor=M.+Funamiauthor=M.+Amanoauthor=Y.+Yamamotoauthor=K.+Aertgeertsauthor=J.+Yanoauthor=H.+Maezaki&title=Discovery+of+a+3-pyridylacetamide+derivative+%28TAK-100%29+as+a+potent%2C+selective+and+orally+active+dipeptidyl+peptidase+IV+%28DPP-IV%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm101236h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101236h%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DY.%26aulast%3DBanno%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DFujimoto%26aufirst%3DT.%26aulast%3DOi%26aufirst%3DS.%26aulast%3DMoritoh%26aufirst%3DY.%26aulast%3DAsakawa%26aufirst%3DT.%26aulast%3DKataoka%26aufirst%3DO.%26aulast%3DTakeuchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIkedo%26aufirst%3DK.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DTsubotani%26aufirst%3DS.%26aulast%3DTani%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DM.%26aulast%3DFunami%26aufirst%3DM.%26aulast%3DAmano%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DMaezaki%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%25203-pyridylacetamide%2520derivative%2520%2528TAK-100%2529%2520as%2520a%2520potent%252C%2520selective%2520and%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520%2528DPP-IV%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D831%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">van der Veken, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haemers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyns, K.</span><span> </span><span class="NLM_article-title">Prolyl peptidase related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">635</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F156802607780091046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=17352682" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsFers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=621-635&author=P.+van+der+Vekenauthor=A.+Haemersauthor=K.+Augustyns&title=Prolyl+peptidase+related+to+dipeptidyl+peptidase+IV%3A+potential+of+specific+inhibitors+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery</span></div><div class="casAuthors">Van der Veken, Pieter; Haemers, Achiel; Augustyns, Koen</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-635</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase IV (DPP IV) is a validated target for the treatment of type 2 diabetes, with several inhibitors currently in phase 3 clin. trials.  This review will mainly focus on proline-specific dipeptidyl peptidases related to DPP IV: fibroblast activation protein (FAP), dipeptidyl peptidase 8 (DPP8), dipeptidyl peptidase 9 (DPP9) and dipeptidyl peptidase II (DPP II).  The biochem. and biol. properties of these enzymes will be discussed, as well as the therapeutic potential of their inhibition.  The development of potent and selective inhibitors for each of these peptidases will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJIONvS_JxQ7Vg90H21EOLACvtfcHk0ljiI_7gYqyNcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsFers7k%253D&md5=7ee3184cc0d1fd12b34cf268ae27aaec</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2174%2F156802607780091046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802607780091046%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DHaemers%26aufirst%3DA.%26aulast%3DAugustyns%26aufirst%3DK.%26atitle%3DProlyl%2520peptidase%2520related%2520to%2520dipeptidyl%2520peptidase%2520IV%253A%2520potential%2520of%2520specific%2520inhibitors%2520in%2520drug%2520discovery%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2007%26volume%3D7%26spage%3D621%26epage%3D635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Ristic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byiers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, D.</span><span> </span><span class="NLM_article-title">Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response</span> <span class="citation_source-journal">Diabetes, Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1463-1326.2005.00539.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=16219012" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1amt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=692-698&author=S.+Risticauthor=S.+Byiersauthor=J.+Foleyauthor=D.+Holmes&title=Improved+glycaemic+control+with+dipeptidyl+peptidase-4+inhibition+in+patients+with+type+2+diabetes%3A+vildagliptin+%28LAF237%29+dose+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: Vildagliptin (LAF237) dose response</span></div><div class="casAuthors">Ristic, S.; Byiers, S.; Foley, J.; Holmes, D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">692-698</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Objective: A novel treatment option for diabetic patients is the enhancement of incretin hormone activity by inhibition of the enzyme dipeptidyl peptidase-4 (DPP-4).  This study was designed to establish a dose of the DPP-4-inhibitor vildagliptin (LAF237) that was effective in reducing HbA1c levels and was safe and well tolerated in patients with type 2 diabetes.  Patients and Methods: The study of 279 patients with type 2 diabetes consisted of a 4-wk run-in phase where patients received placebo and a 12-wk active treatment phase where they received one of the following dosages of vildagliptin: 25 mg twice daily, 25, 50 or 100 mg once daily (qd), or placebo.  Results: There was a statistically significant redn. in HbA1c levels in the vildagliptin 50 mg qd (p = 0.003) and 100 mg qd groups (p = 0.004) compared with the placebo group.  The mean 4-h postprandial glucose level was significantly reduced from placebo in the vildagliptin 50 mg qd group (p = 0.012) and mean 4-h postprandial insulin was significantly increased from baseline vs. placebo in the vildagliptin 100 mg qd group (p = 0.022).  The assessment of β-cell function (HOMA-B) was significantly increased in the vildagliptin 100 mg qd treatment group (p = 0.007).  The incidence of adverse events was similar in all treatment groups including placebo.  Conclusions: Vildagliptin, at 50 and 100 mg qd, was effective in reducing HbA1c levels compared with placebo in patients with type 2 diabetes.  Vildagliptin at dosages up to 100 mg qd appeared safe and well tolerated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoacW0uyENfOLVg90H21EOLACvtfcHk0ljiI_7gYqyNcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1amt73M&md5=0bb376c79066c25a3b4cc8466ef8f80b</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1111%2Fj.1463-1326.2005.00539.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1463-1326.2005.00539.x%26sid%3Dliteratum%253Aachs%26aulast%3DRistic%26aufirst%3DS.%26aulast%3DByiers%26aufirst%3DS.%26aulast%3DFoley%26aufirst%3DJ.%26aulast%3DHolmes%26aufirst%3DD.%26atitle%3DImproved%2520glycaemic%2520control%2520with%2520dipeptidyl%2520peptidase-4%2520inhibition%2520in%2520patients%2520with%2520type%25202%2520diabetes%253A%2520vildagliptin%2520%2528LAF237%2529%2520dose%2520response%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2005%26volume%3D7%26spage%3D692%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Russell-Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gough, S.</span><span> </span><span class="NLM_article-title">Recent advances in incretin-based therapy</span> <span class="citation_source-journal">Clin. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">489</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1365-2265.2012.04483.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22804841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlait77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=489-499&author=D.+Russell-Jonesauthor=S.+Gough&title=Recent+advances+in+incretin-based+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in incretin-based therapies</span></div><div class="casAuthors">Russell-Jones, David; Gough, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Endocrinology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">489-499</span>CODEN:
                <span class="NLM_cas:coden">CLECAP</span>;
        ISSN:<span class="NLM_cas:issn">0300-0664</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Summary: The global burden of type 2 diabetes is growing.  Traditional therapies are suboptimal and there is a clear unmet need for treatments that offer effective glucose control while addressing the comorbid factors assocd. with diabetes, such as obesity and risk of cardiovascular disease, without the fear of hypoglycemia.  Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors offer a novel way of reducing hyperglycemia by targeting the incretin system.  This review provides an overview of the development of incretin-based therapies and explains their differing modes of action compared with traditional interventions.  A comparison of the clin. profiles of current glucagon-like peptide-1 receptor agonists [liraglutide and exenatide (twice-daily and once-weekly)] and dipeptidyl peptidase-4 inhibitors (sitagliptin, saxagliptin, vildagliptin and linagliptin) is performed alongside a discussion of the placement of incretin-based therapies in treatment guidelines.  Further improvements in this class are expected, and we will examine some of the novel glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsNSR5LO-DNrVg90H21EOLACvtfcHk0ljiI_7gYqyNcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlait77L&md5=974697d2411b2f5d5df73dbe9515ae38</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2265.2012.04483.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2265.2012.04483.x%26sid%3Dliteratum%253Aachs%26aulast%3DRussell-Jones%26aufirst%3DD.%26aulast%3DGough%26aufirst%3DS.%26atitle%3DRecent%2520advances%2520in%2520incretin-based%2520therapy%26jtitle%3DClin.%2520Endocrinol.%26date%3D2012%26volume%3D77%26spage%3D489%26epage%3D499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Cox, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J. B.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy</span> <span class="citation_source-journal">Drug Healthcare Patient Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXitFyjtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=7-19&author=M.+E.+Coxauthor=J.+Rowellauthor=L.+Corsinoauthor=J.+B.+Green&title=Dipeptidyl+peptidase-4+inhibitors+in+the+management+of+type+2+diabetes%3A+safety%2C+tolerability%2C+and+efficacy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy</span></div><div class="casAuthors">Cox, Mary Elizabeth; Rowell, Jennifer; Corsino, Leonor; Green, Jennifer B.</div><div class="citationInfo"><span class="NLM_cas:title">Drug, Healthcare and Patient Safety</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">7-19</span>CODEN:
                <span class="NLM_cas:coden">DHPSBA</span>;
        ISSN:<span class="NLM_cas:issn">1179-1365</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Although glycemic control is an important and effective way to prevent and minimize the worsening of diabetes-related complications, type 2 diabetes is a progressive disease which often proves difficult to manage.  Most affected patients will eventually require therapy with multiple medications in order to reach appropriate glycemic targets.  The dipeptidyl peptidase-4 (DPP-4) inhibitors constitute a relatively new class of oral medications for the treatment of type 2 diabetes, which has become widely incorporated into clin. practice.  This review summarizes the available data on the efficacy, safety, and tolerability of these medications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3zlOnURaMwLVg90H21EOLACvtfcHk0liToqd_bNxJqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXitFyjtb8%253D&md5=22788015259562ead81bfa404aa19008</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DM.%2BE.%26aulast%3DRowell%26aufirst%3DJ.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DGreen%26aufirst%3DJ.%2BB.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520in%2520the%2520management%2520of%2520type%25202%2520diabetes%253A%2520safety%252C%2520tolerability%252C%2520and%2520efficacy%26jtitle%3DDrug%2520Healthcare%2520Patient%2520Saf.%26date%3D2010%26volume%3D2%26spage%3D7%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Keeks, E. D.</span><span> </span><span class="NLM_article-title">Linagliptin: a review of its use in the management of type 2 diabetes mellitus</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1793-1824&author=E.+D.+Keeks&title=Linagliptin%3A+a+review+of+its+use+in+the+management+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeeks%26aufirst%3DE.%2BD.%26atitle%3DLinagliptin%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520the%2520management%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DDrugs%26date%3D2012%26volume%3D72%26spage%3D1793%26epage%3D1824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Bohanson, N.</span><span> </span><span class="NLM_article-title">Overview of the gliptin class (dipeptidyl peptidase-4 inhibitors) in clinical practice</span> <span class="citation_source-journal">Postgrad. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=19940423" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=121&author=N.+Bohanson&title=Overview+of+the+gliptin+class+%28dipeptidyl+peptidase-4+inhibitors%29+in+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohanson%26aufirst%3DN.%26atitle%3DOverview%2520of%2520the%2520gliptin%2520class%2520%2528dipeptidyl%2520peptidase-4%2520inhibitors%2529%2520in%2520clinical%2520practice%26jtitle%3DPostgrad.%2520Med.%26date%3D2009%26spage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Karagiannis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paletas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsapas, A.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis</span> <span class="citation_source-journal">BMJ</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">344</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1369</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2012&pages=e1369&author=T.+Karagiannisauthor=P.+Paschosauthor=K.+Paletasauthor=D.+R.+Matthewsauthor=A.+Tsapas&title=Dipeptidyl+peptidase-4+inhibitors+for+treatment+of+type+2+diabetes+mellitus+in+the+clinical+setting%3A+systematic+review+and+meta-analysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKaragiannis%26aufirst%3DT.%26aulast%3DPaschos%26aufirst%3DP.%26aulast%3DPaletas%26aufirst%3DK.%26aulast%3DMatthews%26aufirst%3DD.%2BR.%26aulast%3DTsapas%26aufirst%3DA.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520for%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%2520in%2520the%2520clinical%2520setting%253A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DBMJ%26date%3D2012%26volume%3D344%26spage%3De1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Derosa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maffioli, P.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors: 3 years of experience</span> <span class="citation_source-journal">Diabetes Technol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1089%2Fdia.2011.0204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22324384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=350-364&author=G.+Derosaauthor=P.+Maffioli&title=Dipeptidyl+peptidase-4+inhibitors%3A+3+years+of+experience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience</span></div><div class="casAuthors">Derosa, Giuseppe; Maffioli, Pamela</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Technology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">350-364</span>CODEN:
                <span class="NLM_cas:coden">DTTHFH</span>;
        ISSN:<span class="NLM_cas:issn">1520-9156</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">According to the latest American Diabetes Assocn. guidelines, lowering glycated Hb (HbA1c) to below or around 7% has been shown to reduce microvascular and neuropathic complications of diabetes and, if implemented soon after the diagnosis of diabetes, is assocd. with long-term redn. in macrovascular disease.  Recently a new class of antidiabetes drugs has been developed, dipeptidyl peptidase-4 (DPP-4) inhibitors, which act by inhibiting DPP-4, the enzyme that inactivates glucagon-like peptide-1 (GLP-1).  Through the inhibition of DPP-4, DPP-4 inhibitors enhance the effects of GLP-1 and glucose-dependent insulinotropic peptide, increasing glucose-mediated insulin secretion and suppressing glucagon secretion.  We conducted a review analyzing clin. efficacy and safety of DPP-4 inhibitors, both alone and in combination with other antidiabetes drugs, including randomized controlled trials about sitagliptin, vildagliptin, saxagliptin, and linagliptin conducted in the latest 15 years.  We concluded that, once metformin fails to maintain glycemic control, addn. of DPP-4 inhibitors should be the logical choice: they seems to lower HbA1c levels by 0.6-0.9 percentage points and to have a comparable effect on HbA1c vs. the addn. of a sulfonylurea or glitazone.  They also have pos. effects on β-cell function, and they have neutral effects on body wt.  Furthermore, DPP-4 inhibitors prevent the risk of hypoglycemia posed by sulfonylureas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWF2HG6yjq3bVg90H21EOLACvtfcHk0liToqd_bNxJqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFSnsrk%253D&md5=c17b5978ffa303d88b1ad76dca040199</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1089%2Fdia.2011.0204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fdia.2011.0204%26sid%3Dliteratum%253Aachs%26aulast%3DDerosa%26aufirst%3DG.%26aulast%3DMaffioli%26aufirst%3DP.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%253A%25203%2520years%2520of%2520experience%26jtitle%3DDiabetes%2520Technol.%2520Ther.%26date%3D2012%26volume%3D14%26spage%3D350%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Kim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beconi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eiermann, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalchick, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leiting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsilio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCann, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyvratt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornberry, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, A. E.</span><span> </span><span class="NLM_article-title">(2<i>R</i>)-4-Oxo-4-[3-(trifuloromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-7(8<i>H</i>)-yl]-1-(2,4,5-trifluoro-phenyl)butan-2-amine: a potent orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0493156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=141-151&author=D.+Kimauthor=L.+Wangauthor=M.+Beconiauthor=G.+J.+Eiermannauthor=M.+H.+Fisherauthor=H.+Heauthor=G.+J.+Hickeyauthor=J.+E.+Kowalchickauthor=B.+Leitingauthor=K.+Lyonsauthor=F.+Marsilioauthor=M.+E.+McCannauthor=R.+A.+Patelauthor=A.+Petrovauthor=G.+Scapinauthor=S.+B.+Patelauthor=R.+Sinhaauthor=J.+K.+Wuauthor=M.+J.+Wyvrattauthor=B.+B.+Zhangauthor=L.+Zhuauthor=N.+A.+Thornberryauthor=A.+E.+Weber&title=%282R%29-4-Oxo-4-%5B3-%28trifuloromethyl%29-5%2C6-dihydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%5D-1-%282%2C4%2C5-trifluoro-phenyl%29butan-2-amine%3A+a+potent+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm0493156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493156%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBeconi%26aufirst%3DM.%26aulast%3DEiermann%26aufirst%3DG.%2BJ.%26aulast%3DFisher%26aufirst%3DM.%2BH.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DHickey%26aufirst%3DG.%2BJ.%26aulast%3DKowalchick%26aufirst%3DJ.%2BE.%26aulast%3DLeiting%26aufirst%3DB.%26aulast%3DLyons%26aufirst%3DK.%26aulast%3DMarsilio%26aufirst%3DF.%26aulast%3DMcCann%26aufirst%3DM.%2BE.%26aulast%3DPatel%26aufirst%3DR.%2BA.%26aulast%3DPetrov%26aufirst%3DA.%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%2BK.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DB.%2BB.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DThornberry%26aufirst%3DN.%2BA.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3D%25282R%2529-4-Oxo-4-%255B3-%2528trifuloromethyl%2529-5%252C6-dihydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%255D-1-%25282%252C4%252C5-trifluoro-phenyl%2529butan-2-amine%253A%2520a%2520potent%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D141%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robl, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taunk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abboa-Offei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cap, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzel, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcinkeviciene, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirby, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamann, L G.</span><span> </span><span class="NLM_article-title">Discovery and preclinical profile of saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">5025</span><span class="NLM_x">–</span> <span class="NLM_lpage">5037</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050261p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5025-5037&author=D.+J.+Augeriauthor=J.+A.+Roblauthor=A.+Khannaauthor=J.+G.+Robertsonauthor=A.+Wangauthor=L.+M.+Simpkinsauthor=P.+Taunkauthor=Q.+Huangauthor=S.+P.+Hanauthor=B.+Abboa-Offeiauthor=M.+Capauthor=L.+Xinauthor=L.+Taoauthor=E.+Tozzoauthor=G.+E.+Welzelauthor=D.+M.+Eganauthor=J.+Marcinkevicieneauthor=S.+Y.+Changauthor=S.+A.+Billerauthor=M.+S.+Kirbyauthor=R.+A.+Parkerauthor=L+G.+Hamann&title=Discovery+and+preclinical+profile+of+saxagliptin+%28BMS-477118%29%3A+a+highly+potent%2C+long-acting%2C+orally+active+dipeptidyl+peptidase+IV+inhibitor+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes</span></div><div class="casAuthors">Augeri, David J.; Robl, Jeffrey A.; Betebenner, David A.; Magnin, David R.; Khanna, Ashish; Robertson, James G.; Wang, Aiying; Simpkins, Ligaya M.; Taunk, Prakash; Huang, Qi; Han, Song-Ping; Abboa-Offei, Benoni; Cap, Michael; Xin, Li; Tao, Li; Tozzo, Effie; Welzel, Gustav E.; Egan, Donald M.; Marcinkeviciene, Jovita; Chang, Shu Y.; Biller, Scott A.; Kirby, Mark S.; Parker, Rex A.; Hamann, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5025-5037</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Efforts to further elucidate structure-activity relationships (SAR) within the authors previously disclosed series of β-quaternary amino acid linked L-cis-4,5-methanoprolinenitrile dipeptidyl peptidase IV (DPP-IV) inhibitors led to the investigation of vinyl substitution at the β-position of α-cycloalkyl-substituted glycines.  Despite poor systemic exposure, vinyl-substituted compds. showed extended duration of action in acute rat ex vivo plasma DPP-IV inhibition models.  Oxygenated putative metabolites were prepd. and were shown to exhibit the potency and extended duration of action of their precursors in efficacy models measuring glucose clearance in Zuckerfa/fa rats.  Extension of this approach to adamantylglycine-derived inhibitors led to the discovery of highly potent inhibitors, including hydroxyadamantyl compd. BMS-477118 (saxagliptin), a highly efficacious, stable, and long-acting DPP-IV inhibitor, which is currently undergoing clin. trials for treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGrIJX7K8p67Vg90H21EOLACvtfcHk0lhM_HLblDNnDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsVeltb0%253D&md5=878355880133bb0ddd6bd14ecbf1d070</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Fjm050261p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050261p%26sid%3Dliteratum%253Aachs%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DKhanna%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DJ.%2BG.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DTaunk%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DS.%2BP.%26aulast%3DAbboa-Offei%26aufirst%3DB.%26aulast%3DCap%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DL.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DWelzel%26aufirst%3DG.%2BE.%26aulast%3DEgan%26aufirst%3DD.%2BM.%26aulast%3DMarcinkeviciene%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DS.%2BY.%26aulast%3DBiller%26aufirst%3DS.%2BA.%26aulast%3DKirby%26aufirst%3DM.%2BS.%26aulast%3DParker%26aufirst%3DR.%2BA.%26aulast%3DHamann%26aufirst%3DL%2BG.%26atitle%3DDiscovery%2520and%2520preclinical%2520profile%2520of%2520saxagliptin%2520%2528BMS-477118%2529%253A%2520a%2520highly%2520potent%252C%2520long-acting%252C%2520orally%2520active%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5025%26epage%3D5037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Eckhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langkop, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mark, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadayyon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfengle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guth, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Himmelsbach, E.</span><span> </span><span class="NLM_article-title">8-[(3<i>R</i>)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1<i>H</i>-purine-2,6-dione (BI-1356) a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type-2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6450</span><span class="NLM_x">–</span> <span class="NLM_lpage">6453</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701280z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6450-6453&author=M.+Eckhardtauthor=E.+Langkopauthor=M.+Markauthor=M.+Tadayyonauthor=L.+Thomasauthor=H.+Narauthor=W.+Pfengleauthor=B.+Guthauthor=R.+Lotzauthor=P.+Siegelauthor=H.+Fuchsauthor=E.+Himmelsbach&title=8-%5B%283R%29-3-aminopiperidin-1-yl%5D-7-%28but-2-yn-1-yl%29-3-methyl-1-%5B%284-methylquinazolin-2-yl%29methyl%5D-3%2C7-dihydro-1H-purine-2%2C6-dione+%28BI-1356%29+a+highly+potent%2C+selective%2C+long-acting%2C+and+orally+bioavailable+DPP-4+inhibitor+for+the+treatment+of+type-2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fjm701280z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701280z%26sid%3Dliteratum%253Aachs%26aulast%3DEckhardt%26aufirst%3DM.%26aulast%3DLangkop%26aufirst%3DE.%26aulast%3DMark%26aufirst%3DM.%26aulast%3DTadayyon%26aufirst%3DM.%26aulast%3DThomas%26aufirst%3DL.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DPfengle%26aufirst%3DW.%26aulast%3DGuth%26aufirst%3DB.%26aulast%3DLotz%26aufirst%3DR.%26aulast%3DSiegel%26aufirst%3DP.%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DHimmelsbach%26aufirst%3DE.%26atitle%3D8-%255B%25283R%2529-3-aminopiperidin-1-yl%255D-7-%2528but-2-yn-1-yl%2529-3-methyl-1-%255B%25284-methylquinazolin-2-yl%2529methyl%255D-3%252C7-dihydro-1H-purine-2%252C6-dione%2520%2528BI-1356%2529%2520a%2520highly%2520potent%252C%2520selective%252C%2520long-acting%252C%2520and%2520orally%2520bioavailable%2520DPP-4%2520inhibitor%2520for%2520the%2520treatment%2520of%2520type-2%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6450%26epage%3D6453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Lim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K. S.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitors, after multiple dosing in healthy volunteers</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1365-2125.2009.03376.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=20002082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFOruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2009&pages=883-890&author=K.+S.+Limauthor=J.+Y.+Choauthor=B.+H.+Kimauthor=J.+R.+Kimauthor=H.+S.+Kimauthor=D.+K.+Kimauthor=S.+H.+Kimauthor=H.+J.+Yimauthor=S.+H.+Leeauthor=S.+G.+Shinauthor=I.+J.+Jangauthor=K.+S.+Yu&title=Pharmacokinetics+and+pharmacodynamics+of+LC15-0444%2C+a+novel+dipeptidyl+peptidase+IV+inhibitors%2C+after+multiple+dosing+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers</span></div><div class="casAuthors">Lim, Kyoung Soo; Cho, Joo-Youn; Kim, Bo-Hyung; Kim, Jung-Ryul; Kim, Hwa-Sook; Kim, Dong-Kyu; Kim, Sung-Ho; Yim, Hyeon Joo; Lee, Sung-Hack; Shin, Sang-Goo; Jang, In-Jin; Yu, Kyung-Sang</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">883-890</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">LC15-0444 is a selective and competitive inhibitor of dipeptidyl peptidase (DPP) IV with potential for the treatment of Type 2 diabetes.  The aim was to investigate the pharmacokinetic (PK) and pharmacodynamic (PD) profiles after multiple oral ascending doses of LC15-0444 in healthy male subjects.  A dose block-randomized, double-blind, placebo-controlled, parallel group study was performed in three groups with 10 subjects (eight for active drug; two for placebo) per group; each group received 200, 400, or 600 mg of LC15-0444 once daily for 10 days.  Blood and urine samples were collected up to 24 h after the first dosing and up to 72 h after the last dosing.  The LC15-0444 concn.-time profiles exhibited characteristics of multicompartment disposition.  No dose- or time-dependent change in PK parameters was obsd.  Mean elimination half-life was in a range 16.6-20.1 h in the dose groups.  Mean renal clearance and fraction of unchanged drug excreted in urine was 18.6-21.9 and 0.40-0.48 l/h-1, resp.  In the steady state, mean accumulation ratios by dose groups were between 1.22 and 1.31.  More than 80% inhibition of DPP IV activity from baseline was sustained for >24 h in all dose groups.  This study provides evidence of the pharmacol. activity of LC15-0444 in humans.  LC15-0444 possesses PK and PD characteristics that support a once-daily dosing regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8t1ofBW7qarVg90H21EOLACvtfcHk0lhM_HLblDNnDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFOruw%253D%253D&md5=9f6e162ae8274a38ce5feeb415c6badd</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2009.03376.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2009.03376.x%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DK.%2BS.%26aulast%3DCho%26aufirst%3DJ.%2BY.%26aulast%3DKim%26aufirst%3DB.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BR.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BK.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DYim%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DS.%2BH.%26aulast%3DShin%26aufirst%3DS.%2BG.%26aulast%3DJang%26aufirst%3DI.%2BJ.%26aulast%3DYu%26aufirst%3DK.%2BS.%26atitle%3DPharmacokinetics%2520and%2520pharmacodynamics%2520of%2520LC15-0444%252C%2520a%2520novel%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%252C%2520after%2520multiple%2520dosing%2520in%2520healthy%2520volunteers%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2009%26volume%3D68%26spage%3D883%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Yang, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shivane, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitale, S. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarwal, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dharmalingam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makesh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baik, S. H.</span><span> </span><span class="NLM_article-title">A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes</span> <span class="citation_source-journal">Diabetes, Obes. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">410</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fdom.12042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=23170990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvVems7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=410-416&author=S.+J.+Yangauthor=K.+W.+Minauthor=S.+K.+Guptaauthor=J.+Y.+Parkauthor=V.+K.+Shivaneauthor=S.+U.+Pitaleauthor=P.+K.+Agarwalauthor=A.+Sosaleauthor=P.+Gandhiauthor=M.+Dharmalingamauthor=V.+Mohanauthor=U.+Makeshauthor=D.+M.+Kimauthor=J.+A.+Kimauthor=P.+K.+Kimauthor=S.+H.+Baik&title=A+multicentre%2C+multinational%2C+randomized%2C+placebo-controlled%2C+double-blind%2C+phase+3+trial+to+evaluate+the+efficacy+and+safety+of+gemigliptin+%28LC15-0444%29+in+patients+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes</span></div><div class="casAuthors">Yang, S. J.; Min, K. W.; Gupta, S. K.; Park, J. Y.; Shivane, V. K.; Pitale, S. U.; Agarwal, P. K.; Sosale, A.; Gandhi, P.; Dharmalingam, M.; Mohan, V.; Mahesh, U.; Kim, D. M.; Kim, Y. S.; Kim, J. A.; Kim, P. K.; Baik, S. H.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes, Obesity and Metabolism</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">410-416</span>CODEN:
                <span class="NLM_cas:coden">DOMEF6</span>;
        ISSN:<span class="NLM_cas:issn">1462-8902</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Aim : This study was designed to assess the efficacy and safety of the dipeptidyl peptidase IV inhibitor gemigliptin (LC15-0444) 50 mg vs. placebo in patients with type 2 diabetes.  Methods : We conducted a 24-wk, randomized, double-blind, placebo-controlled phase III trial in 182 patients (74 from Korea and 108 from India) with type 2 diabetes.  After an initial 2 wk of a diet and exercise program followed by 2 wk of a single-blind placebo run-in period, eligible patients were randomized to gemigliptin 50 mg or placebo, receiving the assigned treatment for 24 wk.  HbA1c and fasting plasma glucose (FPG) were measured periodically, and oral glucose tolerance test was performed at baseline and weeks 12 and 24.  Results : At week 24, gemigliptin treatment led to significant redns. in HbA1c measurements compared to placebo (adjust mean after subtracting the placebo effect size: -0.71%, 95% confidence interval: -1.04 to -0.37%).  A significantly greater proportion of patients achieved an HbA1c <7% with gemigliptin than with placebo.  The placebo-subtracted FPG change from baseline at week 24 was -19.80 mg/dL.  The overall incidence rates for adverse events were similar in the gemigliptin and placebo groups.  Conclusions : This study showed the efficacy and safety of gemigliptin 50 mg administered once daily as a monotherapy for type 2 diabetes patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEY87Pr0t-7Vg90H21EOLACvtfcHk0ljoq53z81RGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvVems7Y%253D&md5=2902a431fbc6fb1375ae686679aee126</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1111%2Fdom.12042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fdom.12042%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%2BJ.%26aulast%3DMin%26aufirst%3DK.%2BW.%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DPark%26aufirst%3DJ.%2BY.%26aulast%3DShivane%26aufirst%3DV.%2BK.%26aulast%3DPitale%26aufirst%3DS.%2BU.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26aulast%3DSosale%26aufirst%3DA.%26aulast%3DGandhi%26aufirst%3DP.%26aulast%3DDharmalingam%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DV.%26aulast%3DMakesh%26aufirst%3DU.%26aulast%3DKim%26aufirst%3DD.%2BM.%26aulast%3DKim%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DP.%2BK.%26aulast%3DBaik%26aufirst%3DS.%2BH.%26atitle%3DA%2520multicentre%252C%2520multinational%252C%2520randomized%252C%2520placebo-controlled%252C%2520double-blind%252C%2520phase%25203%2520trial%2520to%2520evaluate%2520the%2520efficacy%2520and%2520safety%2520of%2520gemigliptin%2520%2528LC15-0444%2529%2520in%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDiabetes%252C%2520Obes.%2520Metab.%26date%3D2013%26volume%3D15%26spage%3D410%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Agrawal, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikshit, S. N.</span><span> </span><span class="NLM_article-title">Linagliptin, a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">970</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F138945012800675731" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22420306" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFeku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=970-983&author=R.+Agrawalauthor=J.+Pratimaauthor=S.+N.+Dikshit&title=Linagliptin%2C+a+novel+methylxanthin+based+approved+dipeptidyl+peptidase-4+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor</span></div><div class="casAuthors">Agrawal, Ritesh; Jain, Pratima; Dikshit, S. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">970-983</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chem., methylxanthine nucleus based Linagliptin (BI-1356, BI-1356-BS) is a dipeptidyl peptidase-IV inhibitor, which has been developed by Boehringer Ingelheim in assocn. with Lilly for the treatment of Type-II Diabetes.  Linagliptin was marketed by Lilly under the trade name Tradjenta and Trajenta.  Linagliptin was approved as the once-daily dose by USFDA on 2 May 2011, for the treatment of Type-II Diabetes.  Linagliptin 5mg once daily dose was approved based on a clin. trial program, which was conducted on approx. 4,000 adults with Type-II Diabetes.  Linagliptin demonstrated statistically significant mean difference in HbA1c from placebo of up to 0.72 percent, when it was used monotherapically.  In patients, who were not adequately controlled on metformin or metformin plus sulfonylurea, the addn. of Linagliptin resulted in a statistically significant mean difference in HbA1c from placebo of -0.6 percent.  Linagliptin was obsd. to produce significant redn. in fasting plasma glucose (FPG) compared to placebo, when used as a monotherapy in combination with metformin, sulfonylurea and/or pioglitazone.  Linagliptin demonstrated significant redn. post-prandial glucose (PPG) levels in two hours as compared with placebo in monotherapy as well as in combination with metformin.  In vitro assays also anticipated that Linagliptin is a potent DPP-IV inhibitor as well as it exhibits good selectivity for DPP-IV as compared with other DPPs.  The in-vivo studies also demonstrated same anticipation with respect to Linagliptin.  Consequently, increasing the GLP-1 levels so far improved glucose tolerance in both healthy animals.  X-ray crystallog. anticipates that Linagliptin complexes with human DPP-IV enzyme, e.g. butynyl substituent occupies the S1 hydrophobic pocket of the enzyme; the aminopiperidine substituent in the xanthine scaffold occupies the S2 subsite and its primary amine interacts with the key amino acid residues, which involves in the recognition of peptide substrates.  In the present review, we have tried to cover comparative study of DPP-IV inhibitors, chem., phys. properties, com. synthesis, patent portfolio, cryst. polymorphic forms of Linagliptin and its receptor interaction, Pharmacophore rational, mechanism, clin. studies, preclin., adverse effect, available formulations, dose regimen, co-therapy of Linagliptin, giving emphasis on the medicinal chem. aspects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1laoHnRsVb7Vg90H21EOLACvtfcHk0ljoq53z81RGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFeku7Y%253D&md5=457dcf4f094ac456cc7691285750c01a</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.2174%2F138945012800675731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945012800675731%26sid%3Dliteratum%253Aachs%26aulast%3DAgrawal%26aufirst%3DR.%26aulast%3DPratima%26aufirst%3DJ.%26aulast%3DDikshit%26aufirst%3DS.%2BN.%26atitle%3DLinagliptin%252C%2520a%2520novel%2520methylxanthin%2520based%2520approved%2520dipeptidyl%2520peptidase-4%2520inhibitor%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2012%26volume%3D13%26spage%3D970%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Scheen, A. J.</span><span> </span><span class="NLM_article-title">A review of gliptins in 2011</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1517%2F14656566.2012.642866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22149369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SktLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=81-99&author=A.+J.+Scheen&title=A+review+of+gliptins+in+2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A review of gliptins in 2011</span></div><div class="casAuthors">Scheen, Andre J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-99</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Dipeptidylpeptidase-4 (DPP-4) inhibitors offer new options for the management of type 2 diabetes (T2DM).Areas covered: This paper is an updated review, providing an anal. of both the similarities and the differences between the various compds. known as gliptins, currently used in the clinic (sitagliptin, vildagliptin, saxagliptin, alogliptin and linagliptin).  This paper discusses the pharmacokinetic and pharmacodynamic characteristics of gliptins; both the efficacy and safety profiles of gliptins in clin. trials (compared with classical glucose-lowering agents), given as monotherapy or in combination, including in special populations; the positioning of DPP-4 inhibitors in the management of T2DM in recent guidelines; and various unanswered questions and perspectives.Expert opinion: The role of DPP-4 inhibitors in the therapeutic armamentarium of T2DM is evolving, as their potential strengths and weaknesses become better defined.  Future crit. issues may include the durability of glucose control, resulting from better β-cell protection, pos. effects on cardiovascular outcomes and long-term safety issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3V0SJS_tTbrVg90H21EOLACvtfcHk0ljoq53z81RGCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SktLfF&md5=8d90eb509fb8649ac1f0fc068f874e0a</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1517%2F14656566.2012.642866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.2012.642866%26sid%3Dliteratum%253Aachs%26aulast%3DScheen%26aufirst%3DA.%2BJ.%26atitle%3DA%2520review%2520of%2520gliptins%2520in%25202011%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2012%26volume%3D13%26spage%3D81%26epage%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Gueler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmschrott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeing, C. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erbel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankenstein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleissner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruhpaewar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehlerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dengler, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katus, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doesch, A. O.</span><span> </span><span class="NLM_article-title">Effects of vildagliptin (galvus) therapy in patients with type 2 diabetes</span> <span class="citation_source-journal">Drug Des. Dev. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVSntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2013&pages=297-303&author=I.+Guelerauthor=S.+Muellerauthor=M.+Helmschrottauthor=C.+U.+Oeingauthor=C.+Erbelauthor=L.+Frankensteinauthor=C.+Gleissnerauthor=A.+Ruhpaewarauthor=P.+Ehlermanauthor=T.+J.+Denglerauthor=H.+A.+Katusauthor=A.+O.+Doesch&title=Effects+of+vildagliptin+%28galvus%29+therapy+in+patients+with+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of vildagliptin (Galvus) therapy in patients with type 2 diabetes mellitus after heart transplantation</span></div><div class="casAuthors">Gueler, Ibrahim; Mueller, Susanne; Helmschrott, Matthias; Oeing, Christian U.; Erbel, Christian; Frankenstein, Lutz; Gleissner, Christian; Ruhparwar, Arjang; Ehlermann, Philipp; Dengler, Thomas J.; Katus, Hugo A.; Doesch, Andreas O.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Design, Development and Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">297-303</span>CODEN:
                <span class="NLM_cas:coden">DDDTAQ</span>;
        ISSN:<span class="NLM_cas:issn">1177-8881</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">Background: Type 2 Diabetes mellitus (T2DM) is a common comorbidity in patients after heart transplantation (HTx) and is assocd. with adverse long-term outcomes.  Methods: The retrospective study reported here analyzed the effects of vildagliptin therapy in stable patients post-HTx with T2DM and compared these with control patients for matched-pairs anal.  A total of 30 stable patients post-HTx with T2DM were included in the study.  Fifteen patients (mean age 58.6 ± 6.0 years, mean time post-HTx 4.9 ± 5.3 years, twelve male and three female) were included in the vildagliptin group (VG) and 15 patients were included in the control group (CG) (mean age 61.2 ± 8.3 years, mean time post-HTx 7.2 ± 6.6 years, all male).  Results: Mean glycated Hb (HbA1c) in the VG was 7.4% ± 0.7% before vs. 6.8% ± 0.8% after 8 mo of vildagliptin therapy (P = 0.002 vs. baseline).  In the CG, HbA1c was 7.0% ± 0.7% vs. 7.3% ± 1.2% at follow-up (P = 0.21).  Addnl., there was a significant redn. in mean blood glucose in the VG, from 165.0 ± 18.8 mg/dL to 147.9 ± 22.7 mg/dL (P = 0.002 vs. baseline), whereas mean blood glucose increased slightly in the CG from 154.7 ± 19.7 mg/dL to 162.6 ± 35.0 mg/dL (P = 0.21).  No statistically significant changes in body wt. (from 83.3 ± 10.8 kg to 82.0 ± 10.9 kg, P = 0.20), total cholesterol (1.5%, P = 0.68), or triglyceride levels (8.0%, P = 0.65) were seen in the VG.  No significant changes in immunosuppressive drug levels or dosages were obsd. in either group.  Conclusion: Vildagliptin therapy significantly reduced HbA1c and mean blood glucose levels in post-HTx patients in this study with T2DM and did not have any neg. effects on lipid profile or body wt.  Thus, vildagliptin therapy presented an interesting therapeutic approach for this selected patient cohort.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAIk48pts7FLVg90H21EOLACvtfcHk0lgV7mCkUPEUNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVSntLo%253D&md5=b0a4aa610c5d9cad1aaa897a5f4d7e4e</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGueler%26aufirst%3DI.%26aulast%3DMueller%26aufirst%3DS.%26aulast%3DHelmschrott%26aufirst%3DM.%26aulast%3DOeing%26aufirst%3DC.%2BU.%26aulast%3DErbel%26aufirst%3DC.%26aulast%3DFrankenstein%26aufirst%3DL.%26aulast%3DGleissner%26aufirst%3DC.%26aulast%3DRuhpaewar%26aufirst%3DA.%26aulast%3DEhlerman%26aufirst%3DP.%26aulast%3DDengler%26aufirst%3DT.%2BJ.%26aulast%3DKatus%26aufirst%3DH.%2BA.%26aulast%3DDoesch%26aufirst%3DA.%2BO.%26atitle%3DEffects%2520of%2520vildagliptin%2520%2528galvus%2529%2520therapy%2520in%2520patients%2520with%2520type%25202%2520diabetes%26jtitle%3DDrug%2520Des.%2520Dev.%2520Ther.%26date%3D2013%26volume%3D7%26spage%3D297%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Matteuchi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianpietro, O.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibition: linking chemical properties to clinical safety</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4753</span><span class="NLM_x">–</span> <span class="NLM_lpage">4760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.2174%2F092986711797535290" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=21919850" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4753-4760&author=E.+Matteuchiauthor=O.+Gianpietro&title=Dipeptidyl+peptidase-4+inhibition%3A+linking+chemical+properties+to+clinical+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.2174%2F092986711797535290&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797535290%26sid%3Dliteratum%253Aachs%26aulast%3DMatteuchi%26aufirst%3DE.%26aulast%3DGianpietro%26aufirst%3DO.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibition%253A%2520linking%2520chemical%2520properties%2520to%2520clinical%2520safety%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4753%26epage%3D4760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Gupta, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaltra, S.</span><span> </span><span class="NLM_article-title">Choosing a gliptin</span> <span class="citation_source-journal">Int. J. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=298-308&author=V.+Guptaauthor=S.+Kaltra&title=Choosing+a+gliptin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DV.%26aulast%3DKaltra%26aufirst%3DS.%26atitle%3DChoosing%2520a%2520gliptin%26jtitle%3DInt.%2520J.%2520Endocrinol.%2520Metab.%26date%3D2011%26volume%3D15%26spage%3D298%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Aleskow Stein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamos, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. N.</span><span> </span><span class="NLM_article-title">A review of the efficacy and safety of oral antidiabetic drugs</span> <span class="citation_source-journal">Expert Opin. Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1517%2F14740338.2013.752813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=23241069" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=153-175&author=S.+Aleskow+Steinauthor=E.+M.+Lamosauthor=S.+N.+Davis&title=A+review+of+the+efficacy+and+safety+of+oral+antidiabetic+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1517%2F14740338.2013.752813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.2013.752813%26sid%3Dliteratum%253Aachs%26aulast%3DAleskow%2BStein%26aufirst%3DS.%26aulast%3DLamos%26aufirst%3DE.%2BM.%26aulast%3DDavis%26aufirst%3DS.%2BN.%26atitle%3DA%2520review%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520oral%2520antidiabetic%2520drugs%26jtitle%3DExpert%2520Opin.%2520Drug%2520Saf.%26date%3D2013%26volume%3D12%26spage%3D153%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Landesdorfer, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jusko, W. J.</span><span> </span><span class="NLM_article-title">Mechanism-based population pharmacokinetic modeling in diabetes: vildagliptin as a tight binding inhibitor and substrate of dipeptidyl peptidase IV</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1365-2125.2011.04108.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=391-401&author=C.+B.+Landesdorferauthor=Y.+L.+Heauthor=W.+J.+Jusko&title=Mechanism-based+population+pharmacokinetic+modeling+in+diabetes%3A+vildagliptin+as+a+tight+binding+inhibitor+and+substrate+of+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.04108.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.04108.x%26sid%3Dliteratum%253Aachs%26aulast%3DLandesdorfer%26aufirst%3DC.%2BB.%26aulast%3DHe%26aufirst%3DY.%2BL.%26aulast%3DJusko%26aufirst%3DW.%2BJ.%26atitle%3DMechanism-based%2520population%2520pharmacokinetic%2520modeling%2520in%2520diabetes%253A%2520vildagliptin%2520as%2520a%2520tight%2520binding%2520inhibitor%2520and%2520substrate%2520of%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D73%26spage%3D391%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Gross, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polhamus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monz, B. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staabm, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Retlich, S.</span><span> </span><span class="NLM_article-title">A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, intreatment of type 2 diabetes mellitus</span> <span class="citation_source-journal">BMJ Open</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e001844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=e001844&author=J.+L.+Grossauthor=J.+Rogersauthor=D.+Polhamusauthor=W.+Gillespieauthor=C.+Friedrichauthor=Y.+Gongauthor=B.+U.+Monzauthor=S.+Patelauthor=A.+Staabmauthor=S.+Retlich&title=A+novel+model-based+meta-analysis+to+indirectly+estimate+the+comparative+efficacy+of+two+medications%3A+an+example+using+DPP-4+inhibitors%2C+sitagliptin+and+linagliptin%2C+intreatment+of+type+2+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGross%26aufirst%3DJ.%2BL.%26aulast%3DRogers%26aufirst%3DJ.%26aulast%3DPolhamus%26aufirst%3DD.%26aulast%3DGillespie%26aufirst%3DW.%26aulast%3DFriedrich%26aufirst%3DC.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMonz%26aufirst%3DB.%2BU.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DStaabm%26aufirst%3DA.%26aulast%3DRetlich%26aufirst%3DS.%26atitle%3DA%2520novel%2520model-based%2520meta-analysis%2520to%2520indirectly%2520estimate%2520the%2520comparative%2520efficacy%2520of%2520two%2520medications%253A%2520an%2520example%2520using%2520DPP-4%2520inhibitors%252C%2520sitagliptin%2520and%2520linagliptin%252C%2520intreatment%2520of%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DBMJ%2520Open%26date%3D2013%26volume%3D3%26spage%3De001844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Ervinna, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukmawati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamori, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watada, H.</span><span> </span><span class="NLM_article-title">Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">1260</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2013&pages=1260-1270&author=N.+Ervinnaauthor=T.+Mitaauthor=E.+Yasunariauthor=K.+Azumaauthor=R.+Tanakaauthor=S.+Fujimuraauthor=D.+Sukmawatiauthor=T.+Nomiyamaauthor=A.+Kanazawaauthor=R.+Kawamoriauthor=Y.+Fujitaniauthor=H.+Watada&title=Anagliptin%2C+a+DPP-4+inhibitor%2C+suppresses+proliferation+of+vascular+smooth+muscles+and+monocyte+inflammatory+reaction+and+attenuates+atherosclerosis+in+male+apo+E-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DErvinna%26aufirst%3DN.%26aulast%3DMita%26aufirst%3DT.%26aulast%3DYasunari%26aufirst%3DE.%26aulast%3DAzuma%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DR.%26aulast%3DFujimura%26aufirst%3DS.%26aulast%3DSukmawati%26aufirst%3DD.%26aulast%3DNomiyama%26aufirst%3DT.%26aulast%3DKanazawa%26aufirst%3DA.%26aulast%3DKawamori%26aufirst%3DR.%26aulast%3DFujitani%26aufirst%3DY.%26aulast%3DWatada%26aufirst%3DH.%26atitle%3DAnagliptin%252C%2520a%2520DPP-4%2520inhibitor%252C%2520suppresses%2520proliferation%2520of%2520vascular%2520smooth%2520muscles%2520and%2520monocyte%2520inflammatory%2520reaction%2520and%2520attenuates%2520atherosclerosis%2520in%2520male%2520apo%2520E-deficient%2520mice%26jtitle%3DEndocrinology%26date%3D2013%26volume%3D154%26spage%3D1260%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakairi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakufu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kakigami, T.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Org. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1186%2F2191-2858-1-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22373386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlersLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=7&author=N.+Katoauthor=M.+Okaauthor=T.+Muraseauthor=M.+Yoshidaauthor=M.+Sakairiauthor=M.+Yakufuauthor=S.+Yamashitaauthor=Y.+Yasudaauthor=A.+Yoshikawaauthor=Y.+Hayashiauthor=M.+Shiraiauthor=Y.+Mizunoauthor=M.+Takeuchiauthor=M.+Makinoauthor=M.+Takedaauthor=T.+Kakigami&title=Synthesis+and+pharmacological+characterization+of+potent%2C+selective%2C+and+orally+bioavailable+isoindoline+class+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Kato, Noriyasu; Oka, Mitsuru; Murase, Takayo; Yoshida, Masahiro; Sakairi, Masao; Yakufu, Mirensha; Yamashita, Satoko; Yasuda, Yoshika; Yoshikawa, Aya; Hayashi, Yuji; Shirai, Masahiro; Mizuno, Yukie; Takeuchi, Mitsuaki; Makino, Mitsuhiro; Takeda, Motohiro; Kakigami, Takuji</div><div class="citationInfo"><span class="NLM_cas:title">Organic and Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7/1-7/7</span>CODEN:
                <span class="NLM_cas:coden">OMCLBC</span>;
        ISSN:<span class="NLM_cas:issn">2191-2858</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Focused structure-activity relationships of isoindoline class DPP-IV inhibitors have led to the discovery of dihydroisoindoline I (R = Me) as a highly selective, potent inhibitor of DPP-IV.  In vivo studies in Wistar/ST rats showed that the above compd. was converted into the strongly active metabolite I (R = CH2OH) in high yield, resulting in good in-vivo efficacy for antihyperglycemic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqABXoMC9RVS7Vg90H21EOLACvtfcHk0lgmoV0wYQQ2MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlersLfE&md5=4d9ac4d59d5113c3297fc52db9ddc9fd</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1186%2F2191-2858-1-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-2858-1-7%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DN.%26aulast%3DOka%26aufirst%3DM.%26aulast%3DMurase%26aufirst%3DT.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DSakairi%26aufirst%3DM.%26aulast%3DYakufu%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DS.%26aulast%3DYasuda%26aufirst%3DY.%26aulast%3DYoshikawa%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DShirai%26aufirst%3DM.%26aulast%3DMizuno%26aufirst%3DY.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DMakino%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DKakigami%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520isoindoline%2520class%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DOrg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D1%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chae, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheong, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jo, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, C. Y.</span><span> </span><span class="NLM_article-title">DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2012&pages=21-29&author=M.+K.+Kimauthor=Y.+N.+Chaeauthor=H.+D.+Kimauthor=E.+K.+Yangauthor=E.+J.+Choauthor=S.+H.+Choiauthor=Y.+H.+Cheongauthor=H.+S.+Kimauthor=H.+J.+Kimauthor=Y.+W.+Joauthor=M.+H.+Sonauthor=S.+H.+Kimauthor=C.+Y.+Shin&title=DA-1229%2C+a+novel+and+potent+DPP4+inhibitor%2C+improves+insulin+resistance+and+delays+the+onset+of+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DChae%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DH.%2BD.%26aulast%3DYang%26aufirst%3DE.%2BK.%26aulast%3DCho%26aufirst%3DE.%2BJ.%26aulast%3DChoi%26aufirst%3DS.%2BH.%26aulast%3DCheong%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DJo%26aufirst%3DY.%2BW.%26aulast%3DSon%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DShin%26aufirst%3DC.%2BY.%26atitle%3DDA-1229%252C%2520a%2520novel%2520and%2520potent%2520DPP4%2520inhibitor%252C%2520improves%2520insulin%2520resistance%2520and%2520delays%2520the%2520onset%2520of%2520diabetes%26jtitle%3DLife%2520Sci.%26date%3D2012%26volume%3D90%26spage%3D21%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Yasuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagakura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsutani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emori, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikuta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, I.</span><span> </span><span class="NLM_article-title">E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-<i>4H</i>-imidazo[4,5-<i>d</i>]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase IV inhibitor</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">548</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.ejphar.2006.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=16973152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvFekt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=548&publication_year=2006&pages=181-187&author=N.+Yasudaauthor=T.+Nagakuraauthor=T.+Inoueauthor=K.+Yamazakiauthor=N.+Katsutaniauthor=O.+Takenakaauthor=R.+Clarkauthor=F.+Matsuuraauthor=E.+Emoriauthor=S.+Yoshikawaauthor=K.+Kiraauthor=H.+Ikutaauthor=T.+Okadaauthor=T.+Saekiauthor=O.+Asanoauthor=I.+Tanaka&title=E3024%2C+3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3%2C5-dihydro-4H-imidazo%5B4%2C5-d%5Dpyridazin-4-one+tosylate%2C+is+a+novel%2C+selective+and+competitive+dipeptidyl+peptidase+IV+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor</span></div><div class="casAuthors">Yasuda, Nobuyuki; Nagakura, Tadashi; Inoue, Takashi; Yamazaki, Kazuto; Katsutani, Naruo; Takenaka, Osamu; Clark, Richard; Matsuura, Fumiyoshi; Emori, Eita; Yoshikawa, Seiji; Kira, Kazunobu; Ikuta, Hironori; Okada, Toshimi; Saeki, Takao; Asano, Osamu; Tanaka, Isao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">548</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP-IV) inhibitors are expected to become a useful new class of anti-diabetic agent.  The aim of the present study is to characterize the in vitro and in vivo profile of E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, which is a novel imidazopyridazinone-derived DPP-IV inhibitor.  E3024 inhibited recombinant human and mouse DPP-IV with IC50 values of approx. 100 nM.  E3024 inhibited DPP-IV in human, mouse, rat and canine plasma with IC50 values of 140 to 400 nM.  In contrast, E3024 did not inhibit DPP-8 or DPP-9 activity.  Kinetic anal. indicated that E3024 is a competitive DPP-IV inhibitor.  In Zucker fa/fa rats, E3024 (1 mg/kg) reduced glucose excursion after glucose load, with increases in plasma insulin and active glucagon-like peptide-1 levels.  In fasted rats, this compd. did not cause hypoglycemia.  In a rat 4-wk toxicol. study, no notable changes were found at doses up to 750 mg/kg.  The present preclin. studies indicate that E3024 is a novel selective DPP-IV inhibitor with anti-diabetic effects and a good safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSLh02Uv1y0rVg90H21EOLACvtfcHk0lh-702BZh8Q2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvFekt7g%253D&md5=a419a83adc00184d53fef21b3b112835</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DN.%26aulast%3DNagakura%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DYamazaki%26aufirst%3DK.%26aulast%3DKatsutani%26aufirst%3DN.%26aulast%3DTakenaka%26aufirst%3DO.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DMatsuura%26aufirst%3DF.%26aulast%3DEmori%26aufirst%3DE.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DKira%26aufirst%3DK.%26aulast%3DIkuta%26aufirst%3DH.%26aulast%3DOkada%26aufirst%3DT.%26aulast%3DSaeki%26aufirst%3DT.%26aulast%3DAsano%26aufirst%3DO.%26aulast%3DTanaka%26aufirst%3DI.%26atitle%3DE3024%252C%25203-but-2-ynyl-5-methyl-2-piperazin-1-yl-3%252C5-dihydro-4H-imidazo%255B4%252C5-d%255Dpyridazin-4-one%2520tosylate%252C%2520is%2520a%2520novel%252C%2520selective%2520and%2520competitive%2520dipeptidyl%2520peptidase%2520IV%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D548%26spage%3D181%26epage%3D187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Biftu, T.</span><span> </span><span class="NLM_article-title">MK-3102: A Novel Once-Weekly DPP IV Inhibitor for Type 2 Diabetes</span>. Presented at the Society for Medicines Research Research Symposium, December 5,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>London, U.K.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=T.+Biftu&title=MK-3102%3A+A+Novel+Once-Weekly+DPP+IV+Inhibitor+for+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DBiftu%26aufirst%3DT.%26atitle%3DMK-3102%253A%2520A%2520Novel%2520Once-Weekly%2520DPP%2520IV%2520Inhibitor%2520for%2520Type%25202%2520Diabetes%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Brunavs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P.</span><span> </span><span class="NLM_article-title">Recent disclosures of clinical candidates</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=127-133&author=M.+Brunavsauthor=P.+Cowleyauthor=S.+E.+Wardauthor=P.+Weber&title=Recent+disclosures+of+clinical+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunavs%26aufirst%3DM.%26aulast%3DCowley%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DWeber%26aufirst%3DP.%26atitle%3DRecent%2520disclosures%2520of%2520clinical%2520candidates%26jtitle%3DDrugs%2520Future%26date%3D2013%26volume%3D38%26spage%3D127%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Akarte, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinvasan, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, S.</span><span> </span><span class="NLM_article-title">A novel long-acting DPP-IV inhibitor PKF-275-055 stimulated cell proliferation resulting in improved glucose homeostasis in diabetics rats</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=241-252&author=A.+S.+Akarteauthor=B.+P.+Srinvasanauthor=S.+Gandhi&title=A+novel+long-acting+DPP-IV+inhibitor+PKF-275-055+stimulated+cell+proliferation+resulting+in+improved+glucose+homeostasis+in+diabetics+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkarte%26aufirst%3DA.%2BS.%26aulast%3DSrinvasan%26aufirst%3DB.%2BP.%26aulast%3DGandhi%26aufirst%3DS.%26atitle%3DA%2520novel%2520long-acting%2520DPP-IV%2520inhibitor%2520PKF-275-055%2520stimulated%2520cell%2520proliferation%2520resulting%2520in%2520improved%2520glucose%2520homeostasis%2520in%2520diabetics%2520rats%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D241%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Sutton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunsdon, S, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fillmore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, N. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgs, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krintel, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duttaroy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maniara, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Namoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostermann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerhartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirockin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trappe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassiepen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baeschlin, D. K.</span><span> </span><span class="NLM_article-title">Novel heterocyclic DPP-IV inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1464</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1464-1468&author=J.+M.+Suttonauthor=D.+E.+Clarkauthor=S%2C+J.+Dunsdonauthor=G.+Fentonauthor=A.+Fillmoreauthor=N.+V.+Harrisauthor=C.+Higgsauthor=C.+A.+Hurleyauthor=S.+L.+Krintelauthor=R.+E.+MacKenzieauthor=A.+Duttaroyauthor=E.+Ganglauthor=W.+Maniaraauthor=R.+Sedraniauthor=K.+Namotoauthor=N.+Ostermannauthor=B.+Gerhartzauthor=F.+Sirockinauthor=J.+Trappeauthor=U.+Hassiepenauthor=D.+K.+Baeschlin&title=Novel+heterocyclic+DPP-IV+inhibitors+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSutton%26aufirst%3DJ.%2BM.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DDunsdon%26aufirst%3DS%252C%2BJ.%26aulast%3DFenton%26aufirst%3DG.%26aulast%3DFillmore%26aufirst%3DA.%26aulast%3DHarris%26aufirst%3DN.%2BV.%26aulast%3DHiggs%26aufirst%3DC.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DKrintel%26aufirst%3DS.%2BL.%26aulast%3DMacKenzie%26aufirst%3DR.%2BE.%26aulast%3DDuttaroy%26aufirst%3DA.%26aulast%3DGangl%26aufirst%3DE.%26aulast%3DManiara%26aufirst%3DW.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DNamoto%26aufirst%3DK.%26aulast%3DOstermann%26aufirst%3DN.%26aulast%3DGerhartz%26aufirst%3DB.%26aulast%3DSirockin%26aufirst%3DF.%26aulast%3DTrappe%26aufirst%3DJ.%26aulast%3DHassiepen%26aufirst%3DU.%26aulast%3DBaeschlin%26aufirst%3DD.%2BK.%26atitle%3DNovel%2520heterocyclic%2520DPP-IV%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1464%26epage%3D1468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Jadav, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahekar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joharapurkar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kshirsagar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaikh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sairam, K. V.</span><span> </span><span class="NLM_article-title">Long-acting peptidomimetics based DPP-IV inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3516</span><span class="NLM_x">–</span> <span class="NLM_lpage">3521</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=3516-3521&author=P.+Jadavauthor=R.+Bahekarauthor=S.+R.+Shahauthor=D.+Patelauthor=A.+Joharapurkarauthor=S.+Kshirsagarauthor=M.+Jainauthor=M.+Shaikhauthor=K.+V.+Sairam&title=Long-acting+peptidomimetics+based+DPP-IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJadav%26aufirst%3DP.%26aulast%3DBahekar%26aufirst%3DR.%26aulast%3DShah%26aufirst%3DS.%2BR.%26aulast%3DPatel%26aufirst%3DD.%26aulast%3DJoharapurkar%26aufirst%3DA.%26aulast%3DKshirsagar%26aufirst%3DS.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DShaikh%26aufirst%3DM.%26aulast%3DSairam%26aufirst%3DK.%2BV.%26atitle%3DLong-acting%2520peptidomimetics%2520based%2520DPP-IV%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D3516%26epage%3D3521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Kim, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. J.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase-4 inhibitors with β-amino amide scaffold; synthesis, SAR and biological evaluation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">5545</span><span class="NLM_x">–</span> <span class="NLM_lpage">5549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5545-5549&author=H.+J.+Kimauthor=W.+Y.+Kwakauthor=J.+P.+Minauthor=S.+Y.+Sungauthor=H.+D.+Kimauthor=M.+K.+Kimauthor=H.+S.+Kimauthor=K.+J.+Parkauthor=M.+H.+Sonauthor=S.+H.+Kimauthor=B.+J.+Lee&title=Dipeptidyl+peptidase-4+inhibitors+with+%CE%B2-amino+amide+scaffold%3B+synthesis%2C+SAR+and+biological+evaluation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BJ.%26aulast%3DKwak%26aufirst%3DW.%2BY.%26aulast%3DMin%26aufirst%3DJ.%2BP.%26aulast%3DSung%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DH.%2BD.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DK.%2BJ.%26aulast%3DSon%26aufirst%3DM.%2BH.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DB.%2BJ.%26atitle%3DDipeptidyl%2520peptidase-4%2520inhibitors%2520with%2520%25CE%25B2-amino%2520amide%2520scaffold%253B%2520synthesis%252C%2520SAR%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D5545%26epage%3D5549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Shan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span> </span><span class="NLM_article-title">Discovery of potent dipeptidyl peptidase IN inhibitors derived from β-aminoamides bearing substituted [1,2,3]-triazolopiperidines for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1731</span><span class="NLM_x">–</span> <span class="NLM_lpage">1735</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1731-1735&author=Z.+Shanauthor=M.+Pengauthor=H.+Fanauthor=Q.+Luauthor=P.+Luauthor=C.+Zhaoauthor=Y.+Chen&title=Discovery+of+potent+dipeptidyl+peptidase+IN+inhibitors+derived+from+%CE%B2-aminoamides+bearing+substituted+%5B1%2C2%2C3%5D-triazolopiperidines+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShan%26aufirst%3DZ.%26aulast%3DPeng%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520potent%2520dipeptidyl%2520peptidase%2520IN%2520inhibitors%2520derived%2520from%2520%25CE%25B2-aminoamides%2520bearing%2520substituted%2520%255B1%252C2%252C3%255D-triazolopiperidines%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D1731%26epage%3D1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Xie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span> </span><span class="NLM_article-title">Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimization</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=205-212&author=H.+Xieauthor=L.+Zengauthor=S.+Zengauthor=X.+Luauthor=G.+Zhangauthor=X.+Zhaoauthor=N.+Chengauthor=Z.+Tuauthor=Z.+Liauthor=H.+Xuauthor=Y.+Yang&title=Novel+pyrrolopyrimidine+analogues+as+potent+dipeptidyl+peptidase+IV+inhibitors+based+on+pharmacokinetic+property-driven+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DS.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26atitle%3DNovel%2520pyrrolopyrimidine%2520analogues%2520as%2520potent%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520based%2520on%2520pharmacokinetic%2520property-driven%2520optimization%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D52%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span> </span><span class="NLM_article-title">Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening</span> <span class="citation_source-journal">J. Mol. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4033</span><span class="NLM_x">–</span> <span class="NLM_lpage">4042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1007%2Fs00894-012-1394-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22460522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OrtbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=4033-4042&author=C.+Liauthor=W.+Luauthor=C.+Luauthor=W.+Xiaauthor=X.+Shenauthor=J.+Huangauthor=G.+Liuauthor=Y.+Tang&title=Identification+of+diverse+dipeptidyl+peptidase+IV+inhibitors+via+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of diverse dipeptidyl peptidase IV inhibitors via structure-based virtual screening</span></div><div class="casAuthors">Li, Cui; Lu, Weiqiang; Lu, Chunhua; Xiao, Wen; Shen, Xu; Huang, Jin; Liu, Guixia; Tang, Yun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4033-4042</span>CODEN:
                <span class="NLM_cas:coden">JMMOFK</span>;
        ISSN:<span class="NLM_cas:issn">0948-5023</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPP4) is an important target for the treatment of type II diabetes mellitus.  Inhibition of DPP4 will improve glycemic control in such patients by preventing the rapid breakdown and thereby prolonging the physiol. actions of incretin hormones.  Known DPP4 inhibitors (including marketed drugs and those drug candidates) appear to share similar structural features: the cyanopyrrolidine moieties, the xanthenes/pyrimidine parts and amino-like linkages.  In this study, a multi-step virtual screening strategy including both rigid and flexible docking was employed to search for novel structures with DPP4 inhibition.  From SPECS database, consisting of over 190,000 com. available compds., 99 virtual hits were picked up and 15 of them were eventually identified to have DPP4 inhibitory activities at 5 ∼ 50 μM.  Diverse structures of our compds. were out of usual structural categories.  Hence a pharmacophore model was built to further explore their common binding features on the enzyme.  The results provided a new pathway for the discovery of DPP4 inhibitors and would be helpful for further optimization of DPP4 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0SD-Ww74h5rVg90H21EOLACvtfcHk0ljz7y0Hoq5cqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OrtbbL&md5=7a34282901e72ea605ad4a18d11f0e1b</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1007%2Fs00894-012-1394-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00894-012-1394-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTang%26aufirst%3DY.%26atitle%3DIdentification%2520of%2520diverse%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520via%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Mol.%2520Model.%26date%3D2012%26volume%3D18%26spage%3D4033%26epage%3D4042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Synthesis, structure–activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fj.1747-0285.2012.01365.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22381062" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyhurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=897-906&author=D.+Wuauthor=F.+Jinauthor=W.+Luauthor=J.+Zhuauthor=C.+Liauthor=W.+Wangauthor=Y.+Tangauthor=H.+Jiangauthor=J.+Huangauthor=G.+Liuauthor=J.+Li&title=Synthesis%2C+structure%E2%80%93activity+relationship%2C+and+pharmacophore+modeling+studies+of+pyrazole-3-carbohydrazone+derivatives+as+dipeptidyl+peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, structure-activity relationship, and pharmacophore modeling studies of pyrazole-3-carbohydrazone derivatives as dipeptidyl peptidase IV inhibitors</span></div><div class="casAuthors">Wu, Deyan; Jin, Fangfang; Lu, Weiqiang; Zhu, Jin; Li, Cui; Wang, Wei; Tang, Yun; Jiang, Hualiang; Huang, Jin; Liu, Guixia; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">897-906</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Type 2 diabetes mellitus (T2DM) is a metabolic disease and a major challenge to health care systems around the world.  Dipeptidyl peptidase IV (DPP-4), a serine protease, has been rapidly emerging as an effective therapeutic target for the treatment for T2DM.  In this study, a series of novel DPP-4 inhibitors, featuring the pyrazole-3-carbohydrazone scaffold, have been discovered using an integrated approach of structure-based virtual screening, chem. synthesis, and bioassay.  Virtual screening of SPECS Database, followed by enzymic activity assay, resulted in five micromolar or low-to-mid-micromolar inhibitory level compds. with different scaffold.  N'-[(2-hydroxy-1-naphthalenyl)methylene]-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid hydrazide was selected for the further structure modifications in considering inhibitory activity, structural variability, and synthetic accessibility.  Seventeen new compds. were synthesized and tested with biol. assays.  Nine compds. were found to show inhibitory effects against DPP-4.  Mol. docking models give rational explanation about structure-activity relationships.  Based on eight DPP-4 inhibitors the best pharmacophore model hypo1 was obtained, consisting of one hydrogen bond donor (HBD), one hydrogen bond acceptor (HBA), and two hydrophobic (HY) features.  Both docking models and pharmacophore mapping results are in agreement with pharmacol. results.  The present studies give some guiding information for further structural optimization and are helpful for future DPP-4 inhibitors design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK2DxGN3EOGLVg90H21EOLACvtfcHk0ljz7y0Hoq5cqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyhurs%253D&md5=1343d6f864fbfedc8834d5c6db009cad</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2012.01365.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2012.01365.x%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DF.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520structure%25E2%2580%2593activity%2520relationship%252C%2520and%2520pharmacophore%2520modeling%2520studies%2520of%2520pyrazole-3-carbohydrazone%2520derivatives%2520as%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D897%26epage%3D906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span> </span><span class="NLM_article-title">Design, synthesis, structure–activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(<i>S</i>)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">198</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1111%2Fcbdd.12058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22994702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2013&pages=198-207&author=L.+Zhangauthor=M.+Suauthor=J.+Liauthor=X.+Jiauthor=J.+Wangauthor=Z.+Liauthor=J.+Liauthor=H.+Liu&title=Design%2C+synthesis%2C+structure%E2%80%93activity+relationships%2C+and+docking+studies+of+1-%28%CE%B3-1%2C2%2C3-triazol+substituted+prolyl%29-%28S%29-3%2C3-difluoropyrrolidines+as+a+novel+series+of+potent+and+selective+dipeptidyl+peptidase-4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, structure-activity relationships, and docking studies of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines as a novel series of potent and selective dipeptidyl peptidase-4 inhibitors</span></div><div class="casAuthors">Zhang, Lei; Su, Mingbo; Li, Jingya; Ji, Xun; Wang, Jiang; Li, Zeng; Li, Jia; Liu, Hong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">198-207</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase-4 inhibitors hold great potential for the treatment of type 2 diabetes.  A series of 1-(γ-1,2,3-triazol substituted prolyl)-(S)-3,3-difluoropyrrolidines were designed, synthesized, and evaluated as novel dipeptidyl peptidase-4 inhibitors.  Most of the compds. exhibited good in vitro potency against dipeptidyl peptidase-4.  Among these, 3 compds. displayed good dipeptidyl peptidase-4 activity and excellent selectivity vs. other proteases including dipeptidyl peptidase-8, dipeptidyl peptidase-9, and FAP.  The possible binding modes of these compds. with dipeptidyl peptidase-4 were also explored by mol. docking simulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA0xpXgNAdI7Vg90H21EOLACvtfcHk0lixYQjQLKyrNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKhtrk%253D&md5=8ae3ed9955bbd0e29b986f97dbf867d0</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12058%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520structure%25E2%2580%2593activity%2520relationships%252C%2520and%2520docking%2520studies%2520of%25201-%2528%25CE%25B3-1%252C2%252C3-triazol%2520substituted%2520prolyl%2529-%2528S%2529-3%252C3-difluoropyrrolidines%2520as%2520a%2520novel%2520series%2520of%2520potent%2520and%2520selective%2520dipeptidyl%2520peptidase-4%2520inhibitors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D81%26spage%3D198%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">–</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2013&pages=477-482&author=K.+Linauthor=Z.+Caiauthor=F.+Wangauthor=W.+Zhangauthor=W.+Zhou&title=Synthesis+and+biological+evaluation+of+xanthine+derivatives+on+dipeptidyl+peptidase+4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DK.%26aulast%3DCai%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DW.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520xanthine%2520derivatives%2520on%2520dipeptidyl%2520peptidase%25204%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2013%26volume%3D61%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juillerat, M. A.</span><span> </span><span class="NLM_article-title">Peptides from <i>Lactobacillus</i> hydrolysates of bovine milk caseins inhibit prolyl-peptidases of human colon cells</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">370</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf102803a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2011&pages=370-377&author=L.+Juillerat-Jeanneretauthor=M.+C.+Robertauthor=M.+A.+Juillerat&title=Peptides+from+Lactobacillus+hydrolysates+of+bovine+milk+caseins+inhibit+prolyl-peptidases+of+human+colon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjf102803a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf102803a%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DRobert%26aufirst%3DM.%2BC.%26aulast%3DJuillerat%26aufirst%3DM.%2BA.%26atitle%3DPeptides%2520from%2520Lactobacillus%2520hydrolysates%2520of%2520bovine%2520milk%2520caseins%2520inhibit%2520prolyl-peptidases%2520of%2520human%2520colon%2520cells%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2011%26volume%3D59%26spage%3D370%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Li-Chan, E. C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K. C.</span><span> </span><span class="NLM_article-title">Peptides derived from atlantic salmon skin gelatin as dipeptidyl-peptidase IV inhibitors</span> <span class="citation_source-journal">J. Agric. Food Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/doi/10.1021/jf204720q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=973-978&author=E.+C.+Y.+Li-Chanauthor=S.+L.+Huangauthor=C.+L.+Jaoauthor=K.+P.+Hoauthor=K.+C.+Hsu&title=Peptides+derived+from+atlantic+salmon+skin+gelatin+as+dipeptidyl-peptidase+IV+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjf204720q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf204720q%26sid%3Dliteratum%253Aachs%26aulast%3DLi-Chan%26aufirst%3DE.%2BC.%2BY.%26aulast%3DHuang%26aufirst%3DS.%2BL.%26aulast%3DJao%26aufirst%3DC.%2BL.%26aulast%3DHo%26aufirst%3DK.%2BP.%26aulast%3DHsu%26aufirst%3DK.%2BC.%26atitle%3DPeptides%2520derived%2520from%2520atlantic%2520salmon%2520skin%2520gelatin%2520as%2520dipeptidyl-peptidase%2520IV%2520inhibitors%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2012%26volume%3D60%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Huang, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, K. C.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=114-121&author=S.+L.+Huangauthor=C.+L.+Jaoauthor=K.+P.+Hoauthor=K.+C.+Hsu&title=Dipeptidyl-peptidase+IV+inhibitory+activity+of+peptides+derived+from+tuna+cooking+juice+hydrolysates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS.%2BL.%26aulast%3DJao%26aufirst%3DC.%2BL.%26aulast%3DHo%26aufirst%3DK.%2BP.%26aulast%3DHsu%26aufirst%3DK.%2BC.%26atitle%3DDipeptidyl-peptidase%2520IV%2520inhibitory%2520activity%2520of%2520peptides%2520derived%2520from%2520tuna%2520cooking%2520juice%2520hydrolysates%26jtitle%3DPeptides%26date%3D2012%26volume%3D35%26spage%3D114%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Hsiung, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. P.</span><span> </span><span class="NLM_article-title">Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavage of human β-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1988</span><span class="NLM_x">–</span> <span class="NLM_lpage">1996</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1988-1996&author=H.+M.+Hsiungauthor=D.+L.+Smileyauthor=X.+Y.+Zhangauthor=L.+Zhangauthor=L.+Z.+Yanauthor=L.+Craftauthor=M.+L.+Heimanauthor=D.+P.+Smith&title=Potent+peptide+agonists+for+human+melanocortin+3+and+4+receptors+derived+from+enzymatic+cleavage+of+human+%CE%B2-MSH%285-22%29+by+dipeptidyl+peptidase+I+and+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHsiung%26aufirst%3DH.%2BM.%26aulast%3DSmiley%26aufirst%3DD.%2BL.%26aulast%3DZhang%26aufirst%3DX.%2BY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DL.%2BZ.%26aulast%3DCraft%26aufirst%3DL.%26aulast%3DHeiman%26aufirst%3DM.%2BL.%26aulast%3DSmith%26aufirst%3DD.%2BP.%26atitle%3DPotent%2520peptide%2520agonists%2520for%2520human%2520melanocortin%25203%2520and%25204%2520receptors%2520derived%2520from%2520enzymatic%2520cleavage%2520of%2520human%2520%25CE%25B2-MSH%25285-22%2529%2520by%2520dipeptidyl%2520peptidase%2520I%2520and%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DPeptides%26date%3D2005%26volume%3D26%26spage%3D1988%26epage%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Rosmanho-Salgado, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marques, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grouzman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavadas, C.</span><span> </span><span class="NLM_article-title">Dipeptidyl-peptidase IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-expression</span> <span class="citation_source-journal">Peptides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=49-54&author=J.+Rosmanho-Salgadoauthor=J.+P.+Marquesauthor=M.+Estradaauthor=M.+Santanaauthor=Y.+Cortezauthor=E.+Grouzmanauthor=C.+Cavadas&title=Dipeptidyl-peptidase+IV+by+cleaving+neuropeptide+Y+induces+lipid+accumulation+and+PPAR-expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRosmanho-Salgado%26aufirst%3DJ.%26aulast%3DMarques%26aufirst%3DJ.%2BP.%26aulast%3DEstrada%26aufirst%3DM.%26aulast%3DSantana%26aufirst%3DM.%26aulast%3DCortez%26aufirst%3DY.%26aulast%3DGrouzman%26aufirst%3DE.%26aulast%3DCavadas%26aufirst%3DC.%26atitle%3DDipeptidyl-peptidase%2520IV%2520by%2520cleaving%2520neuropeptide%2520Y%2520induces%2520lipid%2520accumulation%2520and%2520PPAR-expression%26jtitle%3DPeptides%26date%3D2012%26volume%3D37%26spage%3D49%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Jackson, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kochanek, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, D. G.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">757</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2012&pages=757-764&author=E.+K.+Jacksonauthor=S.+J.+Kochanekauthor=D.+G.+Gillespie&title=Dipeptidyl+peptidase+IV+regulates+proliferation+of+preglomerular+vascular+smooth+muscle+and+mesangial+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DKochanek%26aufirst%3DS.%2BJ.%26aulast%3DGillespie%26aufirst%3DD.%2BG.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520regulates%2520proliferation%2520of%2520preglomerular%2520vascular%2520smooth%2520muscle%2520and%2520mesangial%2520cells%26jtitle%3DHypertension%26date%3D2012%26volume%3D60%26spage%3D757%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Liu, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, T. S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV inhibitor attenuate kidney injury in streptozotocin-induced diabetic rats</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">340</span><span class="NLM_x">, </span> <span class="NLM_fpage">248</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1124%2Fjpet.111.186866" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22025647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVSltL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2012&pages=248-255&author=W.+J.+Liuauthor=S.+H.+Xieauthor=Y.+N.+Liuauthor=W.+Kimauthor=H.+Y.+Jinauthor=S.+K.+Parkauthor=Y.+M.+Shaoauthor=T.+S.+Park&title=Dipeptidyl+peptidase+IV+inhibitor+attenuate+kidney+injury+in+streptozotocin-induced+diabetic+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats</span></div><div class="casAuthors">Liu, Wei Jing; Xie, Shu Hua; Liu, Yu Ning; Kim, Won; Jin, Heung Yong; Park, Sung Kwang; Shao, Yi Ming; Park, Tae Sun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">248-255</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase (DPP) IV inhibitors are probably beneficial for preventing diabetic complication and modulating glucagon-like peptide-1 receptor (GLP-1R) expression.  The aim of this study was to det. whether the DPP IV inhibitor LAF237 (vildagliptin) has renoprotective qualities in streptozotocin-induced diabetic rats.  Diabetic and nondiabetic rats were treated with an oral dose of 4 or 8 mg/kg/day LAF237 or placebo for 24 wk, and renal injury was obsd. by light and electron microscopy.  We also assessed DPP IV activity, active GLP-1 level, cAMP and 8-hydroxy-deoxyguanosine excretion, and GLP-1R, cleaved caspase 3, and transforming growth factor-β1 (TGF-β1) expression.  LAF237 significantly decreased proteinuria, albuminuria, and urinary albumin/creatinine ratio, improved creatinine clearance, and dose-dependently inhibited interstitial expansion, glomerulosclerosis, and the thickening of the glomerular basement membrane in diabetic rats.  It is noteworthy that LAF237 markedly down-regulated DPP IV activity and increased active GLP-1 levels, which probably prevented oxidative DNA damage and renal cell apoptosis by activating the GLP-1R and modulating cAMP.  Renoprotection was also assocd. with a redn. in TGF-β1 overexpression.  Our study suggests that DPP IV inhibitors may ameliorate diabetic nephropathy as well as reduce the overprodn. of TGF-β1.  The obsd. renoprotection is probably attributable to inhibition of DPP IV activity, mimicking of incretin action, and activation of the GLP-1R.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprz731SAvmSbVg90H21EOLACvtfcHk0lgACLxwrNcj_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVSltL0%253D&md5=8488a9a54d1ad6a6b4c54165507e4977</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.186866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.186866%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%2BJ.%26aulast%3DXie%26aufirst%3DS.%2BH.%26aulast%3DLiu%26aufirst%3DY.%2BN.%26aulast%3DKim%26aufirst%3DW.%26aulast%3DJin%26aufirst%3DH.%2BY.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DShao%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DT.%2BS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520inhibitor%2520attenuate%2520kidney%2520injury%2520in%2520streptozotocin-induced%2520diabetic%2520rats%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D340%26spage%3D248%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Sangle, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Läuffer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iaboukov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brubaker, P. L.</span><span> </span><span class="NLM_article-title">Novel biological action of the dipeptidylpeptidase-IV inhibitor, sitagliptin, as a glucagon-like peptide-1 secretagogue</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">564</span><span class="NLM_x">–</span> <span class="NLM_lpage">573</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=564-573&author=G.+V.+Sangleauthor=L.+M.+L%C3%A4ufferauthor=A.+Griecoauthor=S.+Trivediauthor=R.+Iaboukovauthor=P.+L.+Brubaker&title=Novel+biological+action+of+the+dipeptidylpeptidase-IV+inhibitor%2C+sitagliptin%2C+as+a+glucagon-like+peptide-1+secretagogue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSangle%26aufirst%3DG.%2BV.%26aulast%3DL%25C3%25A4uffer%26aufirst%3DL.%2BM.%26aulast%3DGrieco%26aufirst%3DA.%26aulast%3DTrivedi%26aufirst%3DS.%26aulast%3DIaboukov%26aufirst%3DR.%26aulast%3DBrubaker%26aufirst%3DP.%2BL.%26atitle%3DNovel%2520biological%2520action%2520of%2520the%2520dipeptidylpeptidase-IV%2520inhibitor%252C%2520sitagliptin%252C%2520as%2520a%2520glucagon-like%2520peptide-1%2520secretagogue%26jtitle%3DEndocrinology%26date%3D2012%26volume%3D153%26spage%3D564%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Pethiyagoda, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, T. P.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells</span> <span class="citation_source-journal">Clin. Exp. Metastasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1023%2FA%3A1010930918055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlvVKit7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=391-400&author=C.+L.+Pethiyagodaauthor=D.+R.+Welchauthor=T.+P.+Fleming&title=Dipeptidyl+peptidase+IV+%28DPPIV%29+inhibits+cellular+invasion+of+melanoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells</span></div><div class="casAuthors">Pethiyagoda, C. L.; Welch, D. R.; Fleming, T. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Experimental Metastasis</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-400</span>CODEN:
                <span class="NLM_cas:coden">CEXMD2</span>;
        ISSN:<span class="NLM_cas:issn">0262-0898</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV) is a 110-kD, trans-membrane, ectoenzyme, with ubiquitous expression.  We have identified DPPIV as a gene that can alter the invasive potential of a no. of melanoma cell lines.  By transfecting the full-length cDNA of DPPIV, we have established stable melanoma cell lines that express comparable levels of the DPPIV protein as normal epidermal melanocytes.  Matrigel invasion assays were utilized to study the effects of DPPIV expression on the invasive potential of these cells.  The parental and vector transfectants readily migrated across the Matrigel while the invasiveness of DPPIV transfected cells was reduced by > 75%.  The effects on cellular invasion are not attributed to overall growth characteristics, as both DPPIV expressing and non-expressing cells behave comparably in culture.  We have also constructed mutants of DPPIV that lack either the extra-cellular serine protease activity or the six amino acid cytoplasmic domain.  Both mutants were stably expressed in melanoma cells.  Matrigel invasion assays performed with cells expressing the two mutant forms of the protein revealed phenotypic effects similar to wild type function.  Thus, expression of a proteolytically active form of the DPPIV protein inhibits the invasiveness of malignant melanoma cell lines lacking endogenous DPPIV expression.  Furthermore, neither the protease activity nor the cytoplasmic domain of DPPIV is required for its anti-invasive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodpER4q6uwiLVg90H21EOLACvtfcHk0lgACLxwrNcj_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlvVKit7w%253D&md5=2e5d69a22938d34f381616bfe397f369</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1023%2FA%3A1010930918055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1010930918055%26sid%3Dliteratum%253Aachs%26aulast%3DPethiyagoda%26aufirst%3DC.%2BL.%26aulast%3DWelch%26aufirst%3DD.%2BR.%26aulast%3DFleming%26aufirst%3DT.%2BP.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520%2528DPPIV%2529%2520inhibits%2520cellular%2520invasion%2520of%2520melanoma%2520cells%26jtitle%3DClin.%2520Exp.%2520Metastasis%26date%3D2001%26volume%3D18%26spage%3D391%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Wesley, U. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=1999&pages=311-322&author=U.+V.+Wesleyauthor=A.+P.+Albinoauthor=S.+Tiwariauthor=A.+N.+Houghton&title=A+role+for+dipeptidyl+peptidase+IV+in+suppressing+the+malignant+phenotype+of+melanocytic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWesley%26aufirst%3DU.%2BV.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26aulast%3DTiwari%26aufirst%3DS.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DA%2520role%2520for%2520dipeptidyl%2520peptidase%2520IV%2520in%2520suppressing%2520the%2520malignant%2520phenotype%2520of%2520melanocytic%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1999%26volume%3D190%26spage%3D311%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Wesley, U. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1002%2Fijc.20091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15027119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1ens74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=855-866&author=U.+V.+Wesleyauthor=S.+Tiwariauthor=A.+N.+Houghton&title=Role+for+dipeptidyl+peptidase+IV+in+tumor+suppression+of+human+non+small+cell+lung+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells</span></div><div class="casAuthors">Wesley, Umadevi V.; Tiwari, Shakuntala; Houghton, Alan N.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">855-866</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Lung cancer is the leading cause of cancer death.  Lung cancers produce a variety of mitogenic growth factors that stimulate tumor cell proliferation and migration.  The cell surface protease, dipeptidyl peptidase IV (DPPIV), is involved in diverse biol. functions, including peptide-mediated cellular growth and differentiation.  DPPIV is expressed in various normal tissues, including lung tissue, and its expression is lost in many types of human cancers.  DPPIV expression and its enzymic activity are detected in normal bronchial and alveolar epithelium but different histol. subtypes of lung carcinomas lose DPPIV expression.  To investigate the role of DPPIV in lung carcinoma, we examd. the expression of DPPIV at both mRNA and protein levels in non small cell lung cancer (NSCLC) cell lines and normal human bronchial epithelial cells.  DPPIV expression was detectable in normal lung epithelial cells, but was absent or markedly reduced in all NSCLC cell lines at both mRNA and protein levels.  Restoration of DPPIV expression in NSCLC cells resulted in profound morphol. changes, inhibition of cell proliferation, anchorage-independent growth, in vitro cell migration and tumorigenicity in nude mice.  DPPIV reexpression also correlated with increased p21 expression, leading to induction of apoptosis and cell cycle arrest in GI stage.  These effects were accompanied by increased expression of cell surface proteins, fibroblast-activating protein (Fapα) and CD44 that are assocd. with suppression of tumor growth and metastasis.  Thus, DPPIV functions as a tumor suppressor, and its downregulation may contribute to the loss of growth control in NSCLC cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2mC47eoN-77Vg90H21EOLACvtfcHk0lgACLxwrNcj_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1ens74%253D&md5=aaa20647ae56c4e8fd285a914387b484</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fijc.20091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20091%26sid%3Dliteratum%253Aachs%26aulast%3DWesley%26aufirst%3DU.%2BV.%26aulast%3DTiwari%26aufirst%3DS.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DRole%2520for%2520dipeptidyl%2520peptidase%2520IV%2520in%2520tumor%2520suppression%2520of%2520human%2520non%2520small%2520cell%2520lung%2520carcinoma%2520cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D109%26spage%3D855%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Bogenrieder, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finstad, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papandreou, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scher, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albino, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuter, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanus, D. M.</span><span> </span><span class="NLM_article-title">Expression and localization of aminopeptidase A, aminopeptidase N and dipeptidyl peptidase IV in benign and malignant human prostate tissue</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">225</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1997&pages=225-232&author=T.+Bogenriederauthor=C.+L.+Finstadauthor=R.+H.+Freemanauthor=C.+N.+Papandreouauthor=H.+I.+Scherauthor=A.+P.+Albinoauthor=V.+E.+Reuterauthor=D.+M.+Nanus&title=Expression+and+localization+of+aminopeptidase+A%2C+aminopeptidase+N+and+dipeptidyl+peptidase+IV+in+benign+and+malignant+human+prostate+tissue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBogenrieder%26aufirst%3DT.%26aulast%3DFinstad%26aufirst%3DC.%2BL.%26aulast%3DFreeman%26aufirst%3DR.%2BH.%26aulast%3DPapandreou%26aufirst%3DC.%2BN.%26aulast%3DScher%26aufirst%3DH.%2BI.%26aulast%3DAlbino%26aufirst%3DA.%2BP.%26aulast%3DReuter%26aufirst%3DV.%2BE.%26aulast%3DNanus%26aufirst%3DD.%2BM.%26atitle%3DExpression%2520and%2520localization%2520of%2520aminopeptidase%2520A%252C%2520aminopeptidase%2520N%2520and%2520dipeptidyl%2520peptidase%2520IV%2520in%2520benign%2520and%2520malignant%2520human%2520prostate%2520tissue%26jtitle%3DProstate%26date%3D1997%26volume%3D33%26spage%3D225%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Asada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aratake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marutsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Araki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumiyoshi, A.</span><span> </span><span class="NLM_article-title">Expression of dipeptidyl aminopeptidase IV activity in human lung carcinoma</span> <span class="citation_source-journal">Histopathology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1993&pages=265-270&author=Y.+Asadaauthor=Y.+Aratakeauthor=T.+Kotaniauthor=K.+Marutsukaauthor=Y.+Arakiauthor=S.+Ohtakiauthor=A.+Sumiyoshi&title=Expression+of+dipeptidyl+aminopeptidase+IV+activity+in+human+lung+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsada%26aufirst%3DY.%26aulast%3DAratake%26aufirst%3DY.%26aulast%3DKotani%26aufirst%3DT.%26aulast%3DMarutsuka%26aufirst%3DK.%26aulast%3DAraki%26aufirst%3DY.%26aulast%3DOhtaki%26aufirst%3DS.%26aulast%3DSumiyoshi%26aufirst%3DA.%26atitle%3DExpression%2520of%2520dipeptidyl%2520aminopeptidase%2520IV%2520activity%2520in%2520human%2520lung%2520carcinoma%26jtitle%3DHistopathology%26date%3D1993%26volume%3D23%26spage%3D265%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Kajiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span> </span><span class="NLM_article-title">Expression of CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma and its negative correlation with tumor grade</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">524</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">248</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2003&pages=245-248&author=H.+Kajiyamaauthor=F.+Kikkawaauthor=K.+Inoauthor=K.+Shibataauthor=S.+Mizutani&title=Expression+of+CD26%2Fdipeptidyl+peptidase+IV+in+endometrial+adenocarcinoma+and+its+negative+correlation+with+tumor+grade"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DKikkawa%26aufirst%3DF.%26aulast%3DIno%26aufirst%3DK.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DMizutani%26aufirst%3DS.%26atitle%3DExpression%2520of%2520CD26%252Fdipeptidyl%2520peptidase%2520IV%2520in%2520endometrial%2520adenocarcinoma%2520and%2520its%2520negative%2520correlation%2520with%2520tumor%2520grade%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2003%26volume%3D524%26spage%3D245%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Kikkawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitzutani, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV in tumor progression</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">1751</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1751&publication_year=2005&pages=45-51&author=F.+Kikkawaauthor=H.+Kajiyamaauthor=K.+Shibataauthor=K.+Inoauthor=S.+Nomuraauthor=S.+Mitzutani&title=Dipeptidyl+peptidase+IV+in+tumor+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKikkawa%26aufirst%3DF.%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DIno%26aufirst%3DK.%26aulast%3DNomura%26aufirst%3DS.%26aulast%3DMitzutani%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520in%2520tumor%2520progression%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2005%26volume%3D1751%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Kajiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikkawa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shibata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">2278</span><span class="NLM_x">–</span> <span class="NLM_lpage">2283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=2278-2283&author=H.+Kajiyamaauthor=F.+Kikkawaauthor=E.+Khinauthor=K.+Shibataauthor=K.+Inoauthor=S.+Mizutani&title=Dipeptidyl+peptidase+IV+overexpression+induces+up-regulation+of+E-cadherin+and+tissue+inhibitors+of+matrix+metalloproteinases%2C+resulting+in+decreased+invasive+potential+in+ovarian+carcinoma+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKajiyama%26aufirst%3DH.%26aulast%3DKikkawa%26aufirst%3DF.%26aulast%3DKhin%26aufirst%3DE.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DIno%26aufirst%3DK.%26aulast%3DMizutani%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520overexpression%2520induces%2520up-regulation%2520of%2520E-cadherin%2520and%2520tissue%2520inhibitors%2520of%2520matrix%2520metalloproteinases%252C%2520resulting%2520in%2520decreased%2520invasive%2520potential%2520in%2520ovarian%2520carcinoma%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D2278%26epage%3D2283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Juillerat-Jeanneret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monnet-Tschudi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zürich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohm, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duijvestijn, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honegger, P.</span><span> </span><span class="NLM_article-title">Regulation of peptidase activity in a three-dimensional aggregate model of brain tumor vasculature</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">311</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">59</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1007%2Fs00441-002-0626-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=12483284" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsV2nt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2003&pages=53-59&author=L.+Juillerat-Jeanneretauthor=F.+Monnet-Tschudiauthor=M.+G.+Z%C3%BCrichauthor=S.+Lohmauthor=A.+M.+Duijvestijnauthor=P.+Honegger&title=Regulation+of+peptidase+activity+in+a+three-dimensional+aggregate+model+of+brain+tumor+vasculature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of peptidase activity in a three-dimensional aggregate model of brain tumor vasculature</span></div><div class="casAuthors">Juillerat-Jeanneret, Lucienne; Monnet-Tschudi, Florianne; Zurich, Marie-Gabrielle; Lohm, Sylvia; Duijvestijn, Adrian M.; Honegger, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-59</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The abnormal vascular system of brain cancers inappropriately expresses membrane proteins, including proteolytic enzymes, ultimately resulting in blood extravasation.  The prodn. of inflammatory mediators, such as cytokines and nitric oxide, and tumor hypoxia have been implicated in these effects.  The authors have previously shown that the activity of aminopeptidase A is increased in the abnormal vascular system of human and rat brain tumors.  To study the mechanisms regulating the activities of peptidases in cerebral vasculature in brain tumors, the authors have developed a three-dimensional model of differentiated rat brain cells in aggregate cultures in which rat brain microvessels were incorporated.  The secretion of interleukin-6 (IL-6) in the culture medium of aggregates was used as an indicator of inflammatory activation.  Addn. to these aggregates of C6 glioma cell medium (C6-CM) conditioned under hypoxic or normoxic conditions or serum mimicked tumor-dependent hypoxia or conditions of dysfunction of brain tumor vasculature.  Hypoxic and normoxic C6-CM, but not serum, regulated peptidase activity in aggregates, and in particular it increased the activity of aminopeptidase A detd. using histoenzymog.  Serum, but not C6-CM, increased IL-6 prodn., but did not increase aminopeptidase A activity in aggregates.  Thus sol. glioma-derived factors, but not serum-derived factors, induce dysfunctions of cerebral vasculature by directly regulating the activity of peptidases, not involving inflammatory activation.  Tumor hypoxia is not necessary to modulate peptidase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8hEqzFFf8H7Vg90H21EOLACvtfcHk0lg5_szmRYt6zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsV2nt7k%253D&md5=005afa67cea2e84ac440a348903eb41a</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2Fs00441-002-0626-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-002-0626-8%26sid%3Dliteratum%253Aachs%26aulast%3DJuillerat-Jeanneret%26aufirst%3DL.%26aulast%3DMonnet-Tschudi%26aufirst%3DF.%26aulast%3DZ%25C3%25BCrich%26aufirst%3DM.%2BG.%26aulast%3DLohm%26aufirst%3DS.%26aulast%3DDuijvestijn%26aufirst%3DA.%2BM.%26aulast%3DHonegger%26aufirst%3DP.%26atitle%3DRegulation%2520of%2520peptidase%2520activity%2520in%2520a%2520three-dimensional%2520aggregate%2520model%2520of%2520brain%2520tumor%2520vasculature%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D311%26spage%3D53%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jesson, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallner, B. P.</span><span> </span><span class="NLM_article-title">PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">5471</span><span class="NLM_x">–</span> <span class="NLM_lpage">5480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=5471-5480&author=S.+Adamsauthor=G.+T.+Millerauthor=M.+I.+Jessonauthor=T.+Watanabeauthor=B.+Jonesauthor=B.+P.+Wallner&title=PT-100%2C+a+small+molecule+dipeptidyl+peptidase+inhibitor%2C+has+potent+antitumor+effects+and+augments+antibody-mediated+cytotoxicity+via+a+novel+immune+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DG.%2BT.%26aulast%3DJesson%26aufirst%3DM.%2BI.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DJones%26aufirst%3DB.%26aulast%3DWallner%26aufirst%3DB.%2BP.%26atitle%3DPT-100%252C%2520a%2520small%2520molecule%2520dipeptidyl%2520peptidase%2520inhibitor%252C%2520has%2520potent%2520antitumor%2520effects%2520and%2520augments%2520antibody-mediated%2520cytotoxicity%2520via%2520a%2520novel%2520immune%2520mechanism%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D5471%26epage%3D5480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Arwert, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mentink, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Driskell, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoste, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldie, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quist, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, F. M.</span><span> </span><span class="NLM_article-title">Upregulation of CD26 expression in epithelial cells and stromal cells during wound-induced skin tumor formation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">992</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=992-1000&author=E.+N.+Arwertauthor=R.+A.+Mentinkauthor=R.+R.+Driskellauthor=E.+Hosteauthor=S.+J.+Goldieauthor=S.+Quistauthor=F.+M.+Watt&title=Upregulation+of+CD26+expression+in+epithelial+cells+and+stromal+cells+during+wound-induced+skin+tumor+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArwert%26aufirst%3DE.%2BN.%26aulast%3DMentink%26aufirst%3DR.%2BA.%26aulast%3DDriskell%26aufirst%3DR.%2BR.%26aulast%3DHoste%26aufirst%3DE.%26aulast%3DGoldie%26aufirst%3DS.%2BJ.%26aulast%3DQuist%26aufirst%3DS.%26aulast%3DWatt%26aufirst%3DF.%2BM.%26atitle%3DUpregulation%2520of%2520CD26%2520expression%2520in%2520epithelial%2520cells%2520and%2520stromal%2520cells%2520during%2520wound-induced%2520skin%2520tumor%2520formation%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D992%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Steinbrecher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quigley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gado, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izikson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansorge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocke, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV in inflammatory CNS disease</span> <span class="citation_source-journal">Adv. Exp. Biol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1007%2F0-306-46826-3_16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=10849741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1yhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2000&pages=145-153&author=A.+Steinbrecherauthor=D.+Reinholdauthor=L.+Quigleyauthor=A.+Gadoauthor=N.+Tresserauthor=L.+Iziksonauthor=I.+Bornauthor=J.+Faustauthor=K.+Neubertauthor=R.+Martinauthor=S.+Ansorgeauthor=S.+Brocke&title=Dipeptidyl+peptidase+IV+in+inflammatory+CNS+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase IV in inflammatory CNS disease</span></div><div class="casAuthors">Steinbrecher, Andreas; Reinhold, Dirk; Quigley, Laura; Gado, Ameer; Tresser, Nancy; Izikson, Leonid; Born, Ilona; Faust, Jurgen; Neubert, Klaus; Martin, Roland; Ansorge, Siegfried; Brocke, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Experimental Medicine and Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">477</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">145-153</span>CODEN:
                <span class="NLM_cas:coden">AEMBAP</span>;
        ISSN:<span class="NLM_cas:issn">0065-2598</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic/Plenum Publishers</span>)
        </div><div class="casAbstract">Current pathogenic concepts of inflammatory demyelinating disorders such as multiple sclerosis (MS) are based on the hypothesis that a T cell-mediated autoimmune response is involved in the disease process.  One of the primary goals in the development of immunotherapies for autoimmune diseases has been to achieve inactivation of disease-inducing lymphocytes either by direct inhibition or suppression through regulatory cells and/or cytokines.  The CD26 antigen is identical with the cell surface ectopeptidase dipeptidyl peptidase IV (DP IV, EC 3.4.14.5) which is involved in regulating T cell activation and growth.  Activated T cells, including those specific for myelin antigens, express high levels of CD26/DP IV.  In vitro, reversible DP IV inhibitors suppress T cell proliferation and pro-inflammatory cytokine prodn. in response to myelin antigens.  Further studies will evaluate the role of DP IV inhibition in T cell-mediated inflammatory disease of the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL0zV8xBlFELVg90H21EOLACvtfcHk0ljEByLvDz5viQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1yhtbk%253D&md5=a5a1a911127b414c183a6e4be5df603a</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1007%2F0-306-46826-3_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F0-306-46826-3_16%26sid%3Dliteratum%253Aachs%26aulast%3DSteinbrecher%26aufirst%3DA.%26aulast%3DReinhold%26aufirst%3DD.%26aulast%3DQuigley%26aufirst%3DL.%26aulast%3DGado%26aufirst%3DA.%26aulast%3DTresser%26aufirst%3DN.%26aulast%3DIzikson%26aufirst%3DL.%26aulast%3DBorn%26aufirst%3DI.%26aulast%3DFaust%26aufirst%3DJ.%26aulast%3DNeubert%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DAnsorge%26aufirst%3DS.%26aulast%3DBrocke%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520in%2520inflammatory%2520CNS%2520disease%26jtitle%3DAdv.%2520Exp.%2520Biol.%2520Med.%26date%3D2000%26volume%3D477%26spage%3D145%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Wrenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mrestani-Klaus, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fengler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockel-Maschek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansorge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhold, D.</span><span> </span><span class="NLM_article-title">Downregulation of T-cell activation following inhibition of dipeptidyl peptidase IV/CD26 by the N-terminal part of the throboxane A2 receptor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">275</span><span class="NLM_x">, </span> <span class="NLM_fpage">22180</span><span class="NLM_x">–</span> <span class="NLM_lpage">22186</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=22180-22186&author=S.+Wrengerauthor=J.+Faustauthor=C.+Mrestani-Klausauthor=A.+Fenglerauthor=A.+Stockel-Maschekauthor=S.+Loreyauthor=T.+Kahneauthor=W.+Brandtauthor=K.+Neubertauthor=S.+Ansorgeauthor=D.+Reinhold&title=Downregulation+of+T-cell+activation+following+inhibition+of+dipeptidyl+peptidase+IV%2FCD26+by+the+N-terminal+part+of+the+throboxane+A2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrenger%26aufirst%3DS.%26aulast%3DFaust%26aufirst%3DJ.%26aulast%3DMrestani-Klaus%26aufirst%3DC.%26aulast%3DFengler%26aufirst%3DA.%26aulast%3DStockel-Maschek%26aufirst%3DA.%26aulast%3DLorey%26aufirst%3DS.%26aulast%3DKahne%26aufirst%3DT.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DNeubert%26aufirst%3DK.%26aulast%3DAnsorge%26aufirst%3DS.%26aulast%3DReinhold%26aufirst%3DD.%26atitle%3DDownregulation%2520of%2520T-cell%2520activation%2520following%2520inhibition%2520of%2520dipeptidyl%2520peptidase%2520IV%252FCD26%2520by%2520the%2520N-terminal%2520part%2520of%2520the%2520throboxane%2520A2%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D22180%26epage%3D22186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Hillebrandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mönnikes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klapp, B. F.</span><span> </span><span class="NLM_article-title">Dipeptidylpeptidase IV (DP IV, CD26) in patients with inflammatory bowel disease</span> <span class="citation_source-journal">Scand. J. Gastroenterol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1067</span><span class="NLM_x">–</span> <span class="NLM_lpage">1072</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1067-1072&author=M.+Hillebrandtauthor=M.+Roseauthor=J.+R%C3%BCterauthor=A.+Salamaauthor=H.+M%C3%B6nnikesauthor=B.+F.+Klapp&title=Dipeptidylpeptidase+IV+%28DP+IV%2C+CD26%29+in+patients+with+inflammatory+bowel+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHillebrandt%26aufirst%3DM.%26aulast%3DRose%26aufirst%3DM.%26aulast%3DR%25C3%25BCter%26aufirst%3DJ.%26aulast%3DSalama%26aufirst%3DA.%26aulast%3DM%25C3%25B6nnikes%26aufirst%3DH.%26aulast%3DKlapp%26aufirst%3DB.%2BF.%26atitle%3DDipeptidylpeptidase%2520IV%2520%2528DP%2520IV%252C%2520CD26%2529%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%26jtitle%3DScand.%2520J.%2520Gastroenterol.%26date%3D2001%26volume%3D10%26spage%3D1067%26epage%3D1072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Sedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vlasicova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vespalec, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simanek, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrichova, J.</span><span> </span><span class="NLM_article-title">Quaternary benzo[<i>c</i>]phenanthridine alkaloids as inhibitors of aminopeptidase N and dipeptidyl peptidase IV</span> <span class="citation_source-journal">Phytother. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1002%2Fptr.969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=11807974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xhs1Wisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=84-87&author=A.+Sedoauthor=K.+Vlasicovaauthor=P.+Bartakauthor=R.+Vespalecauthor=J.+Vicarauthor=V.+Simanekauthor=J.+Ulrichova&title=Quaternary+benzo%5Bc%5Dphenanthridine+alkaloids+as+inhibitors+of+aminopeptidase+N+and+dipeptidyl+peptidase+IV"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary benzo[c]phenanthridine alkaloids as inhibitors of aminopeptidase N and dipeptidyl peptidase IV</span></div><div class="casAuthors">Sedo, Aleksi; Vlasicova, Kvetoslava; Bartak, Petr; Vespalec, Radim; Vicar, Jaroslav; Simanek, Vilim; Ulrichova, Jitka</div><div class="citationInfo"><span class="NLM_cas:title">Phytotherapy Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">84-87</span>CODEN:
                <span class="NLM_cas:coden">PHYREH</span>;
        ISSN:<span class="NLM_cas:issn">0951-418X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Chelerythrine, sanguinarine and an alkaloid ext. from Macleaya cordata-sanguiritrine-were found to be inhibitors of aminopeptidase A and dipeptidyl peptidase IV, while fagaronine inhibited dipeptidyl peptidase IV only.  At 50 μM, chelerythrine, sanguinarine and sanguiritrine inhibited aminopeptidase N by 82%, 82%, 88%, DPP IV by 38%, 62%, 57%, and fagaronine by 34%, resp.  When bovine serum albumin (500 μg/mL) was added, the inhibition of both proteases by quaternary benzo[c]phenanthridine alkaloids (QBA) (50 μM) was significantly diminished.  Strong interaction of chelerythrine and sanguinarine with bovine and human serum albumin was proved by electrophoretic detn. of their resp. conditional binding consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQuZOIQfZiaLVg90H21EOLACvtfcHk0liZQvKgvZ9l_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xhs1Wisbg%253D&md5=d5d46b29819dad8d0160fce1a0bfcd73</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1002%2Fptr.969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fptr.969%26sid%3Dliteratum%253Aachs%26aulast%3DSedo%26aufirst%3DA.%26aulast%3DVlasicova%26aufirst%3DK.%26aulast%3DBartak%26aufirst%3DP.%26aulast%3DVespalec%26aufirst%3DR.%26aulast%3DVicar%26aufirst%3DJ.%26aulast%3DSimanek%26aufirst%3DV.%26aulast%3DUlrichova%26aufirst%3DJ.%26atitle%3DQuaternary%2520benzo%255Bc%255Dphenanthridine%2520alkaloids%2520as%2520inhibitors%2520of%2520aminopeptidase%2520N%2520and%2520dipeptidyl%2520peptidase%2520IV%26jtitle%3DPhytother.%2520Res.%26date%3D2002%26volume%3D16%26spage%3D84%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Busso, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagtmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herling, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chobaz-Péclat, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischof-Delaloye, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">So, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grouzman, E.</span><span> </span><span class="NLM_article-title">Circulating CD26 is negatively associated with inflammation in human and experimental arthritis</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">166</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2FS0002-9440%2810%2962266-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=15681827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVGnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2005&pages=433-442&author=N.+Bussoauthor=N.+Wagtmannauthor=C.+Herlingauthor=V.+Chobaz-P%C3%A9clatauthor=A.+Bischof-Delaloyeauthor=A.+Soauthor=E.+Grouzman&title=Circulating+CD26+is+negatively+associated+with+inflammation+in+human+and+experimental+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Circulating CD26 is negatively associated with inflammation in human and experimental arthritis</span></div><div class="casAuthors">Busso, Nathalie; Wagtmann, Nicolai; Herling, Christian; Chobaz-Peclat, Veronique; Bischof-Delaloye, Angelika; So, Alexander; Grouzmann, Eric</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">433-442</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Dipeptidyl peptidase IV (DPPIV, CD26), a protease-cleaving N-terminal X-Pro dipeptide from selected proteins including some chemokines, is expressed both as a sol. form in plasma and on the cell surface of various immune and nonimmune cell types.  To gain insights into the pathophysiol. role of CD26 in arthritis, the authors explored DPPIV/CD26 expression during murine antigen-induced arthritis (AIA), an exptl. model of arthritis.  AIA induction led to reduced plasma DPPIV activity.  In CD26-deficient mice, the severity of AIA was increased as assessed by enhanced technetium uptake and by increased histol. parameters of inflammation (synovial thickness and exudate).  The authors demonstrated that CD26 controls the in vivo half-life of the intact active form of the proinflammatory chemokine stromal cell-derived factor-1 (SDF-1).  CD26-deficient mice exhibited increased levels of circulating active SDF-1, assocd. with increased nos. of SDF-1 receptor (CXCR4)-pos. cells infiltrating arthritic joints.  In a clin. study, plasma levels of DPPIV/CD26 from rheumatoid arthritis patients were decreased when compared to those from osteoarthritis patients and inversely correlate with C-reactive protein levels.  Thus, decreased circulating CD26 levels in arthritis may influence CD26-mediated regulation of the chemotactic SDF-1/CXCR4 axis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5Ju4Nw5ywmrVg90H21EOLACvtfcHk0liZQvKgvZ9l_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVGnu78%253D&md5=e51ad267e399d02b34604afbe7eb85ff</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0002-9440%2810%2962266-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0002-9440%252810%252962266-3%26sid%3Dliteratum%253Aachs%26aulast%3DBusso%26aufirst%3DN.%26aulast%3DWagtmann%26aufirst%3DN.%26aulast%3DHerling%26aufirst%3DC.%26aulast%3DChobaz-P%25C3%25A9clat%26aufirst%3DV.%26aulast%3DBischof-Delaloye%26aufirst%3DA.%26aulast%3DSo%26aufirst%3DA.%26aulast%3DGrouzman%26aufirst%3DE.%26atitle%3DCirculating%2520CD26%2520is%2520negatively%2520associated%2520with%2520inflammation%2520in%2520human%2520and%2520experimental%2520arthritis%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2005%26volume%3D166%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Reinhold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gran, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbrecher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocke, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrenger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Born, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ansorge, S.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase IV (CD26): role in T cell activation and autoimmune disease</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">477</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=477&publication_year=2000&pages=155-160&author=D.+Reinholdauthor=B.+Hemmerauthor=B.+Granauthor=A.+Steinbrecherauthor=S.+Brockeauthor=T.+Kahneauthor=S.+Wrengerauthor=I.+Bornauthor=J.+Faustauthor=K.+Neubertauthor=R.+Martinauthor=S.+Ansorge&title=Dipeptidyl+peptidase+IV+%28CD26%29%3A+role+in+T+cell+activation+and+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinhold%26aufirst%3DD.%26aulast%3DHemmer%26aufirst%3DB.%26aulast%3DGran%26aufirst%3DB.%26aulast%3DSteinbrecher%26aufirst%3DA.%26aulast%3DBrocke%26aufirst%3DS.%26aulast%3DKahne%26aufirst%3DT.%26aulast%3DWrenger%26aufirst%3DS.%26aulast%3DBorn%26aufirst%3DI.%26aulast%3DFaust%26aufirst%3DJ.%26aulast%3DNeubert%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DAnsorge%26aufirst%3DS.%26atitle%3DDipeptidyl%2520peptidase%2520IV%2520%2528CD26%2529%253A%2520role%2520in%2520T%2520cell%2520activation%2520and%2520autoimmune%2520disease%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D2000%26volume%3D477%26spage%3D155%26epage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Matsubara, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fijiwara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akiyama, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konishi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izumiya, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaikita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jinnouchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsuyama, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, H.</span><span> </span><span class="NLM_article-title">A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.jacc.2011.07.053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22240132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFGlsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2012&pages=265-276&author=J.+Matsubaraauthor=S.+Sigiyamaauthor=K.+Sugamuraauthor=T.+Nakamuraauthor=Y.+Fijiwaraauthor=E.+Akiyamaauthor=H.+Kurokawaauthor=T.+Nozakiauthor=K.+Ohbaauthor=M.+Konishiauthor=H.+Maedaauthor=Y.+Izumiyaauthor=K.+Kaikitaauthor=H.+Sumidaauthor=H.+Jinnouchiauthor=K.+Matsuiauthor=S.+K.+Mitsuyamaauthor=M.+Takeyaauthor=H.+Ogawa&title=A+dipeptidyl+peptidase-4+inhibitor%2C+des-fluoro-sitagliptin%2C+improves+endothelial+function+and+reduces+atherosclerotic+lesion+formation+in+apolipoprotein+E-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice</span></div><div class="casAuthors">Matsubara, Junichi; Sugiyama, Seigo; Sugamura, Koichi; Nakamura, Taishi; Fujiwara, Yukio; Akiyama, Eiichi; Kurokawa, Hirofumi; Nozaki, Toshimitsu; Ohba, Keisuke; Konishi, Masaaki; Maeda, Hirofumi; Izumiya, Yasuhiro; Kaikita, Koichi; Sumida, Hitoshi; Jinnouchi, Hideaki; Matsui, Kunihiko; Kim-Mitsuyama, Shokei; Takeya, Motohiro; Ogawa, Hisao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">265-276</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Objectives: The aim of this study was to investigate the antiatherogenic effects of the dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin (DFS).  Background: The new class of anti-type 2 diabetes drugs, dipeptidyl peptidase-4 inhibitors, improves glucose metab. by increasing levels of active glucagon-like peptide (GLP)-1.  Methods: Endothelial function was examd. by acetylcholine-induced endothelium-dependent vasorelaxation using aortic rings and atherosclerotic lesion development in the entire aorta in apolipoprotein E-deficient mice fed a high-fat diet with or without DFS, and the antiatherogenic effects of DFS were investigated in cultured human macrophages and endothelial cells.  Plasma levels of active GLP-1 were measured in patients with or without coronary artery disease.  Results: DFS significantly improved endothelial dysfunction (89.9 ± 3.9% vs. 79.2 ± 4.3% relaxation at 10-4 mol/l acetylcholine, p < 0.05) assocd. with increased endothelial nitric oxide synthase phosphorylation and reduced atherosclerotic lesion area (17.7% [15.6% to 25.8%] vs. 24.6% [19.3% to 34.6%], p < 0.01) compared with vehicle treatment.  In cultured human macrophages, DFS significantly increased GLP-1-induced cytosolic levels of cyclic adenosine monophosphate compared with GLP-1 alone, resulted in inhibiting phosphorylation of c-jun N-terminal kinase and extracellular signal-regulated kinase 1/2 and nuclear factor-kappa B p65 nuclear translocation through the cyclic adenosine monophosphate/protein kinase A pathway, and suppressed proinflammatory cytokines (i.e., interleukin-1-beta, interleukin-6, and tumor necrosis factor-alpha) and monocyte chemoattractant protein-1 prodn. in response to lipopolysaccharide.  DFS-enhanced GLP-1 activity sustained endothelial nitric oxide synthase phosphorylation and decreased endothelial senescence and apoptosis compared with GLP-1 alone.  In the human study, fasting levels of active GLP-1 were significantly lower in patients with coronary artery disease than those without (3.10 pmol/l [2.40 to 3.62 pmol/l] vs. 4.00 pmol/l [3.10 to 5.90 pmol/l], p < 0.001).  Conclusions: A DPP-4 inhibitor, DFS, exhibited antiatherogenic effects through augmenting GLP-1 activity in macrophages and endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM0MfaOinbf7Vg90H21EOLACvtfcHk0liZQvKgvZ9l_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFGlsr8%253D&md5=15995db59edd9fbe9e01314e8729a791</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2Fj.jacc.2011.07.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jacc.2011.07.053%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DJ.%26aulast%3DSigiyama%26aufirst%3DS.%26aulast%3DSugamura%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DFijiwara%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DE.%26aulast%3DKurokawa%26aufirst%3DH.%26aulast%3DNozaki%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DK.%26aulast%3DKonishi%26aufirst%3DM.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DIzumiya%26aufirst%3DY.%26aulast%3DKaikita%26aufirst%3DK.%26aulast%3DSumida%26aufirst%3DH.%26aulast%3DJinnouchi%26aufirst%3DH.%26aulast%3DMatsui%26aufirst%3DK.%26aulast%3DMitsuyama%26aufirst%3DS.%2BK.%26aulast%3DTakeya%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DH.%26atitle%3DA%2520dipeptidyl%2520peptidase-4%2520inhibitor%252C%2520des-fluoro-sitagliptin%252C%2520improves%2520endothelial%2520function%2520and%2520reduces%2520atherosclerotic%2520lesion%2520formation%2520in%2520apolipoprotein%2520E-deficient%2520mice%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D2012%26volume%3D59%26spage%3D265%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Marchetti, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Carlo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facchiano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cristofaro, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capogrossi, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germane, A.</span><span> </span><span class="NLM_article-title">High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">236</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=236-244&author=C.+Marchettiauthor=A.+Di+Carloauthor=F.+Facchianoauthor=C.+Senatoreauthor=R.+De+Cristofaroauthor=A.+Luziauthor=M.+Federiciauthor=M.+Romaniauthor=M.+Napolitanoauthor=M.+C.+Capogrossiauthor=A.+Germane&title=High+mobility+group+box+1+is+a+novel+substrate+of+dipeptidyl+peptidase-IV"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DC.%26aulast%3DDi%2BCarlo%26aufirst%3DA.%26aulast%3DFacchiano%26aufirst%3DF.%26aulast%3DSenatore%26aufirst%3DC.%26aulast%3DDe%2BCristofaro%26aufirst%3DR.%26aulast%3DLuzi%26aufirst%3DA.%26aulast%3DFederici%26aufirst%3DM.%26aulast%3DRomani%26aufirst%3DM.%26aulast%3DNapolitano%26aufirst%3DM.%26aulast%3DCapogrossi%26aufirst%3DM.%2BC.%26aulast%3DGermane%26aufirst%3DA.%26atitle%3DHigh%2520mobility%2520group%2520box%25201%2520is%2520a%2520novel%2520substrate%2520of%2520dipeptidyl%2520peptidase-IV%26jtitle%3DDiabetologia%26date%3D2012%26volume%3D55%26spage%3D236%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Matheeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jungrathmayr, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span> </span><span class="NLM_article-title">Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.pharmthera.2012.07.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22850530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2kt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2012&pages=267-282&author=V.+Matheeussenauthor=W.+Jungrathmayrauthor=I.+De+Meester&title=Dipeptidyl+peptidase+4+as+a+therapeutic+target+in+ischemia%2Freperfusion+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl peptidase 4 as a therapeutic target in ischemia/reperfusion injury</span></div><div class="casAuthors">Matheeussen, Veerle; Jungraithmayr, Wolfgang; De Meester, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-282</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Dipeptidyl peptidase 4 (DPP4, DPPIV, CD26, EC 3.4.14.5) was discovered more than four decades ago as a serine protease that cleaves off N-terminal dipeptides from peptide substrates.  The development of potent DPP4 inhibitors during the past two decades has led to the identification of DPP4 as a target in the treatment of type 2 diabetes.  The favorable effect of DPP4 inhibitors is based on prevention of the in vivo inactivation of the incretin hormone, glucagon-like peptide-1 (GLP-1) by DPP4.  Apart from GLP-1, a no. of other biol. active peptides are truncated by DPP4.  For these peptides, the physiol. relevance of their truncation has yet to be fully elucidated.Within the last 10 years, DPP4 inhibitors have been employed in several animal models of lung and heart disease, in which injury was induced by an ischemic insult followed by subsequent reperfusion.  In this review, we present a state-of-the-art of the ischemia/reperfusion injury (IRI)-related pharmacol. actions of DPP4 substrates, including GLP-1, stromal cell-derived factor-1 alpha and vasoactive intestinal peptide.  Furthermore, we discuss the large body of exptl. work that now provides compelling evidence for the advantageous impact of DPP4 targeting in IRI.  However, possible risks as well as underlying mechanisms are yet to be elucidated before translating these promising treatment strategies into clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnZ2zL6HXLI7Vg90H21EOLACvtfcHk0ljTBcpBDeWVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2kt77K&md5=8b8b779e3a9f580f65bf3187d0cffb43</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2012.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2012.07.012%26sid%3Dliteratum%253Aachs%26aulast%3DMatheeussen%26aufirst%3DV.%26aulast%3DJungrathmayr%26aufirst%3DW.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26atitle%3DDipeptidyl%2520peptidase%25204%2520as%2520a%2520therapeutic%2520target%2520in%2520ischemia%252Freperfusion%2520injury%26jtitle%3DPharmacol.%2520Ther.%26date%3D2012%26volume%3D136%26spage%3D267%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Jungraithmayr, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Meester, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheeussen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baerts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weder, W.</span><span> </span><span class="NLM_article-title">CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia–reperfusion injury in mouse lung transplantation</span> <span class="citation_source-journal">Eur. J. Cardio-Thorac. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1093%2Fejcts%2Fezr180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22219460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A280%3ADC%252BC38zpsl2qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2012&pages=1166-1173&author=W.+Jungraithmayrauthor=I.+De+Meesterauthor=V.+Matheeussenauthor=L.+Baertsauthor=S.+Arniauthor=W.+Weder&title=CD26%2FDPP-4+inhibition+recruits+regenerative+stem+cells+via+stromal+cell-derived+factor-1+and+beneficially+influences+ischaemia%E2%80%93reperfusion+injury+in+mouse+lung+transplantation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation</span></div><div class="casAuthors">Jungraithmayr Wolfgang; De Meester Ingrid; Matheeussen Veerle; Baerts Lesley; Arni Stephan; Weder Walter</div><div class="citationInfo"><span class="NLM_cas:title">European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1166-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  The CD26 antigen is a transmembrane glycoprotein that is constitutively expressed on activated lymphocytes and in pulmonary parenchyma.  This molecule is also identified as dipeptidyl peptidase-4 (DPP-4) that cleaves a host of biologically active peptides.  Here, we aimed to identify an important substrate of CD26/DPP-4-stromal cell-derived factor-1 (SDF-1/CXCL12)-as a key modulator for stem-cell homing together with its receptor CXCR4 in response to ischaemic injury of the lung.  METHODS:  Orthotopic single lung transplantation (Tx) was performed between syngeneic C57BL/6 mice.  Inhibition of CD26/DPP-4 activity in recipients was achieved using vildagliptin (10 mg/kg, every 12 h) subcutaneously, and 6 h ischaemia time was applied prior to implantation.  Forty-eight hours after Tx, lung histology, SDF-1 levels (enzyme-linked immunosorbent assay) in lung, spleen and plasma, and expression of the SDF-1 receptor CXCR4 in blood and lung were assessed.  Homing of regenerative progenitor cells to the transplanted lung was evaluated using fluorescent-activated cell sorting.  RESULTS:  Compared with untreated lung transplanted mice, systemic DPP-4 inhibition of Tx recipients resulted in an increase in protein concentration of SDF-1 in plasma, spleen and lung.  Concordantly, the frequency of cells bearing the SDF-1 receptor CXCR4 rose significantly in the circulation and also in the lungs of DPP-4-inhibited recipients.  We found co-expression of CXCR4/CD34 in the grafts of animals treated with vildagliptin, and the stem-cell markers Flt-3 and c-kit were present on a significantly increased number of cells.  The morphology of grafts from DPP-4 inhibitor-treated recipients revealed less alveolar oedema when compared with untreated recipients.  CONCLUSIONS:  Targeting the SDF-1-CXCR4 axis through CD26/DPP-4 inhibition increased the intragraft number of progenitor cells contributing to the recovery from ischaemia-reperfusion lung injury.  Stabilization of endogenous SDF-1 is achievable and may be a promising strategy to intensify sequestration of regenerative stem cells and thus emerges as a novel therapeutic concept.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQb7cGa5w_HNmmbXvSEQle5fW6udTcc2eZUlZfbHeo4irntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zpsl2qsQ%253D%253D&md5=46fb3154b2a11baaee57caf7c94a88aa</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1093%2Fejcts%2Fezr180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fejcts%252Fezr180%26sid%3Dliteratum%253Aachs%26aulast%3DJungraithmayr%26aufirst%3DW.%26aulast%3DDe%2BMeester%26aufirst%3DI.%26aulast%3DMatheeussen%26aufirst%3DV.%26aulast%3DBaerts%26aufirst%3DL.%26aulast%3DArni%26aufirst%3DS.%26aulast%3DWeder%26aufirst%3DW.%26atitle%3DCD26%252FDPP-4%2520inhibition%2520recruits%2520regenerative%2520stem%2520cells%2520via%2520stromal%2520cell-derived%2520factor-1%2520and%2520beneficially%2520influences%2520ischaemia%25E2%2580%2593reperfusion%2520injury%2520in%2520mouse%2520lung%2520transplantation%26jtitle%3DEur.%2520J.%2520Cardio-Thorac.%2520Surg.%26date%3D2012%26volume%3D41%26spage%3D1166%26epage%3D1173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Corbett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunnett, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katona, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kearns, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehoe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passmore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepherd, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C.</span><span> </span><span class="NLM_article-title">Drug repositioning for Alzheimer’s disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=833-846&author=A.+Corbettauthor=J.+Pickettauthor=A.+Burnsauthor=J.+Corcoranauthor=S.+B.+Dunnettauthor=P.+Edisonauthor=J.+J.+Haganauthor=C.+Holmesauthor=E.+Jonesauthor=C.+Katonaauthor=I.+Kearnsauthor=P.+Kehoeauthor=A.+Mudherauthor=A.+Passmoreauthor=N.+Shepherdauthor=F.+Walshauthor=C.+Ballard&title=Drug+repositioning+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorbett%26aufirst%3DA.%26aulast%3DPickett%26aufirst%3DJ.%26aulast%3DBurns%26aufirst%3DA.%26aulast%3DCorcoran%26aufirst%3DJ.%26aulast%3DDunnett%26aufirst%3DS.%2BB.%26aulast%3DEdison%26aufirst%3DP.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DE.%26aulast%3DKatona%26aufirst%3DC.%26aulast%3DKearns%26aufirst%3DI.%26aulast%3DKehoe%26aufirst%3DP.%26aulast%3DMudher%26aufirst%3DA.%26aulast%3DPassmore%26aufirst%3DA.%26aulast%3DShepherd%26aufirst%3DN.%26aulast%3DWalsh%26aufirst%3DF.%26aulast%3DBallard%26aufirst%3DC.%26atitle%3DDrug%2520repositioning%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D833%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, S. Y.</span><span> </span><span class="NLM_article-title">Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">52</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm400658e&amp;key=10.1016%2Fj.nbd.2011.12.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm400658e&amp;key=22245388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm400658e&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1OntbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=52-58&author=D.+H.+Kimauthor=J.+W.+Huhauthor=M.+Jangauthor=J.+H.+Suhauthor=T.+W.+Kimauthor=J.+S.+Parkauthor=S.+Y.+Yoon&title=Sitagliptin+increases+tau+phosphorylation+in+the+hippocampus+of+rats+with+type+2+diabetes+and+in+primary+neuron+cultures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Sitagliptin increases tau phosphorylation in the hippocampus of rats with type 2 diabetes and in primary neuron cultures</span></div><div class="casAuthors">Kim, Dong-Hou; Huh, Jae-Wan; Jang, Mi; Suh, Jung-Hyun; Kim, Tae-Wan; Park, Jeong-Su; Yoon, Seung-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">52-58</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Increasing evidence supports an assocn. between Alzheimer's disease (AD) and diabetes.  In this context, anti-diabetic agents such as rosiglitazone and glucagon-like peptide (GLP)-1 have been reported to reduce pathologies assocd. with AD, including tau hyperphosphorylation, suggesting that such agents might be used to treat AD.  One such anti-diabetic agent is sitagliptin, which acts through inhibition of dipeptidyl peptidase (DPP)-IV to increase GLP-1 levels.  Given this action, sitagliptin would be predicted to reduce AD pathol.  Accordingly, we investigated whether sitagliptin is effective in attenuating AD pathologies, focusing on tau phosphorylation in the OLETF type 2 diabetic rat model.  Unexpectedly, we found that sitagliptin was not effective against pathol. tau phosphorylation in the hippocampus of OLETF type 2 diabetes rats, and instead aggravated it.  This paradoxically increased tau phosphorylation was attributed to activation of the tau kinase, GSK3β (glycogen synthase kinase 3β).  Sitagliptin also increased ser-616 phosphorylation of the insulin receptor substrate (IRS)-1, suggesting increased insulin resistance in the brain.  These phenomena were recapitulated in primary rat cortical neurons treated with sitagliptin, further confirming sitagliptin's effects on AD-related pathologies in neurons.  These results highlight the need for caution in considering the use of sitagliptin in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJhELhSe_Yz7Vg90H21EOLACvtfcHk0lgZ0n5wEml0hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1OntbY%253D&md5=10e96b48cd1a32b56da39e592022619b</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2011.12.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2011.12.043%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DHuh%26aufirst%3DJ.%2BW.%26aulast%3DJang%26aufirst%3DM.%26aulast%3DSuh%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DT.%2BW.%26aulast%3DPark%26aufirst%3DJ.%2BS.%26aulast%3DYoon%26aufirst%3DS.%2BY.%26atitle%3DSitagliptin%2520increases%2520tau%2520phosphorylation%2520in%2520the%2520hippocampus%2520of%2520rats%2520with%2520type%25202%2520diabetes%2520and%2520in%2520primary%2520neuron%2520cultures%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2012%26volume%3D46%26spage%3D52%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400658e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-6%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm400658e" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400658e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799744289bd3db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
